Citrus Sinensis ID: 021249
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.980 | 0.730 | 0.681 | 1e-122 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.965 | 0.666 | 0.594 | 1e-100 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.869 | 0.661 | 0.579 | 5e-90 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.787 | 0.604 | 0.575 | 7e-76 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.819 | 0.523 | 0.526 | 6e-75 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.746 | 0.551 | 0.566 | 3e-74 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.746 | 0.551 | 0.566 | 4e-74 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.730 | 0.469 | 0.574 | 1e-73 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.736 | 0.563 | 0.561 | 4e-73 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.736 | 0.596 | 0.561 | 2e-72 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 437 bits (1123), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/323 (68%), Positives = 253/323 (78%), Gaps = 14/323 (4%)
Query: 1 MGCFRCSGKSNKKLDEEIDNK-NKNL----------NKQADKKQLIADTPRVDSNANLKK 49
MGCF CS KS+K+ + D N+ + +K+ D+ Q +D+ +V ++
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 50 EE-VSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY 108
E V + QLS+DVK LNL D +GK A+ FTF ELA ATGNFRSDC LGEGGFGKV+
Sbjct: 61 EGGVGKEDQLSLDVKGLNLNDQV--TGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVF 118
Query: 109 KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168
KG +EK++QVVAIKQLD GVQG+REF EV+TL ADHPNLVKLIG+CAEGDQRLLVYE
Sbjct: 119 KGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYE 178
Query: 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228
YMP GSL+ HLH L +PLDWNTRMKIAAGA+RGL+YLH+++ PVIYRDLKCSNILL
Sbjct: 179 YMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILL 238
Query: 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 288
E Y PKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL
Sbjct: 239 GEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 298
Query: 289 ELITGRKAIDQTKDRKELNLVAW 311
ELITGRKAID TK RK+ NLV W
Sbjct: 299 ELITGRKAIDNTKTRKDQNLVGW 321
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (933), Expect = e-100, Method: Compositional matrix adjust.
Identities = 185/311 (59%), Positives = 218/311 (70%), Gaps = 7/311 (2%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
MGCF C S+ + +D N KQ+ + +++ + K +N G
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQS--QPTVSNNISGLPSGGEKLSSKTNGGS--- 55
Query: 61 DVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVA 120
+ L L D +A F F ELAAAT NF D LGEGGFG+VYKG L+ QVVA
Sbjct: 56 -KRELLLPRDGLGQ-IAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVA 113
Query: 121 IKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180
+KQLD G+QG REF EV+ L HPNLV LIGYCA+GDQRLLVYE+MPLGSL+ HLH
Sbjct: 114 VKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 173
Query: 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240
DL PD LDWN RMKIAAGA++GL++LH++ PVIYRD K SNILL+EG+HPKLSDFG
Sbjct: 174 DLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFG 233
Query: 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
LAK+GP+GDK+HVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID
Sbjct: 234 LAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSE 293
Query: 301 KDRKELNLVAW 311
E NLVAW
Sbjct: 294 MPHGEQNLVAW 304
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 164/283 (57%), Positives = 206/283 (72%), Gaps = 9/283 (3%)
Query: 38 TPRVDSNANLKKEEVS---NDGQLSMDVKNLNLKDDSNNSGK------SAKPFTFDELAA 88
PR N+ + EV+ N+ + K +N ++ +N+ K +A+ F+F ELA
Sbjct: 15 VPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELAT 74
Query: 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP 148
AT NFR +C +GEGGFG+VYKG LEK +VA+KQLD G+QG +EF EV+ L H
Sbjct: 75 ATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHK 134
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
+LV LIGYCA+GDQRLLVYEYM GSL+ HL DL PD PLDW+TR++IA GA+ GL+YL
Sbjct: 135 HLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYL 194
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H++ PVIYRDLK +NILL+ ++ KLSDFGLAK+GP GDK HVS+RVMGTYGYCAP+Y
Sbjct: 195 HDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEY 254
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
TGQLT KSD+YSFGVVLLELITGR+ ID T+ + E NLV W
Sbjct: 255 QRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTW 297
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 7e-76, Method: Compositional matrix adjust.
Identities = 149/259 (57%), Positives = 178/259 (68%), Gaps = 11/259 (4%)
Query: 61 DVKNLNLKDDSNNSGKSAK--PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQV 118
D +DDS A+ PFT EL T +FR D LGEGGFG VYKG ++ +V
Sbjct: 35 DPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRV 94
Query: 119 ------VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172
VA+K L+ G+QG RE+ EV LG HPNLVKLIGYC E D RLLVYE+M
Sbjct: 95 GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLR 154
Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232
GSL+ HL R T PL W+ RM IA GA++GL +LH ++PVIYRD K SNILL+ Y
Sbjct: 155 GSLENHL--FRKTTAPLSWSRRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDY 211
Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
KLSDFGLAK GP GD+THVSTRVMGTYGY AP+Y MTG LT +SD+YSFGVVLLE++T
Sbjct: 212 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLT 271
Query: 293 GRKAIDQTKDRKELNLVAW 311
GRK++D+T+ KE NLV W
Sbjct: 272 GRKSVDKTRPSKEQNLVDW 290
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 6e-75, Method: Compositional matrix adjust.
Identities = 148/281 (52%), Positives = 187/281 (66%), Gaps = 23/281 (8%)
Query: 51 EVSND---GQLSMDVKNLNLKDDSN--------NSGKSAKPFTFDELAAATGNFRSDCCL 99
E SND GQ+S N + S+ N + FTF++L +T NFR + L
Sbjct: 89 EKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLL 148
Query: 100 GEGGFGKVYKGCLEK---------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
GEGGFG V+KG +E+ VA+K L+ G+QG +E+ AE+ LG+ HPNL
Sbjct: 149 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNL 208
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
VKL+GYC E DQRLLVYE+MP GSL+ HL + PL W+ RMKIA GA++GL +LHE
Sbjct: 209 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHE 265
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+ +PVIYRD K SNILL+ Y+ KLSDFGLAK P KTHVSTRVMGTYGY AP+Y M
Sbjct: 266 EALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVM 325
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
TG LT KSD+YSFGVVLLE++TGR+++D+ + E NLV W
Sbjct: 326 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 140/247 (56%), Positives = 176/247 (71%), Gaps = 12/247 (4%)
Query: 74 SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQL 124
S + K FTF+EL AT NFR D LGEGGFG V+KG ++ VVA+K+L
Sbjct: 64 SSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKL 123
Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP 184
G QG +E+ EV LG HPNLVKL+GYC EG+ RLLVYE+MP GSL+ HL R
Sbjct: 124 KTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRR 181
Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
+PL W RMK+A GA++GL +LH+ Q VIYRD K +NILL+ ++ KLSDFGLAK
Sbjct: 182 GAQPLTWAIRMKVAIGAAKGLTFLHDAKSQ-VIYRDFKAANILLDAEFNSKLSDFGLAKA 240
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
GP+GDKTHVST+VMGT+GY AP+Y TG+LT KSD+YSFGVVLLEL++GR+A+D++K
Sbjct: 241 GPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM 300
Query: 305 ELNLVAW 311
E +LV W
Sbjct: 301 EQSLVDW 307
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 4e-74, Method: Compositional matrix adjust.
Identities = 140/247 (56%), Positives = 174/247 (70%), Gaps = 12/247 (4%)
Query: 74 SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQL 124
S + K FTF+EL AT NFR D LGEGGFG V+KG +++ VVA+KQL
Sbjct: 67 SSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQL 126
Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP 184
G QG +E+ EV LG HPNLV L+GYCAEG+ RLLVYE+MP GSL+ HL R
Sbjct: 127 KPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRR 184
Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
+PL W RMK+A GA++GL +LHE Q VIYRD K +NILL+ ++ KLSDFGLAK
Sbjct: 185 GAQPLTWAIRMKVAVGAAKGLTFLHEAKSQ-VIYRDFKAANILLDADFNAKLSDFGLAKA 243
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
GP+GD THVST+V+GT+GY AP+Y TG+LT KSD+YSFGVVLLELI+GR+A+D +
Sbjct: 244 GPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGN 303
Query: 305 ELNLVAW 311
E +LV W
Sbjct: 304 EYSLVDW 310
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 139/242 (57%), Positives = 173/242 (71%), Gaps = 12/242 (4%)
Query: 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK---------IEQVVAIKQLDHRGV 129
K F+F +L AT NFR + LGEGGFG V+KG +E+ VA+K L+ G+
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 130 QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
QG +E+ AE+ LG+ HPNLVKL+GYC E DQRLLVYE+MP GSL+ HL + PL
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 238
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
W+ RMKIA GA++GL +LHE+ +PVIYRD K SNILL+ Y+ KLSDFGLAK P
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
KTHVSTRVMGTYGY AP+Y MTG LT KSD+YSFGVVLLE++TGR+++D+ + E NLV
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
Query: 310 AW 311
W
Sbjct: 359 EW 360
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 275 bits (702), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 136/242 (56%), Positives = 171/242 (70%), Gaps = 10/242 (4%)
Query: 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK---------IEQVVAIKQLDHRGV 129
K FTF EL AAT NFR D LGEGGFG V+KG +++ V+A+K+L+ G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 130 QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
QG +E+ AEV LG HPNLVKLIGYC E + RLLVYE+MP GSL+ HL +PL
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
W R+K+A GA++GL +LH + VIYRD K SNILL+ Y+ KLSDFGLAK GP+GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
K+HVSTR+MGTYGY AP+Y TG LT KSD+YS+GVVLLE+++GR+A+D+ + E LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 310 AW 311
W
Sbjct: 294 EW 295
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 136/242 (56%), Positives = 170/242 (70%), Gaps = 10/242 (4%)
Query: 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQLDHRGV 129
K F+ EL +AT NFR D +GEGGFG V+KG +++ V+A+K+L+ G
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113
Query: 130 QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
QG RE+ AE+ LG DHPNLVKLIGYC E + RLLVYE+M GSL+ HL +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
WNTR+++A GA+RGL +LH Q VIYRD K SNILL+ Y+ KLSDFGLA+ GP GD
Sbjct: 174 SWNTRVRMALGAARGLAFLHNAQPQ-VIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+HVSTRVMGT GY AP+Y TG L+ KSD+YSFGVVLLEL++GR+AID+ + E NLV
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292
Query: 310 AW 311
W
Sbjct: 293 DW 294
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| 449462095 | 421 | PREDICTED: probable serine/threonine-pro | 0.974 | 0.729 | 0.706 | 1e-128 | |
| 356557471 | 485 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.637 | 0.724 | 1e-126 | |
| 7573596 | 405 | protein kinase 1 [Populus nigra] | 0.987 | 0.767 | 0.718 | 1e-126 | |
| 7573598 | 406 | protein kinase 2 [Populus nigra] | 0.984 | 0.763 | 0.716 | 1e-126 | |
| 224104505 | 382 | predicted protein [Populus trichocarpa] | 0.987 | 0.814 | 0.712 | 1e-125 | |
| 255582077 | 385 | receptor serine-threonine protein kinase | 0.863 | 0.706 | 0.782 | 1e-123 | |
| 297849082 | 422 | kinase family protein [Arabidopsis lyrat | 0.980 | 0.732 | 0.689 | 1e-123 | |
| 356541273 | 581 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.531 | 0.704 | 1e-123 | |
| 356542581 | 415 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.742 | 0.711 | 1e-122 | |
| 356550196 | 475 | PREDICTED: probable serine/threonine-pro | 0.955 | 0.633 | 0.711 | 1e-121 |
| >gi|449462095|ref|XP_004148777.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Cucumis sativus] gi|449531771|ref|XP_004172859.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 229/324 (70%), Positives = 265/324 (81%), Gaps = 17/324 (5%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNL----------NKQADKKQLIADTPRVDSNANLKKE 50
MGCFRC+G S+KK E+I+ K+ N +DK ++I++ + DS+ K
Sbjct: 1 MGCFRCTGSSSKK-SEDIEQKDPNTFNSKTHKPDDRTPSDKAKVISNLVKRDSDV---KV 56
Query: 51 EVSNDGQLSMDVKNLNLKDDSNNSGKS---AKPFTFDELAAATGNFRSDCCLGEGGFGKV 107
VS + QL++DVK LNLK++ + G++ AK FTF+ELAAATGNFRSDC LGEGGFGKV
Sbjct: 57 VVSKNDQLALDVKKLNLKNEVSEEGEANGRAKTFTFEELAAATGNFRSDCFLGEGGFGKV 116
Query: 108 YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167
YKG LEK+ +VVAIKQLD G+QG+REF EV+TL ADHPNLVKLIG+CAEGDQRLLVY
Sbjct: 117 YKGYLEKVNEVVAIKQLDRNGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVY 176
Query: 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227
EYMPLGSL+ HLHDLRP + +DWNTRMKIAAGA+RGL+YLHE++K PVIYRDLKCSNIL
Sbjct: 177 EYMPLGSLENHLHDLRPGAKVIDWNTRMKIAAGAARGLEYLHEKMKPPVIYRDLKCSNIL 236
Query: 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
L EGYHPKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL
Sbjct: 237 LGEGYHPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 296
Query: 288 LELITGRKAIDQTKDRKELNLVAW 311
LELITGRKAID +K E NLVAW
Sbjct: 297 LELITGRKAIDHSKPHSEQNLVAW 320
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557471|ref|XP_003547039.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 458 bits (1178), Expect = e-126, Method: Compositional matrix adjust.
Identities = 229/316 (72%), Positives = 261/316 (82%), Gaps = 7/316 (2%)
Query: 1 MGCFRCSGKSNKKLDEE-IDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVS-NDGQL 58
MGCFRC+GKS+KK + I++ K+ N ++K AD +VD N N K+E+ + QL
Sbjct: 1 MGCFRCTGKSSKKTNNNNINHAEKHTNH--NEKHTAADKVKVDLNVNGKQEDNNPKPDQL 58
Query: 59 SMDVKNLNLKDDSNN---SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
S+DV+NLNLK+ SN + A+ FTF ELAAATGNFRSDC LGEGGFGKVYKG +EKI
Sbjct: 59 SLDVENLNLKEVSNEGKVNSYRAQTFTFAELAAATGNFRSDCFLGEGGFGKVYKGRIEKI 118
Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
QVVAIKQLD G+QG+REF EV+TL ADHPNLVKLIG+CAEG+QRLLVYEYMPLGSL
Sbjct: 119 NQVVAIKQLDPHGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGEQRLLVYEYMPLGSL 178
Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
+ HLHDL +P+DWNTRMKIAAGA+RGL+YLH ++K PVIYRDLKCSNILL EGYH K
Sbjct: 179 ENHLHDLPRGRKPIDWNTRMKIAAGAARGLEYLHNKMKPPVIYRDLKCSNILLGEGYHSK 238
Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE+ITGRK
Sbjct: 239 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEIITGRK 298
Query: 296 AIDQTKDRKELNLVAW 311
AID TK KE NLVAW
Sbjct: 299 AIDNTKPAKEQNLVAW 314
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7573596|dbj|BAA94509.1| protein kinase 1 [Populus nigra] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1174), Expect = e-126, Method: Compositional matrix adjust.
Identities = 227/316 (71%), Positives = 261/316 (82%), Gaps = 5/316 (1%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNAN-LKKEEVSNDGQLS 59
MG CSGK +K+L+ N+N + K+ D+ + + + ++ N L KE S D QLS
Sbjct: 1 MGFLCCSGKPSKRLESSSINENNSNIKRKDQTHVTSGSLKMKPYVNNLSKEGESKDDQLS 60
Query: 60 MDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
+DVK+LN+KD D ++GK A+ FTF+ELAAAT NFRSDC LGEGGFGKVYKG L+KI
Sbjct: 61 LDVKSLNMKDEISKDRRSNGKQAQTFTFEELAAATSNFRSDCFLGEGGFGKVYKGYLDKI 120
Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
Q VAIKQLD GVQG+REF EV+TL ADHPNLVKLIG+CAEGDQRLLVYEYMPLGSL
Sbjct: 121 NQAVAIKQLDRNGVQGIREFVVEVVTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPLGSL 180
Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
+ HLHD+ P+ +PLDWNTRMKIAAGA++GL+YLH ++K PVIYRDLKCSNILL EGYHPK
Sbjct: 181 ENHLHDIPPNRQPLDWNTRMKIAAGAAKGLEYLHNEMKPPVIYRDLKCSNILLGEGYHPK 240
Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK
Sbjct: 241 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 300
Query: 296 AIDQTKDRKELNLVAW 311
AIDQ K+R E NLVAW
Sbjct: 301 AIDQRKERGEQNLVAW 316
|
Source: Populus nigra Species: Populus nigra Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7573598|dbj|BAA94510.1| protein kinase 2 [Populus nigra] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-126, Method: Compositional matrix adjust.
Identities = 227/317 (71%), Positives = 259/317 (81%), Gaps = 7/317 (2%)
Query: 1 MGCFRCSGKSNKKLD-EEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEE-VSNDGQL 58
MG SGKS+K+ + ID N N+ K+ D+ QL + + +V N +EE S D QL
Sbjct: 1 MGFLCFSGKSSKRSENSSIDENNSNI-KRKDQTQLTSGSMKVKPYVNDSREEGASKDDQL 59
Query: 59 SMDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK 114
S+DVK+LNLKD D N+G A+ FTF+EL AAT NFRSDC LGEGGFGKVYKG LEK
Sbjct: 60 SLDVKSLNLKDEISKDIRNNGNPAQTFTFEELVAATDNFRSDCFLGEGGFGKVYKGYLEK 119
Query: 115 IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174
I QVVAIKQLD G+QG+REF EV+TL AD+PNLVKLIG+CAEGDQRLLVYEYMPLGS
Sbjct: 120 INQVVAIKQLDQNGLQGIREFVVEVLTLSLADNPNLVKLIGFCAEGDQRLLVYEYMPLGS 179
Query: 175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234
L+ HLHD+ P+ +PLDWN RMKIAAGA++GL+YLH ++ PVIYRDLKCSNILL EGYHP
Sbjct: 180 LENHLHDIPPNRQPLDWNARMKIAAGAAKGLEYLHNEMAPPVIYRDLKCSNILLGEGYHP 239
Query: 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
KLSDFGLAK+GPSGD THVSTRVMGTYGYCAPDYAMTGQLTFKSD+YSFGVVLLELITGR
Sbjct: 240 KLSDFGLAKVGPSGDHTHVSTRVMGTYGYCAPDYAMTGQLTFKSDVYSFGVVLLELITGR 299
Query: 295 KAIDQTKDRKELNLVAW 311
KAIDQTK+R E NLVAW
Sbjct: 300 KAIDQTKERSEQNLVAW 316
|
Source: Populus nigra Species: Populus nigra Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104505|ref|XP_002313458.1| predicted protein [Populus trichocarpa] gi|222849866|gb|EEE87413.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 453 bits (1165), Expect = e-125, Method: Compositional matrix adjust.
Identities = 225/316 (71%), Positives = 260/316 (82%), Gaps = 5/316 (1%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNAN-LKKEEVSNDGQLS 59
MG CSGK +K+ + N+N + K+ D+ Q+ + + ++ N L KE S D QLS
Sbjct: 1 MGFLCCSGKPSKRSESSSINENNSNIKRKDQTQVTSGSLKMKPYVNNLSKEGGSKDDQLS 60
Query: 60 MDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
+DVK+LN+KD D ++GK A+ FTF+ELAAAT NFRSDC LGEGGFGKVYKG L+KI
Sbjct: 61 LDVKSLNMKDEISKDRRSNGKQAQTFTFEELAAATSNFRSDCFLGEGGFGKVYKGYLDKI 120
Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
Q VAIKQLD GVQG+REF EV+TL ADHPNLVKLIG+CAEGDQRLLVYEYMPLGSL
Sbjct: 121 NQAVAIKQLDRNGVQGIREFVVEVVTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPLGSL 180
Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
+ HLHD+ P+ +PLDWN RMKIAAGA++GL+YLH +++ PVIYRDLKCSNILL EGYHPK
Sbjct: 181 ENHLHDIPPNRQPLDWNARMKIAAGAAKGLEYLHNEMEPPVIYRDLKCSNILLGEGYHPK 240
Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK
Sbjct: 241 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 300
Query: 296 AIDQTKDRKELNLVAW 311
AIDQ K+R E NLVAW
Sbjct: 301 AIDQRKERGEQNLVAW 316
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582077|ref|XP_002531835.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223528531|gb|EEF30555.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1151), Expect = e-123, Method: Compositional matrix adjust.
Identities = 216/276 (78%), Positives = 239/276 (86%), Gaps = 4/276 (1%)
Query: 40 RVDSNANLKKEEVSNDGQLSMDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRS 95
+V +N +KEE S D QLS+DVKNLNL D D+ N+ K A+ FTF+ELAAATGNFR
Sbjct: 5 KVKPYSNAQKEEDSKDDQLSIDVKNLNLTDEVSKDARNNAKRAQTFTFEELAAATGNFRL 64
Query: 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
DC LGEGGFGKVYKG LEKI QVVAIKQLD G+QG REF EV+TL ADHPNLVKLIG
Sbjct: 65 DCFLGEGGFGKVYKGYLEKINQVVAIKQLDPNGLQGTREFVIEVLTLSLADHPNLVKLIG 124
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+CAEGDQRLLVYEYMPLGSL+ HLHDL + +PLDWN RMKIAAGA++GL+YLHE++K P
Sbjct: 125 FCAEGDQRLLVYEYMPLGSLEHHLHDLPSNRQPLDWNNRMKIAAGAAKGLEYLHEKMKPP 184
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
VIYRDLKCSNILL EGYHPKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT
Sbjct: 185 VIYRDLKCSNILLGEGYHPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 244
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
FKSD+YSFGVVLLELITGRKAIDQT+D+ E NLV W
Sbjct: 245 FKSDVYSFGVVLLELITGRKAIDQTRDKNEQNLVGW 280
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297849082|ref|XP_002892422.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297338264|gb|EFH68681.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1148), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/322 (68%), Positives = 254/322 (78%), Gaps = 13/322 (4%)
Query: 1 MGCFRCSGKSNKKLDEEIDNK-NKNL----------NKQADKKQLIADTPRVDSNANLKK 49
MGCF CS KS+K+ + D N+ + +K+ D+ Q +D+ +V ++
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVVKSDKRDDQAQPSSDSTKVSPYRDVNN 60
Query: 50 EEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYK 109
E V + QLS+DVK LNL D +GK A+ FTF ELA ATGNFRSDC LGEGGFGKV+K
Sbjct: 61 EGVGKEDQLSLDVKGLNLNDQV--TGKKAQTFTFQELAVATGNFRSDCFLGEGGFGKVFK 118
Query: 110 GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
G +EK++QVVAIKQLD GVQG+REF EV+TL ADHPNLVKLIG+CAEGDQRLLVYEY
Sbjct: 119 GTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEY 178
Query: 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229
MP GSL+ HLHDL +PLDWNTRMKIAAGA+RGLQYLH+++ PVIYRDLKCSNILL
Sbjct: 179 MPQGSLEDHLHDLPSGKKPLDWNTRMKIAAGAARGLQYLHDRMTPPVIYRDLKCSNILLG 238
Query: 230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 289
E Y PKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE
Sbjct: 239 EDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 298
Query: 290 LITGRKAIDQTKDRKELNLVAW 311
LITGRKAID TK RK+ NLV W
Sbjct: 299 LITGRKAIDNTKTRKDQNLVGW 320
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541273|ref|XP_003539103.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/315 (70%), Positives = 254/315 (80%), Gaps = 6/315 (1%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
MG F C GKS+KK E D ++ K + D+ +VD N KE+ S QL++
Sbjct: 1 MGWFCCQGKSSKKSVAEEDYRDSLDQKPTNFTA--TDSVKVDFKVNGNKEDGSKGDQLAL 58
Query: 61 DVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE 116
DVK+LNLK+ D ++G A+ F+F+EL AATGNFR DC LGEGGFGKVYKG LE+I
Sbjct: 59 DVKSLNLKEEVSQDRKDNGNRAQTFSFNELEAATGNFRVDCFLGEGGFGKVYKGHLERIN 118
Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
QVVAIKQLD G+QG+REF EV+TL ADH NLVKLIG+CAEG+QRLLVYEYMPLGSL+
Sbjct: 119 QVVAIKQLDPNGLQGIREFVVEVLTLSLADHTNLVKLIGFCAEGEQRLLVYEYMPLGSLE 178
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
HL D+RP +PLDWNTRMKIAAGA+RGL+YLH+++K PVIYRDLKCSNILL EGYHPKL
Sbjct: 179 DHLLDIRPGRKPLDWNTRMKIAAGAARGLEYLHDKMKPPVIYRDLKCSNILLGEGYHPKL 238
Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
SDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA
Sbjct: 239 SDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 298
Query: 297 IDQTKDRKELNLVAW 311
ID TK KE NL+AW
Sbjct: 299 IDHTKPAKEQNLIAW 313
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542581|ref|XP_003539745.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1142), Expect = e-122, Method: Compositional matrix adjust.
Identities = 224/315 (71%), Positives = 255/315 (80%), Gaps = 7/315 (2%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
MG F C GKS+KK E + + LN Q D+ +VD N KE+ S QL++
Sbjct: 1 MGWFCCPGKSSKKSVTE--DYSDTLN-QKPINFTATDSVKVDFRVNGNKEDGSKGDQLAL 57
Query: 61 DVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE 116
DVK+LNLK+ D ++G A+ F+F+EL AATG+FR DC LGEGGFGKVYKG LE+I
Sbjct: 58 DVKSLNLKEEASQDRKDNGNRAQTFSFNELEAATGSFRLDCFLGEGGFGKVYKGHLERIN 117
Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
QVVAIKQLD G+QG+REF EV+TL ADHPNLVKLIG+CAEG+QRLLVYEYMPLGSL+
Sbjct: 118 QVVAIKQLDPNGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGEQRLLVYEYMPLGSLE 177
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
HL D+RP +PLDWNTRMKIAAGA+RGL+YLH+++K PVIYRDLKCSNILL EGYHPKL
Sbjct: 178 DHLLDIRPGRKPLDWNTRMKIAAGAARGLEYLHDKMKPPVIYRDLKCSNILLGEGYHPKL 237
Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
SDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA
Sbjct: 238 SDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 297
Query: 297 IDQTKDRKELNLVAW 311
ID TK KE NLVAW
Sbjct: 298 IDHTKPAKEQNLVAW 312
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550196|ref|XP_003543474.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 224/315 (71%), Positives = 255/315 (80%), Gaps = 14/315 (4%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVS-NDGQLS 59
MGCFRC+GKS+KK + N+N +K AD +V+SN N KKE+ + QLS
Sbjct: 1 MGCFRCTGKSSKKTN--------NINHA--EKHTPADKVKVNSNLNGKKEDNNPKPDQLS 50
Query: 60 MDVKNLNLKDDSNN---SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE 116
+DVK LNLK+ SN +G A+ FTF ELAAATGNFR DC LGEGGFGKVYKG ++KI
Sbjct: 51 LDVKYLNLKEVSNEGKVNGYRAQTFTFAELAAATGNFRLDCFLGEGGFGKVYKGRIDKIN 110
Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
QVVAIKQLD G+QG+REF EV+TL ADHPNLVKLIG+CAEG+QRLLVYEYM LGSL+
Sbjct: 111 QVVAIKQLDPHGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGEQRLLVYEYMSLGSLE 170
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
LHDL +P+DWN+RMKIAAGA+RGL+YLH ++K PVIYRDLKCSNILL EGYH KL
Sbjct: 171 NRLHDLPRGRKPIDWNSRMKIAAGAARGLEYLHNKMKPPVIYRDLKCSNILLGEGYHSKL 230
Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
SDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE+ITGRKA
Sbjct: 231 SDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEIITGRKA 290
Query: 297 IDQTKDRKELNLVAW 311
ID TK KE NLV+W
Sbjct: 291 IDNTKPAKEQNLVSW 305
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.980 | 0.728 | 0.650 | 7.2e-107 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.949 | 0.582 | 0.612 | 1.1e-94 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.850 | 0.708 | 0.655 | 4.8e-94 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.965 | 0.666 | 0.594 | 6.3e-92 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.780 | 0.677 | 0.661 | 1.7e-84 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.904 | 0.738 | 0.579 | 5.6e-84 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.758 | 0.428 | 0.639 | 1.5e-83 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.907 | 0.750 | 0.602 | 2.4e-83 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.939 | 0.714 | 0.554 | 3.9e-83 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.780 | 0.645 | 0.651 | 1.2e-79 |
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
Identities = 207/318 (65%), Positives = 245/318 (77%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKN----KNLNKQADKKQLI---ADTPRVDSNANLKKEEVS 53
MGCF + KSNK+ D + N K L A++ +L +D +V ++ KE V+
Sbjct: 1 MGCFGRTPKSNKRSDTKTTKNNDFTPKKLTVNANRDKLTQPSSDCLKVSICGDVSKEIVT 60
Query: 54 NDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE 113
QL++D K+ N++D+ K A+ FTF+EL+ +TGNF+SDC LGEGGFGKVYKG +E
Sbjct: 61 KKDQLALDAKDTNVEDEV--IVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIE 118
Query: 114 KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173
KI QVVAIKQLD G QG+REF EV+TL ADHPNLVKLIG+CAEG QRLLVYEYMPLG
Sbjct: 119 KINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLG 178
Query: 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233
SLD HLHDL PL WNTRMKIAAGA+RGL+YLH+ +K PVIYRDLKCSNIL++EGYH
Sbjct: 179 SLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYH 238
Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
KLSDFGLAK+GP G +THVSTRVMGTYGYCAPDYA+TGQLTFKSD+YSFGVVLLELITG
Sbjct: 239 AKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITG 298
Query: 294 RKAIDQTKDRKELNLVAW 311
RKA D T+ R +LV W
Sbjct: 299 RKAYDNTRTRNHQSLVEW 316
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
Identities = 190/310 (61%), Positives = 222/310 (71%)
Query: 2 GCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMD 61
GC C G S K +K + KK+L A V + ++ ++ S +
Sbjct: 3 GCLPCFGSSAKDA----------ASKDSVKKELSAKDGSVTQSHHISLDK-SKSRRGPEQ 51
Query: 62 VKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAI 121
K L + + +A+ FTF ELAAAT NFR +C LGEGGFG+VYKG LE Q+VA+
Sbjct: 52 KKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAV 111
Query: 122 KQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD 181
KQLD G+QG REF EV+ L HPNLV LIGYCA+GDQRLLVYEYMPLGSL+ HLHD
Sbjct: 112 KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 171
Query: 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
L PD PLDW+TRM IAAGA++GL+YLH++ PVIYRDLK SNILL +GYHPKLSDFGL
Sbjct: 172 LPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGL 231
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301
AK+GP GDKTHVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID +
Sbjct: 232 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNAR 291
Query: 302 DRKELNLVAW 311
E NLVAW
Sbjct: 292 APGEHNLVAW 301
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 179/273 (65%), Positives = 211/273 (77%)
Query: 44 NANLKKEEVSNDGQLSMDVKNL--NLKDDSNNSGKS---AKPFTFDELAAATGNFRSDCC 98
N + K + S+D +S K+ + +S + G A+ FTF ELA AT NFR +C
Sbjct: 19 NGDHKLDRKSSDCSVSTSEKSRAKSSLSESKSKGSDHIVAQTFTFSELATATRNFRKECL 78
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEGGFG+VYKG L Q AIKQLDH G+QG REF EV+ L HPNLV LIGYCA
Sbjct: 79 IGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 138
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+GDQRLLVYEYMPLGSL+ HLHD+ P +PLDWNTRMKIAAGA++GL+YLH++ PVIY
Sbjct: 139 DGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIY 198
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RDLKCSNILL++ Y PKLSDFGLAK+GP GDK+HVSTRVMGTYGYCAP+YAMTGQLT KS
Sbjct: 199 RDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKS 258
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
D+YSFGVVLLE+ITGRKAID ++ E NLVAW
Sbjct: 259 DVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAW 291
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
Identities = 185/311 (59%), Positives = 218/311 (70%)
Query: 1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
MGCF C S+ + +D N KQ+ + +++ + K +N G
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQS--QPTVSNNISGLPSGGEKLSSKTNGGSK-- 56
Query: 61 DVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVA 120
+ L L D +A F F ELAAAT NF D LGEGGFG+VYKG L+ QVVA
Sbjct: 57 --RELLLPRDGLGQ-IAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVA 113
Query: 121 IKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180
+KQLD G+QG REF EV+ L HPNLV LIGYCA+GDQRLLVYE+MPLGSL+ HLH
Sbjct: 114 VKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 173
Query: 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240
DL PD LDWN RMKIAAGA++GL++LH++ PVIYRD K SNILL+EG+HPKLSDFG
Sbjct: 174 DLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFG 233
Query: 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
LAK+GP+GDK+HVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID
Sbjct: 234 LAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSE 293
Query: 301 KDRKELNLVAW 311
E NLVAW
Sbjct: 294 MPHGEQNLVAW 304
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 164/248 (66%), Positives = 189/248 (76%)
Query: 66 NLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD 125
N SNN G A+ FTF ELA AT NFR +C +GEGGFG+VYKG LE QVVA+KQLD
Sbjct: 22 NANGPSNNMG--ARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLD 79
Query: 126 HRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD 185
G+QG REF EV+ L H NLV LIGYCA+GDQRLLVYEYMPLGSL+ HL DL P
Sbjct: 80 RNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPG 139
Query: 186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
+PLDWNTR+KIA GA++G++YLH++ PVIYRDLK SNILL+ Y KLSDFGLAK+G
Sbjct: 140 QKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLG 199
Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
P GD HVS+RVMGTYGYCAP+Y TG LT KSD+YSFGVVLLELI+GR+ ID + E
Sbjct: 200 PVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHE 259
Query: 306 LNLVAWLL 313
NLV W L
Sbjct: 260 QNLVTWAL 267
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 841 (301.1 bits), Expect = 5.6e-84, P = 5.6e-84
Identities = 171/295 (57%), Positives = 211/295 (71%)
Query: 22 NKNLNKQADKKQLIADTPRVDSNANLKK-EEVSNDGQLSMDVKNLNLKDDSNNSGK---S 77
++ N+++ +Q I D +D+ N+ + +S S + + ++ GK S
Sbjct: 12 HRRFNRRSSSRQSIKDC--IDAKNNITTFDNISFKTDSS---RRRYISEEIAKLGKGNIS 66
Query: 78 AKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA 137
A FTF EL AT NF D LGEGGFG+VYKG +E EQVVA+KQLD G QG REF
Sbjct: 67 AHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLV 126
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMK 196
EVM L H NLV L+GYCA+GDQR+LVYEYM GSL+ HL +L R +PLDW+TRMK
Sbjct: 127 EVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMK 186
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
+AAGA+RGL+YLHE PVIYRD K SNILL+E ++PKLSDFGLAK+GP+G +THVSTR
Sbjct: 187 VAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTR 246
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
VMGTYGYCAP+YA+TGQLT KSD+YSFGVV LE+ITGR+ ID TK +E NLV W
Sbjct: 247 VMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTW 301
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 1.5e-83, Sum P(2) = 1.5e-83
Identities = 154/241 (63%), Positives = 188/241 (78%)
Query: 73 NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV 132
+ G S K FTF ELA AT NFR +C LGEGGFG+VYKG L+ QVVA+KQLD G+ G
Sbjct: 44 SEGTSLKIFTFRELATATKNFRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGN 103
Query: 133 REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
+EF AEV++LG DHPNLVKLIGYCA+GDQRLLVY+Y+ GSL HLH+ + D+ P+DW
Sbjct: 104 KEFQAEVLSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSDPMDWT 163
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP-SGDKT 251
TRM+IA A++GL YLH++ PVIYRDLK SNILL++ + PKLSDFGL K+GP +GDK
Sbjct: 164 TRMQIAYAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKM 223
Query: 252 H-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
+S+RVMGTYGY AP+Y G LT KSD+YSFGVVLLELITGR+A+D T+ E NLV+
Sbjct: 224 MALSSRVMGTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVS 283
Query: 311 W 311
W
Sbjct: 284 W 284
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 2.4e-83, P = 2.4e-83
Identities = 174/289 (60%), Positives = 205/289 (70%)
Query: 25 LNKQADKKQLIADTPRVDSNANLKKEEVSND--GQLSMDVKNLNLKDDSNNSGKSAKPFT 82
LN + ++ D R +S +D G S+ +N K +S G A+ FT
Sbjct: 8 LNPRTKDIRVDIDNARCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGGARSFT 67
Query: 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL 142
F ELAAAT NFR LGEGGFG+VYKG L+ QVVAIKQL+ G+QG REF EV+ L
Sbjct: 68 FKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIVEVLML 126
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
HPNLV LIGYC GDQRLLVYEYMP+GSL+ HL DL + PL WNTRMKIA GA+
Sbjct: 127 SLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVGAA 186
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
RG++YLH PVIYRDLK +NILL++ + PKLSDFGLAK+GP GD+THVSTRVMGTYG
Sbjct: 187 RGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGTYG 246
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
YCAP+YAM+G+LT KSDIY FGVVLLELITGRKAID + + E NLV W
Sbjct: 247 YCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTW 295
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
Identities = 173/312 (55%), Positives = 214/312 (68%)
Query: 1 MGCFRCSG-KSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLS 59
M CF C KK+ + DN + N + T R D+N K N ++
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRR-NGEV--------TGR-DNN----KTHPENPKTVN 46
Query: 60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
KN N +D + +A+ F+F ELA AT NFR +C +GEGGFG+VYKG LEK +V
Sbjct: 47 EQNKN-NDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIV 105
Query: 120 AIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL 179
A+KQLD G+QG +EF EV+ L H +LV LIGYCA+GDQRLLVYEYM GSL+ HL
Sbjct: 106 AVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHL 165
Query: 180 HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239
DL PD PLDW+TR++IA GA+ GL+YLH++ PVIYRDLK +NILL+ ++ KLSDF
Sbjct: 166 LDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDF 225
Query: 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299
GLAK+GP GDK HVS+RVMGTYGYCAP+Y TGQLT KSD+YSFGVVLLELITGR+ ID
Sbjct: 226 GLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDT 285
Query: 300 TKDRKELNLVAW 311
T+ + E NLV W
Sbjct: 286 TRPKDEQNLVTW 297
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 161/247 (65%), Positives = 188/247 (76%)
Query: 65 LNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
+N K +S G A+ FTF ELAAAT NFR +G+GGFG VYKG L+ QVVAIKQL
Sbjct: 47 VNGKVNSPKPGGGARSFTFKELAAATKNFREGNIIGKGGFGSVYKGRLDS-GQVVAIKQL 105
Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP 184
+ G QG +EF EV L HPNLV LIGYC G QRLLVYEYMP+GSL+ HL DL P
Sbjct: 106 NPDGHQGNQEFIVEVCMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEP 165
Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
D PL W TRMKIA GA+RG++YLH ++ VIYRDLK +NILL++ + KLSDFGLAK+
Sbjct: 166 DQTPLSWYTRMKIAVGAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKV 225
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
GP G++THVSTRVMGTYGYCAP+YAM+G+LT KSDIYSFGVVLLELI+GRKAID +K
Sbjct: 226 GPVGNRTHVSTRVMGTYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNG 285
Query: 305 ELNLVAW 311
E LVAW
Sbjct: 286 EQYLVAW 292
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 315 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-27 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 7e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-53
Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 99 LGEGGFGKVYKGCLE----KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FG+VYKG L+ K + VA+K L + Q + EF E + DHPN+VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C E + +V EYM G L +L RP L + + A +RG++YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+ I+RDL N L+ E K+SDFGL++ D + AP+ G+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 274 LTFKSDIYSFGVVLLELIT 292
T KSD++SFGV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 6e-53
Identities = 75/199 (37%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 99 LGEGGFGKVYKGCLEKI----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FG+VYKG L+ E VA+K L + Q + EF E + DHPN+VKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C E + ++V EYMP G L +L RP L + + A +RG++YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLES--- 121
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+ I+RDL N L+ E K+SDFGL++ D V + AP+ G+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 274 LTFKSDIYSFGVVLLELIT 292
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-51
Identities = 71/195 (36%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LGEGGFG VY +K + VAIK + + E E+ L +HPN+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ + LV EY GSL L + L + ++I GL+YLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS---NGII 114
Query: 218 YRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD-YAMTGQLT 275
+RDLK NILL + KL+DFGL+K + ++GT Y AP+ G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 276 FKSDIYSFGVVLLEL 290
KSDI+S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-50
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FG+VYKG L E E VA+K L + + EF E + HPN+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C +G+ +V EYMP G L L L +++A ++G++YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+ ++RDL N L+ E K+SDFGL++ D + AP+ G+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 274 LTFKSDIYSFGVVLLELITG 293
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 75/200 (37%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG VYK + ++VA+K L R + + E+ L HPN+V+LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ D LV EY G L +L P L + KIA RGL+YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHSN---G 118
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL- 274
+I+RDLK NILL+E K++DFGLAK + ++T V GT Y AP+ + G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176
Query: 275 TFKSDIYSFGVVLLELITGR 294
K D++S GV+L EL+TG+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-47
Identities = 72/197 (36%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LGEG FGKVY +K ++VAIK + + ++ RE E+ L HPN+V+L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ D+ LV EY G L L + R L+YLH + ++
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQILSALEYLH---SKGIV 119
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDLK NILL+E H KL+DFGLA+ G+K T V GT Y AP+ +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMAPEVLLGKGYGKA 176
Query: 278 SDIYSFGVVLLELITGR 294
DI+S GV+L EL+TG+
Sbjct: 177 VDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-46
Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 99 LGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLI 154
LGEG FG+VYKG L+ VA+K L + ++F E + HPN+V+L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLH 209
G C E + LV EYM G L +L R P+ L + A ++G++YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ ++RDL N L+ E K+SDFGL++ D T + AP+
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
G T KSD++SFGV+L E+ T
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG G FG VY + +++A+K L + + E+ L S HPN+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 155 GYC--AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHE 210
G E + + EY+ GSL L P+ + TR + GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGLAYLHS 119
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+++RD+K +NIL++ KL+DFG AK + + V GT + AP+
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
+ +DI+S G ++E+ TG+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-36
Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 99 LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV + + VA+K L+H G Q +F E+ L + DH N+VK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C + R L+ EY+P GSL +L R ++ + ++ +G+ YL Q
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLGSQ 128
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST--RVMGTYGYCAPDYA 269
I+RDL NIL+E K+SDFGLAK+ P + + Y AP+
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
T + + SD++SFGV L EL T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G+GGFG+VYK ++ + VAIK + + + E+ L HPN+VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ D+ +V E+ GSL L + L + + +GL+YLH +I
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH---SNGII 120
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RD+K +NILL KL DFGL+ + ++GT + AP+ +K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYDYK 177
Query: 278 SDIYSFGVVLLELITGR 294
+DI+S G+ +EL G+
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 19/206 (9%)
Query: 99 LGEGGFGKVYKGC----LEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG VYKG EK++ VAIK L + + +E E + S DHP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
+G C Q L+ + MPLG L ++ + + + L+W +IA +G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLEE 127
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+ +++RDL N+L++ H K++DFGLAK+ +K + + + A + +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRK 295
T KSD++S+GV + EL+T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 99 LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
LGEG FGKVYKG L VAIK L V+ EF E + HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL------------HDLRPDTRPLDWNTRMKIAAG 200
L+G C + +++EY+ G L + L LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ G++YL ++RDL N L+ EG K+SDFGL++ S D V ++ +
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
+ P+ + G+ T +SDI+SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPN 149
+ LG+G G VYK + ++ A+K +D ++ E+ TL S + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPY 60
Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
+VK G + EG+ + V EYM GSL DL + IA +GL YL
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPD 267
H + I+RD+K SN+L+ K++DFG++K + + D+ + T V GT Y +P+
Sbjct: 116 HTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
++ +DI+S G+ LLE G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 71/204 (34%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+G FGKV + ++ A+K L + + + V E L +HP +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 156 YCAEGDQR--LLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
+ A + LV EY P G L HL + R R AA L+YLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARF-YAAEIVLALEYLHSL 112
Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+IYRDLK NILL +G H KL+DFGLAK S + +T GT Y AP+ +
Sbjct: 113 ---GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLL 166
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
D +S GV+L E++TG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
LGEG FGKV+ G +E +VA+K L R+ F E L + H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL--HD--------LRPDTRPLDWNTRMKIAAGAS 202
G C EGD ++V+EYM G L+K L H L + ++IA +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
G+ YL Q ++RDL N L+ K+ DFG+++ + D V M
Sbjct: 133 SGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ P+ M + T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 74/215 (34%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
++R LGEG FG+VY + ++VA+K L + + V F E+ L S +HP
Sbjct: 1 SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 149 -NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
N+VKL + + LV EY+ GSL+ L PL + + I A L+Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEY 116
Query: 208 LHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKM----GPSGDKTHVSTRVMGTYG 262
LH + +I+RD+K NILL +G KL DFGLAK+ G + + + +GT G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 263 YCAPDYAM---TGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + + SDI+S G+ L EL+TG
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
+G G FG VYKG + VAIKQ+ + + ++ E+ L + HPN+VK I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G D ++ EY GSL + + P + +GL YLHEQ
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ--- 118
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
VI+RD+K +NIL + KL+DFG+A K+ V+GT + AP+
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMSG 175
Query: 274 LTFKSDIYSFGVVLLELITGR 294
+ SDI+S G ++EL+TG
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 8/194 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V++G L K VAIK L + ++F EV L H +L+ L C+
Sbjct: 14 LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
G+ ++ E M GSL L P+ + L + + +A + G+ YL E Q I+
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QNSIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RDL NIL+ E K++DFGLA++ ++ Y + AP+ A G + KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 279 DIYSFGVVLLELIT 292
D++SFG++L E+ T
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V+ G +V A+K L G F E + H LV+L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
E + +V EYM GSL L + + L + +AA + G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFK 277
RDL NIL+ E K++DFGLA++ + T + + AP+ A G+ T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 278 SDIYSFGVVLLELIT-GR 294
SD++SFG++L E++T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 99 LGEGGFGKVYKGCLEKIE--QVVAIKQLD-HRGVQGVREFS-AEVMTLGSADHPNLVKLI 154
+G+G FGKVY + + ++ +K++D + RE + EV L +HPN++K
Sbjct: 8 IGKGSFGKVYL--VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
E + +V EY G L + + + + +P + L+YLH +
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD------Y 268
+++RD+K NI L KL DFG++K+ S T V GT Y +P+ Y
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPY 180
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKA 296
+KSDI+S G VL EL T +
Sbjct: 181 ------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 74/205 (36%), Positives = 107/205 (52%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG+G FG V + ++ +VVA+K+L H + +R+F E+ L S H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
G C +R LV EY+P GSL +L H R D R L + A+ +G++YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYLGS 126
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPD 267
+ ++RDL NIL+E K+ DFGL K+ P DK + R G + Y AP+
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ + SD++SFGVVL EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 18/202 (8%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG V+KG + I+ VAIK + R G Q +E + ++ +GS DH +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
+G C G LV + PLGSL H+ R P L+W ++ ++G+ YL E
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLEE 127
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+++R+L NILL+ +++DFG+A + DK + + + A + +
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
G+ T +SD++S+GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+G+G FG V G Q VA+K L D + F AE + + HPNLV+L+G
Sbjct: 13 TIGKGEFGDVMLGDYRG--QKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQP 215
+G+ +V EYM GSL + LR R + ++ A G++YL E +
Sbjct: 69 VLQGNPLYIVTEYMAKGSL---VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KN 122
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
++RDL N+L+ E K+SDFGLAK + S ++ + AP+ + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFS 177
Query: 276 FKSDIYSFGVVLLELIT-GR 294
KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 67/210 (31%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 99 LGEGGFGKVYKG-CL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV+ C E+ + +VA+K L ++F E L H ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
G C EG L+V+EYM G L++ L PD + L + IA+ +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
G+ YL ++RDL N L+ +G K+ DFG+++ S D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ P+ + + T +SDI+SFGVVL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-25
Identities = 69/208 (33%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 99 LGEGGFGKV-----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV Y C E+ + +VA+K L ++F E L + H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---------RPLDWNTRMKIAAGASRG 204
G C EGD ++V+EYM G L+K L PD L + + IA + G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
+ YL Q ++RDL N L+ E K+ DFG+++ S D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
P+ M + T +SD++S GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQG---VREFSAEVMTLGSADHPNLVKL 153
LG G FG VY+G A+K+ L G G V++ E+ L HPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G E D + E +P GSL K L P+ +I G L+YLH++
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR-- 121
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-----GTYGYCAPDY 268
++RD+K +NIL++ KL+DFG+AK V G+ + AP+
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEV 172
Query: 269 AM-TGQLTFKSDIYSFGVVLLELITGR 294
G +DI+S G +LE+ TG+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQG-VREFSAEVMTLGSA 145
N LGEG FGKV K +++ VA+K L +R+ +E L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--------------------PD 185
+HP+++KL G C++ LL+ EY GSL L + R PD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
R L + A SRG+QYL E +++RDL N+L+ EG K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
D ++ + A + T +SD++SFGV+L E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 99 LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGV--REFSAEVMTLGSADHPNLVKL 153
+G G FG+V +G L+ K E VAIK L G +F E +G DHPN+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G + +++ EYM GSLDK LR + + + G + G++YL E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKF---LRENDGKFTVGQLVGMLRGIASGMKYLSE--- 124
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPD 267
++RDL NIL+ K+SDFGL++ + T+ T G + AP+
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPE 178
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ T SD++SFG+V+ E+++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG VYKG L K VA+K ++ F E L DHPN+VKLIG C
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ +V E +P GSL L LR L ++++ A+ G++YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCI 115
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL N L+ E K+SDFG+++ G T + AP+ G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 278 SDIYSFGVVLLELITG 293
SD++S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
F LGEG +G VYK ++ QVVAIK + ++E E+ L D P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAA---GASRGLQYL 208
G + +V EY GS+ D+ T + L T +IAA +GL+YL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTL---TEEEIAAILYQTLKGLEYL 115
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPD 267
H K I+RD+K NILL E KL+DFG++ ++ + K + V+GT + AP+
Sbjct: 116 HSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPE 169
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
K+DI+S G+ +E+ G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
LG+G FG VY+G + + E VAIK ++ R EF E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
L+G + G L+V E M G L +L RP+ P +++AA + G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
YL K ++RDL N ++ E K+ DFG+ + D + + + AP
Sbjct: 134 YLAA-KK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ G T KSD++SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-24
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 99 LGEGGFGKVYKGCLEKI------EQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNL 150
LG G FG+VY+G I VA+K L +G Q +EF E + + +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQY 207
VKL+G C + + ++ E M G L +L D R + L + I ++G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 208 LHEQLKQPVIYRDLKCSNILL-EEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
L EQ+ I+RDL N L+ E+GY K+ DFGLA+ D +
Sbjct: 122 L-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ + G+ T +SD++SFGV++ E++T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-24
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 99 LGEGGFGKVYK----GCLEKIEQ-VVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
+G+G FG+V++ G L +VA+K L + +F E + DHPN+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP----------------DTRPLDWNT--R 194
L+G CA G L++EYM G L++ L P PL + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
+ IA + G+ YL E + ++RDL N L+ E K++DFGL++ S D S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ P+ + T +SD++++GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-24
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 99 LGEGGFGKV-----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV Y K + +VA+K L + ++F E L + H ++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTR------MKIAAGA 201
G C +GD ++V+EYM G L+K L PD +P + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
+ G+ YL Q ++RDL N L+ K+ DFG+++ S D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ P+ M + T +SD++SFGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-24
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V++G L VA+K L G ++F AE + HP L++L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ +V E M GSL ++L R L + +AA + G+ YL Q I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFK 277
RDL N+L+ E K++DFGLA++ + + AP+ A+ + + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184
Query: 278 SDIYSFGVVLLELIT-GR 294
SD++SFG++L E++T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-24
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 10/212 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSA-EVMTLGSADHPNLVKLIGY 156
LG+G +G VYK Q A+K++D + Q RE + E+ L S +HPN++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+G++ +V EY P G L K + + + + +I RGLQ LHEQ +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RDLK +NILL K+ D G++K+ K +++ +GT Y AP+ ++
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308
KSDI+S G +L E+ T + + ++L
Sbjct: 181 KSDIWSLGCLLYEMATFAPPF-EARSMQDLRY 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-24
Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVK 152
LG G G V K +++A+K + + Q +RE L + P +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELD----ILHKCNSPYIVG 63
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGASRGLQYLHE 210
G + EYM GSLDK L +++ R L KIA +GL YLHE
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ K +I+RD+K SNIL+ KL DFG++ ++ S KT V GT Y AP+
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
+ KSDI+S G+ L+EL TGR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 9e-24
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 99 LGEGGFGKVYKGC-LEKIEQV--VAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG G FG V KG L K + VA+K L G +EF E + DHP +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
G C +G+ +LV E PLG L K+L R P + + ++ + G+ YL +
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESK- 114
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
++RDL N+LL + K+SDFG+++ +G D +T + AP+
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
G+ + KSD++S+GV L E +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKG----CLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKL 153
LG+G FG V +G K+ V A+K L + + +F E + S DH NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD--WNTRMKIAAGASRGLQYLHEQ 211
G ++V E PLGSL L + + ++IA G ++YL +
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---RVMGTYGYCAPDY 268
I+RDL NILL K+ DFGL + P + +V +V + +CAP+
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
T + SD++ FGV L E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-23
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGE FGK+YKG L Q+VAIK L D Q EF E + HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-------------RPLDWNTRMKIAAG 200
+G + +++EY+ G L + L P + LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ G++YL +++DL NIL+ E H K+SD GL++ S D V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ P+ M G+ + SDI+SFGVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 99 LGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV C + ++VA+K L G Q + E+ L + H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C+E + L+ EY+PLGSL +L P + L+ + A G+ YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHK-LNLAQLLLFAQQICEGMAYLHSQ 126
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAM 270
I+RDL N+LL+ K+ DFGLAK P G + + V + A +
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
+ ++ SD++SFGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI-GYC 157
LG+G FGKVYK ++ A K + + + +F E+ L HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
E +L+ E+ G+LD + +L R L + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-- 275
+RDLK NILL KL+DFG++ S + + +GT + AP+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 276 ---FKSDIYSFGVVLLELITGR 294
+K+DI+S G+ L+EL
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-23
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
+G+G FG V+K + ++V A+KQ+D + A E L D +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ + +V EY G L K L R RPL + + GL +LH + +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH---SKKI 122
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RD+K N+ L+ + K+ D G+AK+ D T+ + ++GT Y +P+
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 277 KSDIYSFGVVLLELITGRKAID 298
KSD+++ GVVL E TG+ D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-23
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G +G+VY+G +K VA+K L ++ V EF E + HPNLV+L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
++ E+M G+L +L + + + ++ + +A S ++YL K+ I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM-------GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
RDL N L+ E + K++DFGL+++ +G K + + AP+
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
+ + KSD+++FGV+L E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 6e-23
Identities = 73/207 (35%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 97 CCLGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLI 154
+G G VY CL E VAIK++D Q V E EV + +HPN+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNE-KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GASRGLQYLHEQ 211
GD+ LV Y+ GS L D+ + P IA +GL+YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-- 119
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTH-VSTRVMGTYGYCAPDYA 269
I+RD+K NILL E K++DFG+ A + GD+T V +GT + AP+
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-V 177
Query: 270 MTGQ--LTFKSDIYSFGVVLLELITGR 294
M FK+DI+SFG+ +EL TG
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD------HRGVQGV-REFSAEVMTLGSADHPNLV 151
+GEG F V ++ + AIK LD + V+ V E EV+T HP ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE--KEVLTR-LNGHPGII 65
Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
KL Y + ++ L V EY P G L +++ LD AA L+YLH
Sbjct: 66 KLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLH- 119
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM------------ 258
+ +I+RDLK NILL++ H K++DFG AK+ +
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 259 ------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
GT Y +P+ SD+++ G ++ +++TG+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-22
Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG VYKG E ++ VAIK L+ G + EF E + + S DHP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
+G C +L V + MP G L ++H+ + + L+W ++ ++G+ YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+ +++RDL N+L++ H K++DFGLA++ +K + + + A +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304
+ T +SD++S+GV + EL+T G K D R+
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQG-----VREFSAEVMTLGSADHPNLVK 152
+GEG +G+VYK +K ++VA+K++ +G +R E+ L HPN+V+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62
Query: 153 LIGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR------- 203
L + +V+EYM HDL T LD + +K +
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMD--------HDL---TGLLD-SPEVKFTESQIKCYMKQLL 110
Query: 204 -GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
GLQYLH +++RD+K SNIL+ KL+DFGLA+ + + T + T
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLW 166
Query: 263 YCAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
Y P+ + + + D++S G +L EL G+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 67/200 (33%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
C+G+G FG+VYK ++ QVVAIK +D + + E+ L P + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+G + ++ EY GS L L+P LD I GL+YLHE+ K
Sbjct: 68 FLKGSKLWIIMEYCGGGSC---LDLLKP--GKLDETYIAFILREVLLGLEYLHEEGK--- 119
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ 273
I+RD+K +NILL E KL+DFG+ SG T ++ +GT + AP+
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV-----SGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 274 LTFKSDIYSFGVVLLELITG 293
K+DI+S G+ +EL G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-21
Identities = 65/196 (33%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG+VYKG + ++VVAIK +D + + + E+ L D P + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+G + ++ EY+ GS L L+P PL+ I +GL YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSA---LDLLKPG--PLEETYIATILREILKGLDYLHSERK---I 123
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RD+K +N+LL E KL+DFG+A G D +GT + AP+ FK
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 278 SDIYSFGVVLLELITG 293
+DI+S G+ +EL G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-21
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQG--VREFSAEVMTLGSADHPNLV 151
LGEG +G VYK +K ++VA+K++ + G+ +RE S L HPN+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
KL+ + LV+EY + L K+L PL N I RGL Y H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+++RDLK NIL+ KL+DFGLA+ +T+ + V+ T Y AP+ +
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILL- 171
Query: 272 GQLTFKS--DIYSFGVVLLELITGR 294
G + + DI+S G + E+ITG+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-21
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V+ G VAIK L +G F AE + HP LV+L
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ + ++ EYM GSL L P+ L N + +AA + G+ ++ + I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIH 125
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
RDL+ +NIL+ E K++DFGLA++ + T R + + AP+ G T
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTI 182
Query: 277 KSDIYSFGVVLLELIT-GR 294
KSD++SFG++L E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-21
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G+G FG VY G L + + A+K L+ ++ V +F E + + HPN++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 155 GYC--AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQYL 208
G C +EG L+V YM G L + +R +T N +K G ++G++YL
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDL---RNFIRSETH----NPTVKDLIGFGLQVAKGMEYL 114
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAP 266
+ ++RDL N +L+E + K++DFGLA+ H T + A
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ T + T KSD++SFGV+L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-21
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQV---VAIK--QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FG V +G L + + VA+K +LD + EF +E + DHPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGL 205
IG C E +++ +M G L L R P + K + G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD---KTHVSTRVMGTYG 262
+YL + I+RDL N +L E ++DFGL+K SGD + ++ +
Sbjct: 127 EYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ A + T KSD+++FGV + E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-21
Identities = 64/201 (31%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G +G VYK ++VAIK + E+ L HPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA---AGASRGLQYLHEQLKQP 215
D+ +V EY GSL R PL + ++IA +GL YLHE K
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR---GPL---SELQIAYVCRETLKGLAYLHETGK-- 122
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYA--- 269
I+RD+K +NILL E KL+DFG+ S T + +GT + AP+ A
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGV-----SAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 270 MTGQLTFKSDIYSFGVVLLEL 290
G K DI++ G+ +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEG G+VYK + VAIK++ R Q E++ + HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN-TRMK---IAAGAS---RGLQYLHEQ 211
GD+ +V EYM GSL T + N RM IA +GL+YLH
Sbjct: 86 VGDELWVVMEYMDGGSL----------TDIITQNFVRMNEPQIAYVCREVLQGLEYLH-- 133
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
Q VI+RD+K NILL + KL+DFG A S V+GT + AP+
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKR 190
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
K DI+S G++ +E+ G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIGYCA 158
G +G+V+ + + AIK + + + E L A P +VKL Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+G + L LV EY+P G L L ++ LD + A L+YLH +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS------TRVMGTYGYCAPDYAMT 271
+RDLK NIL++ H KL+DFGL+K+G + +++ R++GT Y AP+ +
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
+ D +S G +L E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 99 LGEGGFGKVYKG-----CLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
LG G FG+V+ E E +V +K L + ++ EF E+ H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL-----HDLRPDTRPLDWNTRMKIAAGASRGLQY 207
L+G C E + ++ EY LG L + L D + PL ++ + + G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
L ++RDL N L+ K+S L+K + + + ++ + AP+
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ KSD++SFGV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 99 LGEGGFGKVYK------GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
+G G FGKVY G L ++++ I+ D + ++ + + E+ L HPNLVK
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIAD---EMKVLELLKHPNLVK 63
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
G ++ + EY G+L++ L R LD + GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV---MGTYGYCAPDYA 269
+++RD+K +NI L+ KL DFG A + T + V GT Y AP+
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEVI 175
Query: 270 MTGQLTFK---SDIYSFGVVLLELITGRK 295
G+ +DI+S G V+LE+ TG++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 99 LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVK 152
LG G FG+VY+G + +E VA+K L Q +F E + + +H N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR---PLDWNTRMKIAAGASRGLQYLH 209
LIG E R ++ E M G L L + RP L + A ++G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
E I+RD+ N LL G K++DFG+A+ R M + P
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 267 DYAMTGQLTFKSDIYSFGVVLLEL 290
+ + G T K+D++SFGV+L E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+GGFG+V ++ ++ A K+LD + + +G + E L +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
Y E L LV M G L H++++ + AA GL++LH++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR-- 115
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
++YRDLK N+LL++ + ++SD GLA G K GT GY AP+
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
F D ++ G L E+I GR Q K++ E
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 71/211 (33%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSAD 146
FR LG G FGKV +K ++ AIK L V+ + T S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 147 HPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRG 204
HP LV L C + + + V EY G L H+H R AA G
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLG 113
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYG 262
LQYLHE ++YRDLK N+LL+ K++DFGL K MG GD+T ST GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPE 166
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
+ AP+ T D + GV++ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-20
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG+V+KG + ++VVAIK +D + + + E+ L D P + K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ + ++ EY+ GS L L P PLD I +GL YLH + K I
Sbjct: 72 LKDTKLWIIMEYLGGGSA---LDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 123
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RD+K +N+LL E KL+DFG+A G D +GT + AP+ K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+DI+S G+ +EL G + K L L+
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 100 GEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGY 156
G+G FGKV +++ A+K ++ + VR E L +HP LV L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ + LV + + G L HL + + I L+YLH + +
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEIVL-ALEYLHSKG---I 121
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
I+RD+K NILL+E H ++DF +A T T GT GY AP+ +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSV 178
Query: 277 KSDIYSFGVVLLELITGRK 295
D +S GV E + G++
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-20
Identities = 71/205 (34%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
LG GGFG+V ++ + A+K + R + + FS E L +HP +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKL- 58
Query: 155 GYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHE 210
Y D++ + + EY G L L D R L ++ R A +YLH
Sbjct: 59 -YRTFKDKKYIYMLMEYCLGGELWTILRD-----RGLFDEYTARF-YIACVVLAFEYLHN 111
Query: 211 QLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ +IYRDLK N+LL GY KL DFG AK SG KT GT Y AP+
Sbjct: 112 R---GIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEII 164
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
+ F D +S G++L EL+TGR
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-20
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 99 LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLI 154
+G G FG+V++G L+ + E VAIK L + R +F +E +G H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G + +++ EYM G+LDK+L D + ++ G + G++YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD---M 126
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
++RDL NIL+ K+SDFGL+++ P G T ++ + AP+
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAY 184
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
+ T SD++SFG+V+ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-20
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V+ G +V A+K L G F E + H LV+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
E + +V EYM GSL L D + R L + +AA + G+ Y+ + I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
RDL+ +NIL+ +G K++DFGLA++ + T R + + AP+ A+ G+ T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI 182
Query: 277 KSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
KSD++SFG++L EL+T GR +R+ L V
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG+V+KG + +QVVAIK +D + + + E+ L D P + K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+G + ++ EY+ GS L LR P D + +GL YLH + K I
Sbjct: 72 LKGTKLWIIMEYLGGGSA---LDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RD+K +N+LL E KL+DFG+A G D +GT + AP+ K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 278 SDIYSFGVVLLELITG 293
+DI+S G+ +EL G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REFSAEVMTLGSADHPNLVKLIG-Y 156
LGEG G V K L+ + A+K + + ++ E+ S P +VK G +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 157 CAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
E + + EY GSLD ++ + KIA +GL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---K 125
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
+I+RD+K SNILL KL DFG++ ++ S T GT Y AP+
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKPY 180
Query: 275 TFKSDIYSFGVVLLELITGR 294
+ SD++S G+ LLE+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GVQGVREFSA--EVMTLGSADHPNLVK 152
LGEG + VYK ++ ++VAIK+ L R G+ F+A E+ L HPN++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI-NFTALREIKLLQELKHPNIIG 66
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L+ LV+E+M L+K + D P D + M + RGL+YLH
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLHSNW 122
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-T 271
+++RDLK +N+L+ KL+DFGLA+ S ++ +V+ T Y AP+
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAPELLFGA 177
Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
D++S G + EL+
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-19
Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
LG+G FG+V+KG L+ + VA+K Q ++ +F +E L DHPN+VKLIG C
Sbjct: 3 LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
QR +Y M L L LR L +K A A+ G+ YL + I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL N L+ E K+SDFG+++ G + + + + AP+ G+ + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174
Query: 278 SDIYSFGVVLLE 289
SD++S+G++L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 19/215 (8%)
Query: 93 FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADH 147
F+ LG G FG VYKG EK++ VAIK+L + + +E E + S D+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRG 204
P++ +L+G C +L + + MP G L ++ + + + L+W ++ ++G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
+ YL E+ +++RDL N+L++ H K++DFGLAK+ + +K + + +
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
A + + T +SD++S+GV + EL+T G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-19
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG+G FGKVYK ++ + A K +D + + + ++ E+ L S DHPN+VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGAS-RGLQYLHEQLKQPV 216
+ ++ E+ G++D + +L RP T P ++++ + L YLHE +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTLEALNYLHE---NKI 124
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ 273
I+RDLK NIL KL+DFG+ S T R +GT + AP+ M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 274 -----LTFKSDIYSFGVVLLEL 290
+K+D++S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIG 155
+G G FG V+ C K +Q +V IKQ+ + +A E L HPN+++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHD----LRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
E ++V EY P G+L +++ L + L + ++ +A L ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTK 120
Query: 212 LKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
L +++RDLK NILL++ K+ DFG++K+ K+ T V+GT Y +P+
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAID 298
KSDI++ G VL EL + ++A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 13/215 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
+GEG G V+K + + VA+K++ R ++G A E+ L + HP +VKL+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
G +LV EYMP L + L D RPL +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH---ANGI 120
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RDLK +N+L+ K++DFGLA++ + S +V T Y AP+ + G +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGARKY 178
Query: 277 KS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
D+++ G + EL+ G D ++L +V
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
LG+G FG VY+G + + E VAIK ++ R EF E + + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
L+G ++G L++ E M G L +L LRP+ P +++A + G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
YL+ ++RDL N ++ E + K+ DFG+ + D + + + +P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ G T SD++SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
+GEG +G VYK + ++VAIK++ R +A E+ L +HPN++KL+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 157 CAEGDQRLLVYEYMPLGSLDKHL-HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV+E+M D L ++ R L + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTRVMGTYGYCAPDYAMT- 271
+++RDLK N+L+ KL+DFGLA+ P TH V TR Y AP+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGD 173
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ DI+S G + EL++ R + +L +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-19
Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIG-- 155
+GEG +GKVYK +K Q+VAIK +D + E E L ++HPN+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGAF 72
Query: 156 ----YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
DQ LV E GS+ + LR + L I RGL YLHE
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP---- 266
VI+RD+K NILL + KL DFG+ A++ + + + GT + AP
Sbjct: 133 K---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEVIA 186
Query: 267 -DYAMTGQLTFKSDIYSFGVVLLELITG 293
D +SD++S G+ +EL G
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 42/220 (19%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLI 154
+G+G FG V K + +++ K++D+ + +E +EV L HPN+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYY 65
Query: 155 G---------------YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
YC GD L L + + + + ++ +I
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGD----------LAQLIQKC---KKERKYIEEEFIWRILT 112
Query: 200 GASRGLQYLH--EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD---KTHVS 254
L H V++RDLK +NI L+ + KL DFGLAK+ KT+V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
GT Y +P+ KSDI+S G ++ EL
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 71/246 (28%), Positives = 114/246 (46%), Gaps = 32/246 (13%)
Query: 63 KNLNLKDDSNNSG---------KSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE 113
NL LK N G K +K T +++ ++ + + + G G YKG
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSI 712
Query: 114 KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172
K +K++ D + S+E+ +G HPN+VKLIG C L++EY+
Sbjct: 713 KNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232
+L + L R L W R KIA G ++ L++LH + V+ +L I+++
Sbjct: 768 KNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820
Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
P L L + + K +S+ Y AP+ T +T KSDIY FG++L+EL+T
Sbjct: 821 EPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLT 873
Query: 293 GRKAID 298
G+ D
Sbjct: 874 GKSPAD 879
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 85 ELAAATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVRE-FSAE 138
E+ +T F + LGE FGKVYKG L + Q VAIK L + +RE F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMK 196
M HPN+V L+G + +++ Y L + L P D D + +K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 197 ----------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
I + G+++L V+++DL N+L+ + + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ D + + + +P+ M G+ + SDI+S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 99 LGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G FG V+ G KI+ VAIK + G +F E + HPNLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKID--VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ +V EYM G L L+ LR L + + + ++YL I
Sbjct: 69 TKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFI 122
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQL 274
+RDL N L+ E K+SDFGLA+ D + S+ GT + P+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRF 178
Query: 275 TFKSDIYSFGVVLLELITGRK 295
+ KSD++SFGV++ E+ + K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 96 DCCLGEGGFGKVYKGCLEKIE-----QVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHP 148
LGEG FG+V K ++ VA+K L D + + + +E+ + H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------DTRPLDWNTRMK---- 196
N++ L+G C + +V EY G+L L RP D RP + K
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
A +RG+++L + I+RDL N+L+ E + K++DFGLA+ D +T
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFGV+L E+ T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 11/195 (5%)
Query: 99 LGEGGFGKVYKGC-LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G G FG V+ G LEK + VAIK + G +F E + HP LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRK--VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
E LV+E+M G L + LR T + + G+ YL VI
Sbjct: 69 TERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVI 122
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL N L+ E K+SDFG+ + D+ ST + +P+ + + K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 278 SDIYSFGVVLLELIT 292
SD++SFGV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 99 LGEGGFGKVY----KGCLEKIEQ----------VVAIKQLDHRGVQGVR-EFSAEVMTLG 143
LGEG FG+V+ +G E + + +VA+K L + R +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--------PLDWNTRM 195
+PN+++L+G C D ++ EYM G L++ L ++ + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
+A + G++YL ++RDL N L+ Y K++DFG+++ SGD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
R + + A + + G+ T SD+++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGV----REFSAEVMTLGSADHPNLVK 152
LG+G +G VY G L Q++A+KQ LD V + EV L S H N+V+
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+G C + + + E++P GS+ L+ P P+ +I G + YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----MGPSGDKTHVSTRVMGTYGYCAPDY 268
V++RD+K +N++L KL DFG A+ +G G +++ + GT + AP+
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
KSDI+S G + E+ TG+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSA-DHPNLVKL 153
LG+G FGKV L+ +++ A+K L + V + MT L A HP L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
C + RL V EY+ G L H+ D AA GLQ+LHE+
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER- 115
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+IYRDLK N+LL+ H K++DFG+ K G G T ++ GT Y AP+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQ 171
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
D ++ GV+L E++ G+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 99 LGEGGFGKV----YKG--------CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
LG G FG+V +KG L K ++V +KQ++H E L S
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEH--------VLNEKRILQSIR 59
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
HP LV L G + LV EY+P G L HL R R AA L+
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGR-FPEPVARFYAAQVVLALE 115
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
YLH ++YRDLK N+LL+ + K++DFG AK V R GT Y
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEY 164
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
AP+ ++ D ++ G+++ E++ G
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VY+ ++VA+K++ D + +RE + L + HPN+V+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70
Query: 153 LIGYCAEGDQR---LLVYEY--MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
L G LV EY L SL L P + + RGLQY
Sbjct: 71 LK-EVVVGKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
LHE +I+RDLK SN+LL + K++DFGLA+ G T + T Y AP+
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKVVTLWYRAPE 178
Query: 268 --YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
T T D+++ G +L EL+ + + + ++L+L+ LL
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-18
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 99 LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
+GEG FG+V K ++K + AIK++ ++ R+F+ E+ L HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
G C L EY P G+L L R +T P L + AA +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
RG+ YL ++ I+RDL NIL+ E Y K++DFGL++ G + +V + MG
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 174
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ A + T SD++S+GV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-18
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 99 LGEGGFGKVYKGCLE--KIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG G FG V KG + K E+ VA+K L D+ E E + D+P +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G C E + +LV E LG L+K L + T ++ S G++YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE----KNITELVHQVSMGMKYLEET--- 114
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
++RDL N+LL ++ K+SDFGL+K D+ + + G + + AP+
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 273 QLTFKSDIYSFGVVLLE 289
+ + KSD++SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
+G G FG VY + +VVAIK++ + G Q ++ EV L HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV EY LGS L + +PL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD--YAM-TG 272
I+RD+K NILL E KL+DFG A + + +GT + AP+ AM G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 273 QLTFKSDIYSFGVVLLEL 290
Q K D++S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
LGEG + VYKG ++VA+K++ +G +RE S + H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKELKHENIVRL 63
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
++ +LV+EYM L K++ D LD NT +G+ + HE
Sbjct: 64 HDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
V++RDLK N+L+ + KL+DFGLA+ T + V T Y APD + G
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL-GS 175
Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
T+ + DI+S G ++ E+ITGR T + +L +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-18
Identities = 69/212 (32%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLI 154
LG+G FGKV+ L+ Q AIK L V V E L A +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
+ V EY+ G L H+ D AA GLQ+LH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK--- 115
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
++YRDLK NILL+ H K++DFG+ K GD + GT Y AP+ + +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKY 173
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
D +SFGV+L E++ G+ D +EL
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF-HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 7e-18
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 60/233 (25%)
Query: 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----------RGVQGVREFSAEVMTLGSA 145
LG+G FG VY ++ ++VAIK++ R V+ +R+ +
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-------- 56
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASR 203
HPN+VKL E D+ V+EYM + +L+ L +P + I +
Sbjct: 57 -HPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----MGPSGDKTHVSTRVMG 259
GL ++H K +RDLK N+L+ K++DFGLA+ P D +VSTR
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR--- 162
Query: 260 TYGYCAPDYAMTGQLTFKS-------DIYSFGVVLLELIT------GRKAIDQ 299
Y AP ++ +S DI++ G ++ EL T G IDQ
Sbjct: 163 --WYRAP------EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-18
Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
+ R + LG+G FG+V+ G +V AIK L G F E + H LV
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
+L +E + +V EYM GSL L L+ + + L + +AA + G+ Y+
Sbjct: 65 QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 119
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDY 268
+ ++RDL+ +NIL+ E K++DFGLA++ + T R + + AP+
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEA 174
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
A+ G+ T KSD++SFG++L EL T GR +R+ L+ V
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-18
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 99 LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIG 155
LG G FG V KG + K + VAIK L + + VR E E + D+P +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
C E + +LV E G L+K L + D + + +++ S G++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKK-DEITV--SNVVELMHQVSMGMKYLEGK---N 115
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQ 273
++RDL N+LL ++ K+SDFGL+K D ++ R G + + AP+ +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 274 LTFKSDIYSFGVVLLELIT-GRKAIDQTK 301
+ +SD++S+G+ + E + G+K + K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 99 LGEGGFGKVY-------KGCLEKIEQ---------VVAIKQLDHRGVQGVR-EFSAEVMT 141
LGEG FG+V+ + EK +VA+K L R +F EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDT-----RPLDWNTR 194
L PN+ +L+G C ++ EYM G L++ L H + L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
+ +A + G++YL E L ++RDL N L+ + Y K++DFG+++ S D V
Sbjct: 133 LYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
R + A + + G+ T KSD+++FGV L E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EF--SAEVMTLGSADHPNL 150
LG+G FG VY+G I E VA+K ++ R EF A VM + H +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-----RPLDWNTRM-KIAAGASRG 204
V+L+G ++G L+V E M G L +L LRP+ RP M ++AA + G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
+ YL+ + ++RDL N ++ + K+ DFG+ + D + + +
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
AP+ G T SD++SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG-YC 157
LG+G FGKVYK ++ + A K ++ + + + ++ E+ L + +HP +VKL+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+G +++ E+ P G++D + +L R L I LQYLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-- 275
+RDLK N+LL KL+DFG++ + S +GT + AP+ M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 276 ---FKSDIYSFGVVLLEL 290
+K+DI+S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
+ R D LG+G FG+V+ G +V AIK L G F E + H LV
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
L +E + +V E+M GSL L + D + L + +AA + G+ Y+
Sbjct: 65 PLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE-- 119
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYA 269
+ I+RDL+ +NIL+ + K++DFGLA++ + T R + + AP+ A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAA 175
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GR 294
+ G+ T KSD++SFG++L EL+T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 99 LGEGGFGKVYKGCLE---KIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G FG+V +G L+ K E VAIK L + R+F +E +G DHPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G + +++ E+M G+LD LR + + + G + G++YL E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMG---TYGYCAPDYA 269
++RDL NIL+ K+SDFGL++ + D T+ S+ +G + AP+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAPEAI 183
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
+ T SD++S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----------DHRGVQGVREFSAEVMTLGSADHP 148
+G+G +G+VY +++A+KQ+ D R V+ +E+ TL DH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
N+V+ +G+ + + EY+P GS+ L L ++ GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + +++RDLK N+L++ K+SDFG++K + + G+ + AP+
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 269 AMTGQLTF--KSDIYSFGVVLLELITGRK 295
+ + K DI+S G V+LE+ GR+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDH------RGVQGVREFSAEVMTLGSADHPNLVKLIG 155
G FG VY AIK L V V+ A +M G + P + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES--PYVAKLYY 64
Query: 156 YCAEGDQRLLVYEYMP---LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
D LV EY+ SL K L L P DW + A G++ LH
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGL-----PEDWAK--QYIAEVVLGVEDLH--- 114
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
++ +I+RD+K N+L+++ H KL+DFGL++ G + + +GT Y AP+ +
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGV 168
Query: 273 QLTFKSDIYSFGVVLLELITG-----RKAIDQTKDRKELNLVAW 311
SD +S G V+ E + G + D D + W
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 99 LGEGGFGKVYK------GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG G F Y+ G L ++QV ++ + V E+ + +HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
++G E L E+M GS+ L + N ++ RGL YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE-- 121
Query: 213 KQPVIYRDLKCSNILLEE-GYHPKLSDFGLA-KMGPSGDKT-HVSTRVMGTYGYCAPDYA 269
+I+RD+K +N+L++ G +++DFG A ++ G +++GT + AP+
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
Q D++S G V++E+ T + + K L L+
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 99 LGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGVQG-VREFSAEVMTLGS-ADHPNLVKLI 154
+GEG FG+V + ++K ++ AIK L + R+F+ E+ L HPN++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
G C + EY P G+L L R +T P L ++ A+ +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
G+QYL E KQ I+RDL N+L+ E K++DFGL++ G++ +V + MG
Sbjct: 130 TGMQYLSE--KQ-FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRLP 181
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ A + T KSD++SFGV+L E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG+G +G VY + +AIK++ R + V+ E+ H N+V+ +G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS--RGLQYLHEQLKQPV 216
E + E +P GSL LR PL N + I GL+YLH+ +
Sbjct: 76 ENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 217 IYRDLKCSNILLEEGYHP--KLSDFG----LAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
++RD+K N+L+ Y K+SDFG LA + P + GT Y AP+
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVID 182
Query: 271 TGQLTF--KSDIYSFGVVLLELITGR 294
G + +DI+S G ++E+ TG+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS------AD 146
FR LG+GGFG+V + ++ A K+L+ + + ++ E M L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVN 58
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
+V L D LV M G L H++++ D + AA + GL+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLE 116
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
LH ++ ++YRDLK NILL++ H ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+ + TF D + G ++ E+I G+ Q K++
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAE--VMTLGSADHPNLVKL 153
LG+G FGKV L+ + AIK L V V E V+ L HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE-HPFLTHL 61
Query: 154 IGYCA--EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
+C + V EY+ G L H+ + D AA GLQ+LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLH-- 113
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
K+ +IYRDLK N+LL++ H K++DFG+ K +G+ ++ GT Y AP+
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
+ D +SFGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-------VMTLGSADHPNLV 151
LG+G FGKV L+ ++V AIK L + +++ + ++ L +A HP L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILAL-AAKHPFLT 59
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
L D+ V EY+ G L + +R D AA + L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH-- 113
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+ VIYRDLK NILL+ H KL+DFG+ K G T +T GT Y AP+
Sbjct: 114 -RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170
Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
+ D ++ GV++ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 7e-17
Identities = 65/198 (32%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
+G G FG VY + +VVAIK++ + G Q ++ EV L HPN ++ G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV EY LGS L + +PL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
+I+RD+K NILL E KL+DFG A + + +GT + AP+ + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 273 QLTFKSDIYSFGVVLLEL 290
Q K D++S G+ +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-17
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 99 LGEGGFGKVYKGCLE---KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG G FG++ +GCL+ K E VAI L + R F AE +TLG DH N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G G+ ++V EYM G+LD LR L M + G + G++YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG---YCAPDYAMT 271
+++ L +L+ K+S F DK+ M + AP+
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQE-DKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
+ SD++SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-17
Identities = 65/198 (32%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
+G G FG VY +VVA+K++ + G Q ++ EV L HPN ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ LV EY LGS L + +PL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNM-- 142
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
I+RD+K NILL E KL+DFG S K+ + +GT + AP+ + G
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 273 QLTFKSDIYSFGVVLLEL 290
Q K D++S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQ----------------VVAIKQLDHRGVQGVR-EFSAEVMT 141
LGEG FG+V+ E +E+ +VA+K L + R +F E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DTRPLDWNTR 194
+ PN+++L+ C D ++ EYM G L++ L P D + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
+ +A + G++YL ++RDL N L+ + Y K++DFG+++ SGD +
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
R + + + + + G+ T SD+++FGV L E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIG-Y 156
LG G G V K V+A K + VR + E+ + P +V G +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
E + + E+M GSLD+ P + KIA GL YL+ + +
Sbjct: 73 LNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLT 275
++RD+K SNIL+ KL DFG+ SG+ + ++ +GT Y +P+ G+ T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 276 FKSDIYSFGVVLLELITGR 294
KSD++S G+ ++EL G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLE---KIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKL 153
+G G FG+V G L+ K E VAIK L + Q R+F +E +G DHPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G + ++V EYM GSLD L HD + L + + G + G++YL +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYLSD- 124
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPDY 268
++RDL NIL+ K+SDFGL+++ P T ++ + AP+
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEA 180
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
+ T SD++S+G+V+ E+++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAE--VMTLGSADHPNLVKL 153
LG+G FGKV L+ + A+K L V V E V+ L + ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL-AWENPFLTHL 61
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ V E++ G L H+ D D AA GLQ+LH +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-- 115
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+IYRDLK N++L+ H K++DFG+ K GD ++ GT Y AP+ +
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 274 LTFKSDIYSFGVVLLELITGR 294
TF D +SFGV+L E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQV--VAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLI 154
LGEG FG V +G L + + + VA+K + + +F +E + + DHPN+++LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 155 GYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQ 206
G C + + +++ +M G L L R P T+M K + G++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
YL + I+RDL N +L E + ++DFGL+K +GD + A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ T KSD++SFGV + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 23/225 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF----SAEVMTLGSADHPNLVKLI 154
+G G + KV L+K +Q+ A+K + V + + + + ++ +P LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
C + RL LV EY+ G L H+ R P+ + + IA L +LHE+
Sbjct: 63 S-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHER 115
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPDYA 269
+IYRDLK N+LL+ H KL+D+G+ K +GP GD T + GT Y AP+
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEIL 168
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLR 314
+ F D ++ GV++ E++ GR D D ++N +L +
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
+G G FG+V+ G L VA+K ++ +F E L HPN+V+LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
Q+ +Y M L L LR + L +++ A+ G++YL + I
Sbjct: 63 T---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDYAMTGQLT 275
+RDL N L+ E K+SDFG+++ D + ST M + AP+ G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 276 FKSDIYSFGVVLLE 289
+SD++SFG++L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG----SADHPNLVKLI 154
LG G +G V K ++A+K++ R +E +M L S D P V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 155 GYC-AEGDQRLLVYEYMPL--GSLDK-----HLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
G EGD V+ M + SLDK + L L KIA + L+
Sbjct: 67 GALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALE 117
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYC 264
YLH +L VI+RD+K SN+L+ KL DFG+ SG T G Y
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAKTIDAGCKPYM 170
Query: 265 AP---DYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKD 302
AP + + + KSD++S G+ ++EL TGR D K
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
FR LG+GGFG+V + ++ A K+L+ + + ++ E M L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGESMALNEKQILEKVN 58
Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGAS 202
V + Y E D LV M G L H++ + + R + + AA
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAEIC 112
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
GL+ LH ++ ++YRDLK NILL++ H ++SD GLA P G + RV GT G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
Y AP+ + TF D ++ G +L E+I G+ Q K +
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEG FG V +G E Q VA+K + + + F E + H NLV+L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL-DWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ +V E M G+L ++ LR R L ++ + + G++YL + ++
Sbjct: 70 H-NGLYIVMELMSKGNL---VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
+RDL NIL+ E K+SDFGLA++G G D + + + + AP+ + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176
Query: 277 KSDIYSFGVVLLELIT-GR 294
KSD++S+GV+L E+ + GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 99 LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
+GEG FG+V K ++K + AIK++ ++ R+F+ E+ L HPN++ L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
G C L EY P G+L L R +T P L + AA +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
RG+ YL + KQ I+RDL NIL+ E Y K++DFGL++ G + +V + MG
Sbjct: 135 RGMDYLSQ--KQ-FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 186
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ A + T SD++S+GV+L E+++
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
FR LG+GGFG+V + ++ A K+L+ + + ++ E M L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKRILEKVN 58
Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
V + Y E D LV M G L H++++ D + AA GL+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLE 116
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
L ++ ++YRDLK NILL++ H ++SD GLA P G+ V RV GT GY AP
Sbjct: 117 DLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAP 170
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+ + TF D + G ++ E+I G+ + K+R
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 97 CCLGEGGFGKVYKGCLEK-IEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKL 153
+GEG +G V K C K ++VAIK+ + + V++ + EV L H N+V L
Sbjct: 7 GVVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 154 IGYCAEGDQRLLVYEYMP---LGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLH 209
+ LV+EY+ L L+ L PD R W + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH 117
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD-- 267
+I+RD+K NIL+ E KL DFG A+ + + ++ V T Y AP+
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELL 173
Query: 268 --YAMTGQLTFKSDIYSFGVVLLELITGR 294
G D+++ G ++ EL+ G
Sbjct: 174 VGDTNYG---KPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSAD 146
GNF+ + +G+G F VYK +VVA+K++ + + ++ E+ L D
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
HPN++K + E ++ +V E G L + + + R + T K L+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
++H + +++RD+K +N+ + KL D GL + S KT + ++GT Y +P
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 175
Query: 267 DYAMTGQLTFKSDIYSFGVVLLEL 290
+ FKSDI+S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 99 LGEGGFGKVY--KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+GEG FGK+Y K + V+ L V+ EV+ L HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
E + +V EY G L K ++ R + + L W ++ S GL+++H++
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------SLGLKHIHDR- 120
Query: 213 KQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+++RD+K NI L + G KL DFG+A+ D ++ +GT Y +P+
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
K+DI+S G VL EL T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKLI 154
+GEG +G V+K + Q+VAIK+ ++ +++ + E+ L HPNLV LI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKH--LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ LV+EY H L++L + R + + KI + + + H
Sbjct: 67 EVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH--- 117
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKT-HVSTRVMGTYGYCAPDYA 269
K I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y AP+
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL- 171
Query: 270 MTGQLTFKS--DIYSFGVVLLELIT------GRKAIDQ 299
+ G + D+++ G V EL+T G+ +DQ
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V+ G +V A+K L G V+ F E + + H LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ + ++ EYM GSL L L+ D + + +A + G+ Y+ ++ I
Sbjct: 72 KEEPIYIITEYMAKGSL---LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLT 275
+RDL+ +N+L+ E K++DFGLA++ + T R + + AP+ G T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFT 182
Query: 276 FKSDIYSFGVVLLELIT 292
KSD++SFG++L E++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQV----------------VAIKQLDHRGVQGVR-EFSAEVMT 141
LGEG FG+V+ + + + VA+K L + R +F EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRP----------- 188
L PN+++L+G C + D ++ EYM G L++ L H L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 189 --LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
+ +++ + +A + G++YL ++RDL N L+ E K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
+GD + R + + A + + G+ T SD+++FGV L E++
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 99 LGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREF---SAEVMT-LGSADHPN 149
LG G FGKV + L K + V VA+K L RE ++M+ LG+ H N
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HEN 100
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+V L+G C G L++ EY G L L R L + + ++G+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPD 267
+ I+RDL N+LL G K+ DFGLA+ M S + R+ + AP+
Sbjct: 159 SK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPE 213
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
TF+SD++S+G++L E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 99 LGEGGFGKV----YKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV Y + + VA+K L G + + E+ L + H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C E L+ E++P GSL ++L + ++ ++K A +G+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAPDYA 269
++RDL N+L+E + K+ DFGL K DK + + + + + AP+
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
+ + SD++SFGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF----SAEVMTLGSADHPNLVKLI 154
+G G + KV L+K E++ A+K + V + + + + +++HP LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 155 GYCAEGDQRLL-VYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
C + + RL V EY+ G L H+ R P+ ++ + +A L YLHE+
Sbjct: 63 S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHER 115
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAM 270
+IYRDLK N+LL+ H KL+D+G+ K G GD T + GT Y AP+
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 169
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAID 298
F D ++ GV++ E++ GR D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADH 147
+ +G G FG+V+ ++I E A+K + V +++ E L H
Sbjct: 2 DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 148 PNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
P +++L + E DQR L + EY+P G L +L + + +T + A+ L
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN----STGLFYASEIVCAL 114
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYC 264
+YLH + ++YRDLK NILL++ H KL+DFG AK K T + GT Y
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYL 165
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITG 293
AP+ + D ++ G+++ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 93 FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADH 147
L EG FG+++ G L E+ V +K + DH V E L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTR--MKIAAGAS 202
N++ ++ C E G+ ++Y YM G+L L R P +T+ + +A +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPS-----GDKTHVSTR 256
G+ YLH K+ VI++D+ N +++E K++D L++ + P GD + +
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
M A + + + + SD++SFGV+L EL+T
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 98 CLGEGGFGKVYKGCLEKIEQV---VAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
C+GEG FG VY+G E VA+K + VRE F E + DHP++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
IG E + +V E PLG L +L + LD + + + S L YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLE---S 125
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+ ++RD+ N+L+ KL DFGL++ + + +++ + AP+ +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 274 LTFKSDIYSFGVVLLELI 291
T SD++ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 19/193 (9%)
Query: 117 QVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIGYCAEGDQRLL-VYEYMPL 172
VAIK L + + F E HPN+V L+ L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP- 62
Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-- 230
+ L ++ L ++ L H Q +++RDLK NI++ +
Sbjct: 63 ---GRTLREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 231 -GYHPKLSDFGLAKMGP---SGDKTHVS--TRVMGTYGYCAPDYAMTGQLTFKSDIYSFG 284
H K+ DFG+ + P D ++ T V+GT YCAP+ +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 285 VVLLELITGRKAI 297
++ LE +TG++ +
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF---SAEVMTLGSA-DHPNLVKLI 154
+G G + KV L+K ++ A+K + V + E +A +HP LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
C + + RL V E++ G L H+ R + + + R +A S L +LHE+
Sbjct: 63 S-CFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARF-YSAEISLALNFLHER-- 115
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+IYRDLK N+LL+ H KL+D+G+ K G GD T + GT Y AP+
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 273 QLTFKSDIYSFGVVLLELITGRKAID 298
F D ++ GV++ E++ GR D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 16/211 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIG 155
LG+GGFG+V ++ ++ A K+LD + ++ G + E L + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
Y E L LV M G L H++++ R L+ + +A + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM--- 114
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
++YRD+K N+LL++ + +LSD GLA G T+ GT GY AP+
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
++ D ++ G + E++ GR KD KE
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF---KDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYKG +K Q+VA+K++ + GV +RE S L HPN+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS----LLKELQHPNIVC 63
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L + + L++E++ + L K+L L + +D +G+ + H
Sbjct: 64 LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKG-QYMDAELVKSYLYQILQGILFCH--- 118
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+ V++RDLK N+L++ KL+DFGLA+ G V T + T Y AP+ +
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 273 QL-TFKSDIYSFGVVLLELIT------GRKAIDQ 299
+ DI+S G + E+ T G IDQ
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 15/223 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQV--VAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
+G G FGKV G + V +K+L F EV +HPN+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL-DWNTRMKIAAGASRGLQYLHEQLKQ 214
C E LLV E+ PLG L +L R + + ++A + GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP-------D 267
I+ DL N L K+ D+GLA D + AP
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
+ T KS+I+S GV + EL T + D + L V
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG VYKG E ++ VAIK L ++ + +E E + P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPL-DWNTRMKIAAGASRGLQYLHE 210
+G C +L V + MP G L ++ + R ++ L +W ++ ++G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+++RDL N+L++ H K++DFGLA++ + + + + A + +
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304
+ T +SD++S+GV + EL+T G K D R+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G G VY Q VAIKQ++ + E++ + HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V EY+ GSL + + D +IAA LQ L VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 138
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RD+K NILL KL+DFG A++ P K + ++GT + AP+ K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 278 SDIYSFGVVLLELITG 293
DI+S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
+G G FG VY + +VVAIK++ + G Q ++ EV L HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV EY LGS L + +PL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
+I+RD+K NILL E KL DFG A M P+ +GT + AP+ +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPEVILAMDE 188
Query: 272 GQLTFKSDIYSFGVVLLEL 290
GQ K D++S G+ +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-----EVMTLGSADHPNLVKL 153
LG+G FGKV L++ ++ A+K L + + +++L + +HP L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL-ARNHPFLTQL 61
Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
C + RL V E++ G L H+ +R D AA + L +LH++
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK- 115
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+IYRDLK N+LL+ H KL+DFG+ K G KT ++ GT Y AP+
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 273 QLTFKSDIYSFGVVLLELITG 293
D ++ GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 74/216 (34%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 99 LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVREFSAEVM---TLGSADHPNL 150
LG+G FGKV+ + KI Q+ A+K L ++ VR+ M L +HP +
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFI 60
Query: 151 VKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
VKL Y + + +L L+ +++ G L L + + + + +A A L +LH
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELA-LALDHLH 115
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+IYRDLK NILL+E H KL+DFGL+K +K S GT Y AP+
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
T +D +SFGV++ E++TG Q KDRKE
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
FR LG+GGFG+V + ++ A K+L+ + + ++ E M L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI---KKRKGESMALNEKQILEKVN 58
Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
V + Y E D LV M G L H++++ + + AA GL+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLE 116
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
LH ++ +YRDLK NILL++ H ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAP 170
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+ + T D + G ++ E+I G+ K++
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 13/218 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGYC 157
LGEG + V+KG + E +VA+K++ +G + EV L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPV 216
LV+EY LDK L D + +KI RGL Y H ++ V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLT 275
++RDLK N+L+ E KL+DFGLA+ KT+ + V T Y PD + + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
+ D++ G + E+ +GR + EL+L+ LL
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ-----LDHRGVQGVREFSAEVMTLGSAD 146
N+R LG+G FG+VY + +A+KQ + V E+ L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 147 HPNLVKLIGYCAEGDQRLLVY-EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
H +V+ G C D+ L ++ EYMP GS+ L T + TR K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGV 117
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVMG 259
+YLH + +++RD+K +NIL + + KL DFG +K +G K+ V G
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTG 169
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
T + +P+ K+D++S G ++E++T
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 71/232 (30%), Positives = 94/232 (40%), Gaps = 51/232 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKLI 154
+G G FG+V+ + QV A+K L + R A V L AD P +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKL- 66
Query: 155 GYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA----AGASRGLQYL 208
Y + D+ L V EYMP G L L +R D P + R IA A L +
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVLA-----LDSV 117
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------------- 251
H K I+RD+K NIL++ H KL+DFGL K
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 252 -----HVSTRVM-----GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
H RV GT Y AP+ + D +S GV+L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+G FGKV + +++ AIK L + V E L P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
C + RL V EY+ G L H+ + P + AA + GL +LH +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLH---SK 120
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
+IYRDLK N++L+ H K++DFG+ K G KT TR GT Y AP+
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQP 177
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
D ++FGV+L E++ G+ D +D EL
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL----GSADHPNLVKLI 154
+G G FG V K + ++A+K++ R +E +M L S+D P +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 155 GYC-AEGDQRLLVYEYMPLGSLD---KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
G EGD + E M + SLD K+++++ + KIA + L YL E
Sbjct: 70 GALFREGDC-WICMELMDI-SLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALNYLKE 125
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+LK +I+RD+K SNILL+ + KL DFG++ ++ S K TR G Y AP+
Sbjct: 126 ELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERI 179
Query: 270 MTGQLT---FKSDIYSFGVVLLELITGR 294
+SD++S G+ L E+ TG+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 75/233 (32%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDH----RGVQGVREFSAEVMTLGSADHPN 149
LG+GG+GKV++ + K+ ++ A+K L R + AE L + HP
Sbjct: 4 LGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+V LI G + L+ EY+ G L HL R D T + S L++LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE--REGIFMED--TACFYLSEISLALEHLH 117
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDY 268
+Q +IYRDLK NILL+ H KL+DFGL K G TH GT Y AP+
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG---------RKAIDQTKDRKELNLVAWL 312
M D +S G ++ +++TG +K ID+ + +LNL +L
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYL 223
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ----LDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG+G +G VYK +A+K+ LD + E+ L A P +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQI---IMELDILHKAVSPYIVDFY 65
Query: 155 G-YCAEGDQRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
G + EG VY EYM GSLDK L+ T + + +I +GL++L E
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDY- 268
+ +I+RD+K +N+L+ KL DFG++ + S KT++ G Y AP+
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173
Query: 269 ---AMTGQLTF--KSDIYSFGVVLLELITGR 294
T+ +SD++S G+ +LE+ GR
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 99 LGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGSADHPNLV 151
+G GGFG+VY GC + ++ A+K LD + + QG + +M + + D P +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+ D+ + + M G L HL H + + + T + + GL+++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ V+YRDLK +NILL+E H ++SD GLA S K H S +GT+GY AP+
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 270 MTGQLTFKS-DIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
G S D +S G +L +L+ G Q TKD+ E++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G FG V G + VA+K + + + F AE + H NLV+L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQPV 216
E L +V EYM GSL +L R R L + +K + ++YL
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNF 123
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
++RDL N+L+ E K+SDFGL K S D + + + AP+ + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177
Query: 276 FKSDIYSFGVVLLELIT-GR 294
KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G +G VY+G +VVA+K + V ++ A + L + PN+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G +G + ++ EY GS+ + + + R + A L+Y+H K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIH---KV 120
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
VI+RD+K +NIL+ + KL DFG+A + ST V GT + AP+ G+
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVITEGKY 178
Query: 275 -TFKSDIYSFGVVLLELITG 293
K+DI+S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL---------DHRGVQGVREFSAEVMTLGSADHPN 149
+G G FG VY G +++A+KQ+ R + + E+ L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+V+ +G + D + EY+P GS+ L++ L N +I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLH 123
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----GPSGDKTHVSTRVMGTYGYCA 265
+ +I+RD+K +NIL++ K+SDFG++K S + G+ + A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
P+ T K+DI+S G +++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 65/238 (27%), Positives = 93/238 (39%), Gaps = 42/238 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
LG+G G+V+ L+ ++ A+K LD + + V+ E L + DHP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV +Y P G L L +P + R AA L+YLH
Sbjct: 69 SFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARF-YAAEVLLALEYLH---LLG 123
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---------------------- 253
++YRDLK NILL E H LSDF L+K
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 254 --STRVM---GTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGR-----KAIDQT 300
S R GT Y AP+ ++G D ++ G++L E++ G D+T
Sbjct: 184 EPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V+ G + + VAIK ++ G +F E + HP LV+L G C
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ +V E+M G L L+ LR L + + + G++YL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAK-------MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
RDL N L+ K+SDFG+ + SG K V + P+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--------WSPPEVFNF 175
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
+ + KSD++SFGV++ E+ T
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVR-EFSAEVMTLGSADHPN 149
+F LG G G V K L + ++ ++L H + +R + E+ L + P
Sbjct: 2 DFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQ 206
+V G + ++G+ + + E+M GSLD+ L P+ N KI+ RGL
Sbjct: 61 IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE------NILGKISIAVLRGLT 113
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCA 265
YL E+ K +++RD+K SNIL+ KL DFG++ ++ S + V TR Y +
Sbjct: 114 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMS 166
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 297
P+ T +SDI+S G+ L+E+ GR I
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 43/223 (19%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDH--RGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYK + ++VA+K+ L+ GV +RE S L +HPN+V+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNHPNIVR 62
Query: 153 L--IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS---RGLQ 206
L + + + +L LV+E++ L L K++ D+ PL I + +G+
Sbjct: 63 LLDVVHS---ENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MG-PSGDKTHVSTRVMGTYGYC 264
Y H V++RDLK N+L++ KL+DFGLA+ G P TH V+ T Y
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYR 166
Query: 265 APDYAMTGQLTFKS--DIYSFGVVLLELITGR------KAIDQ 299
AP+ + G + + DI+S G + E++ R IDQ
Sbjct: 167 APE-ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG+V+ K +V A+K + G V F AE + + H LVKL
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ + ++ E+M GSL L +PL + +A + G+ ++ ++ I+
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYIH 125
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
RDL+ +NIL+ K++DFGLA++ + T R + + AP+ G T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTI 182
Query: 277 KSDIYSFGVVLLELIT-GR 294
KSD++SFG++L+E++T GR
Sbjct: 183 KSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+GEG FG+ +Q A+K++ + V + E + L HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-KES 66
Query: 158 AEGDQRL-LVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
E D L +V EY G L + + R P+ L W +M + G+Q++HE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
V++RD+K NI L + KL DFG A++ + + T V GT Y P+
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 273 QLTFKSDIYSFGVVLLELIT 292
KSDI+S G +L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 45/244 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LGEG FG+VYK K +VVA+K++ D + +R E+ L HPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 153 LIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR---- 203
LI E +R VY P +D HDL + L+ N +K+ +
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPY--MD---HDL---SGLLE-NPSVKLTESQIKCYML 122
Query: 204 ----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---------MGPSGDK 250
G+ YLHE +++RD+K +NIL++ K++DFGLA+ G G
Sbjct: 123 QLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 251 THVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
T T ++ T Y P+ + + T DI+ G V E+ T R + D +L+L+
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 310 AWLL 313
L
Sbjct: 240 FKLC 243
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
+F LG G G V K K ++ ++L H ++ +R + E+ L + P
Sbjct: 6 DFERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+V G + + E+M GSLD+ L + + + K++ RGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
E K +++RD+K SNIL+ KL DFG++ G D ++ +GT Y +P+
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 174
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ +SDI+S G+ L+EL GR I D KEL +
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI-PPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G G V+ Q VAIKQ++ + E++ + +PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V EY+ GSL + + D +IAA LQ L VI+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMD--------EAQIAAVCRECLQALEFLHANQVIH 138
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RD+K N+LL KL+DFG A++ P K + ++GT + AP+ K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
DI+S G++ +E++ G + L L+A
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 66/202 (32%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKL 153
LG+G FGKV EK A+K L + V ++ A +T L + HP L L
Sbjct: 3 LGKGTFGKVIL-VREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
D+ V EY G L HL R + R A S L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVS-ALGYLHSC-- 114
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTG 272
V+YRDLK N++L++ H K++DFGL K G S G GT Y AP+
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDN 170
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
LGEG + VYKG Q+VA+K + + +GV F+A E L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 157 CAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ V+EYM + +H L P +N R+ + RGL Y+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIH---G 121
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
Q +++RDLK N+L+ KL+DFGLA+ +T+ S V T Y PD + G
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGA 178
Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
+ S DI+ G + +E++ G+ A D E W
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
LGEG FG+V I++ VA+K L D + + + +E+ M H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKI 197
++ L+G C + ++ EY G+L ++L RP + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
+RG++YL Q I+RDL N+L+ E K++DFGLA+ + D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 101 EGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQG-----VREFSAEVMTLGSADHPNLVKL- 153
EG +G VY+ +K ++VA+K+L + +G +RE + L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKLQHPNIVTVK 70
Query: 154 -IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS---------- 202
+ + D+ +V EY+ HDL+ MK S
Sbjct: 71 EVVVGSNLDKIYMVMEYVE--------HDLK------SLMETMKQPFLQSEVKCLMLQLL 116
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
G+ +LH+ +++RDLK SN+LL K+ DFGLA+ G T+++ T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 263 YCAPDYAM-TGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
Y AP+ + + + D++S G + EL+T G+ IDQ
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADH 147
NFR + +G G F +VY+ VA+K++ D + + E+ L +H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
PN++K E ++ +V E G L + + + R + T K L++
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
+H + V++RD+K +N+ + KL D GL + S KT + ++GT Y +P+
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE 176
Query: 268 YAMTGQLTFKSDIYSFGVVLLEL 290
FKSDI+S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 66/202 (32%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
+G+G FGKV + + A+K L + + +E +M L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
D+ V +Y+ G L HL R P+ R R A AS L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIAS-ALGYLHSL 115
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+IYRDLK NILL+ H L+DFGL K G KT ++ GT Y AP+
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
D + G VL E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 70/223 (31%), Positives = 106/223 (47%), Gaps = 23/223 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
LGEG + V+KG + E +VA+K++ +G +RE S L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS----LLKNLKHANIVTL 68
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA-GASRGLQYLHEQL 212
LV+EY LD L + L +KI RGL Y H
Sbjct: 69 HDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--- 120
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
K+ +++RDLK N+L+ E KL+DFGLA+ KT+ + V T Y PD + G
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD-VLLG 177
Query: 273 QLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
+ + D++ G +L E+ TGR + ++EL+L+ LL
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGV-QGVREFSAEV-MTLGSADHPN 149
LGEG FG+V I++ VA+K L + + + +E+ M H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DT-----RPLDWNTRMKI 197
++ L+G C + ++ EY G+L ++L RP DT L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
A +RG++YL Q I+RDL N+L+ E K++DFGLA+ + D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
LG G G VYK +++A+K LD V+ ++ +E+ L D P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
++ + E+M GSLD + R + + +IA +GL YL LK +
Sbjct: 68 FFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW-SLK--I 116
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
++RD+K SN+L+ KL DFG++ ++ S KT+V GT Y AP+ Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 276 FKSDIYSFGVVLLELITGR 294
SD++S G+ +EL GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEVMTLGSAD-HPN 149
LGEG FG+V + I++ VA+K L D+ + + + +E+ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKI 197
++ L+G C + ++ EY G+L + L RP L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
A +RG++YL + I+RDL N+L+ E K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 72/222 (32%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 99 LGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGSADHPNLV 151
+G GGFG+VY GC + ++ A+K LD + + QG + +M + + D P +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKI-AAGASRGLQYL 208
+ D+ + + M G L HL H + + M+ AA GL+++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHM 113
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + V+YRDLK +NILL+E H ++SD GLA S K H S +GT+GY AP+
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 269 AMTGQLTFKS-DIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
G S D +S G +L +L+ G Q TKD+ E++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
LGEG + VYKG + ++VA+K + + +G F+A E L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 157 CAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ LV+EY+ +DKH L P+ L + RGL Y+H++
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIHQRY- 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++RDLK N+L+ + KL+DFGLA+ +H + + T Y PD + G
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD-VLLGS 178
Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKD 302
+ + D++ G + +E+I G A KD
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G G VY Q VAI+Q++ + E++ + +PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V EY+ GSL + + D +IAA LQ L VI+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RD+K NILL KL+DFG A++ P K + ++GT + AP+ K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
DI+S G++ +E+I G + L L+A
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK----QLDHRG--VQGVREFSAEVMTLGSADHPNLVK 152
+G G +G VYK VA+K Q + G + VRE A + L + DHPN+V+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66
Query: 153 LIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
L+ CA D+ LV+E++ L +L + P P + T + RGL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDF 123
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS-TRVMGTYGYCAP 266
LH +++RDLK NIL+ G KL+DFGLA++ ++ T V+ T Y AP
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAP 176
Query: 267 DYAMTGQLTFKSDIYSFGVVLLEL 290
+ + D++S G + E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-13
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYC 157
+G G +G+VYKG K Q+ AIK +D G + E E+ L + H N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 158 AE------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
+ DQ LV E+ GS+ + + + +T +W I RGL +LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAP--- 266
VI+RD+K N+LL E KL DFG++ D+T V R +GT + AP
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVI 183
Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITG 293
D FKSD++S G+ +E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 2e-13
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G G VY Q VAIKQ++ + E++ + +PN+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V EY+ GSL + + D +IAA LQ L VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALDFLHSNQVIH 138
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RD+K NILL KL+DFG A++ P K + ++GT + AP+ K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
DI+S G++ +E++ G + L L+A
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 13/218 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGYC 157
LGEG + VYKG + + +VA+K++ +G + EV L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPV 216
LV+EY LDK L D +K+ RGL Y H ++ V
Sbjct: 74 HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLT 275
++RDLK N+L+ E KL+DFGLA+ KT+ + V T Y PD + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
+ D++ G + E+ TGR + ++L+ + +L
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 17/224 (7%)
Query: 99 LGEGGFGKVYKGCLEK---IEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G FGKV G + QVV +K+L VQ +F E S H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G C E LLV E+ PLG L +L R + D T ++A + GL +LH K
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA--MT 271
I+ DL N LL K+ D+GL+ D ++ + AP+ +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 272 GQL-----TFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
G L T +S+++S GV + EL G + D + L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V G + + VAIK + G EF E + H LV+L G C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ +V EYM G L L+ LR + + +++ G+ YL KQ I+
Sbjct: 70 KQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES--KQ-FIH 123
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
RDL N L+++ K+SDFGL++ D + S+ +G+ + P+ + + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 276 FKSDIYSFGVVLLELIT 292
KSD+++FGV++ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEG G V + + VA+K++D R Q EV+ + HPN+V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V E++ G+L D+ TR ++ + + L +LH Q VI+
Sbjct: 87 VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIATVCLAVLKALSFLH---AQGVIH 138
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RD+K +ILL KLSDFG + ++GT + AP+ +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 279 DIYSFGVVLLELITG 293
DI+S G++++E++ G
Sbjct: 197 DIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
NF+ + +G G F +VY+ + VA+K++ + + ++ E+ L +HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
N++K + E ++ +V E G L + + + R + T K ++++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + V++RD+K +N+ + KL D GL + S KT + ++GT Y +P+
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177
Query: 269 AMTGQLTFKSDIYSFGVVLLEL 290
FKSDI+S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYK + +VVA+K++ + GV +RE S L +HPN+VK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKELNHPNIVK 63
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L+ ++ LV+E++ L K + PL +GL + H
Sbjct: 64 LLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCHSH- 119
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
V++RDLK N+L+ KL+DFGLA+ G T + T Y AP+ +
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 273 QL-TFKSDIYSFGVVLLELITGRKA-------IDQ 299
+ + DI+S G + E++T R+A IDQ
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 35/232 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRG----VQGVREFSAEVMTLGSADHPNLVK 152
+GEG +G+VYK + ++VA+K+ LD+ + +RE + L +H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE----IKILRQLNHRNIVN 70
Query: 153 LIGYCAEGDQRL----------LVYEYMP---LGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
L + L LV+EYM +G L+ L D + MK
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----HIKSFMK--- 123
Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
GL Y H K+ ++RD+KCSNILL KL+DFGLA++ S + + +V+
Sbjct: 124 QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 260 TYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
T Y P+ + + + D++S G +L EL T + ++ +L L++
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGV---QGVREFSAEVMTLGSA--------D 146
LG G FG VYK + Q ++A+K+++ + RE + + S
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD----WNTRMKIAAGAS 202
HPN+V+ E D+ +V + + L +H + L+ + WN +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
L+YLH++ + +++RDL +NI+L E ++DFGLAK K T V+GT
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTIL 178
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
Y P+ K+D+++FG +L ++ T
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+G FGKV + +++ AIK L V V E L D P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
C + RL V EY+ G L H+ + P + AA S GL +LH ++
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLH---RR 120
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
+IYRDLK N++L+ H K++DFG+ K V+TR GT Y AP+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
D +++GV+L E++ G+ D +D EL
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 99 LGEGGFGKVYKGCLEK----------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP 148
LG+G F +YKG L E V +K L + F + H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
+LVKL G C D+ ++V EY+ G LD LH + L W ++ +A + L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117
Query: 209 HEQLKQPVIYRDLKCSNILL-----EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTY 261
+ + +++ ++ NIL+ EGY P KLSD G+ + R+
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 262 GYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
+ AP+ GQ LT +D +SFG LLE+ + + T E
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 45/215 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ----LDHRGV--QGVREFSAEVM-TLGSADHPNLV 151
+GEG +G VYK + VA+K+ L G+ +RE + ++ L S +HPN+V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA--LLKQLESFEHPNIV 64
Query: 152 KLIGYCA--EGDQRL---LVYEYMPLGSLDKHLHD---------LRPDTRPLDWNTRMKI 197
+L+ C D+ L LV+E++ D+ L L P+T + R +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPET--IKDLMRQLL 117
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
RG+ +LH +++RDLK NIL+ K++DFGLA++ T V
Sbjct: 118 -----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSV 166
Query: 258 MGTYGYCAPDYAMTGQLTFKS--DIYSFGVVLLEL 290
+ T Y AP+ + Q ++ + D++S G + EL
Sbjct: 167 VVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
+G+G FGKV + + A+K L + V +E + + L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
++ V +++ G L HL R P R A AS L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIAS-ALGYLH-SIN- 116
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
++YRDLK NILL+ H L+DFGL K G + T +T GT Y AP+
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPY 173
Query: 275 TFKSDIYSFGVVLLELITG 293
D + G VL E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 69/234 (29%), Positives = 101/234 (43%), Gaps = 76/234 (32%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------------EVMTLGS-A 145
LG+G +G V+K + ++VVA+K++ F A E+M L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIMFLQELG 64
Query: 146 DHPNLVKLIG-YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA-- 201
DHPN+VKL+ AE D+ + LV+EYM + LH + I A
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILE 105
Query: 202 -----------SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPS 247
+ L+Y+H VI+RDLK SNILL KL+DFGLA+
Sbjct: 106 DVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162
Query: 248 GDKTHVSTRVMGTYGYCAPD-------YAMTGQLTFKSDIYSFGVVLLELITGR 294
+ V T + T Y AP+ Y T D++S G +L E++ G+
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 19/223 (8%)
Query: 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REFSAEVMT 141
+ L T + +G+G +GKVYK +K + A+K LD + V E AE
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD--PISDVDEEIEAEYNI 71
Query: 142 LGS-ADHPNLVKLIG--YCAE---GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
L S +HPN+VK G Y A+ G Q LV E GS+ + + L + LD
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
I GA GLQ+LH +I+RD+K +NILL KL DFG++ S + +T
Sbjct: 132 YILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNT 187
Query: 256 RVMGTYGYCAPDYAMTGQ-----LTFKSDIYSFGVVLLELITG 293
V GT + AP+ Q + D++S G+ +EL G
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-13
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT--LGSADHPNLVKLIGY 156
LG+GGFG+V + ++ A K+L+ + ++ + + ++ + + H + + Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 157 CAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ L LV M G L H++++ + A GL++LH++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+IYRDLK N+LL+ + ++SD GLA K G S K + GT G+ AP+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGE 172
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
+ F D ++ GV L E+I R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
LGEG + VYKG + Q+VA+K++ +G F+A E L H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDI 71
Query: 157 CAEGDQRLLVYEYM--PLGS-LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
LV+EY+ L +D L N R+ + RGL Y H +
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCH---Q 121
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGL--AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+ V++RDLK N+L+ E KL+DFGL AK PS KT+ + V T Y PD +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVV--TLWYRPPD-VLL 176
Query: 272 GQLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKE 305
G + + D++ G + E+ TGR + D ++
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGY 156
+GEG +G V K ++ Q+VAIK+ L+ + V++ + E+ L H NLV LI
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ LV+E++ LD DL LD + K RG+++ H +
Sbjct: 69 FRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQ 273
I+RD+K NIL+ + KL DFG A+ P T +V+TR Y AP+ + G
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL-LVGD 175
Query: 274 LTFKS--DIYSFGVVLLELITG 293
+ DI++ G ++ E++TG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 99 LGEGGFGK--VYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
LG+G FG+ +Y+ E VV K+++ + + R+ E++ L HPN++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 155 GYCAEGDQRLLVYEYMPLGSL-DKHLH---DLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
+ + + L+ EY G+L DK + L + L + ++ A + Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA------VSYIH- 118
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
K +++RD+K NI L + KL DFG++K+ G + ++ V+GT Y +P+
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQ 174
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ FKSDI++ G VL EL+T ++ D T LNLV
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM-----TLGSADHPNLVKL 153
+G G G+VYK +K V+A+KQ+ R G +E + ++ L S D P +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM-RR--TGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
GY + E M LDK L ++ P+ + K+ + L YL E K
Sbjct: 80 YGYFITDSDVFICMELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--K 133
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG----DKTHVSTRVMGTYGYCAPDY- 268
VI+RD+K SNILL+ + KL DFG+ SG K TR G Y AP+
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGI-----SGRLVDSKAK--TRSAGCAAYMAPERI 186
Query: 269 ---AMTGQLTFKSDIYSFGVVLLELITGR 294
+ ++D++S G+ L+EL TG+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 99 LGEGGFGKVYKGCLEKIE----QVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG+G FG V + L K E Q VA+K L D + EF E + DHPN++K
Sbjct: 7 LGKGEFGSVREAQL-KSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 153 LIGYC--AEGDQRL----LVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRG 204
LIG + RL ++ +M G L L R P L T ++ + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
++YL + I+RDL N +L E ++DFGL+K SGD +
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
A + T SD+++FGV + E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG+V + + AIK L R + + V+ + E L HP +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLD----WNTRMKIAAGASRGLQYLHE 210
+ ++ + E++ G L HL R R P D ++ + +A +YLH
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA------FEYLHS 136
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+ +IYRDLK N+LL+ H K++DFG AK P D+T + GT Y AP+
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQ 188
Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
+ D ++ GV+L E I G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 26/231 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEG G V + + VA+K++D R Q EV+ + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V E++ G+L D+ TR ++ + R L YLH Q VI+
Sbjct: 90 VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIH 141
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RD+K +ILL KLSDFG A++ K ++GT + AP+ +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTE 198
Query: 278 SDIYSFGVVLLELITGR---------KAIDQTKDR-----KELNLVAWLLR 314
DI+S G++++E+I G +A+ + +D K+ + V+ +LR
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
+G+G FGKV + E+ A+K L + + +E S + L + HP LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
D+ V +Y+ G L HL R P R + AA + L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL-- 115
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++YRDLK NILL+ H L+DFGL K + T ++ GT Y AP+
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQP 172
Query: 274 LTFKSDIYSFGVVLLELITG 293
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 35/208 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
+G+GG+G+V+ + ++VA+K++ + VR E L + LVKL+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRP---DTRPLDWN------TRMKIAAGASRGL 205
Y + D+ L L EY+P G D R + L + M A A L
Sbjct: 68 YAFQDDEYLYLAMEYVPGG-------DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
Y+H RDLK N L++ H KL+DFGL+K + + V+G+ Y A
Sbjct: 121 GYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMA 166
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
P+ F D +S G +L E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
+G G G VYK ++ A+K + VR + E+ L +HPN+VK
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ ++ E+M GSL+ T D +A G+ YLH ++ ++
Sbjct: 142 DHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH---RRHIV 190
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT----G 272
+RD+K SN+L+ + K++DFG+++ + + D + S +GT Y +P+ T G
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHG 247
Query: 273 QLT-FKSDIYSFGVVLLELITGR 294
+ DI+S GV +LE GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99 LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
LGEG FG+V EK +V VA+K L + + + +E+ M H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
++ L+G C + ++ EY G+L ++L RP +N +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
A +RG++YL + I+RDL N+L+ E K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
T G + AP+ T +SD++SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
N+R LG+G FG+VY + +A+KQ+ D + +E +A E+ L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 147 HPNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
H +V+ G + +R L E+MP GS+ L T N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQILEG 118
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
+ YLH + +++RD+K +NIL + + KL DFG +K + +G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
GT + +P+ K+DI+S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPNLVKLIGY 156
LG G G V+K K ++ ++L H ++ +R + E+ L + P +V G
Sbjct: 13 LGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ + E+M GSLD+ L + K++ +GL YL E K +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKI 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RD+K SNIL+ KL DFG++ G D ++ +GT Y +P+ +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSV 181
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+SDI+S G+ L+E+ GR I D KEL L+
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPI-PPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV--REFSAEVMTLGSADHPNLVKLIGY 156
+GEG FGK ++ + IK+++ + E EV L + HPN+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
E +V +Y G L K ++ R P+ + LDW ++ +A L+++H++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR- 120
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+++RD+K NI L + KL DFG+A++ S ++ +GT Y +P+
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICENR 176
Query: 273 QLTFKSDIYSFGVVLLELITGRKAID 298
KSDI++ G VL E+ T + A +
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 99 LGEGGFGKVYKGC-LEKIEQVVAIK----QLDHRG--VQGVREFSAEVMTLGSADHPNLV 151
+GEG +GKV+K L+ + VA+K Q G + +RE A + L + +HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 67
Query: 152 KLIGYCA----EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
+L C + + +L LV+E++ L +L + P + T + RGL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLD 124
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
+LH V++RDLK NIL+ KL+DFGLA++ T V+ T Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178
Query: 267 DYAMTGQLTFKSDIYSFGVVLLE------LITGRKAIDQ 299
+ + D++S G + E L G +DQ
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+GEG G V ++ ++VA+K++D R Q EV+ + H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V E++ G+L D+ TR ++ + + L LH Q VI+
Sbjct: 88 VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIAAVCLAVLKALSVLH---AQGVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF-- 276
RD+K +ILL KLSDFG + ++GT + AP+ + +L +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPE--LISRLPYGP 195
Query: 277 KSDIYSFGVVLLELITG 293
+ DI+S G++++E++ G
Sbjct: 196 EVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
+G+G FGKV + A+K L + + +E + + L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQL 212
Y + ++L V +Y+ G L HL R P R + AA + + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSL- 115
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+IYRDLK NILL+ H L+DFGL K G ++T ++ GT Y AP+
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 273 QLTFKSDIYSFGVVLLELITG 293
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 10/93 (10%)
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYG 262
L +LH QL +IYRD+K NILL+ H L+DFGL+K + ++ + GT
Sbjct: 118 LDHLH-QLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171
Query: 263 YCAPDYAMTGQLTFKS--DIYSFGVVLLELITG 293
Y AP+ G D +S GV+ EL+TG
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY- 156
+G G +G+VYKG K Q+ AIK +D + E E+ L + H N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 157 -----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
DQ LV E+ GS+ + + + + DW I RGL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH-- 138
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAP--- 266
VI+RD+K N+LL E KL DFG++ D+T V R +GT + AP
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVI 193
Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITG 293
D ++SDI+S G+ +E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS---------ADHPN 149
+G+G FG+VY+ + ++ A+K L + + +E + T+G + P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA---HTIGERNILVRTLLDESPF 57
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHL-HDLR-PDTRPLDWNTRMKIAAGASRGLQY 207
+V L LV +YM G L HL + R + R + + +A L++
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA------LEH 111
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
LH K ++YRDLK NILL+ H L DFGL+K + +KT + GT Y AP+
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPE 166
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITG 293
+ + T D +S GV++ E+ G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 46/223 (20%)
Query: 98 CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLV 151
C+G G +G+VYK + K + AIK+ Q S E+ L H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVV 65
Query: 152 KLIGYCAEGDQRL--LVYEYMPLGSLDKHLHDL--------RPDTRPLDWNTRMKIAAGA 201
L+ E + L+++Y HDL + + + +
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKM--GP-----SGDK 250
G+ YLH V++RDLK +NIL+ E K+ D GLA++ P D
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
V+ T Y AP+ + + K+ DI++ G + EL+T
Sbjct: 175 ------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
N+R LG+G FG+VY + +A KQ+ D + +E SA E+ L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 147 HPNLVKLIGYCAEGDQRLLV--YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
H +V+ G + ++ L EYMP GS+ L T + +I G S
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS-- 120
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
YLH + +++RD+K +NIL + + KL DFG +K M +G ++ V
Sbjct: 121 --YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-----VT 170
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
GT + +P+ K+D++S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G +G VYK ++ AIK + + E++ + H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
D+ + E+ GSL D+ T PL + ++ +GL YLH + K ++
Sbjct: 77 RRDKLWICMEFCGGGSL----QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLT 275
RD+K +NILL + H KL+DFG++ + S +GT + AP+ A G
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGYN 187
Query: 276 FKSDIYSFGVVLLEL 290
DI++ G+ +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
+G G FG V + Q VAIK++ ++ FS E+ L H N
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
++ L + + + V E + D LH L +RPL+ RGL+Y+
Sbjct: 71 IISLSDIFISPLEDIYFVTELL---GTD--LHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H V++RDLK SNIL+ E K+ DFGLA++ +VSTR Y AP+
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEI 176
Query: 269 AMTGQ-LTFKSDIYSFGVVLLELITGR 294
+T Q + DI+S G + E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 127 RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--P 184
+G++ E+S E +T+ PN+V L Y D LV ++ G L H+ P
Sbjct: 24 KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83
Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAK 243
+ W M +A L LH + ++ RDL +NILL++ H +L+ F ++
Sbjct: 84 EECVKRWAAEMVVA------LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134
Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ S D V YCAP+ + T D +S G +L EL+TG+
Sbjct: 135 VEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 99 LGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH 147
LG+G FGKV Y + + E ++A ++ H E L + H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNTRH 54
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQ 206
P L L D+ V EY G L HL R T R + A L+
Sbjct: 55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-----ERARFYGAEIVSALE 109
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
YLH + V+YRD+K N++L++ H K++DFGL K G S T + GT Y AP
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ D + GVV+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 19/229 (8%)
Query: 77 SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REF 135
S K FD + + +G+G +GKV+K +K A+K LD + + E
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEI 61
Query: 136 SAEVMTLGS-ADHPNLVKLIGY-----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
AE L + +DHPN+VK G GDQ LV E GS+ + +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
+ I A GLQ+LH I+RD+K +NILL KL DFG++ S
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-- 176
Query: 250 KTHVSTRVMGTYGYCAPDY-AMTGQL--TF--KSDIYSFGVVLLELITG 293
+GT + AP+ A QL T+ + D++S G+ +EL G
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIG 155
+GEG +G V+K + ++VA+K +LD +GV + E+ L H N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYD 66
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
D++L LV+EY L K+ D +D +GL + H
Sbjct: 67 -VLHSDKKLTLVFEYCD-QDLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
V++RDLK N+L+ + KL+DFGLA+ G + + T Y PD +L
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176
Query: 275 TFKS-DIYSFGVVLLEL 290
S D++S G + EL
Sbjct: 177 YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD---HRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
+G G +G+V K + VAIK+L + R + E+ L DH N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 156 YCAEGDQRLL----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
L VY L D + + ++ + L + + RGL+Y+H
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLMGADLN-NIVK--CQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+I+RDLK SNI + E K+ DFGLA+ +V+TR Y AP+ +
Sbjct: 138 ---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 189
Query: 272 -GQLTFKSDIYSFGVVLLELITGR 294
DI+S G ++ EL+TG+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 12/198 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
+G+G FGKV + +++ A+K + + E + AE L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
++ LV ++ G L H L+ + R R A L+ LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAE-LLCALENLHKF---N 113
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
VIYRDLK NILL+ H L DFGL K+ D + GT Y AP+ + T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171
Query: 276 FKSDIYSFGVVLLELITG 293
D ++ GV+L E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 11/97 (11%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY- 261
RGL+Y+H V++RDLK SN+LL K+ DFGLA+ D H T + Y
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYV 170
Query: 262 ---GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
Y AP+ + + K+ DI+S G +L E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 62/207 (29%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 99 LGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH 147
LG+G FGKV Y + K E +VA ++ H E L ++ H
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 54
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P L L D+ V EY G L HL R + A L Y
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDY 110
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
LH + + V+YRDLK N++L++ H K++DFGL K G T + GT Y AP+
Sbjct: 111 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 166
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
D + GVV+ E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
N+R LG G FG+VY + +A+KQ+ D + +E +A E+ L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 147 HPNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
H +V+ G + +++ L EYMP GS+ L T N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQILQG 118
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
+ YLH + +++RD+K +NIL + + KL DFG +K M +G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
GT + +P+ K+D++S ++E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQV---VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
+GEG G V C+ + + VA+K +D R Q EV+ + H N+V++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
G++ ++ E++ G+L + R L+ + + L YLH Q
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQ---G 137
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
VI+RD+K +ILL KLSDFG A++ K ++GT + AP+
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPY 194
Query: 275 TFKSDIYSFGVVLLELITG 293
+ DI+S G++++E++ G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVK--- 152
+G+G +G+V + IK+L+ R RE A E L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 153 -----------LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
++G+C GD +Y L + L P+ + ++W ++ +A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA--- 114
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
LQYLHE+ +++RDLK N+ L K+ D G+A++ + + +++ ++GT
Sbjct: 115 ---LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTP 166
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
Y +P+ +KSD+++ G + E+ T + A + KD L
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGS-ADHPNLVKLIG 155
+GEG F +V K K + AIK + + ++ V E+ L + HPN+++LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 156 --YCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ + + LV+E M D +L++L + RPL + L ++H
Sbjct: 66 VLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
+ + +RD+K NIL+ + KL+DFG + T + T Y AP+ +T
Sbjct: 118 RNGIFHRDIKPENILI-KDDILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 272 GQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
G K DI++ G V E+++ G +DQ
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-10
Identities = 62/199 (31%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
LG+G FGKV + + A+K L + E + E L + HP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
D+ V EY+ G L HL R + TR A S L YLH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSED---RTRFYGAEIVS-ALDYLHSG---K 115
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
++YRDLK N++L++ H K++DFGL K G + T + GT Y AP+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYG 173
Query: 276 FKSDIYSFGVVLLELITGR 294
D + GVV+ E++ GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 38/221 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYK + +A+K++ + GV +RE S L H N+V+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS----LLKEMQHGNIVR 65
Query: 153 L--IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQY 207
L + + ++RL LV+EY+ L L KH+ D PD N R+ RG+ Y
Sbjct: 66 LQDVVHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAY 117
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
H V++RDLK N+L++ + KL+DFGLA+ G T + T Y AP
Sbjct: 118 CHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAP 172
Query: 267 DYAMTGQLTFKS--DIYSFGVVLLELIT------GRKAIDQ 299
+ + G + + DI+S G + E++ G ID+
Sbjct: 173 E-ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+G FGKV + +++ AIK L V V E L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
C + RL V EY+ G L + + P + AA + GL +LH +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSK--- 120
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
+IYRDLK N++L+ H K++DFG+ K V+T+ GT Y AP+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
D ++FGV+L E++ G+ + +D EL
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-----EFSAEVMTLGSADHPNLVKL 153
LG+G FG VY +K +K L V + + + E L DHP +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQY 207
E D ++ EY LD L +L+ + + +W ++ + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
+H+ + +++RDLK NI L+ K+ DFG+++ MG S D ++T GT Y +
Sbjct: 122 MHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCD---LATTFTGTPYYMS 173
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLEL 290
P+ KSDI+S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 53/223 (23%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G +G V ++ + VAIK++ D + R E+ L H N++ L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 155 G-------------YCAEGDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMK-IA 198
Y +V E M L + K L D ++
Sbjct: 66 DILRPPSPEDFNDVY--------IVTELMETDLHKVIKSPQPLTDD--------HIQYFL 109
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKT-----H 252
RGL+YLH VI+RDLK SNIL+ K+ DFGLA+ + P D+ +
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
V TR Y AP+ ++ K+ DI+S G + EL+T +
Sbjct: 167 VVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK----QLDHRGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +GKVYK + ++VA+K ++D G+ +RE S M ++ +V+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML---SESIYIVR 65
Query: 153 LIGYCAE------GDQRL-LVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASR 203
L+ E G L LV+EY L S K D R RPL T +
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEY--LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMG--PSGDKTHVSTRVMGT 260
G+ + H K V++RDLK N+L++ + K++D GL + P TH + T
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVT 174
Query: 261 YGYCAPDYAMTGQLTFKS--DIYSFGVVLLELITG 293
Y AP+ + G + + DI+S G + E+
Sbjct: 175 LWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD----HRGVQGVRE--------FSA--EVMTLGS 144
LGEG +GKV K ++VAIK++ V R+ F+ E+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------IA 198
H N++ L+ EGD LV + M DL+ + +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDLK---KVVDRKIRLTESQVKCIL 125
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-------MGP-SGDK 250
GL LH K ++RDL +NI + K++DFGLA+ S D+
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 251 THVSTRVMG----TYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
T M T Y AP+ M + F D++S G + EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 18/195 (9%)
Query: 107 VYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL- 164
+YKG E ++ + H+G + + E+ L D N++K+ G+ + L
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 165 ---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL 221
L+ EY G L + L + L + T++ +A +GL L++ +P Y++L
Sbjct: 96 RLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 222 KCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSD 279
+ L+ E Y K+ GL K+ S +V+ V Y + + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204
Query: 280 IYSFGVVLLELITGR 294
IYS GVVL E+ TG+
Sbjct: 205 IYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKL 153
LG G G V + A+K +D G+ AEV L + D ++VK
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 154 IGYCAEGDQR--------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
A+ D R LV +Y G L + + R GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---------REHEAGL 147
Query: 206 QYL------HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
++ H + +I+RD+K +NILL KL DFG +KM + V G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
T Y AP+ + K+D++S GV+L EL+T ++ D
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 46/146 (31%), Positives = 66/146 (45%), Gaps = 10/146 (6%)
Query: 102 GGFGKVY---KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
G FGKVY K K+ V +K+ D V + AE L + P +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ LV EY+ G + LH D +K + + L YLH + +I+
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM 244
RDLK N+L+ H KL+DFGL+K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 65/267 (24%), Positives = 129/267 (48%), Gaps = 36/267 (13%)
Query: 56 GQLSMDVKNLNLKDDSNNS-----GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKG 110
G+ M+ K L+ ++ S+N+ K D + +++ +G G FG VY+
Sbjct: 26 GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEA 85
Query: 111 -CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY----CAEGDQRLL 165
C++ E+ VAIK++ +Q + + E++ + + +H N++ L Y C + +++ +
Sbjct: 86 ICIDTSEK-VAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140
Query: 166 ----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL 221
V E++P ++ K++ + L + R L Y+H + + +RDL
Sbjct: 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDL 196
Query: 222 KCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS-- 278
K N+L++ H KL DFG AK +G + S + + Y AP+ M G + +
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPEL-MLGATNYTTHI 252
Query: 279 DIYSFGVVLLELI------TGRKAIDQ 299
D++S G ++ E+I +G+ ++DQ
Sbjct: 253 DLWSLGCIIAEMILGYPIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 10/165 (6%)
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
E M L + +HP+++++ G +V +P S D + + L +RPL + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-LTKRSRPLPIDQALII 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
GL+YLH Q +I+RD+K NI + + + D G A+ P + +
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--L 216
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302
GT AP+ + K+DI+S G+VL E++ I +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 3/156 (1%)
Query: 137 AEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK 196
+E+ L + DH +VK D+ LL+ EY G L+K + + P +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYE 170
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
+ + + L E + +++RDLK +NI L KL DFG +K V++
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
GT Y AP+ + + K+D++S GV+L EL+T
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 52/150 (34%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 148 PNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA-SRGL 205
P LV L Y + D +L L+ +Y+ G L HL R ++I +G L
Sbjct: 65 PFLVTL-HYAFQTDTKLHLILDYINGGELFTHL-----SQRERFKEQEVQIYSGEIVLAL 118
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
++LH K +IYRD+K NILL+ H L+DFGL+K D+ + GT Y A
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174
Query: 266 PDYAMTGQLTFKS--DIYSFGVVLLELITG 293
PD G D +S GV++ EL+TG
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGT 260
RGL+Y+H VI+RDLK SN+L+ E ++ DFG+A+ + + T + T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 261 YGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAI 297
Y AP+ ++ + T D++S G + E++ GR+ +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + +QV A+K L + + F E + A+ +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL-- 108
Query: 156 YCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ A D + L V EYMP G L + + P W R A L +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-ARFYTAE-VVLALDAIH---S 160
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
I+RD+K N+LL++ H KL+DFG KM +G T V GT Y +P+ +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQ 218
Query: 272 ---GQLTFKSDIYSFGVVLLELITG 293
G + D +S GV L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCA 158
G +G VY ++ Q A+K+++ + + +++ E L A++P +V + +C+
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM--FCS 69
Query: 159 EGDQRLL--VYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+R L V EY+ G +L K++ L P+D RM A L+YLH
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLKNIGAL-----PVDM-ARMYFAE-TVLALEYLH---N 119
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-------STR------VMGT 260
+++RDLK N+L+ H KL+DFGL+K+G T++ TR V GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
Y AP+ + D ++ G++L E + G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
+G G +G V + + VAIK++ D+R + R E+ L DH N++ +
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLR-EIKLLRHLDHENVIAI 69
Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
R +VYE M D LH + ++ L + RGL+Y
Sbjct: 70 KD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
+H V++RDLK SN+LL K+ DFGLA+ + +K T + T Y AP+
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178
Query: 268 YAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302
+ + T D++S G + EL+ GRK + KD
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFS-AEVMTLGSADHPNLVKLIGY 156
+GEG +G V K ++ +++VAIK+ D + V+E + E+ L + N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ LV+EY+ L+ L + P+ P + K+ + + ++ +H K +
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKNDI 121
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RD+K N+L+ KL DFG A+ G + T + T Y +P+ +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGK 180
Query: 277 KSDIYSFGVVLLELITGR 294
D++S G +L EL G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 52/258 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + A+K L V AE L AD+ +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ D V +Y+P G + L +R D R IA ++ +H K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDL-ARFYIAELTC-AIESVH---KMG 121
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---------------------KMGPSGDKTHVS 254
I+RD+K NIL++ H KL+DFGL M PS + + +
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 255 TRVM--------------------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ GT Y AP+ + T D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 295 KA-IDQTKDRKELNLVAW 311
+ T +L ++ W
Sbjct: 242 PPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 70/262 (26%), Positives = 107/262 (40%), Gaps = 56/262 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG+V C + A+K L + V V AE L AD+ +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ D V +Y+P G + L +R + P + R IA + ++ +H K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--IRMEVFP-EVLARFYIAE-LTLAIESVH---KMG 121
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---------------------KMGPS------- 247
I+RD+K NIL++ H KL+DFGL M PS
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 248 ----GD----------KTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
GD K H ++ ++GT Y AP+ + T D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 291 ITGRKA-IDQTKDRKELNLVAW 311
+ G+ + T +L ++ W
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
RGL+Y+H +I+RDLK SN+ + E K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
Y AP+ + DI+S G ++ EL+TGR T +L L+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 36/112 (32%), Positives = 59/112 (52%), Gaps = 5/112 (4%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
RGL+YLH +++RD+K N+L+ K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 263 YCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
Y AP+ M + T DI+S G + EL+ R ++L+L+ LL
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 99 LGEGGFGKVYKGCLEKI-------EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPN 149
LG+G F K++KG ++ + V +K LD HR +A +M+ S H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKH 60
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
LV G C GD+ ++V EY+ GSLD +L + + W ++++A + L +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLE 117
Query: 210 EQLKQPVIYRDLKCSNILL--EE----GYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTY 261
+ + + + ++ N+LL EE G P KLSD G++ K + R+
Sbjct: 118 D---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVP 172
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
C + L+ +D +SFG L E+ +G
Sbjct: 173 PECIEN---PQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 14/196 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G +G VYK ++ A+K + E+ + H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
++ + EY GSL D+ T PL + +GL YLH + K ++
Sbjct: 77 SREKLWICMEYCGGGSL----QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQL 274
RD+K +NILL + KL+DFG+ AK+ + K +GT + AP+ A G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 275 TFKSDIYSFGVVLLEL 290
DI++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 35/235 (14%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVRE-FSAEVMTLGSADHPNLVKLIG 155
+G+GG G+VY + VA+K++ D +++ F E HP +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 156 YCAEGDQRLLVYEYMP------LGSLDKHLHDLRPDTRPLDWNTRMK----IAAGASRGL 205
C++GD VY MP L SL K + ++ L T + I +
Sbjct: 70 ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-------------GPSGDKTH 252
+Y+H + V++RDLK NILL + D+G A
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 253 VST---RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
T +++GT Y AP+ + + +DIY+ GV+L +++T + K RK
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238
|
Length = 932 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 97 CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
C +G G +G VYK + K E+ A+KQ++ G+ E+ L HPN++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQ 64
Query: 155 G-YCAEGDQRL-LVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQYL 208
+ + D+++ L+++Y L + K + + +P+ M + G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 209 HEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGY 263
H V++RDLK +NIL+ E K++D G A++ S K V+ T+ Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 264 CAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
AP+ + + K+ DI++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 92 NFRSDCCLGEGGFGKVY---------KG------CLEKIEQVVAIKQLDH-RGVQGVREF 135
NF LG G +GKV+ G L+K V K ++H R + V E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTR 194
+ P LV L Y + + +L L+ +Y+ G + HL+ R
Sbjct: 61 VRQS--------PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDE 106
Query: 195 MKIAAGAS-RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
++ +G L++LH K ++YRD+K NILL+ H L+DFGL+K S +K
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITG 293
+ GT Y AP+ K+ D +S G+++ EL+TG
Sbjct: 164 YS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G G V+ ++ VA+K++ Q V+ E+ + DH N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 159 EGDQRL--------------LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS 202
L +V EYM DL + PL
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLL 124
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK-MGPS-GDKTHVSTRVMG 259
RGL+Y+H V++RDLK +N+ + E K+ DFGLA+ + P K ++S ++
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 260 TYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ Y +P ++ T D+++ G + E++TG+ + +++ L+
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPN 149
+ S +G G +G V ++ + VAIK+L R Q + E+ L H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 150 LVKLIGY---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
++ L+ GD+ Y MP D L + PL + + GL+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM--GHPLSEDKVQYLVYQMLCGLK 131
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
Y+H +I+RDLK N+ + E K+ DFGLA+ + +V TR Y AP
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP 183
Query: 267 DYAMTGQLTFKS-DIYSFGVVLLELITGR 294
+ + ++ DI+S G ++ E++TG+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + + A+K + + + V F E L ++ P + +L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ D LV EY P G L L L D + A + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---G 122
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
++RD+K N+L++ H KL+DFG A++ + +K S +GT Y AP+ T
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 272 ---GQLTFKSDIYSFGVVLLELITGR 294
G + D +S GV+ E+I GR
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS---TRVMG 259
GL+Y+H V++RDLK N+L+ K+ DFGLA+ G S + + T +
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVA 171
Query: 260 TYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
T Y AP+ ++ Q K+ D++S G +L EL+ GRK + + KD
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV---REFSAEVMTLGSADHPNLVKLIG 155
+G G +G V ++ Q VA+K+L R Q + R E+ L H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 156 Y---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ VY L D L+++ + D + + I RGL+Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSA- 137
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+I+RDLK SN+ + E ++ DFGLA+ +V+TR Y AP+ M
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE-IMLN 189
Query: 273 QLTFKS--DIYSFGVVLLELITGR------KAIDQTK 301
+ + DI+S G ++ EL+ G+ IDQ K
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 17/174 (9%)
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL---HDLRPDTRPLDWNTRMKIAAGASR 203
HPN+++ +G C E LLV+EY LG L +L R +++ L ++A +
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAA 110
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
G+ ++H K ++ DL N L K+ D+G+ D +
Sbjct: 111 GVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 264 CAP-------DYAMTGQLTFKSDIYSFGVVLLELI-TGRKAIDQTKDRKELNLV 309
AP +T + T S++++ GV L EL + DR+ LN V
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + ++V A+K L + + F E + A+ P +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 156 YCAEGDQRLL--VYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+CA D + L V EYMP G L + + P+ + + +A A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
RD+K N+LL++ H KL+DFG KM +G T V GT Y +P+ +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLKS 217
Query: 272 ----GQLTFKSDIYSFGVVLLELITG 293
G + D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
+G G +G V + VAIK+L +R Q + E+ L H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 156 YCAEG---DQRLLVYEYMP-----LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
D+ Y MP LG L KH L + + +GL+Y
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKY 133
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
+H +I+RDLK N+ + E K+ DFGLA+ S +V TR Y AP+
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185
Query: 268 YAMTG-QLTFKSDIYSFGVVLLELITGR 294
+ T DI+S G ++ E++TG+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 58/240 (24%)
Query: 99 LGEGGFGKVYKGCLEKIE-QVVAIKQLD-----HRG-VQGVREFSAEVMTLGSADHPNLV 151
+G G FG+V + +K + A+K+L + V VR AE L AD+P +V
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR---AERDILAEADNPWVV 64
Query: 152 KLIGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
KL Y + D+ L+ EY+P G + L ++ DT + TR IA + +H
Sbjct: 65 KL--YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEE-ETRFYIAETI-LAIDSIH 118
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL------------------AKMGPSGD-- 249
+L I+RD+K N+LL+ H KLSDFGL A D
Sbjct: 119 -KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 250 -KTHVSTR---------------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
K S R +GT Y AP+ + + D +S GV++ E++ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 50/242 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRG--VQGVREFSAEVMTLGSADHPNLVK 152
+G+G FG+V+K +K +Q+VA+K++ + G + +RE + L H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 75
Query: 153 LIGYC---AEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR- 203
LI C A R LV+E+ HDL L N +K +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG----LLSNKNVKFTLSEIKK 123
Query: 204 -------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHV 253
GL Y+H + +++RD+K +NIL+ + KL+DFGLA+ + +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 254 STRVMGTYGYCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAIDQ-TKDRKELNLVA 310
+ RV+ T Y P+ + G+ + D++ G ++ E+ T R I Q ++ +L L++
Sbjct: 181 TNRVV-TLWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLIS 237
Query: 311 WL 312
L
Sbjct: 238 QL 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 97 CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
C +G G +G VYK + K ++ A+KQ++ G+ E+ L HPN++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQ 64
Query: 155 G-YCAEGDQRL-LVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQYL 208
+ + D+++ L+++Y L + K + + +P+ M + G+ YL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 209 HEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGY 263
H V++RDLK +NIL+ E K++D G A++ S K V+ T+ Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 264 CAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
AP+ + + K+ DI++ G + EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 47/250 (18%)
Query: 62 VKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKV----YKG------C 111
+KNL L +S + +P +++ NF LG G FG+V YK
Sbjct: 4 LKNLQL-HKKKDSDSTKEPKRKNKMKYEDFNFIR--TLGTGSFGRVILATYKNEDFPPVA 60
Query: 112 LEKIEQ--VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
+++ E+ ++ KQ+DH +E L +HP V L G + LV E+
Sbjct: 61 IKRFEKSKIIKQKQVDH--------VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ--YLHEQLKQ-PVIYRDLKCSNI 226
+ G L N R G Q + E L+ ++YRDLK N+
Sbjct: 113 VIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162
Query: 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQLTFKSDIYSF 283
LL++ K++DFG AK+ V TR + GT Y AP+ + +D ++
Sbjct: 163 LLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 284 GVVLLELITG 293
G+ + E++ G
Sbjct: 215 GIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 30/246 (12%)
Query: 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RGVQGVREFSAE 138
+++ +T F+ LGEG FGKV + K ++ A+K + + R + +F +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 139 VMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTR 194
V AD L+K+ Y G +++ +Y P L + KH P
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH--------GPFSHRHL 233
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----------YHPKLSDFGLAK 243
+I L Y H +L +++ DLK NIL+E P +
Sbjct: 234 AQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+G D+ H T ++ T Y +P+ + + +D++S G ++ EL TG+ D +
Sbjct: 292 LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351
Query: 304 KELNLV 309
+ L+L+
Sbjct: 352 EHLHLM 357
|
Length = 467 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 62/265 (23%)
Query: 99 LGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
LG G FG+V CL + + + A+K L + V V AE L AD+ +V+
Sbjct: 9 LGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L + D V +Y+P G + L +R P D R IA + ++ +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDL-ARFYIAE-LTCAVESVH--- 118
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL---------AKMGPSGD-------------- 249
K I+RD+K NIL++ H KL+DFGL +K SGD
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 250 -------------------KTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
+ H ++ ++GT Y AP+ + T D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 288 LELITGRKA-IDQTKDRKELNLVAW 311
E++ G+ + QT ++ ++ W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-------REFSAEVMTLGSADHPNLV 151
+G G G V Q VAIK+L R Q V RE +M L +H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYREL--VLMKL--VNHKNII 78
Query: 152 KLIGYCAEGDQRLL-----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
L+ Q+ L VY M L +D +L + LD + G++
Sbjct: 79 GLLN--VFTPQKSLEEFQDVYLVMEL--MDANLCQVI--QMDLDHERMSYLLYQMLCGIK 132
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
+LH +I+RDLK SNI+++ K+ DFGLA+ +G ++ V+ Y Y AP
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAP 186
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
+ + DI+S G ++ E+I G IDQ
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V L+ ++V A+K L+ + E F E L + D+ + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLH 67
Query: 156 YCAEGDQRL-LVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
Y + + L LV +Y G +L D P+ + M IA + L Y+H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH-- 125
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY--A 269
RD+K NIL++ H +L+DFG + + D T S+ +GT Y +P+ A
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 270 M---TGQLTFKSDIYSFGVVLLELITG 293
M G+ + D +S GV + E++ G
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS-TRVMGTY 261
R L+Y+H V +RDLK NIL K+ DFGLA++ + T + T + T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 262 GYCAPDY--AMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + + T DI+S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 42/174 (24%)
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYE---YMPLGSLDKHLH------DLRPDTRP 188
E++ LG +H N++K+ + +L E YM D L+ RP
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA------ 242
L TR I ++Y+H++ +I+RD+K NI L L DFG A
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 243 ----KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
G G S ++ GYC ++T DI+S G++LL++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 31/112 (27%), Positives = 60/112 (53%), Gaps = 7/112 (6%)
Query: 183 RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
D+ PLD + ++ ++ ++G+ +L + I+RD+ N+LL +G K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 243 K--MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M S + R+ + AP+ T +SD++S+G++L E+ +
Sbjct: 260 RDIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 32/165 (19%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE--QVVAIK-----------QLDHRGVQGVREFSAE 138
+F + +G+G FG+V ++K + ++ A+K QL H V+ AE
Sbjct: 2 DFHTVKVIGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAH-----VK---AE 51
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
L +D P +V L Y + Q L L+ E++P G L L ++ DT D TR +
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDTFSEDV-TRFYM 107
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
A ++ +H K I+RD+K NIL++ G H KLSDFGL+
Sbjct: 108 AE-CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 16/168 (9%)
Query: 127 RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-- 184
+ V G + E+ L + H ++ LI +V MP K+ DL
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MP-----KYKCDLFTYV 176
Query: 185 -DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA- 242
+ PL + I L YLH + +I+RD+K NI L+E + L DFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233
Query: 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
K+ D GT +P+ K+DI+S G+VL E+
Sbjct: 234 KLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
+G G FG+V+ ++ ++ K + +RG++ RE S EV + H N+V+ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYID 79
Query: 156 -YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ + +Q+L ++ E+ G L +++ ++ + + I L Y H
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 214 QP----VIYRDLKCSNILLEEGYH-----------------PKLSDFGLAKMGPSGDKTH 252
P V++RDLK NI L G K+ DFGL+K H
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199
Query: 253 VSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+GT Y +P+ + T KSD+++ G ++ EL +G+ + + +L
Sbjct: 200 ---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 50/194 (25%), Positives = 76/194 (39%), Gaps = 28/194 (14%)
Query: 111 CLE-KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
C++ K + V IK G + E L + +HP++++L G Y
Sbjct: 111 CIDNKTCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKG--------TFTYNK 156
Query: 170 MPLGSLDKHLHDLR---PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226
L ++ DL R + + I R +QYLHE +I+RD+K NI
Sbjct: 157 FTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENI 213
Query: 227 LLEEGYHPK---LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF 283
+ HP L DFG A P + GT AP+ DI+S
Sbjct: 214 FIN---HPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269
Query: 284 GVVLLELITGRKAI 297
G+VL E+ T ++
Sbjct: 270 GIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 3/111 (2%)
Query: 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
L D LD + + ++G+ +L + I+RDL NILL G K+ DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
A+ + V + AP+ TF+SD++S+G++L E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V ++ E++ A+K L+ + E F E L + D + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLH 67
Query: 156 YCAEGDQRL-LVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
Y + + L LV +Y G +L D P+ + M +A + L Y+H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVMGTYGYCAPDY-- 268
RD+K N+LL+ H +L+DFG KM G T S+ +GT Y +P+
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEILQ 176
Query: 269 AM---TGQLTFKSDIYSFGVVLLELITG 293
AM G+ + D +S GV + E++ G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVM 258
+RG+++L + I+RDL NILL E K+ DFGLA+ D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL- 238
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFGV+L E+ +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + +V A+K L + + F E + A+ P +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
Y + D+ L +V EYMP G L + + P+ + + +A A + ++H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
RD+K N+LL++ H KL+DFG KM G T V GT Y +P+ +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAV-GTPDYISPEVLKSQ 218
Query: 272 ---GQLTFKSDIYSFGVVLLELITG 293
G + D +S GV L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 15/131 (11%)
Query: 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226
Y+ + L D + L + +RG+++L + ++RDL N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM--GTY---GYCAPDYAMTGQLTFKSDIY 281
LL +G K+ DFGLA+ D H S V T+ + AP+ T SD++
Sbjct: 269 LLAQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323
Query: 282 SFGVVLLELIT 292
S+G++L E+ +
Sbjct: 324 SYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 50/168 (29%), Positives = 68/168 (40%), Gaps = 38/168 (22%)
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD--TRPLDWNTRMKIAAGASRG 204
HPN++ G ++ +M GS + L P+ + L N I GA RG
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRG 113
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHV-------STR 256
L YLH+ I+R++K S+IL+ LS L + +G K V ST
Sbjct: 114 LNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 257 VM----------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
V+ YGY KSDIYS G+ EL TGR
Sbjct: 171 VLPWLSPELLRQDLYGY-----------NVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
G+++LH +I+RDLK SNI+++ K+ DFGLA+ +G ++ V+ Y Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 184
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
AP+ + DI+S G ++ E++ GR IDQ
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
G+++LH +I+RDLK SNI+++ K+ DFGLA+ +G ++ V+ Y Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
AP+ + DI+S G ++ E+I G IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 9e-05
Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 116 EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173
E V +K LD HR + +A +M+ S H +L + G C G + ++V E++ G
Sbjct: 44 ELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHLAFVHGVCVRGSENIMVEEFVEHG 101
Query: 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL-----L 228
LD L + P+ W ++ +A + L YL + + +++ ++ NIL L
Sbjct: 102 PLDVCLRKEKGRV-PVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155
Query: 229 EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVV 286
EG P KLSD G++ S ++ R+ C P L+ +D +SFG
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREER--VERIPWIAPECVPG---GNSLSTAADKWSFGTT 210
Query: 287 LLEL 290
LLE+
Sbjct: 211 LLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
G+++LH +I+RDLK SNI+++ K+ DFGLA+ + + T + T Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
AP+ + DI+S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
+F S +G G FG+V + + A+K L D + V AE L AD
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
+VK+ + L+ E++P G + L ++ DT + T+ IA + +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLS-EEATQFYIAE-TVLAIDAI 117
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---------------KMGPSGD---- 249
H QL I+RD+K N+LL+ H KLSDFGL P D
Sbjct: 118 H-QLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 250 --------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
+ ++ +GT Y AP+ M D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGP----SGDKTHVS 254
+RG+++L + I+RDL NILL E K+ DFGLA+ P GD +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLP 238
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M AP+ T +SD++SFGV+L E+ +
Sbjct: 239 LKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMG 259
+ G+++L + ++RDL N+L+ EG K+ DFGLA+ M S + ST +
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-- 303
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T SD++SFG++L E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 43/238 (18%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
+F S +G G FG+V + V A+K L D + V AE L AD
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
+VK+ + L+ E++P G + L ++ DT + T+ IA + +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLT-EEETQFYIAE-TVLAIDSI 117
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------------- 251
H QL I+RD+K N+LL+ H KLSDFGL +T
Sbjct: 118 H-QLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 252 ----------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
++ +GT Y AP+ M D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVM 258
++G+++L + I+RDL NILL E K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ AP+ T +SD++SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 38/216 (17%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
C + + K + +VA+K+ LD + ++ E++T HPN++ +
Sbjct: 9 CFEDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 156 YCAEGDQRLLVYEYMPLGS----LDKHLHDLRPDTRPLDWNTRMKIA---AGASRGLQYL 208
+ +V M GS L H + P+ IA L Y+
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---------AIAFILKDVLNALDYI 117
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV--------STRVMGT 260
H + I+R +K S+ILL LS + K S + +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL-- 172
Query: 261 YGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITG 293
+ +P + G KSDIYS G+ EL G
Sbjct: 173 -PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 49/220 (22%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RG------------VQGVREFSAEVMT 141
+G G FG+V ++ QV A+K L+ R V G R + +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW---ITN 65
Query: 142 LGSA--DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
L A D NL ++ Y GD L L + L P+ + M +A
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAEMVLAI 115
Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVM 258
+ L Y+H RD+K N+LL++ H +L+DFG ++ G T S +
Sbjct: 116 DSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAV 164
Query: 259 GTYGYCAPDY--AM---TGQLTFKSDIYSFGVVLLELITG 293
GT Y +P+ AM G+ + D +S GV + E++ G
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 43/163 (26%), Positives = 63/163 (38%), Gaps = 25/163 (15%)
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL------RPDTRPL 189
E L HP ++ L+ G LV L K+ DL R RPL
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV--------LPKYRSDLYTYLGARL--RPL 257
Query: 190 DWNTRMKIAAGASR---GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
++ A A + + Y+H + +I+RD+K N+L+ L DFG A
Sbjct: 258 G---LAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 289
T + GT AP+ T DI+S G+V+ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 99 LGEGGFGKVYKGCL------------EKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGS 144
LG G ++Y G L + E V +K LD HR + + F M +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDIS-LAFFETASM-MRQ 60
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
H ++V L G C + ++V E++ G LD +H + L + K+A +
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASA 117
Query: 205 LQYLHEQLKQPVIYRDLKCSNILL-------EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
L YL + + +++ ++ NILL E G KLSD G+ S + R+
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS--RQECVERI 172
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
C D + L+ +D +SFG L E+
Sbjct: 173 PWIAPECVED---SKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.83 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.39 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.15 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.09 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.04 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.62 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.53 | |
| PLN02236 | 344 | choline kinase | 97.48 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.25 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.12 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.08 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.04 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.99 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.95 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.94 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.65 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.29 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.25 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.25 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.86 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.75 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.73 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=368.23 Aligned_cols=212 Identities=31% Similarity=0.464 Sum_probs=190.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|.+.+.||+|+|++||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467999999999999999999999999999999998773 44567789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC------CceEEeccC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG------YHPKLSDFG 240 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~------~~~kl~Dfg 240 (315)
||||.||+|.+|++. .+.+++..++.++.||+.||++||+. +||||||||.|||++.. -.+||+|||
T Consensus 88 MEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999987 45799999999999999999999998 99999999999999864 458999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+|+...... .....+|+|.|||||++....|+.++|+||+|+|+|+|++|++||+..+..+.+..++
T Consensus 161 fAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~ 227 (429)
T KOG0595|consen 161 FARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK 227 (429)
T ss_pred hhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 999876443 2345699999999999999999999999999999999999999999887776665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=359.73 Aligned_cols=213 Identities=31% Similarity=0.434 Sum_probs=193.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++++.||+|+||+||.++.+.+++.||+|++++... ...+....|..+|..++||.||+++..|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3579999999999999999999999999999999987643 3466788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+||+.||.|...|.+ ...+++..++.++.+|+.||.|||+. +||||||||+|||+|..|+++|+|||+|+...
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999986 57799999999999999999999998 99999999999999999999999999998543
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
... ..+..++||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+..+....|..
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~ 239 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK 239 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence 322 223447999999999999999999999999999999999999999999988877777653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=336.70 Aligned_cols=208 Identities=29% Similarity=0.402 Sum_probs=191.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|+.++.||.|+||+|.+++++.+|..+|+|++++... ...+...+|..+|+.+.||+++++++.|.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 368889999999999999999999999999999987654 34566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++||.|+.+++. ..++++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999987 46799999999999999999999998 999999999999999999999999999986443
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
. ....||||.|+|||++...+|+.++|+|||||++|||+.|.+||.+.+.....++|.
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~ 254 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL 254 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH
Confidence 3 455799999999999999999999999999999999999999999999877777764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=362.09 Aligned_cols=211 Identities=27% Similarity=0.444 Sum_probs=193.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.+|...+.||+|||+.||.+.+..+|+.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999998743 345678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|+|+.++|..+++. .+++++.+++.++.||+.||.|||+. +|+|||||..|+|++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999885 57899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.... ....||||.|.|||++....++..+||||+||++|.||.|++||+..+-.+.++.|+
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 3222 234699999999999999999999999999999999999999999998888887775
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=342.46 Aligned_cols=218 Identities=25% Similarity=0.353 Sum_probs=191.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEe-EEeeCCe-EEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIG-YCAEGDQ-RLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~~lv 166 (315)
.+|.+.++||+|+||+||++.+..+|..+|.|.++-... ...+.+..|+.+|++|+|||||++++ .|.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 358899999999999999999999999999999874432 34667899999999999999999999 4544444 8999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ-PVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~-~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||..|+|...++..+...+.+++..+|+++.|++.||..+|+.+++ -|+||||||.|||++.+|.+||+|||++++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999998888889999999999999999999999994332 3899999999999999999999999999986
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
..... .....+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+.+-.+.-.+|+
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~ 241 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE 241 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH
Confidence 55433 3345689999999999999999999999999999999999999999986555555554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=345.65 Aligned_cols=204 Identities=29% Similarity=0.425 Sum_probs=179.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-------GVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
..+.|.+.+.||+|+||.|.+|..+.+|+.||||++++.... ....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456788999999999999999999999999999999865321 2334789999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---CceEEec
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSD 238 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~---~~~kl~D 238 (315)
..|+||||++||.|.+++-. .+.+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999876 56688888899999999999999999 99999999999999765 6799999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCc---CcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
||+|+..... ......||||.|.|||++.+..+ ..++|+|||||+||-+++|.+||++...
T Consensus 323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 9999975432 33456799999999999987643 3488999999999999999999987543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=333.93 Aligned_cols=210 Identities=29% Similarity=0.389 Sum_probs=183.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-eEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e~ 169 (315)
+.+.++.||+|..|+||++.|+.|++.+|+|++... +....+++.+|+++++..+||+||.+|++|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 455667799999999999999999999999999544 3455778999999999999999999999999998 49999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
|++|+|+++++. .+.+++.....++.+|++||.|||.. ++||||||||+|||++..|.|||||||.++.....
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999986 36699999999999999999999963 39999999999999999999999999999865544
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc--CchhhhhHHhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT--KDRKELNLVAW 311 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~~i~~ 311 (315)
....++||..|||||.+.+..|+.++||||||+.++|+++|+.||... .....+.++..
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA 293 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence 334568999999999999999999999999999999999999999864 22334444443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=347.14 Aligned_cols=216 Identities=24% Similarity=0.320 Sum_probs=192.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|.++..||+|+||.||+|+.+.||..+|+|+++++.. ...+.+..|-.+|...++|.||++|..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45689999999999999999999999999999999988754 456778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++||++..+|.. ...|++..++.++.+++.|+..||.. |+|||||||+|+|||..|++||+|||+|.-.
T Consensus 219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999986 57799999999999999999999998 9999999999999999999999999998521
Q ss_pred CC----------------------CCCc----ee-------------------eeeccccccccCccccccCCcCcccch
Q 021249 246 PS----------------------GDKT----HV-------------------STRVMGTYGYCAPDYAMTGQLTFKSDI 280 (315)
Q Consensus 246 ~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 280 (315)
.. .+.. .. ....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0000 00 113479999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 281 YSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 281 wslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
||||||+||||.|.+||.+.++.+....|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n 402 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVN 402 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999999888887753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=348.93 Aligned_cols=218 Identities=28% Similarity=0.405 Sum_probs=193.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
.-..+|...+.||.|+|++|++|+.+.+++.||||++.++-. ...+.+..|-.+|.+| .||.|+++|-.|+|+..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999999999999999986532 3345577788888888 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|+|+||+++|+|.++|+. .+.+++..++.++.||+.||+|||+. |||||||||+|||+|.+++++|+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999987 46799999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCc---------eee--eeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 244 MGPSGDKT---------HVS--TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 244 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
.+...... ... ..++||..|.+||++.+...++.+|+|+||||||+|+.|.+||.+.++.-..++|-.|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 76432221 111 4589999999999999999999999999999999999999999999988777777544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=325.77 Aligned_cols=214 Identities=27% Similarity=0.310 Sum_probs=188.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
+.|+.+.++|+|+||+||+++++.||+.||||.+-.+.. ...+-..+|+++|+++.|||+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357888899999999999999999999999999965533 234457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||+. ++.+.|... ...++.+.+..+++|++.|+.|||+. ++|||||||+||||+.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9975 444445442 44588999999999999999999998 999999999999999999999999999997664
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
.....+..+.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+.|.+.++.+++.+|...+
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 2334566789999999999887 689999999999999999999999999999999999998765
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=336.65 Aligned_cols=232 Identities=63% Similarity=1.038 Sum_probs=201.0
Q ss_pred CCCCcCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeE
Q 021249 77 SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156 (315)
Q Consensus 77 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 156 (315)
....|+++++..++++|.-...||+|+||.||+|.... |..||||.+.........+|..|+.++.+++|||+|+++|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999876 48999998876554314559999999999999999999999
Q ss_pred EeeCC-eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 157 CAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 157 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
|.+.+ ..+||+|||++|+|.++|...... +++|..+.+|+.++|+||+|||..+...||||||||+|||+|++..+|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 599999999999999999873322 899999999999999999999998767899999999999999999999
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
|+|||+|+..... .....+...||.+|+|||++..+..+.++||||||+++.||+||+.|.+.........+++|.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999765431 222111117999999999999999999999999999999999999999876655566677764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=334.70 Aligned_cols=214 Identities=27% Similarity=0.365 Sum_probs=188.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 166 (315)
+.|+.+++||+|.||.||+|++..+|+.||+|.+.... .....-..+||.+|++|+||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45888899999999999999999999999999987654 34456678999999999999999999988765 789999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+|||+ -+|.-++.. ....+++.++..++.|++.||+|||+. +|+|||||..|||||++|.+||+|||+|++..
T Consensus 197 FeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 99997 466666543 356799999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
...... .+..+-|++|+|||++++. .|+.++|+||+||||.||++|++.|++.++.+++.+|-.|
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 544332 3445789999999998876 7999999999999999999999999999999999999776
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=336.80 Aligned_cols=213 Identities=27% Similarity=0.397 Sum_probs=187.4
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC----Cc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR----GV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD 161 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 161 (315)
...++|.+.+.||+|+||+|++|.+..++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999999999999999987764 12 23456778999999999 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFG 240 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg 240 (315)
.+++||||+.||.|.+++.. ..++.+..+..++.|++.|++|||+. +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999986 56789999999999999999999998 99999999999999999 999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCC-cC-cccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-LT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.+.......|
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki 235 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI 235 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 998753 1222344569999999999999987 86 8999999999999999999999997766555554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=339.31 Aligned_cols=202 Identities=34% Similarity=0.465 Sum_probs=186.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+... .....+.+|+++++.++||||+.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999999999999999999987643 456779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+.| +|..+|.+ ...++++.+..++.+++.||.|||+. +|+|||+||.|||++.++.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9986 99999987 67799999999999999999999998 999999999999999999999999999986443
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.+...+.+.|||.|||||+..+.+|+..+|+||||||+|||++|++||....-
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si 205 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI 205 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH
Confidence 45666778999999999999999999999999999999999999999986653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=331.56 Aligned_cols=207 Identities=36% Similarity=0.572 Sum_probs=178.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeE-EEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-eEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~-vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~ 167 (315)
...+.+.||+|+||+||+|.+. |.. ||+|.+...... ..+.|.+|+.+|.+++|||||++++++.+.. .++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3445556999999999999998 445 999999865432 2568999999999999999999999999987 799999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEecCCCCCEEEcCCC-ceEEeccCCcccC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-VIYRDLKCSNILLEEGY-HPKLSDFGLAKMG 245 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~~ 245 (315)
||+++|+|.+++... ....+++..++.++.||+.||.|||+. + ||||||||+|||++.++ ++||+|||+++..
T Consensus 120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999764 357799999999999999999999998 7 99999999999999997 9999999999865
Q ss_pred CCCCCceeeeeccccccccCccccc--cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.... ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||.+..+.+...
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~ 256 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS 256 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 4432 1222357999999999999 5699999999999999999999999999988744333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=304.58 Aligned_cols=214 Identities=27% Similarity=0.369 Sum_probs=190.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.+|...+.||+|.||.||+|++..+|+.||||.|...... ......+|+..|+.++||||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688888999999999999999999999999999865433 23457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||+ .+|+..+++ ....++...+..++.+++.|++|||+. .|+||||||.|+||+++|.+||+|||+++.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 996 789988887 467799999999999999999999998 9999999999999999999999999999976655
Q ss_pred CCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
.... +..+-|..|+|||.+.|. .|+..+||||.|||+.||+.|.+.|.+.++.+++..|-..+
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~L 218 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRAL 218 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHc
Confidence 4332 333678999999988775 79999999999999999999999999999999999886543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.04 Aligned_cols=213 Identities=31% Similarity=0.472 Sum_probs=188.8
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCe
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 162 (315)
....++|.++++||+|+||+|+++..+.+++.+|||++++... ++.+....|..++...+ ||.++.++..|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3445689999999999999999999999999999999998754 45677888888887775 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||+.||++..+.+ ...+++..+..+++.|+.||.|||+. +|||||||.+|||+|.+|++||+|||+|
T Consensus 444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 999999999999544333 36699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+..-... ...++++|||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.++.+....|
T Consensus 516 Ke~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 516 KEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred cccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 8643222 2345689999999999999999999999999999999999999999998887776655
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=337.62 Aligned_cols=210 Identities=28% Similarity=0.396 Sum_probs=189.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
+-|.+.+.||.|+.|.|.+|++..||+.+|||++.+.. ......+.+|+.+|+.+.|||++.+|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56889999999999999999999999999999998762 223556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++||.|++++.. .+++++.++.+++.||+.|+.|||.. +|+||||||+|+|+|..+++||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999976 67899999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+.. ....||+|.|.+||++.+..|+ .++||||+|||||.||||+.||++.+-+..+.++.
T Consensus 165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~ 225 (786)
T KOG0588|consen 165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ 225 (786)
T ss_pred Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 432 2345899999999999999985 89999999999999999999999888777666653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=330.20 Aligned_cols=212 Identities=27% Similarity=0.402 Sum_probs=194.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
...|.....||+|+.|.||.|....+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45688889999999999999999999999999999988877788899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
|+||+|.|.+.. ..+++.++..|++++++||+|||.. +|+|||||.+|||++.+|.+||+|||+|.......
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998865 4499999999999999999999998 99999999999999999999999999998655543
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
. .....+|||+|||||++....|++++||||||++++||+-|++||-..++...+.+|+.
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ 483 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 483 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence 3 33456899999999999999999999999999999999999999998888888888863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=318.60 Aligned_cols=210 Identities=23% Similarity=0.391 Sum_probs=188.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.-+|.+.+.||+|.||.|-+|.....|+.||||.|++.... +.-.+++|+++++.|+||||+.+|++|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35789999999999999999999889999999999876554 455689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||..+|.|.||+.. ...|++.+++.+++||..|+.|||.. +++|||||.+|||+|.++++||+|||++-...
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999987 56799999999999999999999987 99999999999999999999999999997654
Q ss_pred CCCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... ....+||+|.|.+||++.+.+|. +.+|-|||||+||.|+.|..||++.+....+..|
T Consensus 205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 432 33467999999999999999885 9999999999999999999999987755544433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=325.71 Aligned_cols=215 Identities=27% Similarity=0.362 Sum_probs=191.6
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHH--HHHHHHHhccCC-CCCeeeEEeEEeeCC-eE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSAD-HPNLVKLIGYCAEGD-QR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~--~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~~ 163 (315)
..-++|.+++.||.|+||.||+|+...++..||||.++..-.. .++ -.+|+..|++++ ||||+++.+++.+++ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3456899999999999999999999999999999999765332 222 357999999999 999999999999988 99
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|+|||||+ .+|.++++.. ...+++..++.|+.||++||+|+|.. |++|||+||+|||+.....+||+|||+|+
T Consensus 86 ~fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 99999996 7999999873 68899999999999999999999987 99999999999999988899999999999
Q ss_pred cCCCCCCceeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
...+.. ..+..+.|.+|+|||++. ...|+.+.||||+|||++|+.+-++.|.+.++.+++.+|..++
T Consensus 159 ev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 159 EVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred ccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 655443 345668899999999876 5578999999999999999999999999999999999998876
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=312.08 Aligned_cols=214 Identities=29% Similarity=0.384 Sum_probs=188.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..|++++.||.|.-|+||++....++..+|+|++.+.... ...+.+.|.+||+.++||.+..+|..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4588889999999999999999999999999999876543 3556788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||+||+|..+.+. +..+.+++..++.++.+++.||+|||.+ |||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999888765 3567799999999999999999999999 999999999999999999999999998742100
Q ss_pred ---------------------------------CCC---------------------ceeeeeccccccccCccccccCC
Q 021249 248 ---------------------------------GDK---------------------THVSTRVMGTYGYCAPDYAMTGQ 273 (315)
Q Consensus 248 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 273 (315)
... ...+..++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01123467999999999999999
Q ss_pred cCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 274 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.+.++|+|+|||++|||+.|..||.+.+.++++..|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI 347 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI 347 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH
Confidence 999999999999999999999999999998888765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=305.61 Aligned_cols=214 Identities=27% Similarity=0.365 Sum_probs=187.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc--HHHHHHHHHHhccCCCCCeeeEEeEEee--CCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 166 (315)
+.|+.++.|++|+||.||+|+++.|++.||+|.++.+.... .-...+||.+|.+++|||||.+-++... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45888999999999999999999999999999998654321 2345789999999999999999988754 3579999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||+ -+|..++... ..++...++..++.|++.|++|||.. .|+||||||+|+|++..|.+||+|||+|+...
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99997 6888888763 46799999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
+. ....+..+-|++|+|||.+.+. .|+.+.||||+|||+.||+++++.|.+....+++.+|-.++
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 54 3334566889999999998876 79999999999999999999999999999999999998765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.47 Aligned_cols=212 Identities=26% Similarity=0.327 Sum_probs=183.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999997542 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999874322
Q ss_pred CCCc---------------------------------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCC
Q 021249 248 GDKT---------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294 (315)
Q Consensus 248 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 294 (315)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012347999999999999999999999999999999999999
Q ss_pred CcccccCchhhhhHH
Q 021249 295 KAIDQTKDRKELNLV 309 (315)
Q Consensus 295 ~pf~~~~~~~~~~~i 309 (315)
.||.+.+..+....+
T Consensus 234 ~Pf~~~~~~~~~~~i 248 (363)
T cd05628 234 PPFCSETPQETYKKV 248 (363)
T ss_pred CCCCCCCHHHHHHHH
Confidence 999887766655544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=310.57 Aligned_cols=214 Identities=28% Similarity=0.384 Sum_probs=188.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
...+.|.+.+.||.|..++||+|+...++..||||++..+... ..+.+++|+..++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3456799999999999999999999999999999999876543 368899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|.||.+|++.+.++...+.+ +++..+..|+++++.||.|||.+ |.||||||+.||||+.+|.|||+|||.+....
T Consensus 103 mpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998865443 89999999999999999999998 99999999999999999999999999886443
Q ss_pred CCCC-ceee-eeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 247 SGDK-THVS-TRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.... .... ..+.||++|||||+++. ..|+.++||||||+++.||.+|..||....+.+.|
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 3221 1111 55789999999998664 47999999999999999999999999988765543
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=304.11 Aligned_cols=217 Identities=26% Similarity=0.340 Sum_probs=188.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCC------
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPN-LVKLIGYCAEGD------ 161 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~------ 161 (315)
..|..+++||+|+||+||+|+...+|+.||+|+++.... .......+|+.+|+.++|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 357777889999999999999999999999999986543 23445678999999999999 999999998877
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++|+||++ -+|..++.........++...+..+++||+.||+|||+. +|+||||||.||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 8899999996 799999987543324577789999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
|+...-.. ...+..++|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+++..|-.++
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 98543222 224456899999999999987 79999999999999999999999999999999999887765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=311.82 Aligned_cols=204 Identities=30% Similarity=0.472 Sum_probs=174.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--eEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e 168 (315)
.+|...+.||+|+||+||++.+..+|...|||.+........+.+.+|+.+|++++|||||++++...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35777888999999999999999989999999987654333677999999999999999999999744433 6999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~ 247 (315)
|+++|+|.+++.... .++++..++.+.+||++||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999998742 2799999999999999999999998 9999999999999999 79999999999976543
Q ss_pred -CCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 -GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
...........||+.|||||++.++ ...+++|||||||++.||+||.+||...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 1111222346899999999999853 3446999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=322.26 Aligned_cols=220 Identities=32% Similarity=0.463 Sum_probs=189.1
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
+.+......+.+++.||+|-||.||.|.++. ...||+|.+.... ...+.|.+|+.+|++|+|++||++++++..+..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3344444556778899999999999999985 3479999997653 3457788999999999999999999999998899
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
+||||||+.|+|.+||+. ..+..+.....+.++.|||+||+||++. ++|||||.+.||||++++.+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999986 3467789999999999999999999998 99999999999999999999999999999
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 311 (315)
...+ +.........-...|.|||.+..+.++.+||||||||+||||+| |+.||.++...+.+.+++.
T Consensus 352 ~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~ 419 (468)
T KOG0197|consen 352 LIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER 419 (468)
T ss_pred ccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 4322 22222222234568999999999999999999999999999998 9999999999999888864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=306.71 Aligned_cols=217 Identities=27% Similarity=0.341 Sum_probs=190.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEec--CCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee-----CC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-----GD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 161 (315)
....|...+.||.|+||.|..|.++.+|+.||||++. -......++..+|+.+|+.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456777889999999999999999999999999997 3455567888999999999999999999999865 34
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..|+|+|+| +.+|...++. +..++..++..+++|+++||.|+|+. +++||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 689999999 4778777765 55699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
|+...........+..+-|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+.+..+++.+|-.++
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 99765433334446678899999999775 4589999999999999999999999999999999999997764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=292.68 Aligned_cols=214 Identities=27% Similarity=0.407 Sum_probs=192.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|-||.||+|+.+.++-.||+|++.++.. ....++.+|+++.+.|+||||+++|++|.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3569999999999999999999999999999999976543 2356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+||...|++...|+.. ....+++..++.+..|+|.|+.|+|.. ++|||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999853 256688999999999999999999987 99999999999999999999999999997644
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
.. .....+||..|.|||+..+..++..+|+|++|++.||++.|.+||......+....|..+
T Consensus 176 ~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 176 SN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred CC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence 22 233468999999999999999999999999999999999999999999888888887654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=311.31 Aligned_cols=217 Identities=29% Similarity=0.420 Sum_probs=180.7
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------------ccHHHHHHHHHHhccCCCCCee
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------------QGVREFSAEVMTLGSADHPNLV 151 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv 151 (315)
.....+.|++.+.||+|.||.|.+|++..+++.||||++.+... ...+.+.+||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34456789999999999999999999999999999999975422 1246789999999999999999
Q ss_pred eEEeEEee--CCeEEEEEEecCCCChhhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 152 KLIGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 152 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+++++..+ .+.+|+|+|||..|.+... ....+ +++.+++.++++++.||+|||.+ +||||||||.|+|+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 99999854 5689999999998887432 23455 99999999999999999999999 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCC---CceeeeeccccccccCccccccCC----cCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 229 EEGYHPKLSDFGLAKMGPSGD---KTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
+++|.+||+|||.+.....+. ........+|||.|+|||+..++. .+.+.||||+||+||.|+.|+.||-+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999997552221 112223358999999999877632 3578999999999999999999998877
Q ss_pred chhhhhHHh
Q 021249 302 DRKELNLVA 310 (315)
Q Consensus 302 ~~~~~~~i~ 310 (315)
..+...+|.
T Consensus 324 ~~~l~~KIv 332 (576)
T KOG0585|consen 324 ELELFDKIV 332 (576)
T ss_pred HHHHHHHHh
Confidence 666666553
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=323.40 Aligned_cols=213 Identities=26% Similarity=0.346 Sum_probs=188.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-C-----CCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-H-----PNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~~~~~~~ 162 (315)
+..+|.+.+.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.+|..|+ | -|||+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3347899999999999999999999999999999998764 34566778999999886 3 389999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC--CceEEeccC
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFG 240 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~--~~~kl~Dfg 240 (315)
.|||+|.+. -+|.++|+.. ....++...++.|+.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||
T Consensus 263 lciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999994 8999999884 356699999999999999999999998 99999999999999754 369999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
.+......- ...+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+++.+|-+++
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 997643322 13478889999999999999999999999999999999999999999999999998875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.53 Aligned_cols=208 Identities=27% Similarity=0.341 Sum_probs=179.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|.+++.||+|+||+||+|.+..++..||+|++..... .....+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999999999999999999975432 335568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999876 35689999999999999999999998 9999999999999999999999999997532100
Q ss_pred CC---------------------------------------------ceeeeeccccccccCccccccCCcCcccchhhH
Q 021249 249 DK---------------------------------------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF 283 (315)
Q Consensus 249 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 283 (315)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123479999999999998899999999999
Q ss_pred HHHHHHHHhCCCcccccCchhhh
Q 021249 284 GVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 284 G~il~elltg~~pf~~~~~~~~~ 306 (315)
||++|||++|..||...+..+..
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~ 257 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ 257 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH
Confidence 99999999999999876654443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=322.08 Aligned_cols=211 Identities=24% Similarity=0.327 Sum_probs=180.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46899999999999999999999999999999986532 233556888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999853211
Q ss_pred CCCc---------------------------------------------eeeeeccccccccCccccccCCcCcccchhh
Q 021249 248 GDKT---------------------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYS 282 (315)
Q Consensus 248 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 282 (315)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCcccccCchhhhhH
Q 021249 283 FGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 283 lG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
|||++|||++|.+||...+..+.+..
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~ 259 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRK 259 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 99999999999999987665544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.30 Aligned_cols=205 Identities=27% Similarity=0.397 Sum_probs=181.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999997542 233566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999876 45689999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 225 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22 12479999999999999999999999999999999999999998766544333
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.50 Aligned_cols=209 Identities=26% Similarity=0.361 Sum_probs=180.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||||++.... ......+..|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999999999999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999875 35689999999999999999999998 999999999999999999999999999864322
Q ss_pred CCCce------------------------------------eeeeccccccccCccccccCCcCcccchhhHHHHHHHHH
Q 021249 248 GDKTH------------------------------------VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291 (315)
Q Consensus 248 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 291 (315)
..... .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011246999999999999999999999999999999999
Q ss_pred hCCCcccccCchhhh
Q 021249 292 TGRKAIDQTKDRKEL 306 (315)
Q Consensus 292 tg~~pf~~~~~~~~~ 306 (315)
+|..||...+..+..
T Consensus 234 ~G~~Pf~~~~~~~~~ 248 (364)
T cd05599 234 VGYPPFCSDNPQETY 248 (364)
T ss_pred cCCCCCCCCCHHHHH
Confidence 999999876654443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.42 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=180.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368999999999999999999999999999999875422 33556888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~ 207 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 2246899999999999989999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.49 Aligned_cols=208 Identities=26% Similarity=0.321 Sum_probs=179.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|.+++.||+|+||.||+|.+..+++.||+|++..... .....+..|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999975432 335568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998875 34688999999999999999999998 9999999999999999999999999997522100
Q ss_pred C---------------------------------------------CceeeeeccccccccCccccccCCcCcccchhhH
Q 021249 249 D---------------------------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF 283 (315)
Q Consensus 249 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 283 (315)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000122469999999999999999999999999
Q ss_pred HHHHHHHHhCCCcccccCchhhh
Q 021249 284 GVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 284 G~il~elltg~~pf~~~~~~~~~ 306 (315)
||++|||++|++||...+..+..
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~ 257 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ 257 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999877655443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=316.33 Aligned_cols=210 Identities=30% Similarity=0.428 Sum_probs=188.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..|+..+.||+|+||.||+|.+..+++.||+|++..+.. ..++++++|+.+|.++++|||.++|+.|..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 357777889999999999999999999999999986643 4578899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
|.||++.+.++. ...+.+..+..++++++.|+.|||+. +.+|||||+.|||+..+|.+||+|||++.......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999875 45558888889999999999999998 99999999999999999999999999997655443
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. ...++|||.|||||++....|+.++||||||++++||++|.+|+....+...+.+|
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 33 25579999999999999889999999999999999999999999998876555444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=314.46 Aligned_cols=206 Identities=27% Similarity=0.377 Sum_probs=182.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999999999999999997542 234556888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 12234799999999999999999999999999999999999999987765554433
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=304.99 Aligned_cols=211 Identities=28% Similarity=0.410 Sum_probs=181.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----eEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRLLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv 166 (315)
.|.-.+++|+|+||.||.|....+++.||||..-.+. +.-.+|+.+|+.++|||||++.-+|.... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3667788999999999999999999999999874332 22347899999999999999998885432 34589
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccCCcccC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKMG 245 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg~~~~~ 245 (315)
||||+ .+|..+++........++.-.++-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 799999987655567789999999999999999999997 99999999999999976 89999999999977
Q ss_pred CCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
..+.... ...-|..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.+.+..+++..|..++
T Consensus 177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 6554431 23457789999988876 79999999999999999999999999999999999998775
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.99 Aligned_cols=210 Identities=25% Similarity=0.305 Sum_probs=180.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999865322 23456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999876 35688999999999999999999998 999999999999999999999999999742210
Q ss_pred CC-----------------------------------------CceeeeeccccccccCccccccCCcCcccchhhHHHH
Q 021249 248 GD-----------------------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVV 286 (315)
Q Consensus 248 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 286 (315)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000123479999999999999999999999999999
Q ss_pred HHHHHhCCCcccccCchhhhh
Q 021249 287 LLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 287 l~elltg~~pf~~~~~~~~~~ 307 (315)
+|+|++|+.||...+..+...
T Consensus 234 lyell~G~~Pf~~~~~~~~~~ 254 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL 254 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH
Confidence 999999999998877555433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=313.83 Aligned_cols=205 Identities=25% Similarity=0.350 Sum_probs=179.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCC-eEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 346999999999999999999876554 689999986432 2335568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999876 45689999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 237 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH
Confidence 322 12347999999999999888999999999999999999999999877654433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=310.29 Aligned_cols=200 Identities=31% Similarity=0.371 Sum_probs=174.2
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
+.||+|+||.||+|.+..+|+.||+|++.... ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 35999999999999999999999999997542 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 99998875 45689999999999999999999998 999999999999999999999999999874322111 1
Q ss_pred eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 203 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence 2234799999999999999999999999999999999999999987654443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=316.23 Aligned_cols=212 Identities=23% Similarity=0.274 Sum_probs=180.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999999999999999986432 2234557889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999864 3478899999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccC----CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||...+....+..|
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i 259 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 32221 112235799999999988754 3788999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=310.63 Aligned_cols=214 Identities=26% Similarity=0.345 Sum_probs=192.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc--HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+.+-|.+.+.||+|.|..|.+|++.-+|+.||||++.+..... ...+..|++.++.++|||||++|++...+..+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567899999999999999999999999999999999876544 45688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMG 245 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~ 245 (315)
+|+-++|+|+|||..+ ...+.+..+.+++.||+.|+.|||.. .++||||||+|+.+.+ -|-+||.|||++-.+
T Consensus 96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999999874 45699999999999999999999999 9999999999998764 578999999999765
Q ss_pred CCCCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
..+.. .+..||++.|-|||++.+..|+ +++||||||||||-|++|++||+..++.+.+-+|-.
T Consensus 170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 55433 2346899999999999999997 899999999999999999999999999999888754
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=316.32 Aligned_cols=212 Identities=25% Similarity=0.333 Sum_probs=182.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999999999999999997532 233566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++|++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999875 45689999999999999999999998 999999999999999999999999999864321
Q ss_pred CCC---------------------------------ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCC
Q 021249 248 GDK---------------------------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294 (315)
Q Consensus 248 ~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 294 (315)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 00012347999999999999999999999999999999999999
Q ss_pred CcccccCchhhhhHH
Q 021249 295 KAIDQTKDRKELNLV 309 (315)
Q Consensus 295 ~pf~~~~~~~~~~~i 309 (315)
+||...+..+....+
T Consensus 234 ~Pf~~~~~~~~~~~i 248 (360)
T cd05627 234 PPFCSETPQETYRKV 248 (360)
T ss_pred CCCCCCCHHHHHHHH
Confidence 999877765554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=301.36 Aligned_cols=202 Identities=30% Similarity=0.460 Sum_probs=176.4
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
|+..+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 7788899999999999999999999999999875432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999998887642 234689999999999999999999998 99999999999999999999999999997643221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 1 1234689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.94 Aligned_cols=201 Identities=29% Similarity=0.378 Sum_probs=174.1
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
+.||+|+||.||++.+..+|..||+|++.... ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 35999999999999999999999999997542 233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
+|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 99888865 45689999999999999999999998 999999999999999999999999999874322111 1
Q ss_pred eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 204 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 204 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 12346899999999999999999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.71 Aligned_cols=198 Identities=29% Similarity=0.386 Sum_probs=173.4
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||+|+||.||+|.+..+++.||+|++.... ......+..|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999987532 23455678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999875 35689999999999999999999998 99999999999999999999999999987532221 1123
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~ 201 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence 35799999999999999999999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=306.72 Aligned_cols=201 Identities=29% Similarity=0.379 Sum_probs=174.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
+.||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 35899999999999999999999999997542 233556788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99988865 45689999999999999999999998 99999999999999999999999999987432211 11
Q ss_pred eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 22347999999999999999999999999999999999999999876654443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=307.22 Aligned_cols=210 Identities=27% Similarity=0.329 Sum_probs=188.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 164 (315)
....|.+.+.||+|.||.||++..+.+|..+|+|.+.+.... ....+.+|+.+|+++. |||||.++++|++.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 456799999999999999999999999999999999876543 3468999999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC----CceEEeccC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPKLSDFG 240 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~----~~~kl~Dfg 240 (315)
+|||++.||.|.+.+... .+++..+..++.|++.|+.|||+. +|+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999774 299999999999999999999998 99999999999999643 479999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+..+....|
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI 250 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH
Confidence 9987555 23345579999999999999999999999999999999999999999998876665544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.54 Aligned_cols=215 Identities=23% Similarity=0.267 Sum_probs=181.9
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3344578999999999999999999999999999999986432 1234457789999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999998865 3478899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccC----CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......|
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 259 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 75432211 112235799999999988754 3789999999999999999999999877655444443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=320.20 Aligned_cols=213 Identities=23% Similarity=0.276 Sum_probs=185.2
Q ss_pred CCCcccccccCCceEEEEEEECCC-CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.|.+.+.||+|++|.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 489999999999999999998877 7889999876655555566888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++|+|.+++........++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998876444456789999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~ 281 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ 281 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 223344579999999999999999999999999999999999999998766544433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=300.12 Aligned_cols=212 Identities=28% Similarity=0.383 Sum_probs=181.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 579999999999999999999999999999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
++ ++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 4888887652 34578999999999999999999998 99999999999999999999999999987543222
Q ss_pred CceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
.. .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 158 KT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred cc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11 123468899999998865 5689999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.48 Aligned_cols=208 Identities=29% Similarity=0.411 Sum_probs=178.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCC-CeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHP-NLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~ 167 (315)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..+.|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4888999999999999999999999999999987532 23355677889999888764 6888999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998865 35689999999999999999999998 999999999999999999999999999864322
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 211 12235799999999999999999999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=291.80 Aligned_cols=211 Identities=29% Similarity=0.370 Sum_probs=188.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
-++|..+++||+|.||+|.+++-+.+++.||+|++++.-.. ....-..|-++|+..+||.+..+--.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35688899999999999999999999999999999876543 344567789999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||..||.|+-.|.+ .+.+++..++.+-..|+.||.|||+. +|++||||.+|+|+|.+|++||+|||+|+...
T Consensus 247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999888866 56789999999999999999999998 99999999999999999999999999998532
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. ......+||||.|+|||++....|+.++|+|.+||++|||++|+.||...+......+|
T Consensus 320 ~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 320 KY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred cc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 22 22345679999999999999999999999999999999999999999988877766665
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=303.79 Aligned_cols=208 Identities=27% Similarity=0.391 Sum_probs=177.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
+|.+.+.||+|+||.||+|.+..++..||+|++..... .....+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999875422 2334566677777766 5899999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988865 35689999999999999999999998 999999999999999999999999999874322
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111 12235799999999999999999999999999999999999999988765554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.38 Aligned_cols=212 Identities=29% Similarity=0.361 Sum_probs=184.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46999999999999999999999999999999997542 234566888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999876 35689999999999999999999998 999999999999999999999999999975433
Q ss_pred CC---------------------------CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GD---------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001122346899999999999999999999999999999999999999887
Q ss_pred CchhhhhHH
Q 021249 301 KDRKELNLV 309 (315)
Q Consensus 301 ~~~~~~~~i 309 (315)
+..+....+
T Consensus 234 ~~~~~~~~i 242 (350)
T cd05573 234 TLQETYNKI 242 (350)
T ss_pred CHHHHHHHH
Confidence 755544443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=310.42 Aligned_cols=211 Identities=24% Similarity=0.265 Sum_probs=179.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+..|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999999999999999996532 12344577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998865 3578899999999999999999998 99999999999999999999999999997543
Q ss_pred CCCCceeeeeccccccccCccccccC----CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......|
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 259 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 2211 112234799999999988653 4789999999999999999999999877655444433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=301.94 Aligned_cols=202 Identities=31% Similarity=0.453 Sum_probs=171.5
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhcc-CCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999999999999999997532 1233445566666654 4899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999988875 35689999999999999999999998 99999999999999999999999999997533222 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~ 206 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2233579999999999999899999999999999999999999998776554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=305.37 Aligned_cols=203 Identities=30% Similarity=0.380 Sum_probs=174.3
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
+.||+|+||.||+|.+..++..||+|++.... ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 35999999999999999999999999997542 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 99988865 4568999999999999999999997 5 999999999999999999999999999874322111
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 12234699999999999999999999999999999999999999987665444333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=303.07 Aligned_cols=205 Identities=31% Similarity=0.463 Sum_probs=174.4
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHh---ccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTL---GSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677889999999999999999999999999997542 22344566666554 567899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|..++.. ..+++..++.++.||+.||.|||+. +++||||||+||++++++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999887753 4689999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.... ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+.+.
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2211 1223579999999999999999999999999999999999999998776554443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.63 Aligned_cols=213 Identities=22% Similarity=0.291 Sum_probs=181.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 469999999999999999999999999999999875432 335567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++++.+..+... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777654432 35689999999999999999999998 9999999999999999999999999999764332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+.+..+..
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 211 12234689999999999988999999999999999999999999998776665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=304.42 Aligned_cols=210 Identities=22% Similarity=0.278 Sum_probs=179.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||++.+..+++.||+|++.... ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 223445778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++||+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 34689999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~ 218 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH
Confidence 221 11223469999999998875 467889999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=307.17 Aligned_cols=213 Identities=27% Similarity=0.367 Sum_probs=190.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe-EEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ-RLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~ 167 (315)
++|..++.+|+|+||.+++++++..+..+++|.|..... ...+....|+.+++++.|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578999999999999999999999999999999986543 334568899999999999999999999988887 99999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
+||+||++.+.+...+ +..++++.+..++.|++.|+.|||+. .|+|||||+.|||++.++.|+|+|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998754 56789999999999999999999987 999999999999999999999999999997665
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.. ......+||+.||.||++.+.+|+.++|||||||++|||++-+++|.+.+-......|.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~ 219 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN 219 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh
Confidence 54 22344689999999999999999999999999999999999999999888666655553
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=287.42 Aligned_cols=212 Identities=24% Similarity=0.334 Sum_probs=184.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++... ....+.+.+|+.+-+.|+||||+++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3457888999999999999999999999999999987432 34678899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg~~~ 243 (315)
+|+|.|+.|..-+-. ...+++..+..+++||++||.|+|.. +|+|||+||+|+++-+ ..-+||+|||++.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876654 24578889999999999999999998 9999999999999953 4569999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
....+. ......|||.|||||++...+|+..+||||.|||||-|+.|.+||.+.+.....+.|.
T Consensus 162 ~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 162 EVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred EeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 765332 2334689999999999999999999999999999999999999999977666666553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=311.59 Aligned_cols=208 Identities=30% Similarity=0.505 Sum_probs=179.4
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
.+|....+...+...||+|.||+||+|.|.+ .||||++..... +..+.|..|+.++++-+|.||+-+.|++...+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 5666777778889999999999999999975 599999986543 46788999999999999999999999999876
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
. .||+.||+|.+|+.+++.. ..++.....+.|++||++||.|||.. +|||||||..|||+.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 6 9999999999999999863 46799999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
+.....-..........|...|||||+++. .+|++.+||||||+++|||++|..||...+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~ 597 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN 597 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC
Confidence 975432222222223357889999999874 478999999999999999999999999433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=305.30 Aligned_cols=211 Identities=27% Similarity=0.397 Sum_probs=173.2
Q ss_pred HhCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC-
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG- 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~- 160 (315)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467999999999999999999752 3456899999875432 3356688999999999 899999999988654
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCC-------------------------------------------------------
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPD------------------------------------------------------- 185 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------- 185 (315)
..++++|||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4688999999999999998753210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeecccccc
Q 021249 186 ---TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262 (315)
Q Consensus 186 ---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 262 (315)
..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23588889999999999999999998 999999999999999999999999999975432221111222345678
Q ss_pred ccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCc
Q 021249 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD 302 (315)
Q Consensus 263 y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 302 (315)
|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 999999999999999999999999999997 9999987553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.05 Aligned_cols=210 Identities=23% Similarity=0.279 Sum_probs=178.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999987422 223455788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998652 35689999999999999999999998 999999999999999999999999999865433
Q ss_pred CCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+...
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 218 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH
Confidence 2211 1122368999999998863 457889999999999999999999998765444433
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.04 Aligned_cols=203 Identities=32% Similarity=0.424 Sum_probs=173.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999999999999999987542 23345567788888765 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 999988865 35689999999999999999999998 999999999999999999999999999875322221
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~ 207 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES 207 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 12234689999999999988999999999999999999999999987775554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=306.35 Aligned_cols=211 Identities=26% Similarity=0.339 Sum_probs=181.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368999999999999999999999999999999975422 23456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999763 35689999999999999999999998 999999999999999999999999999976433
Q ss_pred CCCceeeeeccccccccCccccc------cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAM------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+.+..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 220 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH
Confidence 2221 223346899999999886 45678999999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.39 Aligned_cols=204 Identities=29% Similarity=0.436 Sum_probs=174.2
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999999999999999987532 23345667788888766 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999988875 35689999999999999999999998 99999999999999999999999999987432211 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i 208 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 123347999999999999889999999999999999999999999887765544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=331.28 Aligned_cols=219 Identities=25% Similarity=0.279 Sum_probs=192.4
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
.++....++|.+++.||+|+||.|.+++++.+++.||+|++++-. ......|..|-.+|..-+.+-|+.+.-+|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455566789999999999999999999999999999999998732 23455688899999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
.++|+|||||+||+|..++.. ..++++..++.++..|+-||.-||+. |+|||||||+|||+|..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999976 33799999999999999999999999 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccc----c-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAM----T-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.|-.+... ..-.+...+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||....-.+++.+|-
T Consensus 221 sClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM 294 (1317)
T ss_pred hHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh
Confidence 98654432 233344458999999999886 3 579999999999999999999999999888777777664
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.56 Aligned_cols=212 Identities=23% Similarity=0.276 Sum_probs=179.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||++.+..+++.+|+|++.+.. ......+..|+.++..++||+|+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999999999999999986432 122345788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 34689999999999999999999998 999999999999999999999999999864322
Q ss_pred CCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.+..+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 211 1122347999999999886 346889999999999999999999999876655544433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.95 Aligned_cols=201 Identities=31% Similarity=0.443 Sum_probs=172.0
Q ss_pred cccccCCceEEEEEEEC---CCCeEEEEEEecCCC----cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 97 CCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+.||+|+||.||++.+. .+++.||+|++.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 56999999999999863 468899999987532 22345577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998875 45688899999999999999999998 99999999999999999999999999986432221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~ 209 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH
Confidence 1 122346999999999999888999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.21 Aligned_cols=210 Identities=25% Similarity=0.372 Sum_probs=175.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----CeEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQRL 164 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~ 164 (315)
+|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999999999999999998743 223345688999999999999999999987543 2579
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 688888865 35689999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCc-eeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKT-HVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~ 220 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence 3222111 11233478999999998865 67899999999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.17 Aligned_cols=206 Identities=29% Similarity=0.403 Sum_probs=175.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 167 (315)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+. ||+|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777889999999999999999999999999987532 233455777888888775 577888999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998865 35689999999999999999999998 999999999999999999999999999874322
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~ 210 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 211 122346899999999999889999999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=296.57 Aligned_cols=204 Identities=26% Similarity=0.352 Sum_probs=174.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4679999999999999999999998999999999875432 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 677777764 235688999999999999999999998 9999999999999999999999999998753322
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 11 1123468999999998865 4688999999999999999999999987543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=298.87 Aligned_cols=204 Identities=27% Similarity=0.351 Sum_probs=179.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999999999999999987643 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999876 34689999999999999999999985 26999999999999999999999999998754322
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 12346899999999999989999999999999999999999999765543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=297.41 Aligned_cols=203 Identities=32% Similarity=0.461 Sum_probs=172.6
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhcc-CCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..++..||+|+++... .........|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 35999999999999999999999999997542 1234456667777765 5899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999998875 35688999999999999999999998 999999999999999999999999999874322211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12334789999999999998999999999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=298.18 Aligned_cols=202 Identities=31% Similarity=0.453 Sum_probs=172.1
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhcc-CCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..++..||+|++.... .........|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35999999999999999999999999997542 1234456667777765 4899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999988865 35689999999999999999999998 99999999999999999999999999986432211 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2234579999999999999999999999999999999999999998766554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.53 Aligned_cols=200 Identities=30% Similarity=0.398 Sum_probs=170.0
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHH-HhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||+||+|.+..+|+.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 359999999999999999999999999975422 22334445544 56789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999988865 45689999999999999999999998 99999999999999999999999999987432221 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~ 204 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence 22334799999999999999999999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.61 Aligned_cols=212 Identities=24% Similarity=0.349 Sum_probs=175.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-------- 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-------- 160 (315)
...+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999999999999999885432 2345799999999999999999877432
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEecc
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDF 239 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Df 239 (315)
..+++||||++ ++|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 25679999997 578777765444567799999999999999999999998 999999999999999664 6999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99975433221 1234689999999988764 689999999999999999999999998877666665543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.18 Aligned_cols=217 Identities=26% Similarity=0.312 Sum_probs=184.3
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC---
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--- 161 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 161 (315)
....++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+..+..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3445789999999999999999999999999999999875432 34556888999999999999999988775432
Q ss_pred -----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 162 -----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 162 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
.+++||||+++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36899999999999999976544556799999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~ 254 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999997644332222233457999999999999999999999999999999999999999876654433
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.76 Aligned_cols=201 Identities=29% Similarity=0.359 Sum_probs=170.6
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHH-HhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+|..||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35999999999999999999999999987542 122344455554 56789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|..++.. ..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 999888865 45789999999999999999999998 999999999999999999999999999874322211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence 123357999999999999999999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.32 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=169.9
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHH-HHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEV-MTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||+||+|.+..++..||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 359999999999999999999999999875321 1223344444 456789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 999998875 45688899999999999999999998 999999999999999999999999999874322211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 1233579999999999999999999999999999999999999998766554433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=299.34 Aligned_cols=195 Identities=31% Similarity=0.467 Sum_probs=170.2
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 359999999999999999999999999976422 3345678899988887 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988865 35699999999999999999999998 99999999999999999999999999987432211 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 123357999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=299.63 Aligned_cols=194 Identities=29% Similarity=0.463 Sum_probs=169.9
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|+++... ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35999999999999999999999999997542 23345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ..++++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999988865 45699999999999999999999998 99999999999999999999999999986422211 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 12235799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=298.07 Aligned_cols=199 Identities=29% Similarity=0.385 Sum_probs=168.9
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHH-HHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEV-MTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..++..||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 359999999999999999999999999875422 2233444554 467889999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|...+.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 999888765 45688999999999999999999998 99999999999999999999999999987432221 1
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 203 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH
Confidence 1233578999999999998899999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=291.12 Aligned_cols=198 Identities=27% Similarity=0.400 Sum_probs=172.5
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||+|+||+||++.+..+++.||+|.+...... ..+.+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998754322 235577899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.........+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 988865444456799999999999999999999998 9999999999999999999999999998754332221 22
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...||+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=280.73 Aligned_cols=212 Identities=25% Similarity=0.373 Sum_probs=184.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------ccHHHHHHHHHHhccC-CCCCeeeEEeEEe
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSA-DHPNLVKLIGYCA 158 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 158 (315)
.....|.-.+.||.|..++|.++.++.+|..+|+|++..... ...+.-..|+.+|+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 344567778889999999999999999999999999864221 1234567899999997 5999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEec
Q 021249 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
.+...++|+|.|+.|.|+|+|.. ...+++...+.|++|+.++++|||.. +|+||||||+|||++++.+++|+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999976 57799999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccc------cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
||++.....+... ...||||+|+|||.+. ...|+..+|+||+|||+|.|+.|-+||......-++.+|
T Consensus 167 FGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~I 240 (411)
T KOG0599|consen 167 FGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMI 240 (411)
T ss_pred cceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHH
Confidence 9999876665433 3569999999999775 336899999999999999999999999877655555554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.14 Aligned_cols=215 Identities=26% Similarity=0.441 Sum_probs=177.6
Q ss_pred hCCCCcccccccCCceEEEEEEECC----------------CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeee
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK----------------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVK 152 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 152 (315)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4579999999999999999997532 345799999876432 33557889999999999999999
Q ss_pred EEeEEeeCCeEEEEEEecCCCChhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 021249 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP---------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217 (315)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ii 217 (315)
+++++.+.+..++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998865321 123478888999999999999999998 999
Q ss_pred EecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh--CCC
Q 021249 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRK 295 (315)
Q Consensus 218 H~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~ 295 (315)
||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975443332222233456788999999988899999999999999999986 678
Q ss_pred cccccCchhhhh
Q 021249 296 AIDQTKDRKELN 307 (315)
Q Consensus 296 pf~~~~~~~~~~ 307 (315)
||...++.+.+.
T Consensus 241 p~~~~~~~~~~~ 252 (304)
T cd05096 241 PYGELTDEQVIE 252 (304)
T ss_pred CCCcCCHHHHHH
Confidence 888766554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=298.06 Aligned_cols=193 Identities=31% Similarity=0.479 Sum_probs=168.5
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 35999999999999999999999999997542 23345577888888766 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 999888765 45689999999999999999999998 999999999999999999999999999874322111
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 1223579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.65 Aligned_cols=202 Identities=31% Similarity=0.455 Sum_probs=173.1
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||+||+|.+..++..||+|++.... ......+..|+.++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999999999999999997542 23345567788888877 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 999988865 35689999999999999999999998 999999999999999999999999999864222211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 1223468999999999999999999999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=297.81 Aligned_cols=202 Identities=27% Similarity=0.350 Sum_probs=172.4
Q ss_pred CCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCC----cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
+|++.+.||+|+||.||++.+. .++..||+|++.... ....+.+..|+.+++.+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999998864 468899999987532 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998875 45689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 54322211 12235799999999998765 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.29 Aligned_cols=205 Identities=31% Similarity=0.466 Sum_probs=177.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|++.+.||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999999988999999999754322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887642 235689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
.. .....|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+...
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 21 123468999999999998899999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=294.86 Aligned_cols=204 Identities=26% Similarity=0.352 Sum_probs=178.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999999999999999987543 2334668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999875 35688999999999999999999974 27999999999999999999999999998643222
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 1 12346899999999999889999999999999999999999999865543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=297.29 Aligned_cols=202 Identities=30% Similarity=0.394 Sum_probs=173.5
Q ss_pred cccccCCceEEEEEEE---CCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 97 CCLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~---~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
+.||+|+||.||++.+ ..+|..||+|++..... .....+..|+.++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999876 35788999999975432 234456789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998865 45689999999999999999999998 999999999999999999999999999875433211
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+.
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 208 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH
Confidence 1233578999999999998889999999999999999999999998766544443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.44 Aligned_cols=211 Identities=27% Similarity=0.383 Sum_probs=173.7
Q ss_pred CCCCcccccccCCceEEEEEEECC-CCeEEEEEEecCCCc--ccHHHHHHHHHHhccC---CCCCeeeEEeEEe-----e
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCA-----E 159 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~-----~ 159 (315)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 468899999865432 2233455677666654 7999999999885 3
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
...+++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 6898888653 234589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
|++....... ......|++.|+|||.+.+..++.++|||||||++|+|++|.+||.+.++.+.+..+.
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 9997543321 1223468999999999988899999999999999999999999999888777666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=303.50 Aligned_cols=190 Identities=30% Similarity=0.481 Sum_probs=169.7
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
..++.||+|+.|.||+|+.. ++.||||+++.- -..+|+-|++|+||||+.+.++|.....+|||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 44678999999999999987 789999987532 235788899999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
-|...|+. +.++.......+..+||.+|.|||.. .|||||||.-||||..+..|||+|||.++.......
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST--- 267 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST--- 267 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh---
Confidence 99999986 67788899999999999999999998 999999999999999999999999999986544321
Q ss_pred eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.-.++||..|||||++.+.+.+.++|||||||+|||||||+.||.+-+.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 2346899999999999999999999999999999999999999987553
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=299.46 Aligned_cols=212 Identities=27% Similarity=0.448 Sum_probs=175.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 161 (315)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 345799999999999999999986443 3579999997543 33456688999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCC---------------------------------------------------------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRP--------------------------------------------------------- 184 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 184 (315)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998854210
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 185 ---------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 185 ---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
...++++..++.++.||+.||.|||+. +|+||||||+|||+++++.++|+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 123578899999999999999999998 99999999999999999999999999997543322221222
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCch
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR 303 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 303 (315)
...+++.|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 2235668999999998899999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.66 Aligned_cols=212 Identities=25% Similarity=0.353 Sum_probs=179.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----eEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRL 164 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 164 (315)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999999899999999986532 234567889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 577777654 45689999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
....... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..|..+
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 220 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL 220 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 4332211 12234678899999988774 5789999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.04 Aligned_cols=213 Identities=28% Similarity=0.391 Sum_probs=179.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 579999999999999999999999999999999875432 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
++ ++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 4787777652 34588999999999999999999998 99999999999999999999999999987533222
Q ss_pred CceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
.. .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+.+..+..+
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 220 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220 (309)
T ss_pred cc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 11 122367899999998765 46889999999999999999999999988776666655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=288.92 Aligned_cols=205 Identities=28% Similarity=0.398 Sum_probs=184.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
-|.++.+||+|+||.||+|.++.+|..+|||.+.-. .+.+++.+|+.+++++..|++|++|+.|.....+|||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 377888999999999999999999999999998754 357889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
-|++.+.++. ..+++++.++..+++.-+.+|+|||.. .-||||||..|||++.+|..||+|||.+....+. .
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999876 367899999999999999999999998 7899999999999999999999999999654332 2
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.......|||.|||||++..-.|+..+||||||++..||.-|++||.+..+-..+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 2234568999999999999999999999999999999999999999987765443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=299.34 Aligned_cols=195 Identities=24% Similarity=0.275 Sum_probs=170.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999999999999999997532 3467899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 85 688887765 35689999999999999999999998 99999999999999999999999999986432221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 A-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred c-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1 112235799999999999998999999999999999999999988754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=303.64 Aligned_cols=212 Identities=23% Similarity=0.324 Sum_probs=174.7
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC------CCCeeeEEeEEeeC-
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD------HPNLVKLIGYCAEG- 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~~~~~~~~- 160 (315)
...++|.+.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++ |++++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34678999999999999999999999999999999996432 12334455666665554 45689999988764
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCC-------
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGY------- 232 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~------- 232 (315)
..+++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 5788999988 7888888865 3568999999999999999999997 5 999999999999998765
Q ss_pred ---------ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 233 ---------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 233 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.+||+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987532211 22357999999999999999999999999999999999999999988888
Q ss_pred hhhhHHhhhh
Q 021249 304 KELNLVAWLL 313 (315)
Q Consensus 304 ~~~~~i~~~~ 313 (315)
+.+.++..++
T Consensus 352 ~~~~~i~~~~ 361 (467)
T PTZ00284 352 EHLHLMEKTL 361 (467)
T ss_pred HHHHHHHHHc
Confidence 8777776543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=295.33 Aligned_cols=207 Identities=25% Similarity=0.304 Sum_probs=174.4
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD---- 161 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 161 (315)
...++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999999999999999986532 234566788999999999999999999986543
Q ss_pred --eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 162 --QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 162 --~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 57999999975 5655553 2378889999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 168 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 168 GLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred CCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9997532221 1223468999999999999999999999999999999999999999876554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.93 Aligned_cols=206 Identities=32% Similarity=0.429 Sum_probs=184.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|.-++.||+|+||.||-|.+..+.+.||||.++-++ .....++.+|+..|++++|||++.+-++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4777888999999999999999999999999997544 3457789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||- |+-.|++.-. .+++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|||.+.+....
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 995 7888887653 57899999999999999999999998 9999999999999999999999999999765443
Q ss_pred CCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
..++|||+|||||++. .+.|+-++||||||++..||.-.++|+-.++.-..+..|+
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA 238 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 238 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH
Confidence 3468999999999886 4689999999999999999999999998888777777765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=284.73 Aligned_cols=200 Identities=25% Similarity=0.394 Sum_probs=170.6
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCccc---HHHHHHHHHHhccCCCCCeeeEEeEEee----CCeEEEEEEe
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRLLVYEY 169 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~ 169 (315)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 45999999999999984 8899999997654332 4678899999999999999999999876 4578999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++|+|.+++.. ...+++.....++.|++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999875 35688999999999999999999973 278899999999999999999999999987543322
Q ss_pred CceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 12368899999999876 68999999999999999999999999987765554443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=296.21 Aligned_cols=209 Identities=28% Similarity=0.447 Sum_probs=174.1
Q ss_pred hCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 162 (315)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44689999999999999999974 3456789999987543 23355688999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCC----------------------------------------------------------
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRP---------------------------------------------------------- 184 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------- 184 (315)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 185 -------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 185 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 123578889999999999999999998 9999999999999999999999999999754333221
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11222335667999999999999999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.89 Aligned_cols=212 Identities=28% Similarity=0.447 Sum_probs=177.4
Q ss_pred CCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.+|++.+.||+|+||.||+|.+. ..+..||+|.++.... .....+.+|+..++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46889999999999999999865 4467899999876532 3345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 34689999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
..... ......++..|+|||++.+..++.++|||||||++||+++ |..||......+.+..+
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 21111 1112235678999999999999999999999999999775 99999877765554444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.23 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=167.4
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC---CCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA---DHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
||+|+||+||+|.+..++..||+|++..... ........|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865322 1233344566666554 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 999988865 45689999999999999999999998 999999999999999999999999999864322211
Q ss_pred eeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 253 VSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~ 208 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN 208 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence 12234799999999988764 589999999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=291.08 Aligned_cols=197 Identities=26% Similarity=0.386 Sum_probs=166.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 457778899999999999999999999999999865432 3346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+. ....+..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999998542 2346778889999999999999998 99999999999999999999999999997543221
Q ss_pred CceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||...
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1123468999999998743 23456899999999999999999999743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=310.49 Aligned_cols=217 Identities=32% Similarity=0.536 Sum_probs=188.2
Q ss_pred CCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
.+....+.||+|+||+||+|.-. .....||||.++..... ...+|++|++++..++|||||+++|+|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34566778999999999999753 23467999999877655 6788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 165 LVYEYMPLGSLDKHLHDLRP------D----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
+|+|||..|+|.+||....+ . ..+++..+.+.|+.|||.||.||-+. .++||||..+|.||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999975432 1 23488999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
||+|||+++..-+.+-........-..+|||||.+..+.++.+|||||+||+|||+++ |+.||.+..+.+.++.|.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999986544443333333355779999999999999999999999999999997 999999999999888875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=317.45 Aligned_cols=215 Identities=22% Similarity=0.365 Sum_probs=178.1
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee--CC
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GD 161 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~ 161 (315)
.....++|.+++.||+|+||+||+|.+..++..||+|++..... .....+..|+.+++.++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34455789999999999999999999999999999999875432 335668899999999999999999998854 45
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEecCCCCCEEEcCC------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL----KQPVIYRDLKCSNILLEEG------ 231 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----~~~iiH~Dlkp~Nili~~~------ 231 (315)
.+||||||+++++|.++|.........+++..++.|+.||+.||.|||+.. .++|+||||||+||||+.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999999999999999765444567999999999999999999999851 1259999999999999642
Q ss_pred -----------CceEEeccCCcccCCCCCCceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 232 -----------YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 232 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999997543221 1223479999999998864 458899999999999999999999998
Q ss_pred ccCch
Q 021249 299 QTKDR 303 (315)
Q Consensus 299 ~~~~~ 303 (315)
..+..
T Consensus 245 ~~~~~ 249 (1021)
T PTZ00266 245 KANNF 249 (1021)
T ss_pred cCCcH
Confidence 65543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.01 Aligned_cols=209 Identities=23% Similarity=0.331 Sum_probs=177.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999975422 23456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 168 EYMPLGSLDKHLHDLRP-------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
||++|++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864321 123456778889999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCC----------------ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 241 LAKMGPSGDK----------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 241 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
++........ ........||+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9975421100 0111224699999999999999999999999999999999999999976443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=280.30 Aligned_cols=195 Identities=29% Similarity=0.459 Sum_probs=168.7
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||+|+||.||++.+..+|+.||+|.+..... .....+..|+.+++.++||||+++++++.++...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999999999999999864322 1233456799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 9887642 234588999999999999999999998 999999999999999999999999999875433221 22
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3468999999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.95 Aligned_cols=201 Identities=22% Similarity=0.255 Sum_probs=173.2
Q ss_pred HhCCCCcccccccCCceEEEEEEEC--CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
...+|.+.+.||.|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 4568999999999999999999764 35678999988653 2345799999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||++. ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99985 688888743 46799999999999999999999998 99999999999999999999999999997544
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 33322222345799999999999999999999999999999999999999977653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.31 Aligned_cols=216 Identities=33% Similarity=0.535 Sum_probs=180.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCC-----eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46889999999999999999876544 6899999875432 33456889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPD------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~ 232 (315)
++|||+++++|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999998753211 14688899999999999999999998 999999999999999999
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999975433322222233456788999999988899999999999999999998 99999877665554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=281.57 Aligned_cols=204 Identities=29% Similarity=0.441 Sum_probs=176.6
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
|+..+.||+|+||+||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+.+++.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778899999999999999999999999998754322 234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888652 234699999999999999999999998 99999999999999999999999999986543221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||....+..
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 123468999999999998899999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.29 Aligned_cols=215 Identities=31% Similarity=0.484 Sum_probs=180.4
Q ss_pred CCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468889999999999999998743 3578999998765443 4567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 165 LVYEYMPLGSLDKHLHDLR----------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
++|||+++++|.+++.... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997532 1235588999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
+|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999875432222122223346778999999999999999999999999999998 9999987665554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=277.10 Aligned_cols=207 Identities=26% Similarity=0.377 Sum_probs=178.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-----ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|.+.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468999999999999999999998899999999864422 224568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998876 35688999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCcee-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 246 PSGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 246 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 32211111 122457889999999999889999999999999999999999997755433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=281.56 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=175.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|+..+.||+|+||.||++.+..+++.||+|.+...... ....+..|+.+++.++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788899999999999999999999999998754322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988652 234589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 21 122368999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=281.87 Aligned_cols=214 Identities=32% Similarity=0.495 Sum_probs=179.6
Q ss_pred CCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|.+.+.||+|+||.||++.. ..++..+|+|.+..........+.+|+.+++.++||||+++++++...+.+++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688999999999999999985 23456799999876655556778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 166 VYEYMPLGSLDKHLHDLRP---------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 9999999999999875321 223589999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |.+||......+.+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999875433222222222345778999999998899999999999999999998 999998766554333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.64 Aligned_cols=209 Identities=34% Similarity=0.519 Sum_probs=180.7
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHH--HHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR--EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|++.+.||+|+||+||++.+..+++.||+|++......... ....|+.+++.++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999999999999999999877654322 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|.+++.. ...+++..++.++.||+.||.+||+. +++|+||||+||++++++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 99999999973 46689999999999999999999998 999999999999999999999999999975311 1
Q ss_pred ceeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 251 THVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
........++..|+|||++. +..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 12233457899999999988 7889999999999999999999999999875444444443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.15 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=187.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
.|.++..||.|+||.||+|..+.++-..|-|+|...+....+++.-||.+|..++||+||++++.|...+.+|++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46667779999999999999999888899999998888889999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
||.++..+-.. +.+|.+.++..+++|++.||.|||+. +|||||||..|||++-+|.++|+|||.+..... ..
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99998887663 67899999999999999999999998 999999999999999999999999999864322 22
Q ss_pred eeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 252 HVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.....++|||+|||||+.. ..+|+.++||||||++|.||..+.+|....++-..+-+|.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia 248 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 248 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence 2345579999999999764 5689999999999999999999999999888776665554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.46 Aligned_cols=223 Identities=29% Similarity=0.450 Sum_probs=188.6
Q ss_pred CCcCHHHHHHHhCCCCcccccccCCceEEEEEEECCCC----eEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCee
Q 021249 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLV 151 (315)
Q Consensus 79 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv 151 (315)
.|..-..|....++-.+.++||+|+||.||+|.....+ ..||+|...... .....++..|++++++++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 34555566666777788899999999999999976432 238999987532 35577899999999999999999
Q ss_pred eEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q 021249 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG 231 (315)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~ 231 (315)
++||+......++||||+|.||+|.++|+.. ...++..+...++.+.+.||+|||+. ++|||||..+|+|++.+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~ 298 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKK 298 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCC
Confidence 9999999999999999999999999999873 33699999999999999999999998 99999999999999999
Q ss_pred CceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
+.+||+|||+++......... ....-..+|+|||.+....|+.++|||||||++||+++ |..||.+....+....|
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred CeEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 999999999987543111111 01124568999999999999999999999999999998 88999999988777776
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.70 Aligned_cols=204 Identities=30% Similarity=0.414 Sum_probs=174.6
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------eEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------QRLL 165 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~~l 165 (315)
+...+.||+|+||.||+++++.+|+.||||.++... ....+...+|+++|++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455667999999999999999999999999998643 445677889999999999999999999865533 5679
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--CC--ceEEeccCC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GY--HPKLSDFGL 241 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--~~--~~kl~Dfg~ 241 (315)
|||||.||+|...|.+-. +...|++.+.+.++.++..||.|||+. +|+||||||.||++-. +| --||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998644 345599999999999999999999987 9999999999999843 23 359999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
|+...+.. ....++||+.|++||+... ..|+..+|.|||||++|+++||..||--....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99655543 4456799999999998884 78999999999999999999999999754433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=286.85 Aligned_cols=207 Identities=29% Similarity=0.468 Sum_probs=173.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 469999999999999999998765554 48999987543 23456788999999999999999999998764 5779
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+.+|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998762 34588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
.............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 43322221222234668999999999999999999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.61 Aligned_cols=209 Identities=25% Similarity=0.295 Sum_probs=175.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEE-ee---C---
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYC-AE---G--- 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~-~~---~--- 160 (315)
..-++++.+.|.+|||+.||+|.+...|..||+|.+-..+....+.+.+|+.++++|. |||||.+++.. .. +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3446788899999999999999999887999999987777778889999999999996 99999999943 11 1
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
-.++|.||||.||.|-|++..... ..|++.++++|+.|+++|+++||.+ +.+|||||||-+||||+.+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 256799999999999999987543 3399999999999999999999998 6679999999999999999999999999
Q ss_pred CcccCCCCC-Cceee------eeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 241 LAKMGPSGD-KTHVS------TRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 241 ~~~~~~~~~-~~~~~------~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.+....... ..... -...-|+.|+|||++. +...+.++|||||||+||-|+....||...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 986432221 11000 0113688999999874 668899999999999999999999999876
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.61 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=176.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999988999999999765545556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998865 35689999999999999999999998 99999999999999999999999999997543221
Q ss_pred CceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. ......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||.....
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 1 112246888999999874 34578899999999999999999999965543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.47 Aligned_cols=216 Identities=27% Similarity=0.459 Sum_probs=178.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998642 35679999986432 2334568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPD------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753321 23467888999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999875433222211122245778999999988899999999999999999999 789998776554443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=280.74 Aligned_cols=206 Identities=28% Similarity=0.430 Sum_probs=178.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..+.|++.+.||+|+||.||+|.+..++..+++|.+..........+..|+.+++.++||||+++++.+..+..+++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 44679999999999999999999999999999999987766667788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|..++... ...+++..+..++.|++.+|.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999998877542 35689999999999999999999987 9999999999999999999999999998643222
Q ss_pred CCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. .......+++.|+|||++. ...++.++|+|||||++|+|++|.+||...+.
T Consensus 164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 1 1112346888999999875 34578899999999999999999999976553
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.55 Aligned_cols=208 Identities=25% Similarity=0.353 Sum_probs=175.7
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG----- 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 160 (315)
...++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999999999999999875422 2345677899999999999999999987543
Q ss_pred -CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 7888877753 4589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999754332 123468999999998877 56889999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=278.79 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=177.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|.+.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888899999999999999999999999999997665555566888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999998865 35689999999999999999999998 99999999999999999999999999986543221
Q ss_pred ceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 THVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.......|++.|+|||++. ...++.++|+|||||++|+|++|..||.....
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 1122346899999999874 45688999999999999999999999975543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=280.54 Aligned_cols=209 Identities=28% Similarity=0.397 Sum_probs=172.3
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccC---CCCCeeeEEeEEee-----CC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCAE-----GD 161 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~~ 161 (315)
+|++.+.||+|+||+||+|.+..+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48889999999999999999999999999999875322 1223455677666554 79999999998864 34
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..+++|||+. ++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999997 5888887653 234589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+........ .....+++.|+|||++.+..++.++|||||||++|+|++|.+||......+.+..+
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 975432211 12346889999999999889999999999999999999999999877766555544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=293.76 Aligned_cols=204 Identities=28% Similarity=0.364 Sum_probs=183.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
-.+.|.+...||+|.|+.|.+|++..++..||||.|++.... ....+.+|+.+++.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 456799999999999999999999999999999999876443 345689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+.+|.+++++.. ...+.+..+..++.|+..|++|||+. .|+|||||++|||++.+.++||+|||++.+..
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987 45567789999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.... ....+|++.|.|||++.+..|+ +++|+||+|+++|.|+.|.+||++.+-
T Consensus 207 ~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 207 YGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred cccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 4332 3346899999999999988775 899999999999999999999997663
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=281.05 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=179.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..+|++.+.||+|++|.||+|.+..++..||+|.+..........+..|+.+++.++||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999888999999999876656667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 3578899999999999999999998 99999999999999999999999999987533221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 112246888999999998888999999999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=282.11 Aligned_cols=210 Identities=28% Similarity=0.396 Sum_probs=177.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 579999999999999999999998999999999875432 2344577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888887652 34688999999999999999999998 99999999999999999999999999987533222
Q ss_pred CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11 1223578899999987654 5788999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=291.33 Aligned_cols=208 Identities=25% Similarity=0.304 Sum_probs=176.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------ 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 160 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999999999999987532 23456678899999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 467666642 378889999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 997543221 122346899999999999999999999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=280.32 Aligned_cols=202 Identities=29% Similarity=0.398 Sum_probs=179.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||++.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36889999999999999999999899999999987542 233566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999876 35689999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 205 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3 123468899999999988888999999999999999999999998766433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=279.26 Aligned_cols=207 Identities=28% Similarity=0.393 Sum_probs=179.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||.|+||.||+|.+..++..+|+|.+..........+..|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45699999999999999999999888999999999876656667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999988652 35699999999999999999999998 99999999999999999999999999986543222
Q ss_pred CceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. ......+++.|+|||.+. ...++.++|+||||+++|+|++|++||...+..+
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~ 215 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH
Confidence 1 122346889999999875 3457789999999999999999999998765433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.79 Aligned_cols=201 Identities=28% Similarity=0.345 Sum_probs=176.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999999999999999987542 23345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..++++..+..++.|++.||.|||+. .+++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999876 35689999999999999999999973 289999999999999999999999999986432221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 123468899999999888889999999999999999999999997554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=291.42 Aligned_cols=210 Identities=25% Similarity=0.386 Sum_probs=174.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCCc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 161 (315)
..++|.+.+.||+|+||.||+|.+... +..||+|++..... ...+.+.+|+.+++.+. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356899999999999999999987432 35799999975432 33567889999999996 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCC---------------------------------------------------------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRP--------------------------------------------------------- 184 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 184 (315)
..++|||||++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864311
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q 021249 185 -----------------------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229 (315)
Q Consensus 185 -----------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~ 229 (315)
....+++..+..++.||+.||.|||+. +++||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478888999999999999999998 999999999999999
Q ss_pred CCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 230 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999975433222211222356788999999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=290.27 Aligned_cols=206 Identities=23% Similarity=0.281 Sum_probs=174.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG----- 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 160 (315)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35578999999999999999999999899999999987542 23356678899999999999999999988643
Q ss_pred -CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 66665532 478889999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 164 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred cccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997543221 122346899999999999989999999999999999999999999877654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=279.54 Aligned_cols=214 Identities=31% Similarity=0.493 Sum_probs=180.2
Q ss_pred CCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+..........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999854 3456799999877665556778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q 021249 166 VYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~ 233 (315)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975321 124589999999999999999999998 9999999999999999999
Q ss_pred eEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999975433322222223456788999999998899999999999999999999 999997766554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.86 Aligned_cols=207 Identities=29% Similarity=0.468 Sum_probs=172.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++.+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 468889999999999999999876665 477787754322 234567788889999999999999998764 56788
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+++++|.+++... ...+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999752 35689999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 43322222233456778999999988899999999999999999998 999998766544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=272.83 Aligned_cols=207 Identities=27% Similarity=0.375 Sum_probs=180.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||+|++|.||+|.+..++..|++|.+.... ......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778889999999999999999999999999987542 33466788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998763 245689999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 11 1234688899999999998999999999999999999999999987664443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.41 Aligned_cols=204 Identities=28% Similarity=0.441 Sum_probs=177.0
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
|++.+.||+|+||.||+|.+..++..+++|.+..........+..|+.+++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67888899999999999999999999999999776655667788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|..++.. ...++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++....... .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999888764 245689999999999999999999998 99999999999999999999999999986533221 1
Q ss_pred eeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 253 VSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
......+++.|+|||++. +..++.++|+|||||++|+|++|.+||...+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 215 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH
Confidence 122346889999999874 3457889999999999999999999998766444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.62 Aligned_cols=205 Identities=26% Similarity=0.415 Sum_probs=170.9
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 35999999999999998889999999886543 23356688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.. ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999865 234689999999999999999999998 99999999999999999999999999987533221111001
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 1123456999999988889999999999999999998 999997666544333
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=272.82 Aligned_cols=207 Identities=28% Similarity=0.358 Sum_probs=181.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||.|+||.||+|.+..++..+++|++..........+.+|+.+++.++||||+++++++.+...++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35789999999999999999999888999999999876555677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ..++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999988752 35689999999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeeeeccccccccCccccccC---CcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 11234688899999998776 78899999999999999999999998765433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=278.80 Aligned_cols=205 Identities=24% Similarity=0.378 Sum_probs=181.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665556677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|..++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998864 3589999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~ 223 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 11234688899999999888899999999999999999999999987665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.18 Aligned_cols=213 Identities=32% Similarity=0.484 Sum_probs=176.3
Q ss_pred CCCCcccccccCCceEEEEEEEC----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|++.+.||+|+||.||+|.+. .++..+|+|.+..... .....+.+|+.+++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45888899999999999999853 3567899999875432 334678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC
Q 021249 166 VYEYMPLGSLDKHLHDLRP-------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~ 232 (315)
+|||+.+++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123478899999999999999999998 999999999999999999
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
.+||+|||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||.+....+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999975433322222223345678999999988889999999999999999998 99999776544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=275.88 Aligned_cols=195 Identities=28% Similarity=0.384 Sum_probs=171.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+..|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999999999999999987542 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|..+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999998643 2367888999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 12346899999999999989999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.28 Aligned_cols=216 Identities=28% Similarity=0.446 Sum_probs=179.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45789999999999999999988643 3789999987543 23355688899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPD------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998754321 23478889999999999999999988 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence 9999875433322222223356788999999988889999999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.23 Aligned_cols=205 Identities=24% Similarity=0.366 Sum_probs=178.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999899999999886432 233456888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998876544456689999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 112246888999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=276.08 Aligned_cols=214 Identities=31% Similarity=0.506 Sum_probs=178.9
Q ss_pred CCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|.+.+.||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999642 3467899999887665666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 166 VYEYMPLGSLDKHLHDLRPD-----------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
+|||+++++|.+++...... ...+++..++.++.|++.|+.|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998754221 13588999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+.+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 9999999875433222111222345678999999998899999999999999999998 999997766544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=272.74 Aligned_cols=213 Identities=29% Similarity=0.454 Sum_probs=178.5
Q ss_pred CCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||.||+|.+... ...||+|.+..... .....+..|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5689999999999999999998643 45799999875432 2345688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998752 34689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 2222222222235678999999998899999999999999999998 99999766655444333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.42 Aligned_cols=203 Identities=26% Similarity=0.378 Sum_probs=179.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..+|++.+.||+|+||.||+|.+..++..||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999999888999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998864 4578899999999999999999998 99999999999999999999999999987543222
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 1 11234688899999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.68 Aligned_cols=206 Identities=26% Similarity=0.347 Sum_probs=174.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-----cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 163 (315)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46899999999999999999999999999999885321 12345788899999999999999999988763 568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875 34578899999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
........ .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 54321111 1112245888999999998888999999999999999999999999765433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=272.37 Aligned_cols=206 Identities=26% Similarity=0.341 Sum_probs=178.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
+|++.+.||.|+||.||++.+..++..+|+|.+.... ....+.+..|+.+++.++||||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999999999999999986432 334567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988653 245588999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+...
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 207 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH
Confidence 1223468889999999988889999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=275.14 Aligned_cols=212 Identities=31% Similarity=0.481 Sum_probs=182.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3468999999999999999999987 889999999877665667789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999763 245689999999999999999999998 99999999999999999999999999997543321
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..+
T Consensus 159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 11 112245678999999988899999999999999999998 89999877655554443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.78 Aligned_cols=211 Identities=27% Similarity=0.413 Sum_probs=172.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEee-C
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE-G 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~ 160 (315)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+..|+.+++.+ +||||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 34579999999999999999997543 457899999875432 3345678899999999 79999999998754 4
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCC-------------------------------------------------------
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPD------------------------------------------------------- 185 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------------------------- 185 (315)
...++++||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999988642210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccc
Q 021249 186 --TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263 (315)
Q Consensus 186 --~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 263 (315)
..++++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++................++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999998 9999999999999999999999999999754332221112223456789
Q ss_pred cCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCc
Q 021249 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD 302 (315)
Q Consensus 264 ~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 302 (315)
+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=275.24 Aligned_cols=210 Identities=36% Similarity=0.551 Sum_probs=174.5
Q ss_pred cccccccCCceEEEEEEEC----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 95 SDCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 95 ~~~~ig~G~~g~V~~~~~~----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+.+.||.|+||.||+|.+. ..+..|+||.++.... ...+.+.+|+..+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567999999999999987 4567899999965433 3467899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++|+|.+++... ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999873 246789999999999999999999998 99999999999999999999999999998653322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.............|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222223356778999999999999999999999999999999 78999888666555544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=280.69 Aligned_cols=215 Identities=28% Similarity=0.395 Sum_probs=186.4
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCe
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 162 (315)
.....+|..+.+||+|+||.|.+|..+++.+.||||++++.-.. +.+--..|-++|... +-|.++++...|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34456799999999999999999999999999999999876432 234445566777665 47889999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||+.||+|-..+++ -+.+-+..+..++..|+-||-+||+. +||+||||.+||+++.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999988887 35577788999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+.......+ ...++|||.|+|||++...+|+..+|+||+||+||||+.|++||++.++.+..+.|.
T Consensus 498 KEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 498 KENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred cccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 854333332 345799999999999999999999999999999999999999999999888777764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=271.59 Aligned_cols=210 Identities=26% Similarity=0.413 Sum_probs=176.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+..|+.+++.++||||+++++++...+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 458888999999999999998764 56799998865432 3467888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988752 24588999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
. ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+.+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 1 1112234568999999988889999999999999999999 99999877765554444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.31 Aligned_cols=196 Identities=24% Similarity=0.257 Sum_probs=169.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
...|.+.+.||+|+||.||+|.+..++..||+|... ...+.+|+.+++.++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999999999999999642 23356899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6888877642 34699999999999999999999998 99999999999999999999999999997643332
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+-
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222234579999999999999999999999999999999999876553
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=274.32 Aligned_cols=210 Identities=28% Similarity=0.358 Sum_probs=178.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ...+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468899999999999999999998899999999864432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|..++.. ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888776643 34689999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.++.+.+..+
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 211 122357889999998876 45789999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.80 Aligned_cols=215 Identities=29% Similarity=0.447 Sum_probs=177.2
Q ss_pred hCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.+..... .....+..|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568999999999999999999976 678899999875432 2345688899999999999999999999998999
Q ss_pred EEEEEecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEe
Q 021249 164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLS 237 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~ 237 (315)
+++|||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||+|+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 123589999999999999999999998 999999999999998654 58999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~ 232 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999975432221111112234568999999998899999999999999999997 999998766554443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=271.57 Aligned_cols=205 Identities=26% Similarity=0.395 Sum_probs=179.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999889999999886432 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876554556789999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 2211 12246888999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.19 Aligned_cols=202 Identities=28% Similarity=0.446 Sum_probs=174.9
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCC----CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe--EEEEEEe
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ--RLLVYEY 169 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~e~ 169 (315)
...||+|+|-+||+|.+..+|..||.-.++.. .....+++..|+.+|+.|+||||+++|++|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 44599999999999999999999998766533 23456789999999999999999999999987665 7799999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 248 (315)
+..|+|..|+++ .+.++...+..|++||+.||.|||++ .++|||||||.+||||+. -|.|||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999987 45688889999999999999999998 679999999999999985 589999999999875443
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
... ..+|||.|||||+.. ..|+..+||||||+++.||+|+.+||+.....-++.
T Consensus 200 ~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred ccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 322 358999999999655 789999999999999999999999999877555443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=272.24 Aligned_cols=211 Identities=28% Similarity=0.457 Sum_probs=178.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++..++.++++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999999889999999987543 33567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998653 234589999999999999999999998 999999999999999999999999999975433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~ 217 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 217 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 1 1111234567999999988899999999999999999998 9999987655444333
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=271.86 Aligned_cols=210 Identities=30% Similarity=0.432 Sum_probs=172.5
Q ss_pred CCcccccccCCceEEEEEEECC---CCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe-----
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ----- 162 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 162 (315)
|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998754 347899999875432 335678899999999999999999998865544
Q ss_pred -EEEEEEecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 163 -RLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 163 -~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
.++++||+++++|..++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 1234689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99975443322111112235678999999988899999999999999999999 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=271.62 Aligned_cols=205 Identities=26% Similarity=0.454 Sum_probs=176.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
+|.+...||+|++|.||+|.+..++..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999999888999999988654321 13568889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++++||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 35688999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCC----ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 243 KMGPSGDK----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 243 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
+....... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 75532111 11112245788999999998888999999999999999999999999875543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=296.05 Aligned_cols=198 Identities=29% Similarity=0.429 Sum_probs=178.3
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhh
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDK 177 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 177 (315)
+||+|.||+||-|++..+....|||.|........+-+..||.+-+.|+|.|||+++|.+.+++++-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 49999999999999999999999999988777777788999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCCceEEeccCCcccCCCCCCceee
Q 021249 178 HLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVS 254 (315)
Q Consensus 178 ~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 254 (315)
+|+. ..+|+ .+..+-.+..||++||.|||+. .|+|||||-+|+||+ -.|.+||+|||.++..... ..+.
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence 9976 46777 8889999999999999999998 999999999999997 4689999999999865433 3445
Q ss_pred eeccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 255 TRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 255 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
..+.||+.|||||++..+ .|+.++|||||||++.||.||++||-.....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp 784 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP 784 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence 567899999999999765 6899999999999999999999999876543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=273.20 Aligned_cols=203 Identities=31% Similarity=0.426 Sum_probs=179.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||.|++|.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999999999999999987553 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. .++++..++.++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999998865 2789999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~ 204 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH
Confidence 1122346888999999999888999999999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.02 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=177.7
Q ss_pred CCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+|.+.+.||.|+||.||+|.+.. .+..||+|.+...... ....+..|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 47788899999999999998754 3578999999754332 34568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q 021249 166 VYEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~ 233 (315)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985311 1124588889999999999999999998 9999999999999999999
Q ss_pred eEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999875433322222223346778999999988889999999999999999998 88999877665555544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=272.67 Aligned_cols=211 Identities=27% Similarity=0.435 Sum_probs=177.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+..|+.+++.++||||+++++.+.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4579999999999999999998754 66799998865432 356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998753 245688899999999999999999998 99999999999999999999999999997643322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
.. ......++..|+|||++.+..++.++|+|||||++|+|++ |..||......+....
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 11 1122245678999999988889999999999999999998 9999987655444433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=273.50 Aligned_cols=208 Identities=27% Similarity=0.440 Sum_probs=172.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
..+|++.+.||+|+||+||+|.+..++. .||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 3468889999999999999999876665 489999875432 335668899999999999999999999875 4578
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+++||+++|+|.+++... ...+++..++.++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999988652 34689999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 543222111111234678999999988899999999999999999998 999998655443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=279.42 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=162.1
Q ss_pred ccccccCCceEEEEEEEC--CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeEEEEEEecC
Q 021249 96 DCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMP 171 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~ 171 (315)
.+.||+|+||+||+|.+. .++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999965 4678999999875432 3456789999999999999999998854 457899999985
Q ss_pred CCChhhhhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----cCCCceEEeccCCc
Q 021249 172 LGSLDKHLHDLRP-----DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA 242 (315)
Q Consensus 172 ~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili----~~~~~~kl~Dfg~~ 242 (315)
++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 578777653221 223589999999999999999999998 99999999999999 45678999999999
Q ss_pred ccCCCCCC-ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 243 KMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 243 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
........ ........||+.|+|||++.+. .++.++|||||||++|+|++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76433211 1112235789999999988774 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=277.36 Aligned_cols=216 Identities=27% Similarity=0.410 Sum_probs=179.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
...++|++.+.||+|+||.||++.+... ...+|+|.+.... ......+.+|+.+++.+ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3446799999999999999999987643 3789999987543 23345688899999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+.++++|||+++++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999986532 2345689999999999999999999988 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
+.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999976543322211222235568999999988899999999999999999997 99999876654433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=281.90 Aligned_cols=194 Identities=25% Similarity=0.340 Sum_probs=167.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
....+|.+.+.||+|+||.||+|.+..++..||+|+..... ...|+.+++.++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34457999999999999999999999999999999854332 346899999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|++. ++|.+++.. ...++++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 688887764 246789999999999999999999998 999999999999999999999999999974322
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 297 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 297 (315)
.. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 112346899999999999999999999999999999999865444
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=269.67 Aligned_cols=197 Identities=24% Similarity=0.336 Sum_probs=170.4
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.||+|+|+.|--+....+|..||||+|.+.......++.+|++++.+.+ |+||++++++|+++..+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 56999999999999999999999999999887777888999999999985 99999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEeccCCcccCCCC----
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLAKMGPSG---- 248 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~---- 248 (315)
...|.+ ..-+++.++.++..+|+.||.|||.. ||.||||||+|||-.... -+||+||.+..-....
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999887 56699999999999999999999987 999999999999997654 4799999887422111
Q ss_pred -CCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 249 -DKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 249 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
..+......+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1112223457899999999764 236899999999999999999999999874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.10 Aligned_cols=206 Identities=32% Similarity=0.443 Sum_probs=181.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc---HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..+.|+.-++||+|+||.|+-+....||+.||+|.+.+..... ......|-.+|.+++.+.||.+--+|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456888899999999999999999999999999987653321 2346778899999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|+..|.||+|.-.|.+.. ...+++..++.++.+|+.+|++||.. +|++|||||+|||+|+.|+++|+|+|+|...
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999988887643 35699999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
..+... ..-+||.+|||||++.+..|+...|+|||||++|||+.|+.||.....
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 554332 223799999999999999999999999999999999999999987653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=307.33 Aligned_cols=215 Identities=32% Similarity=0.497 Sum_probs=183.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCC-----eEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
..-++.+.||+|+||.||.|...... ..||+|.+.+. +.....+|.+|..+++.++|||||++++++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34567788999999999999875432 34899998764 4566788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPD---TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
|++|||+||+|..||+..+.. ...++....+.++.|||+|+.||+++ ++|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999875432 45689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
|+.....+.........-...|||||.+....++.++|||||||++||++| |..||.+.++.+.+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~ 916 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD 916 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence 984333332222222234568999999999999999999999999999998 8999999988877663
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=274.60 Aligned_cols=215 Identities=27% Similarity=0.453 Sum_probs=180.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCC----------------eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeee
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIE----------------QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVK 152 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~----------------~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 152 (315)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876533 5689999876532 34567889999999999999999
Q ss_pred EEeEEeeCCeEEEEEEecCCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
+++++..++..++++||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876431 123689999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh--CCCcccccCch
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDR 303 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~ 303 (315)
|+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875443332222333456778999999988889999999999999999998 78899876655
Q ss_pred hhhh
Q 021249 304 KELN 307 (315)
Q Consensus 304 ~~~~ 307 (315)
+.+.
T Consensus 241 ~~~~ 244 (296)
T cd05051 241 QVIE 244 (296)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=273.05 Aligned_cols=205 Identities=27% Similarity=0.364 Sum_probs=173.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 48888999999999999999998999999999865432 2346688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|.+++.... ....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888876532 235689999999999999999999998 99999999999999999999999999987533221
Q ss_pred CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|++||......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 112223578899999987654 5789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=272.29 Aligned_cols=212 Identities=27% Similarity=0.456 Sum_probs=176.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe---EEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||.||+|.+..++. .||+|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999999876554 6999998754 233456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 34589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeecc---ccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
............ .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~ 223 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 322211111111 2357999999998899999999999999999886 9999987665544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=269.59 Aligned_cols=212 Identities=30% Similarity=0.449 Sum_probs=178.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|++|.||+|.+.. +..||+|.+..... ....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4568999999999999999998764 57899999876542 356688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999987532 35689999999999999999999998 99999999999999999999999999997654221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.. .......+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+......+..+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 11 1111123457999999988899999999999999999999 99999877665554444
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=275.90 Aligned_cols=215 Identities=29% Similarity=0.357 Sum_probs=179.1
Q ss_pred HHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEe---
Q 021249 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCA--- 158 (315)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~--- 158 (315)
++.+....++|++.+.||+|+||.||+|.+..++..+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455566788999999999999999999999999999999986532 2235677899999998 6999999999873
Q ss_pred --eCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 159 --EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 159 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 45678999999999999998865444456789999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
+|||++......... .....|++.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 166 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 166 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred ccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 999998754332211 122368899999998753 45788999999999999999999999866543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=275.84 Aligned_cols=207 Identities=25% Similarity=0.364 Sum_probs=177.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||++.+..+++.|++|.+..... .....+..|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999876532 23456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++|++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999865 35689999999999999999999998 999999999999999999999999999864211
Q ss_pred CCCc-------------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 248 GDKT-------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 248 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~ 223 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1000 01112357888999999988899999999999999999999999998655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=274.61 Aligned_cols=215 Identities=33% Similarity=0.480 Sum_probs=176.9
Q ss_pred CCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+..|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998743 235789998875432 345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 166 VYEYMPLGSLDKHLHDLRP--------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
++||+.+++|.+++..... ...++++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864321 124588999999999999999999988 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
||+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875432221111122345678999999988899999999999999999998 999998776555
Q ss_pred hhhHH
Q 021249 305 ELNLV 309 (315)
Q Consensus 305 ~~~~i 309 (315)
..+.+
T Consensus 238 ~~~~~ 242 (290)
T cd05045 238 LFNLL 242 (290)
T ss_pred HHHHH
Confidence 44443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=275.47 Aligned_cols=214 Identities=27% Similarity=0.438 Sum_probs=175.8
Q ss_pred CCCCcccccccCCceEEEEEEECCC--------------CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKI--------------EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIG 155 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~--------------~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~ 155 (315)
.+|++.+.||+|+||.||+|.+..+ ...||+|.++... ......+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 2358999987643 233456889999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR--------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
++...+..++||||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999986421 0112478889999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh--CCCcccccCchhh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRKE 305 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~ 305 (315)
+++++.+||+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999975433322222223345678999999988899999999999999999998 6789887665444
Q ss_pred hh
Q 021249 306 LN 307 (315)
Q Consensus 306 ~~ 307 (315)
+.
T Consensus 242 ~~ 243 (295)
T cd05097 242 IE 243 (295)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=269.78 Aligned_cols=207 Identities=26% Similarity=0.358 Sum_probs=175.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-----cccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 163 (315)
.+|...+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36889999999999999999999899999999986432 1234568889999999999999999998865 3678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999875 34588999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCC-ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 244 MGPSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 244 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
....... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 5422111 111122457889999999988889999999999999999999999998665433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=275.39 Aligned_cols=214 Identities=27% Similarity=0.442 Sum_probs=175.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
..++|++.+.||+|+||.||+|.++. .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997642 35589999986543 2234457789999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRP------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
.++||||+++++|.+++..... .....+...+..++.|++.||.|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 123456778899999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||......+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999875433222221222245678999999988899999999999999999998 7899977654443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.89 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=178.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||.||+|.+..++..+|||.+.... ......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888999999999999999998889999999886532 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 221 1123468889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=277.26 Aligned_cols=211 Identities=29% Similarity=0.386 Sum_probs=180.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++||||+++++.+.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688899999999999999999988999999999765433 4556888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988752 245689999999999999999999998 999999999999999999999999999864322
Q ss_pred CCCc---------------------------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKT---------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1100 0111236788999999999889999999999999999999999999876
Q ss_pred Cchhhh
Q 021249 301 KDRKEL 306 (315)
Q Consensus 301 ~~~~~~ 306 (315)
+....+
T Consensus 236 ~~~~~~ 241 (316)
T cd05574 236 NRDETF 241 (316)
T ss_pred chHHHH
Confidence 654433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=269.05 Aligned_cols=210 Identities=28% Similarity=0.398 Sum_probs=175.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 358889999999999999998864 66899999865432 3456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998752 24689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+
T Consensus 156 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 156 TS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred cc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 11 111123457999999988899999999999999999999 89999876655544433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=268.50 Aligned_cols=210 Identities=33% Similarity=0.504 Sum_probs=179.0
Q ss_pred cccccCCceEEEEEEECCC---CeEEEEEEecCCCccc-HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+... +..|++|.+....... ...+..|+..++.++||||+++++++.....++++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3599999999999999865 8899999998654433 67789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 173 GSLDKHLHDLRPD-----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 173 ~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
++|.+++...... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764221 36799999999999999999999997 999999999999999999999999999986544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
...........+++.|+|||.+....++.++|+||||+++|+|++ |..||......+....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 322222233457889999999988889999999999999999999 69999887655444443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=277.79 Aligned_cols=212 Identities=27% Similarity=0.398 Sum_probs=174.9
Q ss_pred hCCCCcccccccCCceEEEEEEECC-------CCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998643 23569999997542 23455688899999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976432 123588999999999999999999988 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
+.++.++|+|||++................+++.|+|||++.+..++.++|+|||||++|+|++ |..||......+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999875432221111111234568999999988889999999999999999998 889997665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=275.13 Aligned_cols=212 Identities=27% Similarity=0.451 Sum_probs=175.0
Q ss_pred CCCCcccccccCCceEEEEEEECC----------------CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK----------------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKL 153 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~----------------~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~ 153 (315)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... ......+..|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999985432 34579999987543 2335678899999999999999999
Q ss_pred EeEEeeCCeEEEEEEecCCCChhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 021249 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD-------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226 (315)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Ni 226 (315)
++++..++..+++|||+.+++|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998763221 23477889999999999999999998 999999999999
Q ss_pred EEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh--CCCcccccCchh
Q 021249 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRK 304 (315)
Q Consensus 227 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~ 304 (315)
|++.++.++|+|||++................+++.|+|||+..+..++.++|+|||||++|||++ |..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433322222222345678999999888889999999999999999998 789997665544
Q ss_pred h
Q 021249 305 E 305 (315)
Q Consensus 305 ~ 305 (315)
.
T Consensus 242 ~ 242 (296)
T cd05095 242 V 242 (296)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=261.35 Aligned_cols=210 Identities=26% Similarity=0.342 Sum_probs=179.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----eE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QR 163 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 163 (315)
..++|++.+.||.|||+-||++....++..||+|.+.-.+.+..+...+|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4568999999999999999999999999999999998777778888999999999999999999998774433 48
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
||+++|...|+|.+.+......+..+++.++++|+.+|++||.+||+. ..+++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999988777777899999999999999999999998 3359999999999999999999999999986
Q ss_pred cCCCCCCce-------eeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 244 MGPSGDKTH-------VSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 244 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
...-.-... .-....-|..|+|||.+. +...+.++|||||||+||+|+.|.-||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 432110000 001123477899999775 45678999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=272.43 Aligned_cols=206 Identities=30% Similarity=0.420 Sum_probs=174.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC------C
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG------D 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~------~ 161 (315)
..+.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567999999999999999999999999999999987543 3345678899999888 699999999998653 4
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.++++|||+.+++|.+++... ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 689999999999999998763 235689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+........ ......|++.|+|||++. +..++.++|+|||||++|+|++|..||.....
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~ 221 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 875432211 122346899999999876 34688899999999999999999999976543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=269.46 Aligned_cols=209 Identities=25% Similarity=0.398 Sum_probs=175.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 458889999999999999998764 45699999875433 3466889999999999999999999999989999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998752 23689999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
. ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 1 1112235568999999988889999999999999999998 9999987665444333
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=277.27 Aligned_cols=209 Identities=30% Similarity=0.448 Sum_probs=172.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeE--EEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV--VAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ......+.+|+.++.++ +||||+++++++..++.+++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4688999999999999999998776654 5777765432 23355688899999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 167 YEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
|||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999875321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
+|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|+| |..||...+..+.
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 232 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH
Confidence 9999999863211110 111134567999999888889999999999999999998 9999976654443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=270.38 Aligned_cols=209 Identities=28% Similarity=0.424 Sum_probs=170.2
Q ss_pred CCcccccccCCceEEEEEEECCCCe--EEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------Ce
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQ 162 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~ 162 (315)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... ....+.+..|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567889999999999999877664 68999887542 33456788899999999999999999976432 24
Q ss_pred EEEEEEecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 163 RLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
.++++||+.+++|.+++...+ .....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2234589999999999999999999997 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9976433322111122245678999999999899999999999999999999 899998765544
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.10 Aligned_cols=208 Identities=25% Similarity=0.367 Sum_probs=180.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|+..+.||.|+||.||.+....++..+++|.+.... ......+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987532 35689999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~ 210 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 1 122346899999999998888999999999999999999999999876554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.40 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=174.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3688899999999999999999989999999998754 223356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|..++.... ....+++..+..++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999988886521 134689999999999999999999963 289999999999999999999999999986532221
Q ss_pred CceeeeeccccccccCccccccC------CcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.......
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 1223578899999987544 35789999999999999999999997655433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=275.64 Aligned_cols=216 Identities=27% Similarity=0.411 Sum_probs=178.2
Q ss_pred hCCCCcccccccCCceEEEEEEEC-------CCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
.++|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457899999999999999999752 234579999987542 33456788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
...+++|||+.+++|.+++..... ....+++..+..++.||+.||.|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999876422 123578889999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999976543322222222345678999999988889999999999999999998 889998766555444
Q ss_pred H
Q 021249 308 L 308 (315)
Q Consensus 308 ~ 308 (315)
.
T Consensus 251 ~ 251 (304)
T cd05101 251 L 251 (304)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=272.11 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=179.1
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||+|++|.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999999998899999999876542 3356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+ +++|.+++... ..++++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999988753 36699999999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
. .......++..|+|||++.+. .++.++||||||+++|+|++|.+||....+.+.+..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 1 112234688999999988654 468999999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=277.87 Aligned_cols=203 Identities=18% Similarity=0.222 Sum_probs=169.1
Q ss_pred cccccccC--CceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 95 SDCCLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 95 ~~~~ig~G--~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++++||+| +|++||++.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 789999999999999999999975432 33456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 34589999999999999999999998 999999999999999999999999986543211110
Q ss_pred -c----eeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 -T----HVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 -~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 0 01112346778999999876 4689999999999999999999999986554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=288.48 Aligned_cols=211 Identities=26% Similarity=0.311 Sum_probs=182.1
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
-|..++.||-|+||.|.+++...|...||+|.+.+.++ .....+..|-.||...+.+-||+||-.|++.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36777889999999999999999999999999987654 235567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++||++-.+|-+ -+-+.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|++||+|||+|.-+...
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999998876 45689999999999999999999998 9999999999999999999999999998522110
Q ss_pred ---------CCc-------------------------------eeeeeccccccccCccccccCCcCcccchhhHHHHHH
Q 021249 249 ---------DKT-------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 288 (315)
Q Consensus 249 ---------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 288 (315)
+.. ......+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 0012346999999999999999999999999999999
Q ss_pred HHHhCCCcccccCchhhhhHH
Q 021249 289 ELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 289 elltg~~pf~~~~~~~~~~~i 309 (315)
||+.|++||-+..+.+...+|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred HHhhCCCCccCCCCCcceeee
Confidence 999999999887766655443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=274.86 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=175.7
Q ss_pred hCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 162 (315)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.+.... ....+.+..|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34699999999999999999975 3346689999987543 23356688999999999 79999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999987522 23489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCch
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR 303 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 303 (315)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 75433222111222345778999999998899999999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=273.22 Aligned_cols=203 Identities=28% Similarity=0.380 Sum_probs=172.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 3679999999999999999999998899999999875432 223446789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. ++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 4898888652 34689999999999999999999998 9999999999999999999999999998643221
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred Ccc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 111 112346788999998875 458899999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=273.72 Aligned_cols=217 Identities=31% Similarity=0.364 Sum_probs=179.9
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC--
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG-- 160 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-- 160 (315)
..+....++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 444456788999999999999999999999999999999986543 2245677889999888 799999999998653
Q ss_pred ---CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 161 ---DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 161 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
...++|+||+++++|.++++........+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence 368999999999999998875444456789999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccC-----CcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
|||++......... .....|+..|+|||++... .++.++|+|||||++|+|++|++||......+.+
T Consensus 171 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 171 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred ecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 99998754332211 1223688899999987543 3688999999999999999999999876654433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.50 Aligned_cols=203 Identities=30% Similarity=0.409 Sum_probs=179.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+|+.+++.++||||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578999999999999999999998889999999876533 678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999865 245689999999999999999999998 999999999999999999999999999875443321
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 122335788999999998889999999999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=269.73 Aligned_cols=212 Identities=27% Similarity=0.436 Sum_probs=176.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCC---eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+..... .....+..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56889999999999999999876443 4799999875432 3356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998752 35689999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCCcee-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 247 SGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
....... .....++..|+|||++.+..++.++|+||||+++|++++ |..||......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~ 221 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH
Confidence 3221111 111223568999999998899999999999999999886 9999987665544333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.15 Aligned_cols=206 Identities=23% Similarity=0.337 Sum_probs=176.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee-CCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 168 (315)
+|++.+.||.|++|.||++.+..+++.||+|.+..... ...+.+..|+.+++.++|||++++++.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999998899999999875432 345568889999999999999999998764 456899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ...++++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998753 235689999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+...
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 2 12233468899999999999999999999999999999999999998665433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.09 Aligned_cols=205 Identities=29% Similarity=0.397 Sum_probs=166.9
Q ss_pred ccccCCceEEEEEEEC--CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCC
Q 021249 98 CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 174 (315)
.||+|+||.||+|.+. .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999864 3456799999875432 234568889999999999999999999999999999999999999
Q ss_pred hhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 175 LDKHLHDLRP-DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 175 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
|.+++..... .....++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 223467778889999999999999998 999999999999999999999999999865333222112
Q ss_pred eeeccccccccCccccccC-------CcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 254 STRVMGTYGYCAPDYAMTG-------QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
.....++..|+|||++.+. .++.++|+||||+++|||++ |..||......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 2234577889999987642 35789999999999999996 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=276.55 Aligned_cols=215 Identities=26% Similarity=0.403 Sum_probs=175.8
Q ss_pred hCCCCcccccccCCceEEEEEEECC-------CCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... ......+..|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4578999999999999999997632 34579999987543 23456688899999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+..+++|||+.+++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999976321 124588999999999999999999988 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975433221111111234567999999988899999999999999999999 899998766544333
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.99 Aligned_cols=212 Identities=27% Similarity=0.349 Sum_probs=190.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
...++..+..||-|+||.|=++..+.....+|+|++++.. ....+.+..|-.+|..++.|.||++|..|.++.+.|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3446777788999999999999887666568999987653 3456778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
+||-|-||.|...|++ ...+....++.++..+++|++|||+. +||+|||||+|.+++.+|.+||.|||+|+..
T Consensus 498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999876 56788999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
..+.. +..++|||.|.|||++.+...+.++|.||||+++|||++|.+||++.++-..+++|-
T Consensus 571 ~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 571 GSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred ccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 65543 356799999999999999999999999999999999999999999999988888773
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=276.10 Aligned_cols=205 Identities=26% Similarity=0.359 Sum_probs=176.7
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
|.....||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456699999999999999888999999998766555567788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ..+++..+..++.||+.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 999988753 3588999999999999999999998 999999999999999999999999999864322211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||...+..+.+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123468899999999988889999999999999999999999998766544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=270.64 Aligned_cols=210 Identities=30% Similarity=0.459 Sum_probs=176.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++.+.||+|+||.||+|.+..+|. .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568899999999999999999876554 589998876543 345678899999999999999999999887 78899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+++++|.+++... ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998752 34589999999999999999999997 9999999999999999999999999999765
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
.............++..|+|||.+....++.++|+||||+++||+++ |..||......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 222 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 43322211111224568999999988899999999999999999998 999998876554433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.92 Aligned_cols=210 Identities=31% Similarity=0.467 Sum_probs=174.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ....+..|+.+++.++||||+++++.+.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 45799999999999999999988765 4699999875433 34568899999999999999999998754 568999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999753 234578999999999999999999998 99999999999999999999999999997543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
.. ......++..|+|||+..+..++.++|+||||+++|+|++ |..||......+.+..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~ 215 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 215 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Confidence 11 1112245678999999988899999999999999999999 8899987765554443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.81 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=175.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-----CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 163 (315)
.+|.+.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999999999999999987532 123355788999999999999999999998664 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++++||+++++|.+++.. ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998865 34588999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
........ .......++..|+|||++.+..++.++|+|||||++|+|++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 216 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence 54321111 11123468889999999988889999999999999999999999998655433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=275.83 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=176.0
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44455799999999999999888999999999765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|..++.. ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 999887754 4588999999999999999999998 999999999999999999999999999864332211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112346889999999998888999999999999999999999999766544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.35 Aligned_cols=204 Identities=29% Similarity=0.442 Sum_probs=177.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45888889999999999999999889999999987543 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998864 4588899999999999999999998 99999999999999999999999999997543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. ......++..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06640 156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208 (277)
T ss_pred c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence 1 1222457889999999988889999999999999999999999998665443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.82 Aligned_cols=211 Identities=29% Similarity=0.435 Sum_probs=173.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe--EEEEEEecCC-CcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHR-GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~i~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||.||+|.+..++. .+++|.+... .....+.+..|+.++.++ +||||+++++++...+.++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999876654 4688887643 223456688899999998 799999999999999999999
Q ss_pred EEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 167 YEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999865321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999863211100 111123457999999988889999999999999999997 999998766544333
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.14 Aligned_cols=203 Identities=25% Similarity=0.410 Sum_probs=174.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+|+..+.||+|++|.||+|.+..++..||+|++..... .....+..|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888899999999999999999999999999875331 134678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCccc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKM 244 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~ 244 (315)
|+||+++++|.+++.. ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999875 35689999999999999999999998 999999999999998775 599999999875
Q ss_pred CCCCCC--ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 245 GPSGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 433211 111223467889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.13 Aligned_cols=206 Identities=29% Similarity=0.392 Sum_probs=164.3
Q ss_pred ccccCCceEEEEEEECC--CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCC
Q 021249 98 CLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~--~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 174 (315)
.||+|+||.||+|.... ....+|+|.+..... .....+.+|+.+++.++||||+++++.+.....+++||||+++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996532 345788998765432 234567889999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 175 LDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 175 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
|.+++...... ....++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 23356778889999999999999998 999999999999999999999999999864322211111
Q ss_pred eeeccccccccCcccccc-------CCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 254 STRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
.....+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+.+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 219 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL 219 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 122345678999998642 356789999999999999999 78999876654433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.69 Aligned_cols=213 Identities=26% Similarity=0.449 Sum_probs=177.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe---EEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.+++.++||||+++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999875554 79999987542 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999865 235689999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceee-eeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 247 SGDKTHVS-TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
........ .....+..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i 223 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 32221111 11123457999999988889999999999999999997 99999877665555444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.58 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=174.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999874 688999998864321 223568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999875 34688999999999999999999998 9999999999999999999999999998743
Q ss_pred CCC----CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 246 PSG----DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 246 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
... ..........++..|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 211 1111122346888999999998888999999999999999999999999865543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.16 Aligned_cols=205 Identities=28% Similarity=0.426 Sum_probs=177.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-----ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ...+.+..|+.+++.++||||+++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988899999999865431 2456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999875 34688999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccccccccCccccccCC-cCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
... ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||......+..
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~ 211 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV 211 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH
Confidence 322 122346888999999887766 899999999999999999999999776644433
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=265.08 Aligned_cols=202 Identities=28% Similarity=0.437 Sum_probs=167.0
Q ss_pred cccCCceEEEEEEEC--CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||+|+||.||+|.+. ..+..||+|++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999765 4466799999876533 234568899999999999999999998864 578999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee-e
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-S 254 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 254 (315)
.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9988642 35689999999999999999999998 999999999999999999999999999975433222111 1
Q ss_pred eeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 255 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS 209 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 11223568999999888889999999999999999996 999998776555443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.04 Aligned_cols=202 Identities=28% Similarity=0.402 Sum_probs=179.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... .....+..|+..+..++||||+++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999999999999999876644 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
+++++|.+++.. ..++++..++.++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999976 3678999999999999999999998 7 9999999999999999999999999998765333
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 154 ~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 154 LDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2221 23357889999999988889999999999999999999999998775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=265.50 Aligned_cols=202 Identities=25% Similarity=0.297 Sum_probs=170.3
Q ss_pred HHhCCCCcc-cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc-CCCCCeeeEEeEEee----CC
Q 021249 88 AATGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYCAE----GD 161 (315)
Q Consensus 88 ~~~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~----~~ 161 (315)
.++++|++. .+||-|-.|.|..+.++.|++.+|+|++..+ ...++|+++--. -.|||||.++++|+. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356677765 4699999999999999999999999998654 334567776433 469999999998864 35
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEec
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSD 238 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~D 238 (315)
.+.+|||.|+||.|+..+.+. ....+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 678999999999999999874 356799999999999999999999999 9999999999999964 45689999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
||+|+..... ......+-||+|.|||++....|+..+|+||+||++|-|++|.+||.....
T Consensus 208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 9999864321 112335789999999999999999999999999999999999999987664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=244.83 Aligned_cols=213 Identities=26% Similarity=0.346 Sum_probs=185.3
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.|.-.++||+|.||+||+|+...+++.||+|.++..+ ........+|+.+|+.+.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3556678999999999999999999999999987543 23356678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
|+ ..|..+.... .+.+..+.++.++.|++++|.++|+. ++.|||+||.|+||+.+|.+||+|||+++-..-
T Consensus 83 cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi-- 153 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI-- 153 (292)
T ss_pred hh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC--
Confidence 96 6777777653 56689999999999999999999998 999999999999999999999999999985432
Q ss_pred CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 313 (315)
...+....+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++.|.+.+-.+++..|-+++
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 23334445789999999998876 58899999999999999985 889999999999999998876
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=283.32 Aligned_cols=213 Identities=25% Similarity=0.409 Sum_probs=174.7
Q ss_pred HhCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 161 (315)
..++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+..|+.++..+. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3446888899999999999999864 3456899999975432 23456889999999997 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCC---------------------------------------------------------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRP--------------------------------------------------------- 184 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 184 (315)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999865321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 185 -------------------------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 185 -------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
....+++..++.++.||+.||.|||+. +++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 113467788899999999999999987 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
++.++.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999975432221111122356788999999988889999999999999999998 899997655433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.36 Aligned_cols=213 Identities=24% Similarity=0.381 Sum_probs=177.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECC----CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEee-CCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~ 162 (315)
..++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34679999999999999999999875 35789999886542 3345668899999999999999999998765 567
Q ss_pred EEEEEEecCCCChhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEec
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPD----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
.+++++|+.+++|.+++...... ...+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998764322 15689999999999999999999988 999999999999999999999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
||+++...............++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 999975433322222222345678999999988899999999999999999999 999998765443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=272.54 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=168.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||+|+||.||+|.+..+|..||+|.+..... .....+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 48888999999999999999999999999999875422 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|.+++... ...+++..++.++.||+.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5787776542 35689999999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 11 1223578899999988764 478999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=265.69 Aligned_cols=209 Identities=31% Similarity=0.436 Sum_probs=180.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||.|+||+||+|.+..++..+|+|++..... .....+.+|+.+++.++||||+++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468999999999999999999988899999999975432 3467789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999876322 24689999999999999999999998 99999999999999999999999999987544332
Q ss_pred Cc--eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. .......|+..|+|||++... .++.++|+||||+++|+|++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 22 122334688999999988776 7889999999999999999999999866543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=265.62 Aligned_cols=205 Identities=30% Similarity=0.446 Sum_probs=173.2
Q ss_pred cccccCCceEEEEEEECC-CC--eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEK-IE--QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~-~~--~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+..|+.++++++||||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999998854 23 3699999987765 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999876322 5689999999999999999999998 99999999999999999999999999997654322211
Q ss_pred -eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 253 -VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 253 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 211 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1112346778999999988899999999999999999998 999997666554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=269.08 Aligned_cols=201 Identities=27% Similarity=0.377 Sum_probs=178.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48889999999999999999998999999999975432 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+.+++|.+++.. ..++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999876 35789999999999999999999998 9999999999999999999999999998754333
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2 11234688899999999888899999999999999999999999987664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=282.17 Aligned_cols=204 Identities=26% Similarity=0.373 Sum_probs=175.7
Q ss_pred HhCCCCc--ccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRS--DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~--~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
+..-|++ .+.||+|.||+||-|+++.+|+.||||+|.+-. ......++.|+.+|+++.||.||.+--.|+..+..+
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3334554 368999999999999999999999999998653 234567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---CceEEeccCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGL 241 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~---~~~kl~Dfg~ 241 (315)
+|||-+.|.-|+-.|.. ....+++.....++.||+.||.|||.. +|+|+||||+|||+.+. -.+||||||+
T Consensus 640 VVMEKl~GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEehhhcchHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence 99999976555544443 467799999999999999999999988 99999999999999754 3689999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
|++..... .....+|||.|+|||++++..|...-||||+|||+|.-++|..||....
T Consensus 714 ARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 714 ARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred eeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 99765543 2345689999999999999999999999999999999999999997543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=272.07 Aligned_cols=216 Identities=22% Similarity=0.309 Sum_probs=187.7
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC--CC----CeeeEEeEEeeC
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD--HP----NLVKLIGYCAEG 160 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~--hp----nIv~~~~~~~~~ 160 (315)
....++|.++..+|+|.||.|-.+.+..++..||||+++... ...+...-|+.+|+++. .| -++.+.++|...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344789999999999999999999999999999999997643 23455667899999984 23 388899999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-----------
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE----------- 229 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~----------- 229 (315)
++.+||+|.+ |.++.++|.. ++..+++...++.++.|+++++++||+. +++|-||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence 9999999998 6799999987 4578899999999999999999999998 999999999999983
Q ss_pred ---------CCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 230 ---------EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 230 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.+..++|+|||.|+...... +..+.|..|+|||++++-+|+.++||||+||||+|+.||...|+..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 13458999999998644432 3357889999999999999999999999999999999999999999
Q ss_pred CchhhhhHHhhhhc
Q 021249 301 KDRKELNLVAWLLR 314 (315)
Q Consensus 301 ~~~~~~~~i~~~~~ 314 (315)
++.++|++++.++.
T Consensus 313 en~EHLaMMerIlG 326 (415)
T KOG0671|consen 313 ENLEHLAMMERILG 326 (415)
T ss_pred CcHHHHHHHHHhhC
Confidence 99999999988763
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.37 Aligned_cols=205 Identities=30% Similarity=0.463 Sum_probs=169.2
Q ss_pred ccccCCceEEEEEEE--CCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 98 CLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999965 45678999999865432 335678899999999999999999998864 5678999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||.||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999865 35689999999999999999999998 999999999999999999999999999975433322111
Q ss_pred -eeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 254 -STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 254 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.....++..|+|||.+....++.++|+|||||++|||++ |..||...+..+....+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~ 212 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 111234578999999888889999999999999999998 999998776555444443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=268.55 Aligned_cols=208 Identities=33% Similarity=0.425 Sum_probs=176.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~------ 161 (315)
..++|++.+.||+|++|.||+|.+..++..+++|++..... ....+..|+.+++.+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999998899999999876543 346788999999998 6999999999996644
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+++||||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999999876443456789999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+........ ......++..|+|||.+.. ..++.++||||||+++|+|++|..||.....
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 223 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence 875432211 1223468889999998753 3467899999999999999999999986544
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.66 Aligned_cols=211 Identities=32% Similarity=0.496 Sum_probs=175.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4578999999999999999998764 66799999876543 34668899999999999999999998864 567899999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ....+++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998752 234589999999999999999999998 99999999999999999999999999997543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..+.+..+
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 11 1111235567999999988889999999999999999999 89999877665554444
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.13 Aligned_cols=217 Identities=28% Similarity=0.404 Sum_probs=177.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-------CCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEee
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE 159 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 159 (315)
...+|++.+.||+|+||.||+|.+.. .+..||+|.+.... ......+..|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34579999999999999999998642 23468999887543 23456788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
.+..++++||+.+++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999875321 234588899999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999875433221111112234567999999999999999999999999999998 89999877655544
Q ss_pred hH
Q 021249 307 NL 308 (315)
Q Consensus 307 ~~ 308 (315)
..
T Consensus 247 ~~ 248 (334)
T cd05100 247 KL 248 (334)
T ss_pred HH
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=272.41 Aligned_cols=207 Identities=28% Similarity=0.354 Sum_probs=175.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688999999999999999999988999999998654322 34567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|..+... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888876653 34589999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||......+.+
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 2 11223457889999998875 35778999999999999999999999866544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.04 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=161.0
Q ss_pred cccccCCceEEEEEEECC--CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe--eCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~--~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~e~~~~ 172 (315)
..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 569999999999999653 567899999876532 345778999999999999999999884 3567899999986
Q ss_pred CChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----cCCCceEEeccCCcc
Q 021249 173 GSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAK 243 (315)
Q Consensus 173 ~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili----~~~~~~kl~Dfg~~~ 243 (315)
++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57777765321 1223588999999999999999999998 99999999999999 456789999999997
Q ss_pred cCCCCCCc-eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
........ .......+|+.|+|||++.+. .++.++|||||||++|+|+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 54332211 112234689999999988764 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=270.68 Aligned_cols=204 Identities=27% Similarity=0.343 Sum_probs=171.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46799999999999999999999988999999998754322 23456789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 6777666542 34578888999999999999999998 9999999999999999999999999998753322
Q ss_pred CCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
... .....+++.|+|||++.+. .++.++|+||||+++|+|++|..||....+
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 211 1223578899999988754 578899999999999999999999986553
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=271.25 Aligned_cols=201 Identities=30% Similarity=0.469 Sum_probs=175.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+..++..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4777788999999999999998889999999987543 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.. .++++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988753 4588999999999999999999987 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 11223578899999999988999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=266.29 Aligned_cols=213 Identities=31% Similarity=0.485 Sum_probs=179.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||.||+|.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......+++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45679999999999999999998764 57799999876543 35678899999999999999999999999899999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999998762 234689999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+......+..+
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05034 157 EYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217 (261)
T ss_pred hhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 111 1111234568999999998889999999999999999998 99999877765555544
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=270.34 Aligned_cols=210 Identities=25% Similarity=0.310 Sum_probs=178.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999999889999999987542 2335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++++.+..+... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998776655543 35589999999999999999999998 9999999999999999999999999998765433
Q ss_pred CCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||......+.+..
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 22 112234678899999999887 889999999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.50 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=177.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|.+.+.||+|+||.||++.+..++..||+|.+........+.+..|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57999999999999999999988889999999987655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999998864 3478899999999999999999998 999999999999999999999999998864433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 11223688899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.82 Aligned_cols=211 Identities=29% Similarity=0.456 Sum_probs=176.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|++.+.||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++||||+++++++.. +..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEE
Confidence 3467999999999999999999865 467899999875543 35678899999999999999999998754 57899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+.+++|.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999988653 245689999999999999999999988 9999999999999999999999999999754422
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
... ......++..|+|||++....++.++|+||||+++|+|++ |++||.+.+..+....
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 111 1112245678999999988889999999999999999999 9999987765554443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=266.96 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=173.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc----------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+..... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788899999999999999988899999998853211 11345788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++|+||+.+++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999876 35689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCC--cCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+................++..|+|||.+.... ++.++|+||||+++|+|++|..||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 97543322111222346888999999887654 78999999999999999999999975543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=265.74 Aligned_cols=206 Identities=25% Similarity=0.347 Sum_probs=178.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEe--eCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~ 167 (315)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... ...+.+..|+.+++.++||||+++++++. .....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999999999999999999875432 33556888999999999999999999775 345789999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH-----EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
||+++++|.+++........++++..++.++.||+.||.||| +. +++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999775555678999999999999999999999 65 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 865433221 1234689999999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.38 Aligned_cols=208 Identities=27% Similarity=0.353 Sum_probs=176.1
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-----cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+|.+.+.||.|++|.||+|.+..++..||+|.+...... ....+..|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478888999999999999999988999999999765432 234567899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998752 23699999999999999999999998 99999999999999999999999999997644
Q ss_pred CCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...++.+.+..
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 154 SPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred CCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 33211 122356788999998754 4678999999999999999999999987666554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=280.92 Aligned_cols=218 Identities=28% Similarity=0.430 Sum_probs=188.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc-HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
......+.++||+|-||.|.++.... +..||+|.++...... ..+|.+|+++|.+|+||||+.++++|..++.+++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34567788999999999999998765 6899999998776544 478999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||++|+|.+|+..+.... +.-.....|+.||+.||+||.+. +++||||.+.|+|++.++++||+|||+++-.-.
T Consensus 615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998753322 34556677999999999999999 999999999999999999999999999986666
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh--CCCcccccCchhhhhHHhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~i~~~ 312 (315)
++........+-..+|||||.+..+.++.++|+|+||+++||+++ .+.||....+++...-.-.+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 665655556677889999999999999999999999999999875 88999999887766544333
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=268.25 Aligned_cols=202 Identities=34% Similarity=0.516 Sum_probs=168.2
Q ss_pred CCC-CcccccccCCceEEEEEEE----CCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCe
Q 021249 91 GNF-RSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQ 162 (315)
Q Consensus 91 ~~y-~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 162 (315)
++| .+.+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988653 35678899999875432 335668889999999999999999998765 346
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 8999999999999999865 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 243 KMGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 243 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 7544322111 111123566799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=268.22 Aligned_cols=203 Identities=28% Similarity=0.341 Sum_probs=176.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 167 (315)
++|...+.||.|++|.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+ .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368888999999999999999998999999999875433 345668899999999999999999998855 34789999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998876544556789999999999999999999998 999999999999999999999999999864332
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1235788999999998889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=263.31 Aligned_cols=204 Identities=32% Similarity=0.509 Sum_probs=169.0
Q ss_pred cccccCCceEEEEEEECCCC---eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+...+ ..+|+|.+..... .....+..|+.+++.++||||+++++++.. +..+++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 36999999999999875544 7899999886543 245678899999999999999999998764 568999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999976 33689999999999999999999998 99999999999999999999999999987543322211
Q ss_pred e-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 253 V-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 253 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 1 111123467999999998899999999999999999998 9999987765544433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.10 Aligned_cols=212 Identities=29% Similarity=0.478 Sum_probs=175.2
Q ss_pred hCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3578999999999999999998743 578899999875432 3345688899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 164 LLVYEYMPLGSLDKHLHDLR------------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
++++||+++++|.+++.... .....+++..++.++.|++.||.|||+. +++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999986421 1123578889999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999874332221111122234667999999988899999999999999999997 888987655444
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=262.04 Aligned_cols=205 Identities=31% Similarity=0.455 Sum_probs=172.0
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.||.|+||.||+|.+.. ++.||+|.+...... ....+..|+.++++++||||+++++++.+....++|+||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999887 899999998765443 456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++... ...+++..+..++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998652 34688999999999999999999988 99999999999999999999999999987543221111111
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~ 207 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence 1223567999999988899999999999999999999 8999977665443333
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=269.86 Aligned_cols=202 Identities=26% Similarity=0.355 Sum_probs=176.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|++.+.||+|+||+||++.+..++..||+|++.... ......+.+|+.+++.++||||+++++.+...+.+++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888999999999999999999889999999886543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..++++..+..++.+++.||.|||+. .+++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999988865 35689999999999999999999973 289999999999999999999999999986432211
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 1224689999999999888999999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=276.57 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=170.3
Q ss_pred hCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEee-CC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE-GD 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~~ 161 (315)
.++|++.+.||+|+||.||+|.+. .+++.||||.++.... .....+.+|+.++..+ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 457999999999999999999853 4578899999975432 3355688899999999 68999999998754 45
Q ss_pred eEEEEEEecCCCChhhhhhhcCCC--------------------------------------------------------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPD-------------------------------------------------------- 185 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 185 (315)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998643210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeecc
Q 021249 186 -------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258 (315)
Q Consensus 186 -------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 258 (315)
...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12467888899999999999999998 99999999999999999999999999987543222111111223
Q ss_pred ccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 259 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5678999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=272.74 Aligned_cols=207 Identities=25% Similarity=0.320 Sum_probs=172.9
Q ss_pred CCCcccccccCCceEEEEEEECC--CCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRL 164 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~--~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 164 (315)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999987 78999999998633 33346678899999999999999999999888 8899
Q ss_pred EEEEecCCCChhhhhhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC----CCceEEecc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE----GYHPKLSDF 239 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~----~~~~kl~Df 239 (315)
+||||++ ++|.+++....... ..+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 46777665433322 3789999999999999999999998 9999999999999999 899999999
Q ss_pred CCcccCCCCCC-ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 240 GLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 240 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99875433222 1111234678899999987764 578999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=263.73 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=169.3
Q ss_pred HHHHHHHhCCCCccccc--ccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEee
Q 021249 83 FDELAAATGNFRSDCCL--GEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE 159 (315)
Q Consensus 83 ~~~~~~~~~~y~~~~~i--g~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 159 (315)
..+.....++|.+.+.+ |+|+||.||++.+..++..+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445556678887777 999999999999999999999999876433221 22222212 69999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEec
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSD 238 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~D 238 (315)
.+.+++||||+++++|.+++.. ..++++..++.++.|++.||.|||+. +++||||+|+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999876 34799999999999999999999998 999999999999999988 999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
||++....... ...++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99987543221 2358889999999998899999999999999999999999998554
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=259.13 Aligned_cols=208 Identities=28% Similarity=0.429 Sum_probs=173.3
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
...+..||+|+.|.|+++.+..+|...|||.+...+ ....+++...+.++... ++|+||+.+++|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344566999999999999999999999999997654 34466677777776555 4999999999999999999999998
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
. ..++.+++.. ..++++..+-++...++.||.||... ++|||||+||+|||+|+.|++||||||++....+...
T Consensus 174 s-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 S-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred H-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 4 5666666653 56799999999999999999999986 6999999999999999999999999999976544332
Q ss_pred ceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccC-chhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTK-DRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i 309 (315)
. +...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+ +-+.+.+|
T Consensus 248 h---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 248 H---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred c---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 2 33479999999998863 478999999999999999999999999865 44444444
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=271.30 Aligned_cols=207 Identities=31% Similarity=0.489 Sum_probs=171.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|+..+.||+|+||.||+|.+..++. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 468888999999999999999876665 578888865432 2234678899999999999999999998754 5678
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998652 34688999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
.............++..|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~ 219 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 43222211222345678999999988899999999999999999997 999997765433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=265.04 Aligned_cols=204 Identities=30% Similarity=0.449 Sum_probs=167.6
Q ss_pred ccccCCceEEEEEEECCCCe--EEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 98 CLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~--~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
.||+|+||.||+|.+..++. .+++|.+.... ......+..|+.++..+ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999987765 46888887433 23456788999999999 7999999999999999999999999999
Q ss_pred ChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 174 SLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 174 ~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999875321 123578999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+....... .......+..|+|||++....++.++|+|||||++|+|++ |..||...+..+...
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 222 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH
Confidence 85321110 0111123567999999988889999999999999999997 999997765444333
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=268.09 Aligned_cols=212 Identities=29% Similarity=0.407 Sum_probs=176.4
Q ss_pred HHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEee--
Q 021249 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE-- 159 (315)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 159 (315)
..+.....+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444556678999999999999999999999999999999986543 2345678889988888 69999999999853
Q ss_pred ----CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 160 ----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 160 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
...++++|||+.+++|.+++.... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 467899999999999999987633 34588888999999999999999998 999999999999999999999
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|+|||++........ ......|++.|+|||.+. +..++.++|+|||||++|+|++|..||....+
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 999999874322111 112346889999999875 34678899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=264.29 Aligned_cols=207 Identities=25% Similarity=0.359 Sum_probs=164.9
Q ss_pred ccccCCceEEEEEEECCC--CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCC
Q 021249 98 CLGEGGFGKVYKGCLEKI--EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~--~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 174 (315)
.||+|+||.||+|..... ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 3456777766543 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceee
Q 021249 175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254 (315)
Q Consensus 175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 254 (315)
|.+++.........++...++.++.||+.||.|||+. +++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976433345567788889999999999999998 9999999999999999999999999998542221111112
Q ss_pred eeccccccccCcccccc-------CCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 255 TRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 255 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
....++..|+|||++.. ..++.++||||||+++|||++ |..||...++.+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~ 219 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN 219 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 23467889999998743 245789999999999999997 577897766554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=262.03 Aligned_cols=210 Identities=34% Similarity=0.527 Sum_probs=177.2
Q ss_pred CCcccccccCCceEEEEEEECCCC----eEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
+++.+.||.|+||.||++.+...+ ..||+|.+...... ....+..|+..++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456788999999999999998766 88999999765433 5678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987622 12289999999999999999999998 999999999999999999999999999976544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
...... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.......
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 322111 11236789999999988889999999999999999998 8899987655444433
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=270.81 Aligned_cols=213 Identities=29% Similarity=0.393 Sum_probs=177.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 165 (315)
.++|++.+.||.|+||.||+|.+..+|..||+|.+...... ....+.+|+.+++.++||||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45799999999999999999999999999999998744322 233456799999999999999999998755 56899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5788887653 35689999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...++.+.+..+..
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 432211 122245778999998865 4678999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.20 Aligned_cols=206 Identities=32% Similarity=0.490 Sum_probs=170.3
Q ss_pred ccccCCceEEEEEEECCCC------eEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 98 CLGEGGFGKVYKGCLEKIE------QVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~------~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.||+|+||.||+|.+.... ..+|+|.+.... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999876433 679999886543 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-----ceEEeccCCc
Q 021249 171 PLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-----HPKLSDFGLA 242 (315)
Q Consensus 171 ~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-----~~kl~Dfg~~ 242 (315)
++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999875322 224478899999999999999999988 999999999999999877 8999999998
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
................++..|+|||++.+..++.++|||||||++|+|++ |..||...++.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence 75433222222222345678999999999999999999999999999998 99999876554433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=263.84 Aligned_cols=192 Identities=26% Similarity=0.385 Sum_probs=161.5
Q ss_pred ccccCCceEEEEEEECC------------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 98 CLGEGGFGKVYKGCLEK------------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~------------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.||+|+||.||+|.... ....+++|.+..........+..|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998542 233689999876555555678889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc-------eEEec
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-------PKLSD 238 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~-------~kl~D 238 (315)
+|||+++++|..++.. ...++++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999888764 235689999999999999999999998 9999999999999986654 89999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHH-hCCCcccccC
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELI-TGRKAIDQTK 301 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-tg~~pf~~~~ 301 (315)
||++....... ...++..|+|||++. +..++.++|||||||++|+|+ +|..||....
T Consensus 156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99986433221 235788899999886 467899999999999999998 5889987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=264.53 Aligned_cols=202 Identities=27% Similarity=0.393 Sum_probs=171.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++++||++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 34444579999999999999988899999999887666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCCC
Q 021249 172 LGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 248 (315)
+++|.+++... ..++ ++..+..++.||+.||.|||+. +|+||||+|+||+++. ++.++|+|||++......
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 89 GGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999998752 2334 7888899999999999999998 9999999999999986 678999999998654322
Q ss_pred CCceeeeeccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.. ......+++.|+|||++.+. .++.++|+||||+++|+|++|..||....
T Consensus 163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 21 11223578899999988654 37889999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=266.92 Aligned_cols=202 Identities=32% Similarity=0.473 Sum_probs=169.7
Q ss_pred CCCCcccccccCCceEEEEEEE----CCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 164 (315)
.+|++.+.||+|+||.||+|.. ..++..||+|.+..........+.+|+.+++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 45688999999987665666788999999999999999999997643 45689
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+|+||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998652 34589999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCcee-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 245 GPSGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 245 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
......... .....++..|+|||++.+..++.++|+||||+++|||++|..|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 543322111 111123456999999988899999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=264.97 Aligned_cols=211 Identities=27% Similarity=0.422 Sum_probs=174.7
Q ss_pred CCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.+|.+.+.||+|+||.||+|.+... ...||+|.+.... ....+.+..|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688889999999999999987543 3468999887654 3445678899999999999999999999876 457899
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999752 34589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
..... ......++..|+|||.+....++.++||||||+++|+|++ |..||......+.+..+
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 221 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221 (270)
T ss_pred cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 33211 1112234568999999888889999999999999999996 99999877665544443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.38 Aligned_cols=203 Identities=30% Similarity=0.448 Sum_probs=176.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ....+..|+.+++.++||||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999999888999999998765443 567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999875 34578899999999999999999998 99999999999999999999999999987654332
Q ss_pred Ccee--eeeccccccccCccccccCC---cCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 250 KTHV--STRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 250 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.... .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 2111 11245788999999988765 8899999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=262.26 Aligned_cols=205 Identities=25% Similarity=0.338 Sum_probs=177.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999999889999999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988652 234578999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~ 207 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH
Confidence 11 12235788999999998888999999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=265.88 Aligned_cols=215 Identities=26% Similarity=0.409 Sum_probs=178.1
Q ss_pred CCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|++...||.|+||.||+|..+. ....+++|.+...... ....+..|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 468899999999999999999753 3467999988765443 4567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPD-----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
+||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998764321 12689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+...+..+
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~ 231 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence 99864322211 11122346778999999988889999999999999999998 88999776655444433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.59 Aligned_cols=202 Identities=31% Similarity=0.504 Sum_probs=175.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 357889999999999999999876 78899999976644 467788999999999999999999999989999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999998752 223689999999999999999999998 99999999999999999999999999997542221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
. ....+..|+|||.+....++.++|+||||+++|+|++ |..||......+
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 1 1234567999999988889999999999999999997 999997765443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=265.50 Aligned_cols=211 Identities=29% Similarity=0.400 Sum_probs=177.4
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
+|++.+.||.|++|.||+|.+..+|..||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 48889999999999999999999999999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++ +|.+++.... ...++++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 84 8888876532 235689999999999999999999998 999999999999999999999999999975432211
Q ss_pred ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 11223578899999987654 5788999999999999999999999887766554443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=264.47 Aligned_cols=202 Identities=30% Similarity=0.446 Sum_probs=175.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
-|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47788899999999999999988899999999865432 33566889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.. .++++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999988854 4588999999999999999999987 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
. .....++..|+|||.+.+..++.++|+|||||++|+|++|..||......
T Consensus 157 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 207 (277)
T cd06641 157 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM 207 (277)
T ss_pred h--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH
Confidence 1 12246788999999998888899999999999999999999999765543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.61 Aligned_cols=204 Identities=27% Similarity=0.380 Sum_probs=176.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||+|+||.||+|.+..++..+|+|.+.... ......+..|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999999899999999987543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 248 (315)
+++++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++++ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997632 34589999999999999999999998 99999999999999865 45799999999765433
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 207 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH
Confidence 21 12246888999999998888899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=265.06 Aligned_cols=202 Identities=27% Similarity=0.421 Sum_probs=174.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCC---CCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++ |||++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999999899999999987542 334567888999998886 999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. .++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998854 3689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.... .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||......
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 3221 2234688899999987654 5789999999999999999999999766543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=266.90 Aligned_cols=206 Identities=27% Similarity=0.367 Sum_probs=173.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||.|++|.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4888899999999999999999899999999987543 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6888887653 245689999999999999999999998 99999999999999999999999999987543221
Q ss_pred CceeeeeccccccccCccccccCC-cCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
.. .....+++.|+|||++.+.. ++.++|+||||+++|+|+||+.||...++...
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~ 209 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 209 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 11 12235688999999877644 68899999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=262.33 Aligned_cols=203 Identities=29% Similarity=0.437 Sum_probs=179.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
....+|.++++||+|+|.+|.++.++.|.+.||+|+++++- .+++.-++.|-.+..+. +||.+|-+..+|+.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34568999999999999999999999999999999998642 23455567777777664 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++|.||++||+|.-.+++ ..+++++.++.+...|+.||.|||++ |||+||||.+|+|+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 999999999999766665 57799999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
..... -.....++|||.|.|||++++..|+..+|+|+||++++||+.|+.||+-
T Consensus 400 e~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 400 EGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 54322 2234567999999999999999999999999999999999999999973
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.06 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=175.6
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
|...+.||+|++|.||++.+..++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44456899999999999999888999999998765545556688999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. .++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999998865 4588999999999999999999998 999999999999999999999999998864332211
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 11224688999999999888899999999999999999999999976554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.97 Aligned_cols=210 Identities=32% Similarity=0.470 Sum_probs=173.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|||++++++++.. +..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEc
Confidence 35688999999999999999988764 468999886543 234568889999999999999999998864 568899999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999998753 234588999999999999999999988 99999999999999999999999999997543322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+.+....
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ 215 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 11 1112245678999999988889999999999999999999 9999987766554443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=274.47 Aligned_cols=211 Identities=27% Similarity=0.364 Sum_probs=173.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----Ce
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 162 (315)
..++|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3568999999999999999999999999999999986432 23345678899999999999999999987554 35
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++++||+. ++|.+.+.. .++++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 577776643 4689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCC-ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 243 KMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 243 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
........ ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~ 221 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 75432211 111123468899999998654 5688999999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=274.54 Aligned_cols=207 Identities=26% Similarity=0.305 Sum_probs=175.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG----- 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 160 (315)
...++|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3567899999999999999999999999999999998643 233455677899999999999999999988643
Q ss_pred -CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 578777653 278899999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
|++........ .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+......
T Consensus 163 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 163 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred ccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99975433211 122357889999999999999999999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.04 Aligned_cols=200 Identities=29% Similarity=0.427 Sum_probs=169.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEE-eeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e~ 169 (315)
.+|.+.+.||+|+||.||++... +..+|+|.+.... ..+.+..|+.+++.++|||++++++++ ..++..++++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46889999999999999999776 7789999986543 345688999999999999999999975 455678999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998753 234588999999999999999999998 99999999999999999999999999987533221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 304 (315)
. ...++..|+|||++.+..++.++|||||||++|+|++ |+.||......+
T Consensus 157 ~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05082 157 D-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred C-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 1234568999999988899999999999999999997 999997655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.30 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=174.7
Q ss_pred CCCcccccccCCceEEEEEEECC-CCeEEEEEEecCCC----------cccHHHHHHHHHHhcc-CCCCCeeeEEeEEee
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRG----------VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAE 159 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 159 (315)
.|++.+.||+|+||.||+|.+.. .+..+|+|.+.... ......+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888899999999999999987 67899999886322 1234456778887764 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
++..+++|||+++++|.+++.........+++..++.++.|++.+|.|||+. .+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998865444456799999999999999999999963 28999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|.+....... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~ 218 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM 218 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence 9997644332 22334688899999999988899999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=267.37 Aligned_cols=199 Identities=32% Similarity=0.447 Sum_probs=171.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 458889999999999999999988899999999864432 33456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+. +++.+++... ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5776766542 34689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.. ...+++.|+|||++. ...++.++||||||+++|+|++|.+||...+.
T Consensus 168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 21 235788999999874 35688999999999999999999999976554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=265.74 Aligned_cols=203 Identities=28% Similarity=0.351 Sum_probs=168.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHH-hccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 368899999999999999999999999999999875432 223345555554 667789999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++ ++|.+++.........+++..++.++.||+.||.|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 788888876544456799999999999999999999974 28999999999999999999999999998754322
Q ss_pred CCceeeeeccccccccCcccccc----CCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT----GQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
. ..+...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 1122357889999998764 4568899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.31 Aligned_cols=210 Identities=24% Similarity=0.296 Sum_probs=173.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCe-----
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ----- 162 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~----- 162 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999999999999999865432 23456788999999995 6999999999877665
Q ss_pred EEEEEEecCCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccC
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFG 240 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg 240 (315)
.+++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 788887653322 45689999999999999999999998 9999999999999998 8899999999
Q ss_pred CcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
++......... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...++.+.+
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 221 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 98754222111 112256788999998765 45789999999999999999999999876655443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=266.27 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=168.9
Q ss_pred CCCcccccccCCceEEEEEEE----CCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRL 164 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 164 (315)
.|++++.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999974 4568899999987543 33456789999999999999999999998775 5789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998652 34589999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcc
Q 021249 245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 297 (315)
Q Consensus 245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 297 (315)
....... .......++..|+|||++.+..++.++||||||+++|+|+++..|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 4332221 1112335677899999998889999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.79 Aligned_cols=209 Identities=26% Similarity=0.350 Sum_probs=175.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 166 (315)
++|++.+.||.|+||.||+|.+..++..+|+|.++..... ....+.+|+.+++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688999999999999999999989999999999754322 233567899999999999999999998877 899999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+||+. ++|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 5888888652 23689999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||......+.+..
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218 (293)
T ss_pred CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 33211 1223578899999988754 468999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=265.11 Aligned_cols=195 Identities=25% Similarity=0.370 Sum_probs=161.3
Q ss_pred ccccCCceEEEEEEECC------------------------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeE
Q 021249 98 CLGEGGFGKVYKGCLEK------------------------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~------------------------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 153 (315)
.||+|+||.||+|.... ....|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997532 124589999876544445678889999999999999999
Q ss_pred EeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-
Q 021249 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY- 232 (315)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~- 232 (315)
++++.+.+..++||||+++++|..++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988865 245688999999999999999999988 999999999999997643
Q ss_pred ------ceEEeccCCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHH-hCCCcccccCchh
Q 021249 233 ------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELI-TGRKAIDQTKDRK 304 (315)
Q Consensus 233 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~ 304 (315)
.++++|||++....... ...++..|+|||.+.+ ..++.++|+|||||++|||+ +|..||......+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 37999999875432211 1257788999998865 56899999999999999995 7999998765443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=262.99 Aligned_cols=192 Identities=30% Similarity=0.406 Sum_probs=161.1
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCccc---HHHHHHHH---HHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEV---MTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
.||+|+||.||+|.+..+++.||+|.+....... ......|. ..++...||+|+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999999889999999987543221 11223333 34455689999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
|++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999988864 45699999999999999999999998 999999999999999999999999999864432211
Q ss_pred eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 252 HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
....|+..|+|||++.+. .++.++|+||+|+++|+|++|..||...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 223689999999988754 6899999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.32 Aligned_cols=210 Identities=27% Similarity=0.441 Sum_probs=175.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 45689999999999999999998654 5679999887543 235678889999999999999999999887 77899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999998753 245678889999999999999999987 9999999999999999999999999998754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
... ......++..|+|||++....++.++|+|||||++|++++ |..||...+..+...
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 211 1112235667999999988889999999999999999999 999998766554443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=264.21 Aligned_cols=193 Identities=30% Similarity=0.423 Sum_probs=160.7
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHH---hccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMT---LGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
.||+|+||.||++.+..++..+|+|.+...... .......|..+ +...+||||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999999988999999998754321 11223344433 334579999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988865 35699999999999999999999998 99999999999999999999999999986432221
Q ss_pred eeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 252 HVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.....|++.|+|||.+. +..++.++|+|||||++|+|++|..||....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 12236899999999876 4568999999999999999999999997544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=258.67 Aligned_cols=201 Identities=31% Similarity=0.450 Sum_probs=168.2
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChh
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 176 (315)
.||+|+||.||+|... ++..+|+|.+...... ....+..|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 5899999999999865 5788999998765432 3446888999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeee
Q 021249 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256 (315)
Q Consensus 177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 256 (315)
+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 988652 34578999999999999999999988 999999999999999999999999999864322211 11111
Q ss_pred ccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 257 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||.........
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~ 204 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR 204 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 234567999999988889999999999999999998 99999876554433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=262.54 Aligned_cols=210 Identities=24% Similarity=0.315 Sum_probs=174.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCC----eEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee-C
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE-G 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~ 160 (315)
.....|+++..||+|.||.||+|...++. +.+|+|.++.++. ..-...-+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34557999999999999999999765443 3689999976522 223456789999999999999999999877 7
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC----CceE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP-DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPK 235 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~----~~~k 235 (315)
...|+++||.+ -+|...|+..+. ..+.++...+..|+.||+.++.|||+. -|+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 89999999997 577777765432 345689999999999999999999998 89999999999999876 8999
Q ss_pred EeccCCcccCCCCCCce-eeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 236 LSDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
|+|||+++.....-..- .....+-|..|+|||.+.+. .|+++.||||+|||+.||+|-++.|.+..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999999765543322 23345678999999998876 79999999999999999999999997643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=271.75 Aligned_cols=210 Identities=29% Similarity=0.413 Sum_probs=178.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-Cc------ccHHHHHHHHHHhccCCCCCeeeEEeEE-ee
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GV------QGVREFSAEVMTLGSADHPNLVKLIGYC-AE 159 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~ 159 (315)
...++|-++.+||+|+|+.||+|.+....+.||||+-... ++ ...+...+|..+-+.|+||.||++|++| .+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456789999999999999999999988999999985432 12 2244577899999999999999999998 46
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEE
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKL 236 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl 236 (315)
.+.+|-|+|||+|.+|+-||++ .+.+++.+++.|+.||+.||.||... +.+|||-||||.|||+.+ -|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6789999999999999999987 56799999999999999999999987 779999999999999965 468999
Q ss_pred eccCCcccCCCCCCc-----eeeeeccccccccCccccccC----CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 237 SDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+|||+++++...... .......||.+|++||++.-+ ..+.++||||+|||+|+.+.|+.||.....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 999999977554322 334456899999999988644 467899999999999999999999976543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.44 Aligned_cols=193 Identities=32% Similarity=0.447 Sum_probs=171.1
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||.|++|.||+|.+..++..+|+|++..... .....+..|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999998899999999975432 2346688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999876 34589999999999999999999998 99999999999999999999999999997654332 112
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 2468889999999888889999999999999999999999998766
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=264.30 Aligned_cols=200 Identities=31% Similarity=0.388 Sum_probs=176.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+.....+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357888899999999999999999999999999876543 3456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
+.+++|.+++... ..++++..+..++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998763 2678999999999999999999998 7 9999999999999999999999999998654222
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
... ...++..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 155 ~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 155 LAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred Hhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 111 146888999999998889999999999999999999999999755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.81 Aligned_cols=196 Identities=31% Similarity=0.432 Sum_probs=169.0
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||+|+||+||+|.+..+|+.||+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999875432 2244567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 99987532 24689999999999999999999998 999999999999999999999999999875432111 12
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
...++..|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 23578899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=263.47 Aligned_cols=205 Identities=29% Similarity=0.389 Sum_probs=178.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.+.|.....||+|++|.||+|.+..++..+++|++..... ....+..|+..++.++||||+++++.+...+..++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4568888889999999999999998899999999976543 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998632 3799999999999999999999997 99999999999999999999999999886433221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 112235788999999998888999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=264.67 Aligned_cols=210 Identities=25% Similarity=0.329 Sum_probs=173.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999998999999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~ 247 (315)
|++ ++|.+++... ....+++..++.++.||+.||.|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5787776542 233468888899999999999999998 9999999999999985 56799999999975332
Q ss_pred CCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
... ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||......+.+..
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 211 11223578899999988664 578999999999999999999999987665544443
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=259.74 Aligned_cols=197 Identities=26% Similarity=0.355 Sum_probs=166.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHH-hccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||.|+||.||+|.+..+++.||+|.+...... ....+..|..+ ....+||||+++++++..++.+++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4599999999999999988999999998754321 22233444443 4456899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
++|.+++.. ..++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 999999875 35689999999999999999999998 9999999999999999999999999998753321
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 151 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 202 (260)
T cd05611 151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202 (260)
T ss_pred --ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 2236888999999998888899999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=267.23 Aligned_cols=217 Identities=24% Similarity=0.365 Sum_probs=176.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----- 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 161 (315)
..++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34579999999999999999999999999999999864322 22344567999999999999999999886543
Q ss_pred ---eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEec
Q 021249 162 ---QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 162 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 4599999996 578777754 234689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCCCCCCc--eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 239 FGLAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 239 fg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+....+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999754332211 111233578889999987664 4788999999999999999999999887766665555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=264.45 Aligned_cols=196 Identities=25% Similarity=0.416 Sum_probs=163.8
Q ss_pred cccccCCceEEEEEEECCCCe-------EEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~-------~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+.||+|+||.||+|.+...+. .+|+|.+........+.+..|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 359999999999998865443 4888888665545566788899999999999999999999998999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--------eEEeccCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--------PKLSDFGL 241 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~--------~kl~Dfg~ 241 (315)
+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998752 34689999999999999999999998 9999999999999987654 69999998
Q ss_pred cccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhC-CCcccccCchh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITG-RKAIDQTKDRK 304 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg-~~pf~~~~~~~ 304 (315)
+...... ....+++.|+|||++.+. .++.++||||||+++|+|++| .+||...+...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 8643321 123578899999998764 578999999999999999998 57776655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.36 Aligned_cols=202 Identities=30% Similarity=0.453 Sum_probs=179.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
+|.+.+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.++|||++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788899999999999999998899999999987655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
+++|.+++... ..++++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999988762 25789999999999999999999997 999999999999999999999999999876544321
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 2234688899999999888899999999999999999999999987643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=245.37 Aligned_cols=211 Identities=24% Similarity=0.292 Sum_probs=174.8
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhc-cCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
..-+..||+|++|.|-+-++..+|...|+|.+...-. ....+..+|+.+.. ...+|.+|.+|+........||.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3445569999999999999999999999999975532 34556777887754 457999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+ .+|..+-+.....+..+++..+-+|+..++.||.|||++ ..+||||+||+||||+.+|++|+||||++....+.-.
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 5 788887766666678899999999999999999999997 5999999999999999999999999999976544322
Q ss_pred ceeeeeccccccccCcccccc----CCcCcccchhhHHHHHHHHHhCCCccccc-CchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMT----GQLTFKSDIYSFGVVLLELITGRKAIDQT-KDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i 309 (315)
.. ...|...|||||.+.. ..|+.++||||||++++||.+++.||... .+-+++..+
T Consensus 205 kt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 205 KT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred HH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 11 1257788999998753 37999999999999999999999999854 455666554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.87 Aligned_cols=206 Identities=27% Similarity=0.420 Sum_probs=181.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||.|+||.||++.+..++..|++|++..... .....+..|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58888999999999999999998899999999976543 4566788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543457799999999999999999999998 99999999999999999999999999997543332
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.......|++.|+|||...+..++.++|+||+|+++|+|++|..||...+.
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 208 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence 122234688899999998888899999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.12 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=173.8
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
...||+|+||.||++....++..||+|.+..........+.+|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35699999999999999999999999998765545566788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~ 174 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK 174 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence 887753 3578999999999999999999998 999999999999999999999999999865432211 112
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+.+
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~ 225 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 225 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 346888999999988888999999999999999999999999866544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.88 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=173.6
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||.|+||.||+|.+..+++.+++|.+..... .....+..|+.+++.++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999976543 3456788899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC-----
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK----- 250 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~----- 250 (315)
.+++.. ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999876 23689999999999999999999998 999999999999999999999999999875433211
Q ss_pred -ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 251 -THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 251 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
........++..|+|||...+..++.++|+||||+++|+|++|..||......+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11222346788999999998888999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=285.71 Aligned_cols=207 Identities=21% Similarity=0.281 Sum_probs=160.8
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCC-CeEEEEEEec--------------C---CCcccHHHHHHHHHHhccCCCCC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLD--------------H---RGVQGVREFSAEVMTLGSADHPN 149 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~i~--------------~---~~~~~~~~~~~E~~~l~~l~hpn 149 (315)
...++|++++.||+|+||+||+|..+.. +..++.|.+. + ........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876432 2222222111 0 11122445789999999999999
Q ss_pred eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 150 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
|+++++++.+.+..+++++++. ++|.+++.... ..........++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 56766664321 1122344667788999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCC-cccc
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK-AIDQ 299 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-pf~~ 299 (315)
+.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999976543221 11223579999999999999999999999999999999999875 4543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=259.03 Aligned_cols=209 Identities=27% Similarity=0.445 Sum_probs=175.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......++++||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468888999999999999998864 67899998875433 3456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|.+++... ..++++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988652 34688999999999999999999998 999999999999999999999999999875432211
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.+..
T Consensus 156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 1 1112234568999999988899999999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=273.48 Aligned_cols=205 Identities=22% Similarity=0.268 Sum_probs=170.2
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecC--CCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 164 (315)
.....|++++.||+||.+.||++.....+ .||+|.+.. .+.....-+..|+.+|.+|. |.+|+++|++-..++.+|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34456999999999999999999876544 556665432 33455777999999999995 999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||= ..+|...|++. ...++...++.+..||+.|+.++|.. ||||.||||.|+|+-. |.+||+|||+|..
T Consensus 437 mvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 999985 47888888763 33344448889999999999999998 9999999999999985 5999999999987
Q ss_pred CCCCCCceeeeeccccccccCccccccCC-----------cCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-----------LTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.......-.....+||+.||+||.+.... .++++||||||||||+|+.|++||....
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 76666555666789999999999886432 4678999999999999999999997644
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=272.03 Aligned_cols=212 Identities=25% Similarity=0.355 Sum_probs=176.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEe----eCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCA----EGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~ 163 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999999999999999987542 234566788999999999999999999875 34578
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 688888754 45589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCC--ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDK--THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... ........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~ 224 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHH
Confidence 5432221 111223468889999998765 46889999999999999999999999887665554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=265.34 Aligned_cols=200 Identities=32% Similarity=0.459 Sum_probs=171.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|...+.||+|+||.||+|.+..++..+|+|.+..... .....+..|+.+++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47788899999999999999988899999999875422 334568889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. |+|.+.+.. ...++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 577777654 245689999999999999999999998 9999999999999999999999999998653322
Q ss_pred CCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
....+++.|+|||++. ...++.++|+|||||++|+|++|..||...+...
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 231 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 1236888999999874 4568899999999999999999999997765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=259.26 Aligned_cols=192 Identities=28% Similarity=0.446 Sum_probs=163.4
Q ss_pred cccccCCceEEEEEEECCCC----------eEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIE----------QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~----------~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 35899999999999998766 35888887654433 5778899999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-------ceEEecc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-------HPKLSDF 239 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-------~~kl~Df 239 (315)
|||+++++|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998762 23689999999999999999999998 999999999999999887 7999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccC--CcCcccchhhHHHHHHHHHh-CCCcccccCc
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELIT-GRKAIDQTKD 302 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 302 (315)
|++...... ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||.....
T Consensus 153 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 153 GIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred Ccccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 998754331 122467789999998876 78999999999999999999 5888877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.09 Aligned_cols=200 Identities=28% Similarity=0.440 Sum_probs=169.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4689999999999999999864 47889999986542 345788999999999999999999998765 478999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+++|.+++... ....+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999998753 234588999999999999999999987 99999999999999999999999999987533221
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..+.
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 206 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 11234567999999988899999999999999999997 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.84 Aligned_cols=211 Identities=30% Similarity=0.417 Sum_probs=174.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC--CeE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG--DQR 163 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~ 163 (315)
..++|.+.+.||+|+||.||+|.+..++..+|+|.+... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456799999999999999999999888999999988542 223345677899999999 999999999988643 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 588888764 2678889999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCc---eeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 244 MGPSGDKT---HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 244 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
........ .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~ 224 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 54333211 22233468899999998765 4678999999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=255.67 Aligned_cols=203 Identities=33% Similarity=0.464 Sum_probs=179.3
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||+|++|.||+|.+..++..|++|.+..... .....+.+|+.+++.++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47888999999999999999998899999999976654 4566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..++++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999876 35789999999999999999999988 99999999999999999999999999997654432
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. .....++..|+|||...+..++.++|+||||+++|+|++|..||...+..
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~ 205 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 21 22346888999999988888899999999999999999999999765543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=263.75 Aligned_cols=206 Identities=19% Similarity=0.192 Sum_probs=158.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCCcccH-H----------HHHHHHHHhccCCCCCeeeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQGV-R----------EFSAEVMTLGSADHPNLVKLI 154 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~~~~-~----------~~~~E~~~l~~l~hpnIv~~~ 154 (315)
..++|.+.+.||+|+||+||+|.+..+ +..+|+|+......... + ....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346799999999999999999998876 66777776543322110 0 112233455677899999999
Q ss_pred eEEeeCC----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q 021249 155 GYCAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE 230 (315)
Q Consensus 155 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~ 230 (315)
+.+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765443 3467778764 466666554 23357788899999999999999998 9999999999999999
Q ss_pred CCceEEeccCCcccCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 231 GYHPKLSDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 231 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|.+||.....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999754321111 111224699999999999999999999999999999999999999987743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=268.20 Aligned_cols=213 Identities=26% Similarity=0.338 Sum_probs=175.6
Q ss_pred hCCCCc-ccccccCCceEEEEEEECCCCeEEEEEEecCCCccc--------------HHHHHHHHHHhccCCCCCeeeEE
Q 021249 90 TGNFRS-DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--------------VREFSAEVMTLGSADHPNLVKLI 154 (315)
Q Consensus 90 ~~~y~~-~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~~~ 154 (315)
.++|.. .+.||.|+||+||+|.+..+++.||+|.+....... ...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 467999999999999999899999999986543221 12467899999999999999999
Q ss_pred eEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
+++...+..+++|||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999997 688888864 45689999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCC------------CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 235 KLSDFGLAKMGPSGD------------KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
+|+|||.+....... .........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987543110 01111223467889999988764 46899999999999999999999999887
Q ss_pred chhhhhHHh
Q 021249 302 DRKELNLVA 310 (315)
Q Consensus 302 ~~~~~~~i~ 310 (315)
+.+.+..+.
T Consensus 239 ~~~~~~~i~ 247 (335)
T PTZ00024 239 EIDQLGRIF 247 (335)
T ss_pred HHHHHHHHH
Confidence 766665543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.97 Aligned_cols=205 Identities=30% Similarity=0.435 Sum_probs=179.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|++.+.||.|+||.||++.+..++..+|+|.+.... ......+..|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999999899999999987543 23355678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876444456789999999999999999999998 99999999999999999999999999997654431
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11235788999999999888999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=258.05 Aligned_cols=200 Identities=30% Similarity=0.473 Sum_probs=161.5
Q ss_pred cccccCCceEEEEEEECC---CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEe-eCCeEEEEEEecC
Q 021249 97 CCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCA-EGDQRLLVYEYMP 171 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~ 171 (315)
+.||+|+||.||+|.+.. ....+|+|.+.... ......+..|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 358999999999998643 34679999986432 334567888999999999999999999765 4566889999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 251 (315)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998752 33467788889999999999999998 9999999999999999999999999998743322111
Q ss_pred ee--eeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCc
Q 021249 252 HV--STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD 302 (315)
Q Consensus 252 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 302 (315)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 10 112245678999999988899999999999999999999 5677765543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=287.41 Aligned_cols=214 Identities=27% Similarity=0.438 Sum_probs=187.8
Q ss_pred CCCcccccccCCceEEEEEEECCCC---eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
...+.++||.|.||.|++|..+..| ..||||.++.... ....+|..|+.||.+++||||+++.++........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567789999999999999987655 4699999987654 45678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||++|+|+.||+.. ...++..+...+++.|+.||.||.+. +++||||...|||++.+..+|++|||+++...+
T Consensus 710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999873 45688889999999999999999998 999999999999999999999999999997755
Q ss_pred CCCceeeee-ccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhh
Q 021249 248 GDKTHVSTR-VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 248 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 311 (315)
......++. ..-..+|.|||.+....++.++||||+|+++||.++ |+.||-++.+.+.++.|++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 543222221 122469999999999999999999999999999886 9999999999999988875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=259.68 Aligned_cols=210 Identities=28% Similarity=0.403 Sum_probs=169.9
Q ss_pred CCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------
Q 021249 93 FRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 161 (315)
|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999864 457899999987542 234567889999999999999999999886532
Q ss_pred eEEEEEEecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
..+++++|+.+++|.+++.... .....++...++.++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999988875322 1233578999999999999999999988 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
|++................+++.|++||.+.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH
Confidence 99875433222111222345678999999988889999999999999999999 8999987655443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=261.30 Aligned_cols=209 Identities=27% Similarity=0.376 Sum_probs=176.1
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVYE 168 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e 168 (315)
|.+.+.||.|++|.||+|.+..++..+|+|.+.... ......+..|+.+++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999999889999999998653 33455688899999999999999999999888 89999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++ ++|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 4888877642 25789999999999999999999998 9999999999999999999999999999765443
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 211 1122356788999997765 46789999999999999999999999877765544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=260.09 Aligned_cols=206 Identities=26% Similarity=0.317 Sum_probs=169.3
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeC--CeEEEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEG--DQRLLVYE 168 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv~e 168 (315)
|++.+.||+|+||.||+|.+..++..||+|.+..... ........|+..+..+. ||||+++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6778899999999999999998899999999875421 22233457888888885 99999999999887 88999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. ++|.+++... ...+++..++.++.|++.||.|||+. +++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5787777652 35689999999999999999999998 9999999999999999 99999999999754332
Q ss_pred CCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... ....++..|+|||++.. ..++.++|+|||||++|+|++|.+||...+..+.+..+
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 221 22357889999997654 45788999999999999999999999877655444333
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=261.72 Aligned_cols=201 Identities=28% Similarity=0.369 Sum_probs=170.4
Q ss_pred CCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCc----ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
+|++.+.||.|+||.||+|.+. .+|..||+|.+..... ...+.+..|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999874 4688999999875322 2345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++|+||+++++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999875 35688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCceeeeeccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
........ ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 54332211 11234688899999988753 4678999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=269.87 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=174.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----Ce
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 162 (315)
..+|.+.+.||+|+||+||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999999999999999987532 22345677899999999999999999987654 34
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++++||+. ++|.+++.. ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 688887764 45699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 221 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence 7543322 11223457889999998765 46889999999999999999999999876544444333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=268.38 Aligned_cols=211 Identities=26% Similarity=0.357 Sum_probs=175.9
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG- 160 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~- 160 (315)
.++....++|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 455567789999999999999999999998899999999987532 22345677899999999999999999988543
Q ss_pred -----CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 161 -----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 161 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3467888887 7889887753 3589999999999999999999998 999999999999999999999
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999998753222 122367889999998766 4688999999999999999999999987665544443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=262.34 Aligned_cols=204 Identities=33% Similarity=0.478 Sum_probs=172.7
Q ss_pred CCCCcccccccCCceEEEEEEEC----CCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~----~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 163 (315)
..|++.+.||+|+||.||+|.+. .++..+|+|.+...... ....+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45788899999999999999864 34789999999866543 46679999999999999999999999877 5678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999763 23589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCcee-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 244 MGPSGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 244 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 6542222111 11123456799999998889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=263.36 Aligned_cols=214 Identities=27% Similarity=0.375 Sum_probs=176.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----- 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 161 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45679999999999999999999998899999999875432 23356778999999999999999999987654
Q ss_pred -----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 162 -----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 162 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
.+++++||+++ ++.+++.. ....+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 67666654 234689999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...++.+.+..+.
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999754333211 1112245778999998765 357899999999999999999999998777665554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=261.26 Aligned_cols=205 Identities=26% Similarity=0.364 Sum_probs=172.7
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|++.+.||.|++|.||+|.+..+|..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6778889999999999999998999999999875432 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
. ++|.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68988886532 24689999999999999999999998 999999999999999999999999999864322211
Q ss_pred ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
. .....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||...++...
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1 1223568899999987664 578999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=255.28 Aligned_cols=203 Identities=28% Similarity=0.400 Sum_probs=178.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 167 (315)
+|...+.||+|++|.||+|.+..++..|++|++..... .....+.+|+.+++.++||||+++++.+.+. ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788899999999999999998899999999876543 4467788999999999999999999999988 8999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999876 23789999999999999999999997 999999999999999999999999999976544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 432111223468889999999988889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=257.77 Aligned_cols=205 Identities=27% Similarity=0.400 Sum_probs=175.9
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999999999999999987542 23445678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc-eEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-PKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~ 248 (315)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998652 234579999999999999999999998 9999999999999998764 699999998754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 208 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 21 122235888999999988888999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.10 Aligned_cols=208 Identities=28% Similarity=0.422 Sum_probs=179.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 166 (315)
++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+..|+.+++.++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 368899999999999999999998999999999875322 23456788999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 34799999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCc------------------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 247 SGDKT------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 247 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
..... .......++..|+|||...+..++.++|+||||+++|++++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 32210 112234578899999998888899999999999999999999999987664333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=260.49 Aligned_cols=199 Identities=32% Similarity=0.464 Sum_probs=170.2
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
|...+.||+|+||+||+|.+..++..|++|.+..... .....+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 6677789999999999999998999999999875432 3345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+. +++.+++.. ...++++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 577777654 245689999999999999999999998 9999999999999999999999999998643221
Q ss_pred CceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
....|+..|+|||++. ...++.++|+|||||++|+|++|..||...+...
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~ 227 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 1246888999999874 4568899999999999999999999997765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=260.18 Aligned_cols=208 Identities=28% Similarity=0.359 Sum_probs=177.5
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|.+.+.||+|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++||||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999999888999999998755332 3566888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++ +|.+++... ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 74 888777652 35789999999999999999999998 99999999999999999999999999987654432
Q ss_pred ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111224578899999988776 7899999999999999999999999887765555444
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=267.57 Aligned_cols=211 Identities=27% Similarity=0.374 Sum_probs=179.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----eEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRL 164 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 164 (315)
+|.+.+.||.|++|.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999999889999999987643 334567889999999999999999999988765 789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++|||+. ++|.+++.. ..++++..++.++.||+.||.|||+. +++||||||.||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 578888765 34799999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCc-eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 5443210 112234678899999999887 88999999999999999999999998887665555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.11 Aligned_cols=203 Identities=28% Similarity=0.345 Sum_probs=172.3
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee-CCeEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRL 164 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 164 (315)
.+.++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46778999999999999999999999999999999886432 2335667889999999999999999999865 56789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+++||+ +++|.+++.. .+++...+..++.|++.||.|||+. +++||||+|.||++++++.++|+|||.+..
T Consensus 87 lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 5688877753 4578888999999999999999998 999999999999999999999999999874
Q ss_pred CCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
..... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||.......
T Consensus 158 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 158 QDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred cCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 32211 22357889999998765 578999999999999999999999998765433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=266.39 Aligned_cols=203 Identities=26% Similarity=0.327 Sum_probs=172.3
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD---- 161 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 161 (315)
...++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999999999999999999864322 23456788999999999999999999987653
Q ss_pred --eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 162 --QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 162 --~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||+|+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 7788887753 4689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
|++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+...
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9987543221 22357889999998876 458899999999999999999999998765433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=302.06 Aligned_cols=207 Identities=29% Similarity=0.391 Sum_probs=178.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.+-++.-...||.|.||.||-|.+..+|...|+|.|.-.. ......+.+|+.+|..++|||+|++|++-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 3446777788999999999999999999999999886433 33456688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||++|+|.+.+.. ++-.++.....+..|++.|+.|||+. ||+||||||.||+++.+|.+|++|||.|....
T Consensus 1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999876 45567777888999999999999998 99999999999999999999999999997654
Q ss_pred CCCC--ceeeeeccccccccCccccccC---CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDK--THVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.... .......+||+.|||||++.+. ...-++|||||||++.||+||+.||...+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 3321 1112245899999999999764 466899999999999999999999987764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=268.16 Aligned_cols=209 Identities=24% Similarity=0.356 Sum_probs=172.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC---------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--------- 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------- 160 (315)
.++|.+.+.||.|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999999776656667788999999999999999999876543
Q ss_pred -----CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCce
Q 021249 161 -----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHP 234 (315)
Q Consensus 161 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~ 234 (315)
...++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 588877753 4588999999999999999999998 9999999999999974 5678
Q ss_pred EEeccCCcccCCCCCC-ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 235 KLSDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
+|+|||.+........ ........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...++.+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999875432211 111122357889999997654 568889999999999999999999998776544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=263.88 Aligned_cols=213 Identities=29% Similarity=0.382 Sum_probs=173.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeC-------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEG------- 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------- 160 (315)
.++|++.+.||.|+||.||+|.+..++..+|+|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999999999999999998643322 234567899999999999999999987543
Q ss_pred -CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
..+++|+||+. ++|...+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35699999986 466666543 245699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCc---------eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKT---------HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|++......... ...+...+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.++...+..+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754322111 111233568889999987654 5789999999999999999999999887776655554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=275.92 Aligned_cols=214 Identities=26% Similarity=0.422 Sum_probs=185.9
Q ss_pred CCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+...+.+.||+|.||.|++|.|..- ...||||.+...... ...+|.+|+.+|-+|+|||++++|++..+ ...-+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3456677899999999999998643 346999999876654 67889999999999999999999999988 678899
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||++++|+|.+.|+. .....|.......++.||+.||.||.++ ++|||||...|+|+-....|||+|||+++-..
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999987 3456788888999999999999999998 99999999999999999999999999999766
Q ss_pred CCCCceeeeec-cccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 247 SGDKTHVSTRV-MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 247 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
..+..+..... .-...|+|||.+....++.++|+|++||++|||+| |+.||.+....+.|.+|+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 65554433322 23457999999999999999999999999999997 889999999999998886
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=262.86 Aligned_cols=202 Identities=23% Similarity=0.306 Sum_probs=166.1
Q ss_pred ccccC--CceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCC
Q 021249 98 CLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 98 ~ig~G--~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
.||.| +||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46766 89999999999999999999987543 233567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC-ce
Q 021249 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-TH 252 (315)
Q Consensus 174 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 252 (315)
+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++||+.+........ ..
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999987643 24588999999999999999999988 999999999999999999999999986532211110 00
Q ss_pred e----eeeccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 253 V----STRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 253 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
. .....++..|+|||++.+. .++.++|||||||++|+|++|..||......+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 0 0111345679999998764 57899999999999999999999998765433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.28 Aligned_cols=212 Identities=28% Similarity=0.442 Sum_probs=180.4
Q ss_pred CCCCcccccccCCceEEEEEEECC----CCeEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK----IEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~----~~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+...+.++||.|-||.||.|.... ..-.||||..+.. ..+..+.|..|..++++++||||++++|++.+ ...||
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999998642 2345999998763 45567889999999999999999999999987 47899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|||+++.|.|..||+. +...++......++.||+.||+|||+. .++||||...|||+.+...+||+|||+++..
T Consensus 468 vmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999987 356689999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
........+ ...-...|||||.+.-..++.++|||.|||++||++. |..||.+-.+.+.+-.|+
T Consensus 542 ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE 606 (974)
T KOG4257|consen 542 EDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE 606 (974)
T ss_pred cccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec
Confidence 665433322 3345668999999999999999999999999999986 999999877666554443
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=258.64 Aligned_cols=204 Identities=26% Similarity=0.337 Sum_probs=167.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+|...+.||+|+||.||++.+..++..+|+|.+..... .....+..|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 46667789999999999999999999999999875432 34556888999998886 99999999999998999999999
Q ss_pred cCCCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 170 MPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 170 ~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
+. +++.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 4665543221 11236689999999999999999999973 38999999999999999999999999998653322
Q ss_pred CCceeeeeccccccccCccccccC---CcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
... ....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 111 223578899999988766 68999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=255.40 Aligned_cols=208 Identities=27% Similarity=0.382 Sum_probs=172.1
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccC---CCCCeeeEEeEEeeCCe-----
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSA---DHPNLVKLIGYCAEGDQ----- 162 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~----- 162 (315)
|++.+.||+|+||.||+|.+..++..||+|.+...... ....+..|+.+++.+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67788899999999999999888999999999743222 234456677766555 69999999999988776
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999997 58888886532 23589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
........ .....++..|+|||++.+..++.++|+|||||++|+|++|.+||......+.+..+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 76433221 12235788999999999889999999999999999999999999887766555444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.09 Aligned_cols=204 Identities=26% Similarity=0.359 Sum_probs=169.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------C
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------D 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 161 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999999889999999986532 22345678899999999999999999998654 3
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+++|+||+. .+|..++ ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999986 4665543 23588999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
+....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~ 226 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 226 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 87532211 22357889999998876 4688999999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=257.73 Aligned_cols=203 Identities=27% Similarity=0.350 Sum_probs=166.2
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHh-ccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTL-GSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
+-+..||.|+||+|++-.++.+|+..|||.|+.... ....++..|.+.. +.-++||||++|++...++..|+.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 344569999999999999999999999999987654 4456677787764 44579999999999999999999999995
Q ss_pred CCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 172 LGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 172 ~~~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.+|..+-+.. ......+++..+-.|....+.||.||... ..|||||+||+|||++..|.+||||||++......-.
T Consensus 147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 6765543321 11245688988889999999999999975 4899999999999999999999999999964433211
Q ss_pred ceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 THVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.+.-.|-..|||||.+.. ..|+.++|+||||++|||+.||..||...++
T Consensus 224 ---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 224 ---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred ---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 122368889999998864 3689999999999999999999999987764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=262.18 Aligned_cols=208 Identities=25% Similarity=0.297 Sum_probs=169.8
Q ss_pred CCCcccccccCCceEEEEEEECCC--CeEEEEEEecCCC--cccHHHHHHHHHHhccC-CCCCeeeEEeEEee----CCe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKI--EQVVAIKQLDHRG--VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE----GDQ 162 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~--~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----~~~ 162 (315)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ......+..|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999887 8899999987432 22345678899999998 59999999987533 245
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.+++++|+. ++|.+++.. ..++++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 688888754 45689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc--eeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 243 KMGPSGDKT--HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 243 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
......... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~ 220 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence 754322111 11123468999999998765 468999999999999999999999998776544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=258.33 Aligned_cols=199 Identities=32% Similarity=0.435 Sum_probs=169.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|...+.||+|+||.||+|.+..++..+|+|.+.... .....++.+|+.+++.++|||++++++++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4777788999999999999999889999999986432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+. +++.+++... ..++++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 6777776542 35689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 220 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH
Confidence 1235788999999874 346788999999999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=282.70 Aligned_cols=147 Identities=31% Similarity=0.409 Sum_probs=133.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999975432 2346688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999875 34588999999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=255.76 Aligned_cols=211 Identities=26% Similarity=0.352 Sum_probs=178.4
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-----eEEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRLLV 166 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv 166 (315)
+-.+.||.|+||.||.+.+..+|+.||+|++...- ....+.+.+|+.+|..++|.|++..++..+... .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34567999999999999999999999999986532 234567889999999999999999988765432 34677
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+|.|. .+|...+- ...+++...+.-+++||+++|.|||+. +|.||||||.|+|++++..+||||||+++...
T Consensus 136 TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 78774 45544443 467799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
..+ ....+..+-|.+|+|||++++. .|+.+.||||+|||+.||+.++..|+..++.+++.+|..|+
T Consensus 208 ~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 208 QRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred hhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 433 3334455678999999999876 68999999999999999999999999999999999999886
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=249.88 Aligned_cols=197 Identities=34% Similarity=0.438 Sum_probs=172.0
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
||.|+||.||++.+..+++.+|+|.+...... ....+..|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998765432 355788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 255 (315)
.+++.. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999876 34689999999999999999999997 99999999999999999999999999987543321 1122
Q ss_pred eccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 200 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 3467889999999988888999999999999999999999997666433
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=255.32 Aligned_cols=208 Identities=31% Similarity=0.395 Sum_probs=176.9
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|+..+.||+|++|.||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999999999999999998653 233466788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
. ++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5899998762 24689999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||......+.+..+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 11223467789999988776 7899999999999999999999999877655554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=258.55 Aligned_cols=196 Identities=20% Similarity=0.242 Sum_probs=162.6
Q ss_pred CceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhh
Q 021249 103 GFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180 (315)
Q Consensus 103 ~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 180 (315)
++|.||++....+++.||+|++... .......+..|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666778999999998754 33456779999999999999999999999999999999999999999999987
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC-----ceeee
Q 021249 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-----THVST 255 (315)
Q Consensus 181 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 255 (315)
... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 THF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 632 34588999999999999999999998 999999999999999999999999998864322111 11112
Q ss_pred eccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 256 RVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 256 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
...++..|+|||++... .++.++|+|||||++|+|++|..||......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 23567789999988763 5889999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=269.28 Aligned_cols=200 Identities=24% Similarity=0.330 Sum_probs=175.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------ccHHHHHHHHHHhccCC---CCCeeeEEeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSAD---HPNLVKLIGYC 157 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~---hpnIv~~~~~~ 157 (315)
...+|..++.+|.|+||.|++|.++.+...|+||.|.++.. ...-.+..||.+|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34469999999999999999999999999999999987643 11223667999999997 99999999999
Q ss_pred eeCCeEEEEEEec-CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 158 AEGDQRLLVYEYM-PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 158 ~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
++++++||+||-- +|.+|++++.. ...+++.++..|++||+-|+++||++ +|+|||||-+|+.++.+|.+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 9999999999964 56789999876 56799999999999999999999999 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccc
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~ 299 (315)
+|||.+....++. ...+.||..|.|||++.+..| +..-|||+||++||.++..+.||..
T Consensus 712 idfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 712 IDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999997654443 234689999999999998887 5789999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=285.11 Aligned_cols=200 Identities=29% Similarity=0.367 Sum_probs=162.2
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG----- 160 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 160 (315)
.....+|..+..||+||||.||+++++-+|..||||+|.... ......+.+|+..|.+|+|||||++|..|.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345567888999999999999999999999999999998653 23355688999999999999999998543110
Q ss_pred --------------------------------------------------------------------------------
Q 021249 161 -------------------------------------------------------------------------------- 160 (315)
Q Consensus 161 -------------------------------------------------------------------------------- 160 (315)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 021249 161 ----------------------------------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206 (315)
Q Consensus 161 ----------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~ 206 (315)
..+||-||||+..++.+++.+.... -....+|+++++|++||.
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 1237888999887887777662111 146788999999999999
Q ss_pred HHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC----------------CCCCceeeeeccccccccCccccc
Q 021249 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP----------------SGDKTHVSTRVMGTYGYCAPDYAM 270 (315)
Q Consensus 207 ~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~ 270 (315)
|+|+. |||||||||.|||+++++.|||+|||++.... .+......+..+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99998 99999999999999999999999999997511 011111235568999999999887
Q ss_pred cCC---cCcccchhhHHHHHHHHHh
Q 021249 271 TGQ---LTFKSDIYSFGVVLLELIT 292 (315)
Q Consensus 271 ~~~---~~~~~DiwslG~il~ellt 292 (315)
+.. |+.++|||||||+++||+.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc
Confidence 654 9999999999999999984
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=252.87 Aligned_cols=205 Identities=27% Similarity=0.353 Sum_probs=172.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-----cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
+|.+.+.||+|+||.||++.+...+..+++|++.... ......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999998777767777665321 12334567789999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998876544556799999999999999999999998 9999999999999985 569999999987543
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 3221 12234578899999998888889999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=253.39 Aligned_cols=208 Identities=29% Similarity=0.393 Sum_probs=173.8
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|.+.+.||+|++|.||+|....+++.|++|.+..... .......+|+..++.++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6778889999999999999988899999999865432 12233456889999998 999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988886532 34689999999999999999999998 999999999999999999999999999975433221
Q ss_pred ceeeeeccccccccCccccc-cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.....++..|+|||++. +..++.++|+||||+++|+|++|.+||......+.+..+
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 12235788999999875 446789999999999999999999999877665554433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=264.04 Aligned_cols=206 Identities=27% Similarity=0.363 Sum_probs=174.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ---- 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 162 (315)
..++|.+.+.||+|++|.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999999999999999986532 2334567789999999999999999998866554
Q ss_pred --EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 163 --RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 163 --~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
.++|+||+ +++|.+++.. .++++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799888764 4689999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~ 227 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 99754322 122367889999998765 3678999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=273.81 Aligned_cols=218 Identities=30% Similarity=0.405 Sum_probs=186.7
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEee---
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE--- 159 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--- 159 (315)
+.....++.|.+.+.||.|.+|.||++++..+++.+|+|+...... .-+++..|.++|+.+ +|||++.+|++|.-
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3444456679999999999999999999999999999999876543 335677888888887 69999999999853
Q ss_pred --CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 160 --GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
++.+|||||||.||+..|+++... +..+.|..+..|++.++.|+.+||.. .++|||+|-.|||++.++.|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 578999999999999999999876 67899999999999999999999987 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|||++........ .....+|||.|||||++.- ..|+..+|+||||++..||.-|.+|+-++.+...|-+|
T Consensus 166 DFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I 240 (953)
T KOG0587|consen 166 DFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 240 (953)
T ss_pred eeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence 9999975444332 2344689999999998863 35788999999999999999999999998887766554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=267.79 Aligned_cols=221 Identities=27% Similarity=0.424 Sum_probs=192.9
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
++|.....+.....+||-|.||.||.|.|+.-.-.||||.++... ...++|..|+.+++.+.|||+|+++++|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 777777788888899999999999999999988999999997653 4578899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|||+|||..|+|.+||+.. +...++.-..+.++.||..||+||... ++|||||...|.|+.++..+|++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999874 345577788899999999999999987 99999999999999999999999999999
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 311 (315)
++.....+. .....-...|.|||-+....++.++|||+|||+|||+.| |-.||.+.+-.+.+.+++.
T Consensus 414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK 481 (1157)
T ss_pred hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc
Confidence 765543221 112233568999999999999999999999999999997 8899998887666666654
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=254.08 Aligned_cols=200 Identities=29% Similarity=0.362 Sum_probs=168.9
Q ss_pred CCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCc----ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
+|++.+.||+|++|.||++.+. .++..||+|.+..... .....+..|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 4578899999875322 2345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+.+++|.+++.. ...+++..+..++.|++.+|.|||+. +++||||+|.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998865 35688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCceeeeeccccccccCccccccCC--cCcccchhhHHHHHHHHHhCCCcccc
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
....... .......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||..
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 5433221 1112346888999999887654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=258.77 Aligned_cols=197 Identities=31% Similarity=0.491 Sum_probs=164.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc--CCCCCeeeEEeEEeeCC----eEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCAEGD----QRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~----~~~ 164 (315)
...++.+.||+|.||.||+|... ++.||||+++.. ..+.+..|-++.+. +.|+||++++++-...+ .+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34556678999999999999887 689999999754 45667777777665 58999999999876655 899
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEecCCCCCEEEcCCCceEEec
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------KQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
||++|.+.|+|.+||+. ..++|....+++..|++||+|||+-. +++|+|||||..|||+.+++++.|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999986 45899999999999999999999643 56899999999999999999999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCC-c-----CcccchhhHHHHHHHHHhCCCcc
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-L-----TFKSDIYSFGVVLLELITGRKAI 297 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~il~elltg~~pf 297 (315)
||+|.....+.........+||.+|||||++.+.. . -.+.||||+|.+||||+++-..+
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99998766554444444578999999999887652 1 14789999999999999864433
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.05 Aligned_cols=202 Identities=29% Similarity=0.452 Sum_probs=166.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.++... .||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568899999999999999999998899999999975432 2344566677666555 5999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+. +++.+++... ..++++..+..++.|++.||.|||+. ++++||||+|+||++++++.++|+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 5777766542 34789999999999999999999973 2899999999999999999999999999875432
Q ss_pred CCCceeeeeccccccccCccccccCC----cCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 2211 1235778999999887553 788999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=267.26 Aligned_cols=198 Identities=30% Similarity=0.363 Sum_probs=168.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..+.|.+...+|.|+|+.|..+.+..+++..++|++.+.. .+..+|+.++... +||||+++.+.+.++...|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999999999999999999998762 2233566554444 6999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE-cCCCceEEeccCCcccCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili-~~~~~~kl~Dfg~~~~~~ 246 (315)
|.+.|+.+.+.+.. .+.....+..|+.+|+.|+.|||+. |++||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999998887765 2223377888999999999999998 99999999999999 588999999999998654
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.. ....+-|..|.|||++...+|++++||||||++||+||+|+.||......
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 43 11236788999999999999999999999999999999999999877655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=245.61 Aligned_cols=182 Identities=26% Similarity=0.307 Sum_probs=155.6
Q ss_pred CCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhh
Q 021249 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD 181 (315)
Q Consensus 102 G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 181 (315)
|.+|.||++.+..+++.||+|.+..... ...|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999999999999999976532 22344444556799999999999999999999999999999999865
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccc
Q 021249 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261 (315)
Q Consensus 182 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 261 (315)
...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence 34589999999999999999999998 99999999999999999999999999875433221 1234677
Q ss_pred cccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 262 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 899999988888999999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=248.87 Aligned_cols=216 Identities=24% Similarity=0.365 Sum_probs=179.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEee--------C
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--------G 160 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------~ 160 (315)
+.|.-..+||+|.||.||+|..+++|+.||+|++-.+ ...-.....+|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566677899999999999999999999999976432 22234456789999999999999999887632 3
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
..+|+||.+|+ -+|.-+|.. ....++..++..++.+++.+|.|+|.. .|+|||+||+|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 45899999997 567666654 246689999999999999999999988 99999999999999999999999999
Q ss_pred CcccCCCCCC--ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 241 LAKMGPSGDK--THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 241 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
+++.+..... ....+..+-|+.|++||.+.+. .|+++.|||+.|||+.||.||.+.|++..+.+++.+|..|.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 9975433222 1223344569999999988764 79999999999999999999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=287.02 Aligned_cols=192 Identities=31% Similarity=0.537 Sum_probs=163.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
...|.....||+|+||.||+|.+..++..||+|.+...... ...|+..+++++||||+++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677888999999999999999888999999998654322 12468889999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++|+|.++++. +++..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. |+........
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999853 7889999999999999999995544599999999999999998887775 5554322111
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
....+++.|+|||++.+..++.++|||||||++|||+||+.||+.
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 122578999999999999999999999999999999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=249.82 Aligned_cols=210 Identities=26% Similarity=0.339 Sum_probs=169.1
Q ss_pred CHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc--CCCCCeeeEEeEEee
Q 021249 82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCAE 159 (315)
Q Consensus 82 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~ 159 (315)
+.--...+..+..+.+.||+|.||.||+|.|. |+.||||++...+. +.+.+|.++.+. |+|+||+.+++.-..
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 33455667788999999999999999999999 88999999987643 455666666654 699999999987543
Q ss_pred C----CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEecCCCCCEEEcC
Q 021249 160 G----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-----LKQPVIYRDLKCSNILLEE 230 (315)
Q Consensus 160 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~iiH~Dlkp~Nili~~ 230 (315)
+ ..+|||++|-+.|+|+|||.. ..++.+..++++..+|.||++||.. .++.|.|||||..|||+.+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 3 368999999999999999976 5689999999999999999999953 3567999999999999999
Q ss_pred CCceEEeccCCcccCCCCC-C-ceeeeeccccccccCccccccCC----c--CcccchhhHHHHHHHHHhC---------
Q 021249 231 GYHPKLSDFGLAKMGPSGD-K-THVSTRVMGTYGYCAPDYAMTGQ----L--TFKSDIYSFGVVLLELITG--------- 293 (315)
Q Consensus 231 ~~~~kl~Dfg~~~~~~~~~-~-~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~il~elltg--------- 293 (315)
++.+.|+|+|+|....... . .-.....+||.+|||||++...- + -..+||||||.++||++-+
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9999999999997543331 1 11223358999999999886542 1 2468999999999999752
Q ss_pred -CCcccccC
Q 021249 294 -RKAIDQTK 301 (315)
Q Consensus 294 -~~pf~~~~ 301 (315)
++||.+.-
T Consensus 432 y~~Pyyd~V 440 (513)
T KOG2052|consen 432 YQLPYYDVV 440 (513)
T ss_pred hcCCcccCC
Confidence 57887654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=269.99 Aligned_cols=212 Identities=32% Similarity=0.469 Sum_probs=182.4
Q ss_pred CCcccccccCCceEEEEEEECCCC----eEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
....++||+|+||+||+|.+...| .+||+|++... ......++..|+.++.+++|||++++++++..+. .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 344577999999999999985444 47999998654 3455678999999999999999999999998865 88999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
+|+++|+|.|+++.. ..++..+..+.|+.||++||.|||.+ +++||||..+|+|+.+...+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999884 46688899999999999999999988 999999999999999999999999999998766
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 311 (315)
...........-.+.|||-|.+....|+.++|||||||++||++| |..|+.+...++.-.+++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ 915 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK 915 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc
Confidence 555444333345668999999999999999999999999999998 9999999987776666543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=230.51 Aligned_cols=209 Identities=19% Similarity=0.325 Sum_probs=176.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeC--CeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEG--DQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~l 165 (315)
..++|++.+++|+|-++.||.|....+.+.++||++++.. .+.+.+|+.+|+.|. ||||++++++..+. ..+.|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3467999999999999999999998889999999997653 456789999999997 99999999998664 45679
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccCCccc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKM 244 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg~~~~ 244 (315)
|+||+.+.+...+. ..++...++.++.+++.||.||||. ||.|||+||.|++||.. -.++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999877665443 3477888999999999999999999 99999999999999964 4699999999988
Q ss_pred CCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcc-cccCchhhhhHHhhhh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAI-DQTKDRKELNLVAWLL 313 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~ 313 (315)
...+..... -+.+..|--||.+..- .|+..-|+|||||++..|+..+.|| .+.++.+++.+|+.+|
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 766543322 2467789999988764 6889999999999999999988665 5778899999998876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=244.06 Aligned_cols=132 Identities=25% Similarity=0.322 Sum_probs=114.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----C---CCeeeEEeEEee---
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H---PNLVKLIGYCAE--- 159 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~~~~~~~--- 159 (315)
++|.+.++||.|.|++||+|.+....+.||+|+.+... ...+....||.+|++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 78999999999999999999999999999999986542 33456778999998873 3 369999999954
Q ss_pred -CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 160 -GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+.+.|+|+|++ |.+|..+|... ..+-++...+.+|++||+.||.|||..| +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56899999998 78888888763 4667899999999999999999999975 99999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=231.63 Aligned_cols=209 Identities=32% Similarity=0.369 Sum_probs=178.0
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
|.+.+.||.|++|.||++.+..++..+|+|.+...... ....+.+|+..++.++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56678899999999999999988899999999876554 56788999999999999999999999999899999999999
Q ss_pred CCChhhhhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 172 LGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+++|.+++... .. +++..+..++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999998763 23 78999999999999999999998 999999999999999999999999999876544320
Q ss_pred ceeeeeccccccccCcccc-ccCCcCcccchhhHHHHHHHHHhCCCcccc-cCch-hhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELITGRKAIDQ-TKDR-KELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~-~~~~~i 309 (315)
. ......++..|++||.+ ....++.++|+||||+++++|++|+.||.. .++. +..+.|
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 0 11223578889999988 666788899999999999999999999977 4433 444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=256.18 Aligned_cols=222 Identities=23% Similarity=0.229 Sum_probs=189.4
Q ss_pred CHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC------CCeeeEEe
Q 021249 82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH------PNLVKLIG 155 (315)
Q Consensus 82 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~ 155 (315)
.+.......++|.+....|+|-|++|.+|.+..-|..||||+|...... .+.=..|+.+|++|+. -++++++.
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3344455677899999999999999999999988999999999876543 3445689999999953 37999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ce
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HP 234 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~ 234 (315)
.|...+++|+|||-+. .+|.+.|+.+.. ...|....+..++.|+.-||..|... +|+|.||||.|||+++.. .+
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 9999999999999985 799999988654 34588889999999999999999988 999999999999999764 57
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
||||||.|........+ .+.-+..|.|||++.+-.|+...|+||+||+||||.||+..|.+..+.++|.+...|.
T Consensus 577 KLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 577 KLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 99999999765444332 2345668999999999999999999999999999999999999999999999887664
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-33 Score=230.40 Aligned_cols=210 Identities=25% Similarity=0.289 Sum_probs=179.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 161 (315)
..+|.-++.+|.|+- .|..|.+.-.+++||+|..... .....++..+|..++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888888999998 7778888888999999987543 2344667889999999999999999999996543
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..|+|||+|. .+|...+.. .++...+..++.|++.|+.|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 5689999996 688777752 367788899999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
++.... ....+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+.+..++..+|...+
T Consensus 165 ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 165 ARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred hcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 975322 234556688999999999999999999999999999999999999999999888888876554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=225.74 Aligned_cols=187 Identities=35% Similarity=0.484 Sum_probs=166.3
Q ss_pred CceEEEEEEECCCCeEEEEEEecCCCccc-HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhh
Q 021249 103 GFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD 181 (315)
Q Consensus 103 ~~g~V~~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 181 (315)
+||.||+|.+..++..+|+|++....... ...+..|+..++.++|+||+++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999998765544 67899999999999999999999999998999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccc
Q 021249 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261 (315)
Q Consensus 182 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 261 (315)
. ..++...++.++.+++.++.+||+. +++|+||+|.||++++++.++|+|||.+....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 2388999999999999999999998 99999999999999999999999999997654432 122346788
Q ss_pred cccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 262 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999888899999999999999999999999977
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=246.77 Aligned_cols=207 Identities=20% Similarity=0.254 Sum_probs=152.1
Q ss_pred HhCCCCcccccccCCceEEEEEEEC----------------CCCeEEEEEEecCCCcccHHH--------------HHHH
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLE----------------KIEQVVAIKQLDHRGVQGVRE--------------FSAE 138 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~----------------~~~~~vavK~i~~~~~~~~~~--------------~~~E 138 (315)
..++|.+.++||+|+||+||+|.+. ..++.||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 234679999986543222222 2345
Q ss_pred HHHhccCCCCC-----eeeEEeEEee--------CCeEEEEEEecCCCChhhhhhhcCC--------------------C
Q 021249 139 VMTLGSADHPN-----LVKLIGYCAE--------GDQRLLVYEYMPLGSLDKHLHDLRP--------------------D 185 (315)
Q Consensus 139 ~~~l~~l~hpn-----Iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~ 185 (315)
+..+.+++|.+ +++++++|.. .+..|+|+||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66666665554 4667776643 3568999999999999998864211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccC
Q 021249 186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265 (315)
Q Consensus 186 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 265 (315)
...+++..++.++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++.......... .....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 12346778889999999999999998 99999999999999999999999999996543221111 111245789999
Q ss_pred ccccccCC--------------------cC--cccchhhHHHHHHHHHhCCC-cccc
Q 021249 266 PDYAMTGQ--------------------LT--FKSDIYSFGVVLLELITGRK-AIDQ 299 (315)
Q Consensus 266 PE~~~~~~--------------------~~--~~~DiwslG~il~elltg~~-pf~~ 299 (315)
||.+.... ++ ...|+||+||++|+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99875432 11 24799999999999999985 7753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=254.04 Aligned_cols=202 Identities=23% Similarity=0.264 Sum_probs=144.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCC----CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeE------Ee
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKI----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY------CA 158 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------~~ 158 (315)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... +....+ .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 456899999999999999999999988 899999998654321 111111 1112222222222221 24
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 021249 159 EGDQRLLVYEYMPLGSLDKHLHDLRP----------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK 222 (315)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlk 222 (315)
.....++|+||+.+++|.+++..... .........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 56689999999999999998864210 001112344668999999999999998 99999999
Q ss_pred CCCEEEcC-CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCC----------------------cCcccc
Q 021249 223 CSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ----------------------LTFKSD 279 (315)
Q Consensus 223 p~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~D 279 (315)
|+|||++. ++.+||+|||+++...... ........+++.|+|||.+.... ++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5789999999997543221 12223457899999999654322 334569
Q ss_pred hhhHHHHHHHHHhCCCccc
Q 021249 280 IYSFGVVLLELITGRKAID 298 (315)
Q Consensus 280 iwslG~il~elltg~~pf~ 298 (315)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999877654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=253.96 Aligned_cols=213 Identities=30% Similarity=0.464 Sum_probs=175.2
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEEC---C----CCeEEEEEEecCCC-cccHHHHHHHHHHhccCC-CCCeeeEEe
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLE---K----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSAD-HPNLVKLIG 155 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~---~----~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~ 155 (315)
.+....++..+.+.||+|+||.|++|... . ....||||.++... ....+.+..|+.+++.+. ||||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34445555667779999999999999743 1 14579999987543 345677999999999984 999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcC---CCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR---PDT---------RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC 223 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp 223 (315)
++...+..++|+||+..|+|.++++..+ ... ..++....+.++.||+.|++||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 111 2389999999999999999999998 999999999
Q ss_pred CCEEEcCCCceEEeccCCcccCCCCCCceeeeeccc--cccccCccccccCCcCcccchhhHHHHHHHHHh-CCCccccc
Q 021249 224 SNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG--TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQT 300 (315)
Q Consensus 224 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 300 (315)
+|||+.++..+||+|||+++........... ...+ ...|||||.+....|+.++||||+|++|||++| |..||.+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999854333222211 1122 346999999999999999999999999999998 88999885
Q ss_pred C
Q 021249 301 K 301 (315)
Q Consensus 301 ~ 301 (315)
.
T Consensus 526 ~ 526 (609)
T KOG0200|consen 526 P 526 (609)
T ss_pred C
Confidence 5
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=248.01 Aligned_cols=213 Identities=27% Similarity=0.366 Sum_probs=187.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+...+|+|.||.||+++++.+++..|+|+++........-++.|+-+++..+||||+.+++.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34679999999999999999999999999999999998877778888999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||.||+|.+.-+- ..++++.++...++..++++.|||+. +-+|||||-.||++++.|.+|++|||.+......
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999876543 68899999999999999999999998 8899999999999999999999999998643322
Q ss_pred CCceeeeeccccccccCcccc---ccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYA---MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
- .....+.||++|||||+. +.+.|...+|+|++|++..|+---++|.-+..+.+.+.++.
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT 228 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT 228 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence 1 223346899999999965 35689999999999999999998888887777766666553
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=248.57 Aligned_cols=202 Identities=27% Similarity=0.368 Sum_probs=162.7
Q ss_pred CCcccccccCCceE-EEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 93 FRSDCCLGEGGFGK-VYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 93 y~~~~~ig~G~~g~-V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
|.-.+.+|.|+-|+ ||+|... |+.||||.+-... ..-..+|+..|+.. +|||||++|+.-.+.+..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44446699999875 7999987 7899999875432 34567899999887 4999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---C--CceEEeccCCcccC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---G--YHPKLSDFGLAKMG 245 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~--~~~kl~Dfg~~~~~ 245 (315)
. .+|.+++...............+.++.|++.||++||+. +|+||||||.||||+. + .+++|+|||+|+..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 799999976311111111144578899999999999998 9999999999999975 2 57899999999876
Q ss_pred CCCCC-ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCcccccCch
Q 021249 246 PSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDR 303 (315)
Q Consensus 246 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~ 303 (315)
..+.. ........||-+|+|||++....-+.++|||||||++|+.++| ..||.+.-.+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 54432 2223456799999999999988888899999999999999986 8999876555
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=218.02 Aligned_cols=212 Identities=23% Similarity=0.365 Sum_probs=167.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEe-EEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIG-YCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~-~~~~~~~~~lv 166 (315)
..+.|.+.+.||+|.||.+.++.|+.+...+++|.++..- ....+|.+|...--.| .|.||+..|+ .|+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4456999999999999999999999999999999987653 3467888988764445 4899999887 46778899999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--CCceEEeccCCccc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKM 244 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~ 244 (315)
+||++.|+|..-+.. ..+.+.....++.|++.|+.|+|+. +++|||||.+||||-. .-++||||||..+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999877654 4478888999999999999999998 9999999999999953 34799999999874
Q ss_pred CCCCCCceeeeeccccccccCcccccc---C--CcCcccchhhHHHHHHHHHhCCCcccccC--chhhhhHHhhhhc
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMT---G--QLTFKSDIYSFGVVLLELITGRKAIDQTK--DRKELNLVAWLLR 314 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~ 314 (315)
....-. ..-.+..|.+||.... . ...+.+|+|.||+++|.++||.+||+... +..-.+-..|+.|
T Consensus 173 ~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 173 VGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred cCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 322211 1134567999996542 2 34688999999999999999999998433 3334444555544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=200.08 Aligned_cols=184 Identities=39% Similarity=0.561 Sum_probs=160.2
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDK 177 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~ 177 (315)
||+|++|.||++....++..+++|++...... ....+.+|+..++.+.|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999866443 35678899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCCCCCceeeee
Q 021249 178 HLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTR 256 (315)
Q Consensus 178 ~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 256 (315)
++... ...++...++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98762 14689999999999999999999998 9999999999999999 89999999999976443321 1122
Q ss_pred ccccccccCccccccC-CcCcccchhhHHHHHHHH
Q 021249 257 VMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLEL 290 (315)
Q Consensus 257 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el 290 (315)
..+...|++||..... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3578889999988777 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=217.49 Aligned_cols=213 Identities=26% Similarity=0.333 Sum_probs=173.3
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECC---CCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCC
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD 161 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 161 (315)
+....+.|..+++||.|+|++||++.+.. ....||+|.+...+ ....+..|++.|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34456679999999999999999999876 68899999987654 3456889999999885 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFG 240 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg 240 (315)
...+|+||++.....++... ++...+..+++.++.||.++|.. |||||||||.|+|.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999998888887765 67889999999999999999998 9999999999999985 4678999999
Q ss_pred CcccC-----------------CC--C--------------CCc---------eeeeeccccccccCccccccC-CcCcc
Q 021249 241 LAKMG-----------------PS--G--------------DKT---------HVSTRVMGTYGYCAPDYAMTG-QLTFK 277 (315)
Q Consensus 241 ~~~~~-----------------~~--~--------------~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~ 277 (315)
++... .. + ... .......||++|.|||++... ..+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 98610 00 0 000 001123699999999988765 56899
Q ss_pred cchhhHHHHHHHHHhCCCccc-ccCchhhhhHHh
Q 021249 278 SDIYSFGVVLLELITGRKAID-QTKDRKELNLVA 310 (315)
Q Consensus 278 ~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~ 310 (315)
+||||.|+|+.-+++++.||- ..++.+.+.-|.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHH
Confidence 999999999999999999975 444555444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=213.99 Aligned_cols=224 Identities=24% Similarity=0.376 Sum_probs=183.9
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCC-----eEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEE
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYC 157 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 157 (315)
.++.....++++...+-+|.||.||.|.+.... +.|-+|.++.. +.-....+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455666778888999999999999999876432 33556655433 334466788899999999999999999987
Q ss_pred e-eCCeEEEEEEecCCCChhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC
Q 021249 158 A-EGDQRLLVYEYMPLGSLDKHLHDLRPD----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232 (315)
Q Consensus 158 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~ 232 (315)
. +....++++.++..|+|..|+...+.. ...++-.+...++.|++.|++|||.. ++||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 4 556788999999999999999854422 24567778889999999999999998 999999999999999999
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
++||+|=.+++..-..+-.......-....||+||.+.+..|+.++|+||||+++|||+| |+.|+...++.+....++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 999999999986655554444444456778999999999999999999999999999997 999999999888776654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=213.95 Aligned_cols=213 Identities=21% Similarity=0.221 Sum_probs=172.9
Q ss_pred CCCcccccccCCceEEEEEEECCCC-eEEEEEEecCCCcccHHHHHHHHHHhccCC----CCCeeeEEeEE-eeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSAD----HPNLVKLIGYC-AEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~i~~~~~~~~~~~~~E~~~l~~l~----hpnIv~~~~~~-~~~~~~~l 165 (315)
+|.+.+.||+|+||.||.|.+..++ ..+|+|............+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999987764 678999876553332225677888887776 36899999998 57788999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-----CceEEeccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----YHPKLSDFG 240 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-----~~~kl~Dfg 240 (315)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 899999776533 57799999999999999999999998 99999999999999765 368999999
Q ss_pred Ccc--cCCCCCC---c-e-e-eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 241 LAK--MGPSGDK---T-H-V-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 241 ~~~--~~~~~~~---~-~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+++ ....... . . . .....||..|+++.+..+.+.+++.|+||++.++.+++.|..||...........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 3211111 0 1 1 123569999999999999999999999999999999999999998777554444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=199.74 Aligned_cols=218 Identities=22% Similarity=0.245 Sum_probs=182.6
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC-CCeeeEEeEEeeCCeEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 166 (315)
...+.|.++++||+|+||.+|+|.....|..||||+-+... ...++.-|..+.+.|++ ..|..+.-+..+..+-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 45678999999999999999999999999999999865442 23456778888888864 6788888888888899999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg~~~ 243 (315)
|+.+ |.+|++++.-. ...++..+++-++-|++.-++|+|.. ++|||||||+|+|..- ...+.|+|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 78999988753 45689999999999999999999988 9999999999999963 3468999999998
Q ss_pred cCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhhc
Q 021249 244 MGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLR 314 (315)
Q Consensus 244 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 314 (315)
...+.... .......||.+|.+-....+.+.+.+.|+-|+|.+|.++.-|..||++.......++.+.+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH
Confidence 65332211 112345799999999988888999999999999999999999999999988888777777654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=215.49 Aligned_cols=181 Identities=19% Similarity=0.154 Sum_probs=137.2
Q ss_pred HHHHHHHhCCCCcccccccCCceEEEEEEECC-CCeEEEEEEecCC-----CcccHHHHHHHHHHhccCCCCCeee-EEe
Q 021249 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVK-LIG 155 (315)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~-~~~ 155 (315)
.+......++|.+.+.||+|+||+||+|.+.. ++..+|||.+... .......+.+|+.+|+.++|+|+++ +++
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 33445567889999999999999999998875 6778899987533 1123456899999999999999985 443
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEcCCCce
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL-KCSNILLEEGYHP 234 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dl-kp~Nili~~~~~~ 234 (315)
. +..++||||++|++|.. +.. .. ...++.|++.||.|||+. +|+|||| ||+|||++.++.+
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCE
Confidence 2 45799999999999962 211 11 146789999999999998 9999999 9999999999999
Q ss_pred EEeccCCcccCCCCCCcee------eeeccccccccCccccccC------CcCcccchh
Q 021249 235 KLSDFGLAKMGPSGDKTHV------STRVMGTYGYCAPDYAMTG------QLTFKSDIY 281 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~------~~~~~~Diw 281 (315)
+|+|||+++.......... .+...+++.|+|||++... ..+..+|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999986543321111 1245688889999987643 233456666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=200.59 Aligned_cols=205 Identities=22% Similarity=0.304 Sum_probs=174.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.-.|++.++||.|+||..+.|..--++++||||.-...+ ...++..|.+..+.|. .++|...|-+..++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 447999999999999999999998889999999865443 3456777888888774 7999999988888888999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-----CceEEeccCCcc
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----YHPKLSDFGLAK 243 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-----~~~kl~Dfg~~~ 243 (315)
++ |-+|+|++.-+ ++.++...+..++.|++.-++|+|+. .+|.|||||+|+||... ..+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 98 78999987653 57799999999999999999999998 99999999999999643 358999999998
Q ss_pred cCCCCCCce-----eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 244 MGPSGDKTH-----VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 244 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
...+..... ......||.+||+-....+.+.+.+.|+-|||-++++.|-|.+||++....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 665443221 123457999999999999999999999999999999999999999986643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-28 Score=197.31 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=198.5
Q ss_pred CCCcccchhhhhhhhcccccccccccccccCCCCcCcccccccccccCCCCccccccccccCCCCCCCCCCCCCcCHHHH
Q 021249 7 SGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDEL 86 (315)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (315)
++..++++.+..++.+++.+..+.+.+.|..+.++++++++.+.....-++
T Consensus 141 kp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~----------------------------- 191 (448)
T KOG0195|consen 141 KPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSS----------------------------- 191 (448)
T ss_pred chHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcchhh-----------------------------
Confidence 445566778888899999999999999999998888877777654322222
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
..+.-+|.....|..|+|++.++ .++.|++.-.. ...-++|..|.-.|+.+.||||+.+++.|.....+.
T Consensus 192 ------lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 192 ------LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred ------hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 12233477888899999999854 56667765443 334567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe-cCCCCCEEEcCCCceEEe--ccCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR-DLKCSNILLEEGYHPKLS--DFGL 241 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~-Dlkp~Nili~~~~~~kl~--Dfg~ 241 (315)
++..||+.|+|+..++.. ....++..++.+++.+|+++++|||+.. +++-| .|....++||++.+.+|. |-.+
T Consensus 264 ~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred EeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheeccccee
Confidence 999999999999999863 3455778899999999999999999983 66666 799999999999877664 4333
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcC---cccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT---FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+.. .. .....|.||+||.+...+-+ .++|+|||++++|||.|.+.||.+..+-+.--+|
T Consensus 340 sfq---e~------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 340 SFQ---EV------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred eee---cc------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 321 10 11457899999998876543 6899999999999999999999998877655444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=228.55 Aligned_cols=149 Identities=18% Similarity=0.204 Sum_probs=114.1
Q ss_pred cCCC-CCeeeEEeEE-------eeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 021249 144 SADH-PNLVKLIGYC-------AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215 (315)
Q Consensus 144 ~l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ 215 (315)
.++| +||+.++++| .....+++++||+ +++|.++|.. ...++++..++.++.||+.||.|||+. +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3445 5777888877 2334567888987 5799999964 245699999999999999999999998 9
Q ss_pred eEEecCCCCCEEEcCC-------------------CceEEeccCCcccCCCCCC--------------ceeeeecccccc
Q 021249 216 VIYRDLKCSNILLEEG-------------------YHPKLSDFGLAKMGPSGDK--------------THVSTRVMGTYG 262 (315)
Q Consensus 216 iiH~Dlkp~Nili~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~ 262 (315)
|+||||||+||||+.. +.+|++|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666543211000 000112358899
Q ss_pred ccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 263 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
|||||++.+..++.++|||||||++|||++|.+||..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=192.12 Aligned_cols=203 Identities=37% Similarity=0.550 Sum_probs=171.1
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---cHHHHHHHHHHhccCCCC-CeeeEEeEEeeCCeEEEEEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHP-NLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e 168 (315)
|.+...||.|+||.||.+.+. ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677788999999999999887 67899998765433 366789999999999988 79999999988778899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCcccCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGPS 247 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~~~~ 247 (315)
++.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999776542111 3689999999999999999999998 999999999999999988 799999999975433
Q ss_pred CCCce----eeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 248 GDKTH----VSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 248 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
..... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32211 2345689999999999887 5788999999999999999999999877663
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=186.71 Aligned_cols=172 Identities=12% Similarity=0.105 Sum_probs=133.8
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHH---H------HHHHHHHhccCCCCCeeeEEeEEe
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR---E------FSAEVMTLGSADHPNLVKLIGYCA 158 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~---~------~~~E~~~l~~l~hpnIv~~~~~~~ 158 (315)
...++|++.+.+|.|+||.||++.. ++..+|+|++......... . +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3678999999999999999999655 3668999999755332222 2 678999999999999999998866
Q ss_pred eC--------CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q 021249 159 EG--------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE 230 (315)
Q Consensus 159 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~ 230 (315)
.. ...+++|||++|.+|.++.. +++ ....+++.+|..||+. |++|||++|+||++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 35789999999999977632 222 2466999999999998 9999999999999999
Q ss_pred CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHH
Q 021249 231 GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291 (315)
Q Consensus 231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 291 (315)
++ ++|+|||........... ..++....|+.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988643221111 11345556778999999999986553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=177.77 Aligned_cols=138 Identities=14% Similarity=0.098 Sum_probs=107.2
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--c------------------------HHHHHHHHHHhccCCCCC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--G------------------------VREFSAEVMTLGSADHPN 149 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~------------------------~~~~~~E~~~l~~l~hpn 149 (315)
...||+|+||.||+|.+. +|+.||+|+++..... . ......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999987 7999999999754211 0 012235889999998777
Q ss_pred eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEecCCCCCEEE
Q 021249 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL-HEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 150 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiH~Dlkp~Nili 228 (315)
+......... ..++||||++|+++...... ..+++...+..++.|++.+|.+| |+. +|+||||||+|||+
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 6443332222 23899999998776544322 35688999999999999999999 687 99999999999999
Q ss_pred cCCCceEEeccCCccc
Q 021249 229 EEGYHPKLSDFGLAKM 244 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~ 244 (315)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=171.02 Aligned_cols=139 Identities=16% Similarity=0.128 Sum_probs=109.6
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--c------------------------HHHHHHHHHHhccCCCCC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--G------------------------VREFSAEVMTLGSADHPN 149 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~------------------------~~~~~~E~~~l~~l~hpn 149 (315)
.+.||+|++|.||+|.+. +|+.||||+++..... . ...+..|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 7999999998764211 0 112357888999999998
Q ss_pred eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEE
Q 021249 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 150 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili 228 (315)
+.....+... ..++||||++|+++...... ..+++...+..++.|++.++.+||+ . +|+||||||+||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 7554444333 24899999998755433211 2457888999999999999999999 7 99999999999999
Q ss_pred cCCCceEEeccCCcccC
Q 021249 229 EEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~ 245 (315)
+ ++.++|+|||++...
T Consensus 152 ~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 152 H-DGKPYIIDVSQAVEL 167 (190)
T ss_pred E-CCCEEEEEcccceec
Confidence 9 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=169.81 Aligned_cols=108 Identities=28% Similarity=0.274 Sum_probs=94.4
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
|+|.+++... ..++++..++.++.||+.||.|||+. + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888752 45699999999999999999999987 5 999999999999999 99987643321
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 258899999999999999999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=165.50 Aligned_cols=188 Identities=20% Similarity=0.157 Sum_probs=139.1
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc----HHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG----VREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.+...|++|+||+|+.+.. .+.+++.+.+.....-. ...+.+|+++|++|. |+++.+++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3456799999999997765 37788877776554311 224789999999995 5889999886 34689999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCEEEcCCCceEEeccCCcccCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL-KCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dl-kp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|+.|.+|...+.. ....++.|++.+|.++|+. ||+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999988643211 1135788999999999998 9999999 79999999999999999999985443
Q ss_pred CCCc----e---e----eeeccccccccCccccccC-CcC-cccchhhHHHHHHHHHhCCCcccccC
Q 021249 248 GDKT----H---V----STRVMGTYGYCAPDYAMTG-QLT-FKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 248 ~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.... . . ......++.|++|+...-- ..+ .+.++++.|+-+|.++||..|+-..+
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 0 0 0011357778888743321 233 67899999999999999998876544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=203.57 Aligned_cols=204 Identities=24% Similarity=0.296 Sum_probs=164.0
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecC-----CCccc-HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~-----~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.....+|.|++|.|+.+......+.++.|.+.. ..... ...+..|..+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345679999999888887765555555555431 11111 112566777778899999999888877766666669
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||++ +|..++.. ...+....+-.++.|++.|+.|||+. ||.|||+||+|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99988875 34688889999999999999999998 999999999999999999999999999976544
Q ss_pred CCCc--eeeeeccccccccCccccccCCcCc-ccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 248 GDKT--HVSTRVMGTYGYCAPDYAMTGQLTF-KSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 248 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
.... ......+|+..|+|||.+.+..|++ ..||||.|++++.|++|+.||......+.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 4333 5566778999999999999999985 68999999999999999999987665433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-24 Score=195.28 Aligned_cols=186 Identities=30% Similarity=0.375 Sum_probs=157.4
Q ss_pred cccCCceEEEEEEE---CCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 99 LGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 99 ig~G~~g~V~~~~~---~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+|.|+||.|+++.. ...|..+|+|+..+.... .......|..++...+ ||.++++...++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999998643 344678999998764321 1224456777777776 99999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
|.|...+.. ...+.+.....+...++-|++++|.. +++|||+|++||+++.+|++++.|||+++........
T Consensus 82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999877765 45577778888999999999999998 9999999999999999999999999999865444332
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
+||..|||||++. ....++|.||||++++||+||-.||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999887 678899999999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=163.86 Aligned_cols=134 Identities=21% Similarity=0.240 Sum_probs=106.7
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-----CCCCeeeEEeEEeeCC---e-EEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKLIGYCAEGD---Q-RLLV 166 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~-~~lv 166 (315)
...||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ +||||++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 45699999999995 7666655 69998765555567799999999999 6799999999998874 4 3478
Q ss_pred EEe--cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEecCCCCCEEEcC----CCceEEecc
Q 021249 167 YEY--MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL-QYLHEQLKQPVIYRDLKCSNILLEE----GYHPKLSDF 239 (315)
Q Consensus 167 ~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~iiH~Dlkp~Nili~~----~~~~kl~Df 239 (315)
+|| +.+++|.+++.+ ..+++. ..++.|++.++ .|||+. +|+||||||+|||++. +..++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 557999999965 225554 35577888777 999998 9999999999999974 347999994
Q ss_pred CCc
Q 021249 240 GLA 242 (315)
Q Consensus 240 g~~ 242 (315)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=195.61 Aligned_cols=201 Identities=19% Similarity=0.215 Sum_probs=159.9
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc---HHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
+.......|.|.+.||+|+||+||+|.... |+.||+|+-+....-. -.++...+. -.--+.|..+..++.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCC
Confidence 344456678899999999999999999987 9999999977654321 112222222 111356777777777778
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-------CCce
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-------GYHP 234 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-------~~~~ 234 (315)
..+||+||.+.|+|.+++.. .+.+++..+..+..|++..++.||.. +|||+||||+|+||.. ..-+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 88999999999999999973 56789999999999999999999998 9999999999999942 3358
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
+|+|||.+..+..-.........++|-.+-.+|+..|..|+..+|.|.|+.+++-||.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998644332222334456789999999999999999999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=163.13 Aligned_cols=141 Identities=15% Similarity=0.120 Sum_probs=111.0
Q ss_pred CCCcccccccCCceEEEEEE-ECCCCeEEEEEEecCCCcc------------------------cHHHHHHHHHHhccCC
Q 021249 92 NFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLDHRGVQ------------------------GVREFSAEVMTLGSAD 146 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~-~~~~~~~vavK~i~~~~~~------------------------~~~~~~~E~~~l~~l~ 146 (315)
.|.+.+.||+|++|.||+|. +..+|..||+|++...... ....+..|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6678999999998754210 0123567999999987
Q ss_pred CC--CeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEecCCC
Q 021249 147 HP--NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-VIYRDLKC 223 (315)
Q Consensus 147 hp--nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-iiH~Dlkp 223 (315)
+. .+.++++. ...++||||+.|.+|...... ..++....+..++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 23344432 235899999999888665422 23456667789999999999999998 8 99999999
Q ss_pred CCEEEcCCCceEEeccCCccc
Q 021249 224 SNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 224 ~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 78999999999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=165.48 Aligned_cols=201 Identities=17% Similarity=0.246 Sum_probs=130.3
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCC----------CCeeeEEeEE--
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADH----------PNLVKLIGYC-- 157 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~h----------pnIv~~~~~~-- 157 (315)
+...+.||.|+++.||.+.+..|++.+|+|++.... ....+.+.+|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345677999999999999999999999999975332 2345666666655444322 1222222221
Q ss_pred -------ee---CCeE-----EEEEEecCCCChhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 021249 158 -------AE---GDQR-----LLVYEYMPLGSLDKHLHD---LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219 (315)
Q Consensus 158 -------~~---~~~~-----~lv~e~~~~~~L~~~l~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~ 219 (315)
.. ...+ +++|+-+. ++|.+++.. .......+.......+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1122 56777764 677776542 111222344455566779999999999998 99999
Q ss_pred cCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCcccccc--------CCcCcccchhhHHHHHHHHH
Q 021249 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--------GQLTFKSDIYSFGVVLLELI 291 (315)
Q Consensus 220 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell 291 (315)
||+|+|+|++.+|.+.|+||+....... .... ...+..|.|||.... -.++.+.|.|+||+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999988764221 1111 245578999996543 25788999999999999999
Q ss_pred hCCCcccccCc
Q 021249 292 TGRKAIDQTKD 302 (315)
Q Consensus 292 tg~~pf~~~~~ 302 (315)
+|..||....+
T Consensus 245 C~~lPf~~~~~ 255 (288)
T PF14531_consen 245 CGRLPFGLSSP 255 (288)
T ss_dssp HSS-STCCCGG
T ss_pred HccCCCCCCCc
Confidence 99999986543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=159.88 Aligned_cols=134 Identities=21% Similarity=0.268 Sum_probs=112.5
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
+.||+|++|.||+|.+ .|..+++|+....... ....+.+|+.++..+.|++|.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5699999999999987 4678999986643321 12357789999999999998877777777788899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
|++|++|.+++... . . ....++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988641 1 1 7788999999999999998 999999999999999 78899999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=188.25 Aligned_cols=174 Identities=26% Similarity=0.397 Sum_probs=130.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
..+|..++.|..|+||.||.++|+.+.+.+|+ .+++.+.. .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee------------------
Confidence 45799999999999999999999999999999 44443211 110 33333344433
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
|+-.+.++. -++++... +.|++|||+. +|+|||+||+|.+|..-|++|++|||+++......
T Consensus 136 ---gDc~tllk~----~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhccc----CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 444444443 33444432 6799999998 99999999999999999999999999987532111
Q ss_pred Cc-------------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 250 KT-------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 250 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.. ......+|||.|.|||++....|+..+|+|++|+|+||.+.|..||.+..+++.+.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 10 01123589999999999999999999999999999999999999999886655443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=154.51 Aligned_cols=130 Identities=22% Similarity=0.276 Sum_probs=105.4
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.||+|+||.||+|.+. +..+++|........ ....+.+|+.+++.+.|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 3899999999999854 678999986543211 135577899999999888765555555566677899999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++|++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998877541 11 7899999999999998 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=185.94 Aligned_cols=196 Identities=24% Similarity=0.248 Sum_probs=149.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHH---HHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFS---AEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.|...+.||++.|=+|.+|++.. |. |+||++-+.+ .-..+.+. .|+. ...+++||++++.-+-..+...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 57778889999999999999875 54 8999986554 22333333 3344 45568999999988877777778888
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC--
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-- 245 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~-- 245 (315)
+|.. .+|.|.+.. ..-+...+.+.|+.|++.||.-+|.. +|+|||||.+||||++-+-+.|+||...+..
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 8884 688887754 34467788899999999999999998 9999999999999999999999999876532
Q ss_pred CCCCCc---eeeeeccccccccCccccccC----------C-cCcccchhhHHHHHHHHHh-CCCccc
Q 021249 246 PSGDKT---HVSTRVMGTYGYCAPDYAMTG----------Q-LTFKSDIYSFGVVLLELIT-GRKAID 298 (315)
Q Consensus 246 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ellt-g~~pf~ 298 (315)
+..+.. .....-..-.+|+|||.+... . .+++.||||+||+++||++ |++||.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 222111 111222334579999987642 1 5788999999999999998 688885
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=146.82 Aligned_cols=138 Identities=16% Similarity=0.037 Sum_probs=107.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc----------------------cHHHHHHHHHHhccCCC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ----------------------GVREFSAEVMTLGSADH 147 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~----------------------~~~~~~~E~~~l~~l~h 147 (315)
.-.|.+.+.||+|+||.||++.+. +|+.||||+++..... .......|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 334888899999999999999875 6999999987643210 01135678888888877
Q ss_pred CC--eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 148 PN--LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 148 pn--Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
++ +...++ ....+++|||++|++|...... .....++.+++.++.++|+. +++||||+|+|
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFN 155 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCccc
Confidence 74 444443 2456899999999988654321 23457889999999999998 99999999999
Q ss_pred EEEcCCCceEEeccCCcccC
Q 021249 226 ILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~ 245 (315)
|++++++.++|+|||.+...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=167.78 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=112.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--Cc------ccHHHHHHHHHHhccCCCCCeeeEEeEEee
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GV------QGVREFSAEVMTLGSADHPNLVKLIGYCAE 159 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 159 (315)
.....|...+.||+|+||+||+|.+... .+++|+.... .. .....+.+|+.+++.++|++++....++.+
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3344567788999999999999987643 3444432211 11 113457889999999999999888777777
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
....++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+||++ .++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence 777899999999999988774 2467899999999999998 99999999999999 5779999999
Q ss_pred CCcccC
Q 021249 240 GLAKMG 245 (315)
Q Consensus 240 g~~~~~ 245 (315)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=161.43 Aligned_cols=124 Identities=26% Similarity=0.382 Sum_probs=106.3
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
+++|.|++|.-.+|.++|...+. ....++.....++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975433 4456788899999999999999 4 899999999999999999999999999
Q ss_pred cccCCCCC----CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh
Q 021249 242 AKMGPSGD----KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292 (315)
Q Consensus 242 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 292 (315)
........ .....+...||+.||+||.+.+..|+.++||||||+||+|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87543332 1222345689999999999999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=130.37 Aligned_cols=135 Identities=21% Similarity=0.142 Sum_probs=112.8
Q ss_pred cccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC--CCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH--PNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 95 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.+.||+|.++.||++.... ..+++|.+..... ...+..|+.+++.++| +++.+++.++...+..++++||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45679999999999998864 6799999866543 4568889999999976 5899999988888889999999988
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..+..+ +......++.+++.++.+||.....+++|+|++|.||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777433 4456677899999999999986334799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9e-18 Score=137.25 Aligned_cols=134 Identities=19% Similarity=0.165 Sum_probs=95.7
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHH----------------------HHHHHHHhccCCCCC--
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE----------------------FSAEVMTLGSADHPN-- 149 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn-- 149 (315)
.+.||+|+||+||+|.+. ++..||||++...... .... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999887 7899999998754221 1111 134555555553332
Q ss_pred eeeEEeEEeeCCeEEEEEEecCCCChhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEE
Q 021249 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDK-HLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 150 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nil 227 (315)
+.+.++. ...+++|||++++.+.. .+.... .. ..+..++.+++.++.++|. . +|+|+||+|+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 3444433 24689999999854422 122110 11 5678899999999999998 6 9999999999999
Q ss_pred EcCCCceEEeccCCccc
Q 021249 228 LEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~ 244 (315)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-17 Score=137.98 Aligned_cols=134 Identities=19% Similarity=0.153 Sum_probs=102.6
Q ss_pred cccc-cCCceEEEEEEECCCCeEEEEEEecCCCc-------------ccHHHHHHHHHHhccCCCCCe--eeEEeEEeeC
Q 021249 97 CCLG-EGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------------QGVREFSAEVMTLGSADHPNL--VKLIGYCAEG 160 (315)
Q Consensus 97 ~~ig-~G~~g~V~~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~ 160 (315)
..|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3476 7888889888765 67899998854221 123457889999999998875 6666654332
Q ss_pred -C---eEEEEEEecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 161 -D---QRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 161 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
. ..++|+|+++| .+|.+++.. .+++.. .+.+++.+|.+||+. ||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688888754 235543 367899999999998 999999999999999988999
Q ss_pred EeccCCccc
Q 021249 236 LSDFGLAKM 244 (315)
Q Consensus 236 l~Dfg~~~~ 244 (315)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.5e-19 Score=166.85 Aligned_cols=208 Identities=25% Similarity=0.319 Sum_probs=166.7
Q ss_pred CCCCcccccccCCceEEEEEEECC-CCeEEEEEEecCCC--cccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 166 (315)
..|.+.+.||+|+|+.|-...... ....+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 357778889999999998876643 34457777766443 233455666777777777 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCccc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH-EQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKM 244 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~ 244 (315)
++|..|+++.+.+.. ......+...+..++.|+..++.|+| .. ++.|||+||+|.+++..+ .++++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999887731 12224566677889999999999999 66 999999999999999999 999999999986
Q ss_pred CCC-CCCceeeeeccc-cccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 245 GPS-GDKTHVSTRVMG-TYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 245 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
... ..........+| ++.|+|||...+. -..+..|+||+|+++..+++|..|+......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 655 333344445678 9999999988875 4468899999999999999999999865543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=150.45 Aligned_cols=154 Identities=31% Similarity=0.509 Sum_probs=128.1
Q ss_pred hccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EEec
Q 021249 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV-IYRD 220 (315)
Q Consensus 142 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-iH~D 220 (315)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ....+++.....+.++|+.+|.|||.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 4678999999999999999999999999999999999976 356688888999999999999999987 44 9999
Q ss_pred CCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCC-------cCcccchhhHHHHHHHHHhC
Q 021249 221 LKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-------LTFKSDIYSFGVVLLELITG 293 (315)
Q Consensus 221 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~elltg 293 (315)
+++.|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987654311111111123445799999887641 46679999999999999999
Q ss_pred CCcccccC
Q 021249 294 RKAIDQTK 301 (315)
Q Consensus 294 ~~pf~~~~ 301 (315)
..||....
T Consensus 155 ~~~~~~~~ 162 (484)
T KOG1023|consen 155 SGPFDLRN 162 (484)
T ss_pred cCcccccc
Confidence 99998744
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=137.84 Aligned_cols=145 Identities=24% Similarity=0.297 Sum_probs=108.6
Q ss_pred CCCCeeeEEeEEee---------------------------CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHH
Q 021249 146 DHPNLVKLIGYCAE---------------------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198 (315)
Q Consensus 146 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~ 198 (315)
.|||||.+..+|.+ +..+|+||..+. .+|..++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 69999999988754 234688888774 688888865 335667778899
Q ss_pred HHHHHHHHHHHhcCCCCeEEecCCCCCEEEc--CCC--ceEEeccCCcccCCCC--CCcee--eeeccccccccCccccc
Q 021249 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLE--EGY--HPKLSDFGLAKMGPSG--DKTHV--STRVMGTYGYCAPDYAM 270 (315)
Q Consensus 199 ~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~--~~~--~~kl~Dfg~~~~~~~~--~~~~~--~~~~~gt~~y~aPE~~~ 270 (315)
.|+++|+.|||.. +|.|||+|.+|||+. +++ .+.|+|||+|--.... ..... ....-|....||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999987 999999999999993 333 4789999998532210 00111 11234777899999765
Q ss_pred cCC-----c-CcccchhhHHHHHHHHHhCCCcccc
Q 021249 271 TGQ-----L-TFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 271 ~~~-----~-~~~~DiwslG~il~elltg~~pf~~ 299 (315)
..+ . -.++|.|+.|.+.||++....||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 321 1 2489999999999999999999987
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.3e-15 Score=135.46 Aligned_cols=170 Identities=15% Similarity=0.183 Sum_probs=131.5
Q ss_pred EEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCC
Q 021249 109 KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP 188 (315)
Q Consensus 109 ~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 188 (315)
-|..+.++.+|.|+..+.+.........+-+..|+.++||||+++++.++..+..|||+|-+ ..|..+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 35666778899999988766544555677788899999999999999999999999999997 467777776
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccc
Q 021249 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268 (315)
Q Consensus 189 l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 268 (315)
+.......-+.||+.||.|||.. .+++|++|.-..|++++.|..||++|-++......... ......-..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhh
Confidence 33566777899999999999975 49999999999999999999999999887543322210 011112224667765
Q ss_pred cccCCcCcccchhhHHHHHHHHHhC
Q 021249 269 AMTGQLTFKSDIYSFGVVLLELITG 293 (315)
Q Consensus 269 ~~~~~~~~~~DiwslG~il~elltg 293 (315)
+.... ...|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 44333 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=133.68 Aligned_cols=139 Identities=19% Similarity=0.151 Sum_probs=95.2
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHH----------------------------------------HHH
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR----------------------------------------EFS 136 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~----------------------------------------~~~ 136 (315)
+.||+|++|.||+|+.. +|+.||||+.++....... ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999876 5899999998654211100 133
Q ss_pred HHHHHhccC----C-CCCeeeEEeEE-eeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 021249 137 AEVMTLGSA----D-HPNLVKLIGYC-AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR-GLQYLH 209 (315)
Q Consensus 137 ~E~~~l~~l----~-hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH 209 (315)
.|+..+..+ . ++++ .+-.++ ......+|||||++|++|.++..... .... ...++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHH
Confidence 344444433 2 3332 222222 23445789999999999988764311 1122 2345556655 467788
Q ss_pred hcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 210 ~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
.. |++|+|++|.||+++.++.++++|||++....
T Consensus 275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 77 99999999999999999999999999997544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=140.32 Aligned_cols=145 Identities=14% Similarity=0.068 Sum_probs=95.0
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc----------------------------------HH----
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG----------------------------------VR---- 133 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~----------------------------------~~---- 133 (315)
.|.. +.||+|++|.||+|....+|+.||||++++.-... .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999998889999999997542100 01
Q ss_pred --HHHHHHHHhccC----CCCCeeeEEeEEe-eCCeEEEEEEecCCCChhhhh--hhcCCCCCCCCHHHHHHHHHHHHHH
Q 021249 134 --EFSAEVMTLGSA----DHPNLVKLIGYCA-EGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRG 204 (315)
Q Consensus 134 --~~~~E~~~l~~l----~hpnIv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~~~i~~qi~~a 204 (315)
++..|+..+.++ .+...+.+-.++. -....++||||++|+.+.+.- .....+...+....+..++.|+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~- 278 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR- 278 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-
Confidence 123343333333 2333333333332 245667999999999997742 221111123444444555555542
Q ss_pred HHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEeccCCcccCCC
Q 021249 205 LQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPS 247 (315)
Q Consensus 205 l~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~Dfg~~~~~~~ 247 (315)
. |++|+|++|+||+++.++ .++++|||++.....
T Consensus 279 ------~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 ------D---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------C---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 999999999999999888 999999999875533
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.9e-14 Score=112.70 Aligned_cols=130 Identities=18% Similarity=0.122 Sum_probs=94.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCee-eEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 45889999999998875 77899999765432 123456788888887655544 344443 2345799999999887
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
.+. . . ....++.+++.+|..||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 542 0 1 11345778999999999871 11259999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=131.65 Aligned_cols=202 Identities=26% Similarity=0.280 Sum_probs=159.4
Q ss_pred CCCCccccccc--CCceEEEEEEE--CCCCeEEEEEE--ecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeE
Q 021249 91 GNFRSDCCLGE--GGFGKVYKGCL--EKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~--G~~g~V~~~~~--~~~~~~vavK~--i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 163 (315)
..|.+...+|. |.+|.||.+.. ..++..+|+|. +.........+-.+|+....+++ |+|.++.+..++..+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35777888999 99999999887 77888999998 33332233333345666666664 99999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEec
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSD 238 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~D 238 (315)
++-+|+|. .+|..+.... ...++...++..+.+... |+.++|+. +++|-|++|.||++..+ ..++++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999984 7777776652 344778888999999999 99999998 99999999999999998 8899999
Q ss_pred cCCcccCCCCCCce---eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 239 FGLAKMGPSGDKTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 239 fg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
||+........... ...+..|...|++|| +.+.-++..+|+||+|.++.+..+|..++...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99997665544221 122335788899999 45667889999999999999999987766544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.6e-12 Score=105.64 Aligned_cols=136 Identities=15% Similarity=0.123 Sum_probs=97.1
Q ss_pred ccccccCCceEEEEEEECC------CCeEEEEEEecCCCc----------------------ccHHHH----HHHHHHhc
Q 021249 96 DCCLGEGGFGKVYKGCLEK------IEQVVAIKQLDHRGV----------------------QGVREF----SAEVMTLG 143 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~------~~~~vavK~i~~~~~----------------------~~~~~~----~~E~~~l~ 143 (315)
...||.|-.+.||.|.... .+..+|||+.+.... .....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3469999999999997653 357899998753110 001122 37888888
Q ss_pred cCCC--CCeeeEEeEEeeCCeEEEEEEecCCCChh-hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEe
Q 021249 144 SADH--PNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL-HEQLKQPVIYR 219 (315)
Q Consensus 144 ~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~iiH~ 219 (315)
++.. -++..++++ ...+|||||+.+..+. ..+++ ..++......+..+++.+|..| |.. +|+|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8743 345555554 4578999999764332 12322 2345566677889999999999 777 99999
Q ss_pred cCCCCCEEEcCCCceEEeccCCccc
Q 021249 220 DLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 220 Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
||+|.||+++. +.+.|+|||.+..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCcee
Confidence 99999999974 6899999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-12 Score=102.45 Aligned_cols=144 Identities=18% Similarity=0.185 Sum_probs=108.8
Q ss_pred cccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 95 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
....|.+|+.+.|+++.+. |+.++||.-...... ...+...|+++|.++.--.|.-..-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4567899999999999887 788888865443321 134577899999887655555555566777778899
Q ss_pred EEecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEeccCCc
Q 021249 167 YEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLA 242 (315)
Q Consensus 167 ~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~Dfg~~ 242 (315)
|||++| .++.+++..... .+........++..|-+.+.-||.. +|||+||..+||++..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 999987 478888876432 2233334467899999999999987 999999999999997654 3589999998
Q ss_pred ccC
Q 021249 243 KMG 245 (315)
Q Consensus 243 ~~~ 245 (315)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=8e-15 Score=124.08 Aligned_cols=190 Identities=24% Similarity=0.311 Sum_probs=133.9
Q ss_pred EEEEEEECCCCeEEEEEEecCC---Cc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----CeEEEEEEecCCCChh
Q 021249 106 KVYKGCLEKIEQVVAIKQLDHR---GV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQRLLVYEYMPLGSLD 176 (315)
Q Consensus 106 ~V~~~~~~~~~~~vavK~i~~~---~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~ 176 (315)
.||++.+...|.+|+.-.++-. +. ...+....-...|-++.|.|||++..++.+. ....++.|||..|++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 4666666666666654433211 11 1111122223344556799999999988654 3467899999999999
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC--CCCceee
Q 021249 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS--GDKTHVS 254 (315)
Q Consensus 177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~ 254 (315)
.+|++.+.....+......+|+.||+.||.|||+. ...|+|+++..+.|++..+|-+|+.---....... .......
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence 99998877788899999999999999999999997 78999999999999999998888763211110000 0000011
Q ss_pred eeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 255 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
....+-++|.+||.-.....+-++|||+||+...+|..|..-
T Consensus 240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 112467789999976655667899999999999999988743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-12 Score=101.06 Aligned_cols=130 Identities=23% Similarity=0.280 Sum_probs=99.0
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.+++|+-+.++.+.+. |..+++|.-.+.... ...+..+|+.++.++.--.|.-.+-++.+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5889999999998765 555777764333221 133467789998887654554444455566778899999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++|..|.+.+... ...++..+-..+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888762 145677788888899988 999999999999998764 99999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-14 Score=134.21 Aligned_cols=212 Identities=20% Similarity=0.202 Sum_probs=156.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..+.+.+.+.+.+|+++.++.+.-..+|...+.++...... ...+....+-.++-...+|-++...-.+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34567777789999999999988777776666665543221 122333333333333456777766655666778899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
+++|..+++|...++. ....+..-++.....+..++++||+. .+.|+|++|.|+++..++..++.|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999888876 23466666677888899999999987 6899999999999999999999999843211
Q ss_pred CCC-----------------------------CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 246 PSG-----------------------------DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 246 ~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
... +.........||+.|.+||.+.+.....++|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 000 000112235689999999999999999999999999999999999999
Q ss_pred ccccCchhhhh
Q 021249 297 IDQTKDRKELN 307 (315)
Q Consensus 297 f~~~~~~~~~~ 307 (315)
|.+....+...
T Consensus 1035 ~na~tpq~~f~ 1045 (1205)
T KOG0606|consen 1035 FNAETPQQIFE 1045 (1205)
T ss_pred CCCcchhhhhh
Confidence 98877665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-11 Score=103.29 Aligned_cols=142 Identities=16% Similarity=0.185 Sum_probs=106.8
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCC--CeeeEEeEEeeC---CeEEEEEEec
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHP--NLVKLIGYCAEG---DQRLLVYEYM 170 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~---~~~~lv~e~~ 170 (315)
+.|+.|..+.||++.... |..+++|....... .....+..|..+++.+.+. .+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999998754 67899999765432 1345678899999988653 456677766553 2668999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-------------------------------------- 212 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 212 (315)
+|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888765421 34666777778888888888888531
Q ss_pred ---------------CCCeEEecCCCCCEEEcC--CCceEEeccCCccc
Q 021249 213 ---------------KQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKM 244 (315)
Q Consensus 213 ---------------~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~ 244 (315)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999988863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-12 Score=118.71 Aligned_cols=207 Identities=22% Similarity=0.201 Sum_probs=149.8
Q ss_pred CCCcCHHH-HHHHhCCCCcccccccCCceEEEEEEEC-CCCeEEEEEEecCCCcccHHH--HHHHHHHhccC-CCCCeee
Q 021249 78 AKPFTFDE-LAAATGNFRSDCCLGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSA-DHPNLVK 152 (315)
Q Consensus 78 ~~~~~~~~-~~~~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~i~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~ 152 (315)
.+.+...+ ......+|..+..||.|.|+.|+.+... .++..|++|.....-.....+ -..|+.+...+ .|.+++.
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 33444444 4456678999999999999999987755 567789999876543322222 12344444344 4888899
Q ss_pred EEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-
Q 021249 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG- 231 (315)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~- 231 (315)
++..|......++-.|||+++++...+.- ...+.+...+.+..|++.++.++|+. .++|+|++|.||++.++
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence 88888777788899999999988766522 23467778889999999999999987 99999999999999886
Q ss_pred CceEEeccCCcccCCCCCCceeeeecccccccc--CccccccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC--APDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
+..++.|||+........ ....+.-+++ +|.......+..+.|++|||..+.+.++|.+.
T Consensus 404 ~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred hhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 778999999986321111 1112333444 44444566788999999999999999988643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.4e-10 Score=102.87 Aligned_cols=170 Identities=17% Similarity=0.178 Sum_probs=127.7
Q ss_pred ceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe----eCCeEEEEEEecCC-CChhhh
Q 021249 104 FGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA----EGDQRLLVYEYMPL-GSLDKH 178 (315)
Q Consensus 104 ~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~e~~~~-~~L~~~ 178 (315)
-.+.|++....+|..|++|.++............-++.++++.|+|+|++.++|. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999999999999999995433222222334567899999999999999886 34578999999875 466665
Q ss_pred hhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 179 LHDLR-----------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 179 l~~~~-----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
-.... ..+...++..+|.++.|+..||.++|+. |+..+-|.|.+|+++.+.+++|...|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 32211 1235578899999999999999999998 999999999999999888999988877754333
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCC
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 295 (315)
.. . |-+.. -.+-|.=.||.++..|.||..
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 22 0 11211 234588899999999999943
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-09 Score=93.28 Aligned_cols=139 Identities=14% Similarity=0.082 Sum_probs=95.6
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCccc-H----------HHHHHHHHHhccCCCCC--eeeEEeEEee-----C
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-V----------REFSAEVMTLGSADHPN--LVKLIGYCAE-----G 160 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~-~----------~~~~~E~~~l~~l~hpn--Iv~~~~~~~~-----~ 160 (315)
+-......|+++... |+.|.||......... . ..+.+|...+..|..-+ ...++++.+. .
T Consensus 30 v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333446666554 7789999775433211 1 13667887776663222 2233444432 2
Q ss_pred CeEEEEEEecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-------CC
Q 021249 161 DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-------GY 232 (315)
Q Consensus 161 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-------~~ 232 (315)
...+||+|++++. +|.+++.... ..+.+......++.+++..+.-||.. ||+|+|++|.|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3568999999875 7988886432 23456677788999999999999998 9999999999999975 46
Q ss_pred ceEEeccCCccc
Q 021249 233 HPKLSDFGLAKM 244 (315)
Q Consensus 233 ~~kl~Dfg~~~~ 244 (315)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.5e-10 Score=90.08 Aligned_cols=124 Identities=23% Similarity=0.234 Sum_probs=78.9
Q ss_pred EEEEEEECCCCeEEEEEEecCCCc-------------c-------------cHHHHHHHHHHhccCCCC--CeeeEEeEE
Q 021249 106 KVYKGCLEKIEQVVAIKQLDHRGV-------------Q-------------GVREFSAEVMTLGSADHP--NLVKLIGYC 157 (315)
Q Consensus 106 ~V~~~~~~~~~~~vavK~i~~~~~-------------~-------------~~~~~~~E~~~l~~l~hp--nIv~~~~~~ 157 (315)
.||.|... .|..+|+|+...... . ......+|...|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888775 478999998753210 0 022467899999998765 455566542
Q ss_pred eeCCeEEEEEEecC--CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 158 AEGDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY-LHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 158 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
..+|||||++ |..+.. +... .++......++.+++..+.. +|.. ||+|+||.+.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 3469999998 555543 3331 11123445677788885555 5676 99999999999999987 99
Q ss_pred EEeccCCccc
Q 021249 235 KLSDFGLAKM 244 (315)
Q Consensus 235 kl~Dfg~~~~ 244 (315)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999999864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.8e-09 Score=90.30 Aligned_cols=135 Identities=19% Similarity=0.096 Sum_probs=96.2
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--------------------c--ccHHHHHHHHHHhccCCCC-
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--------------------V--QGVREFSAEVMTLGSADHP- 148 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--------------------~--~~~~~~~~E~~~l~~l~hp- 148 (315)
-+.+...||-|--+.||.|.+. .|.++|||.=+... + ......++|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4567788999999999999887 48899999632110 0 0123467899999998644
Q ss_pred -CeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 149 -NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 149 -nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
.+.+.+++ +...+||||++|-.|...- +.......++..|++-+.-+-.. |++|+|+++-||+
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence 56666654 6778999999987664321 12233344555555555544454 9999999999999
Q ss_pred EcCCCceEEeccCCcc
Q 021249 228 LEEGYHPKLSDFGLAK 243 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~ 243 (315)
++++|.+.++||--+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999997664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.7e-09 Score=91.61 Aligned_cols=197 Identities=16% Similarity=0.207 Sum_probs=128.6
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeE------EeeCC-eEEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY------CAEGD-QRLLV 166 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------~~~~~-~~~lv 166 (315)
...+.||+|+-+.+|-.-.. +..| -|++.........+...|+ .+--.||-+-.-+.+ ..+.+ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchh-heeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34566999999999854221 2234 4777665444333322222 222346543321111 11222 25677
Q ss_pred EEecCCCC-hhhhhh--hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 167 YEYMPLGS-LDKHLH--DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~-L~~~l~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|..+.|.. +..++. ..+.......|..+++.++.++.+.+.||.. |..-+|++++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77776642 222221 1223345578999999999999999999998 99999999999999999999999754433
Q ss_pred cCCCCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhC-CCcccccC
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITG-RKAIDQTK 301 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~pf~~~~ 301 (315)
....+. .....+|...|.+||.-. +..-+...|.|.||+++|+++.| +.||++..
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 221211 122347899999999543 33556789999999999999987 89998754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-09 Score=100.12 Aligned_cols=142 Identities=16% Similarity=0.121 Sum_probs=91.9
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCccc------------------------------HH----------HHH
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG------------------------------VR----------EFS 136 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~------------------------------~~----------~~~ 136 (315)
..|+.++-|.||+|.... |+.||||+.++.-... .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 569999999999999986 9999999987531110 00 133
Q ss_pred HHHHHhccC-----CCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 021249 137 AEVMTLGSA-----DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211 (315)
Q Consensus 137 ~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~ 211 (315)
+|+..+.++ +.|++.-..-+++-.+.-.++|||++|..+.+...-. ...++...+.....++.--.-+-|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHHHHHhc--
Confidence 444444433 2454443333444566778999999999998874221 122333332222222221112223
Q ss_pred CCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 212 ~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|++|+|.+|.||+++.++++.+.|||+......
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999875433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-08 Score=82.44 Aligned_cols=105 Identities=21% Similarity=0.227 Sum_probs=78.5
Q ss_pred HHHHHHHHHhccCCCC--CeeeEEeEEeeC----CeEEEEEEecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 021249 133 REFSAEVMTLGSADHP--NLVKLIGYCAEG----DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205 (315)
Q Consensus 133 ~~~~~E~~~l~~l~hp--nIv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 205 (315)
....+|...+..|..- ...+.+++.+.. ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence 3466777766655322 233444444332 2458999999874 788888752 2256667788999999999
Q ss_pred HHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEeccCCccc
Q 021249 206 QYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLAKM 244 (315)
Q Consensus 206 ~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~Dfg~~~~ 244 (315)
.-||.. ||+|+|++|.|||++.++ .+.++||+-++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999998 999999999999999887 899999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.2e-08 Score=78.51 Aligned_cols=138 Identities=13% Similarity=0.070 Sum_probs=90.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHH---------HHHHHHHhccC---CCCCeeeEEeE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---------FSAEVMTLGSA---DHPNLVKLIGY 156 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~---------~~~E~~~l~~l---~hpnIv~~~~~ 156 (315)
..++|.+.+.+-......|.+... .|..+++|..........+. ..+++..+..+ ....+..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 556788888888777666665443 47889999987654322111 22233333332 22333333332
Q ss_pred E-----eeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q 021249 157 C-----AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG 231 (315)
Q Consensus 157 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~ 231 (315)
. .-....+++|||++|..|.+... +++ .+...+.+++.-||.. |+.|+|.+|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 2 22345679999999988865432 222 2445677789999998 99999999999999965
Q ss_pred CceEEeccCCccc
Q 021249 232 YHPKLSDFGLAKM 244 (315)
Q Consensus 232 ~~~kl~Dfg~~~~ 244 (315)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-07 Score=78.66 Aligned_cols=140 Identities=16% Similarity=0.152 Sum_probs=84.5
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEEeEEeeCCeEEEEEEecCCCC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~~~ 174 (315)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 35899999999983 14467888876533 3355788999888875333 4566777777778889999999863
Q ss_pred -hhhh---------------------hhhcCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhcC-CCCeEEec
Q 021249 175 -LDKH---------------------LHDLRPDTRPLDWNTRMKIAA----------GASR-GLQYLHEQL-KQPVIYRD 220 (315)
Q Consensus 175 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------qi~~-al~~LH~~~-~~~iiH~D 220 (315)
+... ++........++... ..+.. .+.. ...+|.... ...++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 1111 111100111111100 00100 0111 122222221 23578999
Q ss_pred CCCCCEEEcCCCceEEeccCCccc
Q 021249 221 LKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 221 lkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.5e-07 Score=76.89 Aligned_cols=137 Identities=14% Similarity=0.122 Sum_probs=97.8
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCC---C---cccHHHHHHHHHHhccCCCCC--eeeEEeEEe---eC--CeEEE
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHR---G---VQGVREFSAEVMTLGSADHPN--LVKLIGYCA---EG--DQRLL 165 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~---~---~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~---~~--~~~~l 165 (315)
-|+||.+.|++.... |..+-+|.-... + +.....+.+|...|..|..-+ +.+.. ++. .. -..+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 567899999987665 446778876421 1 123567889999888874222 33333 221 11 23579
Q ss_pred EEEecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--eEEeccCCc
Q 021249 166 VYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFGLA 242 (315)
Q Consensus 166 v~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~--~kl~Dfg~~ 242 (315)
|+|-+.| .+|.+++... ...+.+......++.+++.++.-||+. |+.|+|+.+.||+++.++. +.++||--+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997753 5888887542 223567777789999999999999998 9999999999999986666 999999665
Q ss_pred c
Q 021249 243 K 243 (315)
Q Consensus 243 ~ 243 (315)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 4
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.8e-09 Score=97.49 Aligned_cols=186 Identities=18% Similarity=0.097 Sum_probs=131.8
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCCeEEEEEEecC
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~~~ 171 (315)
+....-.++++++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++..++.++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 334445789999999997765543333 5554332 44556889999999999 7777888888889999999998
Q ss_pred CC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 172 LG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 172 ~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++ +....... ....+..-+...+++.-+.+++++|+. .-+|+| ||+..+ +..+..||+.........
T Consensus 318 ~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 318 TGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred CCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-
Confidence 76 22221111 112233333345666677889999976 458888 777665 578999999886543332
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
......+++.|+|||+.....+....|.||+|.-..+|.-|.+|-.
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2334579999999999999999999999999987778877777654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.5e-07 Score=84.19 Aligned_cols=139 Identities=17% Similarity=0.104 Sum_probs=88.6
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCccc-------------------------------HH------HHHHHH
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-------------------------------VR------EFSAEV 139 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~-------------------------------~~------~~~~E~ 139 (315)
+.||..+.|.|++|+.+. |+.||||+-++.-... .+ +|..|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999887 9999999976531110 00 122333
Q ss_pred HHh----ccCCCCC------eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021249 140 MTL----GSADHPN------LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209 (315)
Q Consensus 140 ~~l----~~l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 209 (315)
+.. +.+.|-+ |.++|- .-.....|+||||+|..+.|.-.- ....++...+..-+.+...-+-+.|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 222 2233433 333332 234567899999999988765322 1233555554444444333333334
Q ss_pred hcCCCCeEEecCCCCCEEEcC----CCceEEeccCCcccCC
Q 021249 210 EQLKQPVIYRDLKCSNILLEE----GYHPKLSDFGLAKMGP 246 (315)
Q Consensus 210 ~~~~~~iiH~Dlkp~Nili~~----~~~~kl~Dfg~~~~~~ 246 (315)
|++|+|-+|.||++.. ++.+.+.|||+.....
T Consensus 321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -----CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999983 5689999999987543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=9.6e-07 Score=74.27 Aligned_cols=143 Identities=20% Similarity=0.214 Sum_probs=82.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCC--CeeeEEeEE---eeCCeEEEEEEecC
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP--NLVKLIGYC---AEGDQRLLVYEYMP 171 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~---~~~~~~~lv~e~~~ 171 (315)
+.|+.|..+.||++.... ..+++|..... .....+..|..+++.+... .+.+++... ......+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 568899999999998775 48899997654 3456677888888777432 244555533 33445789999999
Q ss_pred CCChhh----------------hhh---hcCCCCCCCCHHHH--H----H---H------------HHHHHH-HHHHHHh
Q 021249 172 LGSLDK----------------HLH---DLRPDTRPLDWNTR--M----K---I------------AAGASR-GLQYLHE 210 (315)
Q Consensus 172 ~~~L~~----------------~l~---~~~~~~~~l~~~~~--~----~---i------------~~qi~~-al~~LH~ 210 (315)
|..+.. .+. .......+...... . . . ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987776 111 11011111111110 0 0 0 111222 3333432
Q ss_pred c----CCCCeEEecCCCCCEEEc-CCCceEEeccCCcc
Q 021249 211 Q----LKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAK 243 (315)
Q Consensus 211 ~----~~~~iiH~Dlkp~Nili~-~~~~~kl~Dfg~~~ 243 (315)
. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 134699999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-06 Score=74.30 Aligned_cols=141 Identities=19% Similarity=0.169 Sum_probs=83.0
Q ss_pred cccCCc-eEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEecCCCChh
Q 021249 99 LGEGGF-GKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176 (315)
Q Consensus 99 ig~G~~-g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 176 (315)
|..|.. ..||++... +..+.+|...... ...+.+|+.+++.+. +--+.+++++...++..++|||+++|.++.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444544 788988654 3578888876543 334667888877763 334556777777667789999999988776
Q ss_pred hhh-------------------hhcCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhc----
Q 021249 177 KHL-------------------HDLRPDTRPLDWN--TRMKIAA--------------------GASRGLQYLHEQ---- 211 (315)
Q Consensus 177 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~al~~LH~~---- 211 (315)
... +.......++... ....... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 1100001111100 0000000 011112222111
Q ss_pred CCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 212 ~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999987788999988753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1e-06 Score=69.36 Aligned_cols=130 Identities=18% Similarity=0.110 Sum_probs=91.2
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeee-EEeEEeeCCeEEEEEEecCC
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK-LIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~~~~ 172 (315)
...+.|++|.+|.||++.+. |..+|+|+-..++ ....+..|+++|..+.-.++.+ +|.+-. -++.|||++|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 34567999999999999988 5689999876654 3467889999999887666544 444422 3355999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC-CCCEEEcCCCceEEeccCCcccC
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK-CSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlk-p~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
..|.+.-.. ....+ ...++++.--|-.. ||-|+.|. |...++.+++.+.|+||..|++.
T Consensus 97 ~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 97 RPLGKLEIG-------GDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cchhhhhhc-------ccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 888665432 12222 33444554444444 99999886 66666666679999999998743
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-08 Score=93.58 Aligned_cols=101 Identities=20% Similarity=0.352 Sum_probs=76.8
Q ss_pred HHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCcee-------eeeccccccccCcccccc
Q 021249 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-------STRVMGTYGYCAPDYAMT 271 (315)
Q Consensus 199 ~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 271 (315)
.+++.|+.|+|.. .+++|+.|.|++|.++.++..||+.|+++........... ..-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3445899999976 5899999999999999999999999999864433211110 011124557999999999
Q ss_pred CCcCcccchhhHHHHHHHHH-hCCCcccccC
Q 021249 272 GQLTFKSDIYSFGVVLLELI-TGRKAIDQTK 301 (315)
Q Consensus 272 ~~~~~~~DiwslG~il~ell-tg~~pf~~~~ 301 (315)
...++++|+||+|+++|.+. .|+.-|...+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC
Confidence 88899999999999999999 4555555443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=71.38 Aligned_cols=152 Identities=20% Similarity=0.168 Sum_probs=97.5
Q ss_pred cCHHHHHHHhCCCCccc---ccccCCceEEEEEEECCCCeEEEEEEecCCCcc-------------------cHH-----
Q 021249 81 FTFDELAAATGNFRSDC---CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-------------------GVR----- 133 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~~~---~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-------------------~~~----- 133 (315)
.+...+.....+..+.. .|++|-.+.||+|.. ..+..+|+|++...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 44455555555555544 466778889999866 34789999998643211 001
Q ss_pred HHHHHHHHhccCC--CCCeeeEEeEEeeCCeEEEEEEecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 021249 134 EFSAEVMTLGSAD--HPNLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210 (315)
Q Consensus 134 ~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 210 (315)
-..+|...|+++. +-.+.+.+.+. ...|||||+... .-.-.|++ .++....+..+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 1345666666653 23334444442 346999998543 22222322 233444677778888888877765
Q ss_pred cCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 211 ~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
. .+++|+||+.-|||+. ++.+.++|||-+...
T Consensus 185 ~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 185 E--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred h--cCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 2 2999999999999999 779999999988643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.39 E-value=7e-06 Score=81.87 Aligned_cols=150 Identities=15% Similarity=0.221 Sum_probs=91.5
Q ss_pred ccccccCCceEEEEEEECCCC--eEEEEEEecCCC-cccHHHHHHHHHHhccCC-CCCe--eeEEeEEeeC---CeEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIE--QVVAIKQLDHRG-VQGVREFSAEVMTLGSAD-HPNL--VKLIGYCAEG---DQRLLV 166 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~--~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~~~lv 166 (315)
+..++.|.+..+|+......+ ..+++|+..... ......+.+|..+++.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 456889999999998765432 467778765432 223456889999999885 6654 7777777664 467899
Q ss_pred EEecCCCChhh--------------------hh---hhcCCC-------CCCCC--HHHHHHHH---------------H
Q 021249 167 YEYMPLGSLDK--------------------HL---HDLRPD-------TRPLD--WNTRMKIA---------------A 199 (315)
Q Consensus 167 ~e~~~~~~L~~--------------------~l---~~~~~~-------~~~l~--~~~~~~i~---------------~ 199 (315)
|||++|..+.+ .+ +..... ..+.. ...+..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 11 111000 01111 11121111 1
Q ss_pred HHHHHHHHHHhcCC--------CCeEEecCCCCCEEEcCC-Cc-eEEeccCCcccC
Q 021249 200 GASRGLQYLHEQLK--------QPVIYRDLKCSNILLEEG-YH-PKLSDFGLAKMG 245 (315)
Q Consensus 200 qi~~al~~LH~~~~--------~~iiH~Dlkp~Nili~~~-~~-~kl~Dfg~~~~~ 245 (315)
.+...+.+|..... ..++|+|++|.|++++.+ +. +-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566743221 259999999999999853 33 578999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.3e-05 Score=65.54 Aligned_cols=131 Identities=18% Similarity=0.221 Sum_probs=90.5
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCC----------------cccHHHHHHHHHHhccCC------CCCeeeEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----------------VQGVREFSAEVMTLGSAD------HPNLVKLI 154 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~~~ 154 (315)
..||+|+.-.||. |.. ....+||+..... .....+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4599999999996 443 4557889987655 122455666766555544 78999999
Q ss_pred eEEeeCCeEEEEEEecCC------CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 155 GYCAEGDQRLLVYEYMPL------GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
|+.+.+....+|+|.+.. .+|.++++. ..++. .. ...+-+-..||-+. +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999999999998642 367777754 33554 33 33334445566665 89999999999999
Q ss_pred cCC---C-ceEEec-cCCc
Q 021249 229 EEG---Y-HPKLSD-FGLA 242 (315)
Q Consensus 229 ~~~---~-~~kl~D-fg~~ 242 (315)
... . .+.|+| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 532 2 577777 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.32 E-value=7e-06 Score=69.48 Aligned_cols=73 Identities=12% Similarity=0.115 Sum_probs=44.4
Q ss_pred cccccCCce-EEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCC---CeeeEEeEEeeC---CeEEEEEEe
Q 021249 97 CCLGEGGFG-KVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP---NLVKLIGYCAEG---DQRLLVYEY 169 (315)
Q Consensus 97 ~~ig~G~~g-~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~---~~~~lv~e~ 169 (315)
+.|+.|+.. .||+. +..+++|..+... ....+..|..+++.+... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 346766665 58875 2357778755422 245688899888776421 233344433221 245889999
Q ss_pred cCCCChh
Q 021249 170 MPLGSLD 176 (315)
Q Consensus 170 ~~~~~L~ 176 (315)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=7.5e-06 Score=66.61 Aligned_cols=104 Identities=23% Similarity=0.215 Sum_probs=79.6
Q ss_pred HHHHHHhccCCC-CCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 021249 136 SAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214 (315)
Q Consensus 136 ~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ 214 (315)
..|..+++.+.+ +++.+++|+|-. +++.||...+++...-.. ......-+|..+.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357778888875 699999999833 568899876655321000 00123468999999999999999999986555
Q ss_pred CeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 215 ~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
.+.-.|++|+|+-+++++++|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 678889999999999999999999987753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.6e-05 Score=68.24 Aligned_cols=139 Identities=15% Similarity=0.036 Sum_probs=77.9
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCee-eEEeEEeeCCeEEEEEEecCCCChhh
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLGSLDK 177 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~~~L~~ 177 (315)
+..|-...+|+... .+..+++|..........-....|..+++.+....++ +++... . -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 55677888998763 3668888876543222112346788888887543332 333332 2 368999999876532
Q ss_pred h-----------------hhhcCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEEecCCCCC
Q 021249 178 H-----------------LHDLRPDTRPLDWNT-RMKIAAGA---------SRGLQYLHEQ-----LKQPVIYRDLKCSN 225 (315)
Q Consensus 178 ~-----------------l~~~~~~~~~l~~~~-~~~i~~qi---------~~al~~LH~~-----~~~~iiH~Dlkp~N 225 (315)
. ++.......+++... +..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111112222221 11211111 1112222111 02358999999999
Q ss_pred EEEcCCCceEEeccCCccc
Q 021249 226 ILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~ 244 (315)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.7e-05 Score=61.99 Aligned_cols=137 Identities=27% Similarity=0.377 Sum_probs=93.0
Q ss_pred CCCCCCCcCHHHHHHHhCCCCcccccccCCc-eEEEEEEECCCCeEEEEEEecC---CCc------------------cc
Q 021249 74 SGKSAKPFTFDELAAATGNFRSDCCLGEGGF-GKVYKGCLEKIEQVVAIKQLDH---RGV------------------QG 131 (315)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~y~~~~~ig~G~~-g~V~~~~~~~~~~~vavK~i~~---~~~------------------~~ 131 (315)
++....+|+. -..+++.++.||.|.- |.||++... |..||+|++.. ... ..
T Consensus 25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y 97 (207)
T PF13095_consen 25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY 97 (207)
T ss_pred CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhh
Confidence 3344455554 2267889999999999 999999887 77999999321 110 11
Q ss_pred HHHHHHHHHHhccC---CCCCe--eeEEeEEeeC------------------CeEEEEEEecCCCChhhhhhhcCCCCCC
Q 021249 132 VREFSAEVMTLGSA---DHPNL--VKLIGYCAEG------------------DQRLLVYEYMPLGSLDKHLHDLRPDTRP 188 (315)
Q Consensus 132 ~~~~~~E~~~l~~l---~hpnI--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 188 (315)
...|..|.+...+| .+.++ |+.+++..-. ....||.||++... .
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~ 164 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------P 164 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------c
Confidence 23477788776665 45566 8888887322 12357777765322 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 189 l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
++.. -+.+|.+-|..+|.. +|+-+|+++.|.. .-+|+|||.+
T Consensus 165 ~~~~----~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIR----DIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cchh----HHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 2333 345666777889988 9999999999986 3589999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=65.01 Aligned_cols=74 Identities=18% Similarity=0.171 Sum_probs=46.0
Q ss_pred cccccCCceEEEEEEECC-CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEEEecCCCC
Q 021249 97 CCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~ 174 (315)
+.|..|-...+|++.... .+..|++|+....... ......|+.+++.+...++ .+++..+. -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999986543 2567889977643221 1233468888877753333 33444332 247999999876
Q ss_pred h
Q 021249 175 L 175 (315)
Q Consensus 175 L 175 (315)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00014 Score=65.96 Aligned_cols=75 Identities=16% Similarity=0.118 Sum_probs=51.8
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCC------C-cccHHHHHHHHHHhccCC---CCCeeeEEeEEeeCCeEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR------G-VQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv 166 (315)
+.||.|.+..||++.....++.++||.-.+. . .-..++...|.+.|+.+. ...+.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4589999999999988654468999985421 1 123456677888877753 2356667666 34567899
Q ss_pred EEecCCC
Q 021249 167 YEYMPLG 173 (315)
Q Consensus 167 ~e~~~~~ 173 (315)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00011 Score=65.13 Aligned_cols=143 Identities=16% Similarity=0.123 Sum_probs=75.1
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-----CCCCeeeEE---eEEeeCCeEEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKLI---GYCAEGDQRLLVYE 168 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~---~~~~~~~~~~lv~e 168 (315)
+.|+.|....+|+.... +..+++|++.... ...+..|+.++..| ..|.++.-. .+....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT--QGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeC--CCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45667777889987654 3368899876222 23333444444443 234333211 01233567889999
Q ss_pred ecCCCChh-----------hhh---hhcCCC-------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 021249 169 YMPLGSLD-----------KHL---HDLRPD-------TRPLDW-NTRMK------------IAAG-ASRGLQYLHEQ-- 211 (315)
Q Consensus 169 ~~~~~~L~-----------~~l---~~~~~~-------~~~l~~-~~~~~------------i~~q-i~~al~~LH~~-- 211 (315)
|++|..+. ..+ +..... ...+.+ ..... .+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99987532 111 111000 001111 11100 1111 11122333210
Q ss_pred --CCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 212 --LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 212 --~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245899999999999999765568999998853
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00013 Score=64.06 Aligned_cols=76 Identities=11% Similarity=0.029 Sum_probs=53.0
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC---CCeeeEEeEEee---CCeEEEEEEe
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---PNLVKLIGYCAE---GDQRLLVYEY 169 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~---~~~~~lv~e~ 169 (315)
.+.||.|..+.||...... + .+.+|..+.. .....+..|...|+.+.- -.+.++++++.. .+..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4569999999999975442 3 4666774331 123567889888887742 356777777654 3668999999
Q ss_pred cCCCCh
Q 021249 170 MPLGSL 175 (315)
Q Consensus 170 ~~~~~L 175 (315)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.6e-05 Score=65.38 Aligned_cols=144 Identities=17% Similarity=0.137 Sum_probs=82.4
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEEeE------EeeCCeEEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGY------CAEGDQRLLVY 167 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~------~~~~~~~~lv~ 167 (315)
.+.|..|....+|+.... +..+++|+.... ....+..|+.++..+.+.+ +.+++.. ....+..++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 445777877899987653 447889987652 2345566777766663222 3444331 23345678999
Q ss_pred EecCCCChhh-----------h---hhhcCCC-C------CCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 021249 168 EYMPLGSLDK-----------H---LHDLRPD-T------RPLDWNTRM----------KIAAGASRGLQYLHE----QL 212 (315)
Q Consensus 168 e~~~~~~L~~-----------~---l~~~~~~-~------~~l~~~~~~----------~i~~qi~~al~~LH~----~~ 212 (315)
+|++|..+.. . ++..... . ....+.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 1110000 0 001111100 011112334444442 11
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 213 ~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..+++|+|+.|.||++++++.+.|+||..+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 34799999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00055 Score=60.35 Aligned_cols=145 Identities=17% Similarity=0.155 Sum_probs=79.7
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEEeE------EeeCCeEEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGY------CAEGDQRLLVY 167 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~------~~~~~~~~lv~ 167 (315)
+..++.|....+|++... +..+++|...... ....+..|..++..|...+ +.+++.. ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 345777777889987643 3367889875432 1234455666665553211 3333331 12345678999
Q ss_pred EecCCCChhh-----------h---hhhcCCCC-CC------C-CHHHHH------------HHHHHHHHHHHHHHh---
Q 021249 168 EYMPLGSLDK-----------H---LHDLRPDT-RP------L-DWNTRM------------KIAAGASRGLQYLHE--- 210 (315)
Q Consensus 168 e~~~~~~L~~-----------~---l~~~~~~~-~~------l-~~~~~~------------~i~~qi~~al~~LH~--- 210 (315)
+|++|..+.. . ++...... .+ + .|.... .....+...+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999855321 1 11100000 00 0 000000 011123334555532
Q ss_pred -cCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 211 -QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 211 -~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
....+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1235899999999999999887678999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=4.6e-05 Score=66.00 Aligned_cols=135 Identities=14% Similarity=0.028 Sum_probs=90.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--------------------Cccc--HHHHHHHHHHhccCCC-C
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--------------------GVQG--VREFSAEVMTLGSADH-P 148 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--------------------~~~~--~~~~~~E~~~l~~l~h-p 148 (315)
-+.+.+.||-|--+.+|.+.+.. |.+.++|.=+.. ++-. .-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 47788999999999999998764 778888853210 0000 1134567777777742 1
Q ss_pred C-eeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 149 N-LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 149 n-Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
. +.+.++ -+..++|||++.|-.|...-+- ..+..+...+..-+.-|-.. |+||+|++-=||+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIM 234 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHc---CceecccchheeE
Confidence 1 233333 3577899999998877543211 11223444555555556555 9999999999999
Q ss_pred EcCCCceEEeccCCccc
Q 021249 228 LEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~ 244 (315)
+++++.++++||.-+..
T Consensus 235 v~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVS 251 (465)
T ss_pred EecCCCEEEeechHhhc
Confidence 99999999999986643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=8.5e-06 Score=82.65 Aligned_cols=162 Identities=15% Similarity=0.020 Sum_probs=115.2
Q ss_pred HHHHHHHhccCCCCCeeeEEeEEee--CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 021249 135 FSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212 (315)
Q Consensus 135 ~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 212 (315)
...|...++...|+++...+.-... +...|..++|+.+|.+++.+-.-.....++...-+.....+.+.+..-+|++.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444455556789998887776543 34568899999999999988654333344444333333333355555656542
Q ss_pred --CCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHH
Q 021249 213 --KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290 (315)
Q Consensus 213 --~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 290 (315)
++-.+|+++++.|.+|..+-+++++++|+.+..... ........+++.|+.|+....-.++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 223689999999999999999999999999842221 2222345678889999987777888889999999999999
Q ss_pred HhCCCccc
Q 021249 291 ITGRKAID 298 (315)
Q Consensus 291 ltg~~pf~ 298 (315)
..|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 98888874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00093 Score=58.73 Aligned_cols=142 Identities=22% Similarity=0.246 Sum_probs=80.6
Q ss_pred ccccCCceEEEEEEECC------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEEEec
Q 021249 98 CLGEGGFGKVYKGCLEK------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~ 170 (315)
.+..|-...+|++.... .++.+++|+..... ........|..+++.+...++ .+++.++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45566667889886543 25789999976543 223345677777777643333 344544432 3689999
Q ss_pred CCCChhhh-----------------hhhcCCCC-----CCCC--HHHHHH--------------------------HHHH
Q 021249 171 PLGSLDKH-----------------LHDLRPDT-----RPLD--WNTRMK--------------------------IAAG 200 (315)
Q Consensus 171 ~~~~L~~~-----------------l~~~~~~~-----~~l~--~~~~~~--------------------------i~~q 200 (315)
+|.++... ++...... ...+ +..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766431 11111110 0111 101100 1122
Q ss_pred HHHHHHHHHh------cCCCCeEEecCCCCCEEEcCC----CceEEeccCCccc
Q 021249 201 ASRGLQYLHE------QLKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAKM 244 (315)
Q Consensus 201 i~~al~~LH~------~~~~~iiH~Dlkp~Nili~~~----~~~kl~Dfg~~~~ 244 (315)
+...+.+|-. ..+..++|+|+.|.||+++++ +.+.++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 123478999999999999974 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0014 Score=58.73 Aligned_cols=142 Identities=17% Similarity=0.184 Sum_probs=79.6
Q ss_pred ccccCCceEEEEEEECC----CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCee-eEEeEEeeCCeEEEEEEecCC
Q 021249 98 CLGEGGFGKVYKGCLEK----IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~----~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~ 172 (315)
.|..|-.-.+|++.... .++.|++|+........+. -..|..+++.+..-++. ++++.+..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 35457777899886532 2467899988664332222 25688887777543333 445555332 57999987
Q ss_pred CChhhh-----------------hhhcCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-c
Q 021249 173 GSLDKH-----------------LHDLRPDTR--PLDWNTRMKIAAGA-----------------SRGLQYL----HE-Q 211 (315)
Q Consensus 173 ~~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~L----H~-~ 211 (315)
.++... ++....... +..+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 766421 111110111 11222232332211 1112222 11 1
Q ss_pred CCCCeEEecCCCCCEEEcC-CCceEEeccCCccc
Q 021249 212 LKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKM 244 (315)
Q Consensus 212 ~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~ 244 (315)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999986 46799999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00049 Score=68.64 Aligned_cols=154 Identities=21% Similarity=0.187 Sum_probs=109.6
Q ss_pred HHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE----EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 021249 133 REFSAEVMTLGSADHPNLVKLIGYCAEGDQRL----LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208 (315)
Q Consensus 133 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L 208 (315)
.....|+..+.+..|+|++.++.+.......- +..+++..-++...+.. -..++....+.+..++..++.|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHH
Confidence 34556777788889999999999876543322 33467777777776665 45688899999999999999999
Q ss_pred HhcCCCCeEEecCCCC---CEEEcCCCceEEe--ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcc--cchh
Q 021249 209 HEQLKQPVIYRDLKCS---NILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK--SDIY 281 (315)
Q Consensus 209 H~~~~~~iiH~Dlkp~---Nili~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Diw 281 (315)
|+. ...|.-+... +...+..+.+..+ ||+.+......... ....-+..+.+||......++.+ .|+|
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence 987 6666655544 4444556666666 88887654433221 11234556888887777666544 7999
Q ss_pred hHHHHHHHHHhCCCc
Q 021249 282 SFGVVLLELITGRKA 296 (315)
Q Consensus 282 slG~il~elltg~~p 296 (315)
.+|..+..+..|..+
T Consensus 377 ~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHHHhhhhhcCcc
Confidence 999999999987654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0025 Score=55.98 Aligned_cols=138 Identities=16% Similarity=0.178 Sum_probs=80.0
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecC--CCcccHHHHHHHHHHhccCCC--CCeeeEEeEEeeCC--eEEEEEEec
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADH--PNLVKLIGYCAEGD--QRLLVYEYM 170 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~e~~ 170 (315)
+.+..|-.-.+|..... ++++++. .+. ..........+|..+++.+.- .-+...++.+.++. ..|.||+|+
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 33433333344444343 7788888 432 223345556677888777632 12334456665554 679999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHH-HHHHHHHHHHHhcC-------------------------------------
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIA-AGASRGLQYLHEQL------------------------------------- 212 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~~------------------------------------- 212 (315)
+|..+.+.+.. .+.. .+++ ..++..|.-||+..
T Consensus 108 eGe~~~~~~~~-------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPP-------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCc-------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 98543222111 0000 1111 13344444444322
Q ss_pred ------------------CCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 213 ------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 213 ------------------~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
+..++|+|+.+.|++++.++.+-+.||+.+....
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 1358999999999999999889999999997543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=57.42 Aligned_cols=139 Identities=16% Similarity=0.152 Sum_probs=92.9
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------------------------ccH--HHHHHHHHHhccCCC
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------------------------QGV--REFSAEVMTLGSADH 147 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------------------------~~~--~~~~~E~~~l~~l~h 147 (315)
.+..+|..|--+.||.|... +|..+|||+++.+-. ... .-...|++-|++++.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34567888999999998655 478899998753210 000 113567777777755
Q ss_pred CCeeeEEeEEeeCCeEEEEEEecCCCC-hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 021249 148 PNLVKLIGYCAEGDQRLLVYEYMPLGS-LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226 (315)
Q Consensus 148 pnIv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Ni 226 (315)
..|.-.--... ....|||+|+.... ..-.|+ ...++...+..+-.|++.-|.-|-..| +++|.||.--|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 44322111111 23569999984211 111222 355777788888888888888887764 899999999999
Q ss_pred EEcCCCceEEeccCCcc
Q 021249 227 LLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 227 li~~~~~~kl~Dfg~~~ 243 (315)
|+.+ |.+.++|.+-+.
T Consensus 297 Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eEEC-CEEEEEEccccc
Confidence 9875 589999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0022 Score=55.59 Aligned_cols=30 Identities=30% Similarity=0.402 Sum_probs=25.5
Q ss_pred CeEEecCCCCCEEEcCCCc-eEEeccCCccc
Q 021249 215 PVIYRDLKCSNILLEEGYH-PKLSDFGLAKM 244 (315)
Q Consensus 215 ~iiH~Dlkp~Nili~~~~~-~kl~Dfg~~~~ 244 (315)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 56999999865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0038 Score=54.33 Aligned_cols=73 Identities=18% Similarity=0.222 Sum_probs=45.4
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC---CCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
.+.++.|....+|+.. .++..+.||+-... ....+..|..-|+.|. .-.+.+.+++....+..+|++||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4568889999999876 55778999987622 2345677887777763 34577788888777777999999986
Q ss_pred C
Q 021249 173 G 173 (315)
Q Consensus 173 ~ 173 (315)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.006 Score=54.43 Aligned_cols=73 Identities=14% Similarity=0.197 Sum_probs=47.1
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecC------CC-cccHHHHHHHHHHhccCC--CCC-eeeEEeEEeeCCeEEEEE
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDH------RG-VQGVREFSAEVMTLGSAD--HPN-LVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~------~~-~~~~~~~~~E~~~l~~l~--hpn-Iv~~~~~~~~~~~~~lv~ 167 (315)
.||.|....||++.....++.++||.-.. .+ .-...+..-|...|+... .|. +.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999764446899997431 11 223455566777776653 353 4445443 445667999
Q ss_pred EecCC
Q 021249 168 EYMPL 172 (315)
Q Consensus 168 e~~~~ 172 (315)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.005 Score=54.34 Aligned_cols=32 Identities=19% Similarity=0.241 Sum_probs=28.7
Q ss_pred CCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 213 ~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+.+++|+|+.+.|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999998999999988864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0063 Score=54.26 Aligned_cols=142 Identities=18% Similarity=0.230 Sum_probs=76.9
Q ss_pred ccccCCceEEEEEEECCC---CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCee-eEEeEEeeCCeEEEEEEecCCC
Q 021249 98 CLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLG 173 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e~~~~~ 173 (315)
.|..|-.-.+|++..... +..|++|+....... .-.-..|..+++.+..-++. ++++++. ++ +|.+|++|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 344466678888765432 337889987654322 22235677787777544443 4555553 22 588999876
Q ss_pred Chhh--------------hh---hhcCCC-C-CCCCHHHHHHHHHHH----------------------HHHHHHHHhc-
Q 021249 174 SLDK--------------HL---HDLRPD-T-RPLDWNTRMKIAAGA----------------------SRGLQYLHEQ- 211 (315)
Q Consensus 174 ~L~~--------------~l---~~~~~~-~-~~l~~~~~~~i~~qi----------------------~~al~~LH~~- 211 (315)
+|.. .+ +..... . .+-.+..+..+..++ ..-+..+...
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6521 11 111100 0 111222222222221 1112222211
Q ss_pred ----CCCCeEEecCCCCCEEEcC-CCceEEeccCCccc
Q 021249 212 ----LKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKM 244 (315)
Q Consensus 212 ----~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~ 244 (315)
...-++|.|+.|.||++++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 0113799999999999974 57899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.013 Score=53.24 Aligned_cols=73 Identities=16% Similarity=0.114 Sum_probs=48.5
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCC----Cc---ccHHHHHHHHHHhccCC---CCCeeeEEeEEeeCCeEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR----GV---QGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~----~~---~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~l 165 (315)
.+.||.|....||+..+. +..++||.-... +. ....+-..|...|+.+. ...+.+++.++.+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 456899999999998764 456889986521 11 12344445566666553 2467778887764 4678
Q ss_pred EEEecCC
Q 021249 166 VYEYMPL 172 (315)
Q Consensus 166 v~e~~~~ 172 (315)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0076 Score=53.11 Aligned_cols=30 Identities=23% Similarity=0.351 Sum_probs=26.1
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 214 ~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 48999999999999987 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.022 Score=50.57 Aligned_cols=140 Identities=23% Similarity=0.315 Sum_probs=79.7
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC---CC---eeeEEe----EEeeCCeEEEEEE
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---PN---LVKLIG----YCAEGDQRLLVYE 168 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pn---Iv~~~~----~~~~~~~~~lv~e 168 (315)
|.+ .-..+|+..... |. +++|+.... ....++..|+..+..|.- |= +..+-+ ........+-+++
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456788876653 44 489988776 334566677777776631 11 111111 1122237888999
Q ss_pred ecCCCChhh-h--------------hh----hcC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 021249 169 YMPLGSLDK-H--------------LH----DLR----PDTRPLDWNT-------------RMKIAAGASRGLQYLHEQL 212 (315)
Q Consensus 169 ~~~~~~L~~-~--------------l~----~~~----~~~~~l~~~~-------------~~~i~~qi~~al~~LH~~~ 212 (315)
|++|..+.. . |+ ... +......|.. ......++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887762 1 11 110 0011122220 0112334444444444322
Q ss_pred ----CCC---eEEecCCCCCEEEcCCCc-eEEeccCCcc
Q 021249 213 ----KQP---VIYRDLKCSNILLEEGYH-PKLSDFGLAK 243 (315)
Q Consensus 213 ----~~~---iiH~Dlkp~Nili~~~~~-~kl~Dfg~~~ 243 (315)
... +||+|+.|.||+++.+.. +.++||+.+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 999999999999998875 8999999885
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0055 Score=55.34 Aligned_cols=75 Identities=17% Similarity=0.166 Sum_probs=48.9
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecC-----CC-cccHHHHHHHHHHhccCC--CCC-eeeEEeEEeeCCeEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RG-VQGVREFSAEVMTLGSAD--HPN-LVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~-----~~-~~~~~~~~~E~~~l~~l~--hpn-Iv~~~~~~~~~~~~~lv 166 (315)
.+.||.|.-..||++.+...+..|+||.-.. .+ .-..++..-|...|+... .|. +.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3468999999999998854356799997421 11 223566667777777653 454 4445543 44566788
Q ss_pred EEecCC
Q 021249 167 YEYMPL 172 (315)
Q Consensus 167 ~e~~~~ 172 (315)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998853
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0034 Score=55.56 Aligned_cols=87 Identities=18% Similarity=0.149 Sum_probs=61.1
Q ss_pred CCCeeeEEeEE-eeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 147 HPNLVKLIGYC-AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 147 hpnIv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
.++..+.+-+- .++.+.|++|++- |+++. .+ ....+.++..|+.+.+..+.-+... -..-|||+...|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~n 352 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-II-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDN 352 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceee-ee-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccc
Confidence 34444444333 2334567777763 55552 22 2245678888998888877777764 478999999999
Q ss_pred EEEcCCCceEEeccCCcccC
Q 021249 226 ILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~ 245 (315)
|||+ +|++.|+||.+++..
T Consensus 353 iLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 353 ILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eeee-cCceEEEEeeeeecc
Confidence 9999 899999999999853
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0045 Score=51.37 Aligned_cols=29 Identities=34% Similarity=0.359 Sum_probs=20.7
Q ss_pred CeEEecCCCCCEEE-cCCCceEEeccCCcc
Q 021249 215 PVIYRDLKCSNILL-EEGYHPKLSDFGLAK 243 (315)
Q Consensus 215 ~iiH~Dlkp~Nili-~~~~~~kl~Dfg~~~ 243 (315)
-++|.|+.|.||++ +.++.++++||-.|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 57899999999999 788999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.27 Score=43.72 Aligned_cols=72 Identities=13% Similarity=-0.031 Sum_probs=41.4
Q ss_pred CCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEE---e--EEeeCCeEEEEEEecCCCC
Q 021249 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLI---G--YCAEGDQRLLVYEYMPLGS 174 (315)
Q Consensus 102 G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~---~--~~~~~~~~~lv~e~~~~~~ 174 (315)
+....||+.... ++..+++|+.+... .....+..|...+..|.... ++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345678887653 36678999876432 23455666777666552111 12111 1 1233567888999998764
Q ss_pred h
Q 021249 175 L 175 (315)
Q Consensus 175 L 175 (315)
.
T Consensus 114 ~ 114 (325)
T PRK11768 114 P 114 (325)
T ss_pred C
Confidence 3
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.015 Score=52.40 Aligned_cols=60 Identities=18% Similarity=0.080 Sum_probs=41.3
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~ 229 (315)
..++-+|..|.++..+++. ...++.....++.-.++|+--+--. .+++|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 3566678889999888865 3345555556665555554433322 2899999999999994
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.084 Score=54.21 Aligned_cols=32 Identities=34% Similarity=0.327 Sum_probs=26.8
Q ss_pred CCCeEEecCCCCCEEEcCCC--ceE-EeccCCccc
Q 021249 213 KQPVIYRDLKCSNILLEEGY--HPK-LSDFGLAKM 244 (315)
Q Consensus 213 ~~~iiH~Dlkp~Nili~~~~--~~k-l~Dfg~~~~ 244 (315)
+.++||+|+++.|||++.++ .+. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 45899999999999999775 554 999998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.053 Score=44.94 Aligned_cols=117 Identities=12% Similarity=0.029 Sum_probs=72.3
Q ss_pred CCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhh
Q 021249 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180 (315)
Q Consensus 102 G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 180 (315)
++.++.-.+.-+- | +..+|++...... ...-+..+..++.++. .|+++..= +.-.+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 3444444443322 3 4556666554333 3344677788887763 67777632 33356689999842111
Q ss_pred hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 181 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
... .+...=+.+|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|=+..
T Consensus 142 --------~~~----N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 --------NFS----NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred --------chh----HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 1122224567778854 458999999999999999999999997653
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.15 Score=46.42 Aligned_cols=75 Identities=16% Similarity=0.158 Sum_probs=43.6
Q ss_pred cccccCCceEEEEEEECCCC-e-----EEEEEEecCCCcccHHHHHHHHHHhccCCCCCeee-EEeEEeeCCeEEEEEEe
Q 021249 97 CCLGEGGFGKVYKGCLEKIE-Q-----VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK-LIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~-~-----~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~~~~~lv~e~ 169 (315)
+.|..|-...+|++...... . .|.++..... ....-+-.+|+.+++.+...++.+ +++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 34555777889988654321 1 2444443222 121222356888888886555444 5555532 589999
Q ss_pred cCCCChh
Q 021249 170 MPLGSLD 176 (315)
Q Consensus 170 ~~~~~L~ 176 (315)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.015 Score=50.87 Aligned_cols=55 Identities=20% Similarity=0.103 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEEEcC------------------CCceEEeccCCcccC
Q 021249 191 WNTRMKIAAGASRGLQYLHEQL-KQPVIYRDLKCSNILLEE------------------GYHPKLSDFGLAKMG 245 (315)
Q Consensus 191 ~~~~~~i~~qi~~al~~LH~~~-~~~iiH~Dlkp~Nili~~------------------~~~~kl~Dfg~~~~~ 245 (315)
.+.++.++.||+-..-.+-..+ -.+.+|-||||+|||+-+ .-.++|.||.+++..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 3456778888886654443332 347999999999999932 224677888888653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.017 Score=50.83 Aligned_cols=56 Identities=21% Similarity=0.096 Sum_probs=37.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcC-CCCeEEecCCCCCEEEc------------------CCCceEEeccCCcccC
Q 021249 190 DWNTRMKIAAGASRGLQYLHEQL-KQPVIYRDLKCSNILLE------------------EGYHPKLSDFGLAKMG 245 (315)
Q Consensus 190 ~~~~~~~i~~qi~~al~~LH~~~-~~~iiH~Dlkp~Nili~------------------~~~~~kl~Dfg~~~~~ 245 (315)
-.+.++.++.||+-..--+-+.+ -.+.+|-||||+|||+- +.-.++|.||.+++..
T Consensus 273 ~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 273 NVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 34556677888775442232221 24799999999999993 2334688899888754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 315 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-47 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-41 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-21 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 424 bits (1092), Expect = e-151
Identities = 102/248 (41%), Positives = 143/248 (57%), Gaps = 19/248 (7%)
Query: 74 SGKSAKPFTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL--- 124
S F+F EL T NF +GEGGFG VYKG + VA+K+L
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAM 65
Query: 125 -DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
D + ++F E+ + H NLV+L+G+ ++GD LVY YMP GSL L
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-L 124
Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
T PL W+ R KIA GA+ G+ +LHE I+RD+K +NILL+E + K+SDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+T +++R++GT Y AP+ + G++T KSDIYSFGVVLLE+ITG A+D+ R
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238
Query: 304 KELNLVAW 311
+ L+
Sbjct: 239 EPQLLLDI 246
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-150
Identities = 105/241 (43%), Positives = 147/241 (60%), Gaps = 4/241 (1%)
Query: 71 SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
S + +L AT NF +G G FGKVYKG L VA+K+ Q
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQ 77
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
G+ EF E+ TL HP+LV LIG+C E ++ +L+Y+YM G+L +HL+ T +
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
W R++I GA+RGL YLH + +I+RD+K NILL+E + PK++DFG++K G D+
Sbjct: 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
TH+ST V GT GY P+Y + G+LT KSD+YSFGVVL E++ R AI Q+ R+ +NL
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 311 W 311
W
Sbjct: 255 W 255
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-144
Identities = 104/250 (41%), Positives = 149/250 (59%), Gaps = 5/250 (2%)
Query: 65 LNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
+ ++D K F+ EL A+ NF + LG GGFGKVYKG L +VA+K+L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRL 62
Query: 125 DHRGVQGV-REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
QG +F EV + A H NL++L G+C +RLLVY YM GS+ L +
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
PLDW R +IA G++RGL YLH+ +I+RD+K +NILL+E + + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
+ D THV+T V GT G+ AP+Y TG+ + K+D++ +GV+LLELITG++A D +
Sbjct: 183 LMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 304 KE--LNLVAW 311
+ + L+ W
Sbjct: 242 NDDDVMLLDW 251
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 9e-80
Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 27/264 (10%)
Query: 65 LNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
+ ++SG + L + + G FG V+K L + VA+K
Sbjct: 1 MGHHHHHHSSGV---DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF 55
Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLLVYEYMPLGSLDKHLH 180
+ Q + EV +L H N+++ IG G L+ + GSL L
Sbjct: 56 PIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-------KQPVIYRDLKCSNILLEEGYH 233
+ WN IA +RGL YLHE + K + +RD+K N+LL+
Sbjct: 115 A-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLL 288
++DFGLA +G + +GT Y AP+ + D+Y+ G+VL
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 289 ELITGRKAIDQTKDRKELNLVAWL 312
EL + A D D L +
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEI 253
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-62
Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 8/198 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
+G G FG V++ VA+K L + V EF EV + HPN+V +G
Sbjct: 45 IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ +V EY+ GSL + LH LD R+ +A ++G+ YLH + P+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++R+LK N+L+++ Y K+ DFGL+++ S + S GT + AP+
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 277 KSDIYSFGVVLLELITGR 294
KSD+YSFGV+L EL T +
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-62
Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 27/212 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-------VREFSAEVMTLGSADHPNLV 151
+G+GGFG V+KG L K + VVAIK L +G +EF EV + + +HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
KL G +V E++P G L L D P+ W+ ++++ + G++Y+
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 212 LKQPVIYRDLKCSNILLEEG-----YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
P+++RDL+ NI L+ K++DFGL++ H + ++G + + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAP 195
Query: 267 DYAMTGQL---TFKSDIYSFGVVLLELITGRK 295
+ + + T K+D YSF ++L ++TG
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 67/198 (33%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G FG V K + VAIKQ++ + + F E+ L +HPN+VKL G C
Sbjct: 16 VGRGAFGVVCKAKWRA--KDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ LV EY GSL LH P M S+G+ YLH + +I+
Sbjct: 72 --NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 219 RDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
RDLK N+LL G K+ DFG A D T G+ + AP+ + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 278 SDIYSFGVVLLELITGRK 295
D++S+G++L E+IT RK
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-61
Identities = 61/252 (24%), Positives = 102/252 (40%), Gaps = 32/252 (12%)
Query: 81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM 140
E + N + +G G +G VYKG L+ E+ VA+K Q +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINE-KNIY 59
Query: 141 TLGSADHPNLVKLIGYCAEGD-----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
+ +H N+ + I + LLV EY P GSL K+L DW +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSC 114
Query: 196 KIAAGASRGLQYLHEQL------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----- 244
++A +RGL YLH +L K + +RDL N+L++ +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 245 -GPSGDKTHVSTRVMGTYGYCAPDYAM-------TGQLTFKSDIYSFGVVLLELITGRKA 296
G++ + + +GT Y AP+ + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 297 IDQTKDRKELNL 308
+ + E +
Sbjct: 235 LFPGESVPEYQM 246
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-59
Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
L E G+++KG + + +K L R R+F+ E L HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 157 CAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
C + +MP GSL LH+ +D + +K A +RG+ +LH L+
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ- 273
+ L +++++E ++S + + S M + AP+ A+ +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 274 ---LTFKSDIYSFGVVLLELITGR 294
+D++SF V+L EL+T
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-58
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G GGFGKVY+ VA+K D Q + E HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G C + LV E+ G L++ L + + + + A +RG+ YLH++
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 215 PVIYRDLKCSNILLEEGYHP--------KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
P+I+RDLK SNIL+ + K++DFGLA+ +T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAP 183
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ + SD++S+GV+L EL+TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-57
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG+G FG+ K + +V+ +K+L + R F EV + +HPN++K IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ + + EY+ G+L + + W+ R+ A + G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM------------GPSGDKTHVSTRVMGTYGYCAP 266
RDL N L+ E + ++DFGLA++ V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
+ K D++SFG+VL E+I A
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-56
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+G G FG VYKG VA+K L Q ++ F EV L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
Q +V ++ SL HLH + + IA +RG+ YLH + +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP---DYAMTGQ 273
I+RDLK +NI L E K+ DFGLA +H ++ G+ + AP +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 274 LTFKSDIYSFGVVLLELITGR 294
+F+SD+Y+FG+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-56
Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 24/210 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
+G+G FG+VY G VAI+ +D ++ F EVM H N+V +G
Sbjct: 41 IGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
C ++ +L + D + LD N +IA +G+ YLH + +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAP------- 266
+++DLK N+ + G ++DFGL + +G + G + AP
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ SD+++ G + EL
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-51
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
+G+G +G+V+ G + VA+K RE E+ H N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99
Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+G Q L+ +Y GSL +L LD + +K+A + GL +LH ++
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 213 -----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCA 265
K + +RDLK NIL+++ ++D GLA S +GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 266 P---DYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
P D ++ +D+YSFG++L E+ + ++ +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-51
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
C+G+G +G+V++G + + VA+K R + RE E+ H N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70
Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
Q L+ Y +GSL +L LD + ++I + GL +LH ++
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 213 -----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV--STRVMGTYGYCA 265
K + +RDLK NIL+++ ++D GLA M + +GT Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 266 P------DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
P + DI++FG+VL E+ + +D K
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
+G+G FG+V++G + VA+K R + RE AE+ H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104
Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-- 210
+ + Q LV +Y GSL +L+ + +K+A + GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 211 ---QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCA 265
Q K + +RDLK NIL+++ ++D GLA S T +GT Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 266 P---DYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
P D ++ + ++DIY+ G+V E+ +D +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG+G FG V + +VA+KQL H G R+F E+ L + +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
G ++ LV EY+P G L L R LD + + ++ +G++YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS-- 145
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
+ ++RDL NIL+E H K++DFGLAK+ P +V G + AP+
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ +SD++SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 7/195 (3%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G G FG+V+ G L +VA+K + +F E L HPN+V+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ +V E + G LR + L T +++ A+ G++YL + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL N L+ E K+SDFG+++ G + AP+ G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 278 SDIYSFGVVLLELIT 292
SD++SFG++L E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG+G FG V + +VVA+K+L H + +R+F E+ L S H N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
G C +R L+ EY+P GSL +L + +D ++ + +G++YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT-- 163
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
+ I+RDL NIL+E K+ DFGL K+ P + + G + AP+
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ + SD++SFGVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG+G FG V + +VVA+K+L H + +R+F E+ L S H N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
G C +R L+ EY+P GSL +L + +D ++ + +G++YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT-- 132
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
+ I+RDL NIL+E K+ DFGL K+ P + G + AP+
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
+ + SD++SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG VYKG EK++ VAIK+L + + +E E + S D+P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C L+ + MP G L ++ + + + + + ++G+ YL ++
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++RDL N+L++ H K++DFGLAK+ + +K + + + A + +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV + + VA+K L G + + E+ L + H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C E L+ E++P GSL ++L + ++ ++K A +G+ YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAP 266
++RDL N+L+E + K+ DFGL K + + + + AP
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M + SD++SFGV L EL+T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 69/221 (31%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV C + ++VA+K L G Q + E+ L + H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C + LV EY+PLGSL +L L + A G+ YLH Q
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAP 266
I+RDL N+LL+ K+ DFGLAK P G + + + G + AP
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306
+ + + SD++SFGV L EL+T + EL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG V+KG E I+ V IK + D G Q + + ++ +GS DH ++V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C G LV +Y+PLGSL H+ R L + ++G+ YL E
Sbjct: 81 LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEEH-- 134
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++R+L N+LL+ +++DFG+A + P DK + + + A + G+
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
T +SD++S+GV + EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G +G+VY+G +K VA+K L V EF E + HPNLV+L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
++ E+M G+L +L + + + + +A S ++YL + + I
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+R+L N L+ E + K++DFGL+++ +GD + AP+ + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 278 SDIYSFGVVLLELIT 292
SD+++FGV+L E+ T
Sbjct: 400 SDVWAFGVLLWEIAT 414
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-40
Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG G FG VYKG EK++ VAIK+L + + +E E + S D+P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G C L+ + MP G L ++ + + + + + ++G+ YL ++
Sbjct: 83 LGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++RDL N+L++ H K++DFGLAK+ + +K + + + A + +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-39
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG+G FG VY+G + + E VAIK + + ++ EF E + + ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTRMKIAAGASRGLQ 206
L+G ++G L++ E M G L +L LRP P + +++A + G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV------MGT 260
YL+ ++RDL N ++ E + K+ DFG+ + D + M
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+P+ G T SD++SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-39
Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG+G FG V +G VA+K L + + +F EV + S DH NL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L G +V E PLGSL L + T + A + G+ YL +
Sbjct: 86 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESK- 140
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYA 269
I+RDL N+LL K+ DFGL + P D +V + +CAP+
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRK 295
T + SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV+ + + +VA+K L ++F E L H ++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
G C EG L+V+EYM G L++ L PD + PL + +A+ +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----- 257
G+ YL L ++RDL N L+ +G K+ DFG+++ S D V R
Sbjct: 169 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 258 -MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
M P+ + + T +SD++SFGVVL E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 19/210 (9%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNL 150
+ D +G G F VYKG + VA + + F E L HPN+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 151 VKLIGYC---AEGDQRLLVY-EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
V+ +G + +++ E M G+L + + +GLQ
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 207 YLHEQLKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
+LH + P+I+RDLKC NI + G K+ D GLA + + + V+GT +
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFAKAVIGTPEFM 197
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGR 294
AP+ + D+Y+FG+ +LE+ T
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-38
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 99 LGEGGFGKVYKGCL--EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LG G FG V KG +K+ + VA+K L + E AE + D+P +V++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G C E + +LV E LG L+K+L R + +++ S G++YL E+
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-EESN- 137
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPDY 268
++RDL N+LL ++ K+SDFGL+K + + + + + AP+
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT-GRK 295
+ + KSD++SFGV++ E + G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G G+V G L + + VAIK L + R+F +E +G DHPN+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G G ++V EYM GSLD LR + + G G++YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTF---LRTHDGQFTIMQLVGMLRGVGAGMRYLSD---L 170
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++RDL N+L++ K+SDFGL++ + D + +T + AP+
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
+ SD++SFGVV+ E++ G +
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGER 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 99 LGEGGFGKVYKGCL--EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG V +G K + VAIK L E E + D+P +V+LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
C + + +LV E G L K L + + ++ S G++YL E+
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 130
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPDYA 269
++RDL N+LL ++ K+SDFGL+K + D + + + AP+
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRK 295
+ + +SD++S+GV + E ++ G+K
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 31/206 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G +G+VY+G +K VA+K L V EF E + HPNLV+L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
++ E+M G+L +L + + + +A S ++YL E+ I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYL-EKKN--FIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY------------CAP 266
RDL N L+ E + K++DFGL+ R+M Y AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIKWTAP 181
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ + + KSD+++FGV+L E+ T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FGKV+ + + +VA+K L + ++F E L + H ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------------PLDWNTRMKIAAGA 201
G C +GD ++V+EYM G L+K L PD L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV---- 257
+ G+ YL ++RDL N L+ K+ DFG+++ S D V
Sbjct: 143 ASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 258 --MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
M P+ M + T +SD++SFGV+L E+ T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LGE FGKVYKG L Q VAIK L D EF E M HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------------PLDWNTRMKIAAG 200
L+G + +++ Y G L + L P + L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV- 257
+ G++YL V+++DL N+L+ + + K+SD GL + + D K ++ +
Sbjct: 137 IAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 258 ---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
M AP+ M G+ + SDI+S+GVVL E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 99 LGEGGFGKVYKGCL-----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG G FG+VY+G + + VA+K L + Q +F E + + +H N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---RPLDWNTRMKIAAGASRGLQYLH 209
IG + R ++ E M G L L + RP L + +A + G QYL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
E+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 157 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M G T K+D +SFGV+L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG+G FG+V+ G VAIK L G F E + H LV+L
Sbjct: 191 KLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+E + +V EYM GSL L + L + +AA + G+ Y+ +
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL+ +NIL+ E K++DFGLA++ ++ + AP+ A+ G+ T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 278 SDIYSFGVVLLELIT 292
SD++SFG++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
+G G FG+VYKG L K E VAIK L + +F E +G H N+++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G ++ +++ EYM G+LDK LR + + G + G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPD 267
++RDL NIL+ K+SDFGL+++ + +T G + AP+
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT-GRK 295
+ T SD++SFG+V+ E++T G +
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G FG VY G L + + A+K L + V +F E + + HPN++ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 155 GYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G C + L+V YM G L + + + + ++G++YL
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS--- 146
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG------TYGYCAPD 267
+ ++RDL N +L+E + K++DFGLA+ + V + A +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
T + T KSD++SFGV+L EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G G FG+V G L K E VAIK L + R+F E +G DHPN+++L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G + ++V EYM GSLD LR + + G + G++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSF---LRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++RDL NIL+ K+SDFGL + + + + + + +P+ +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
T SD++S+G+VL E+++ G +
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG+G FG+V+ G VAIK L G F E + H LV+L
Sbjct: 274 KLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+E + +V EYM GSL L + L + +AA + G+ Y+ +
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
+RDL+ +NIL+ E K++DFGLA++ ++ + AP+ A+ G+ T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 278 SDIYSFGVVLLELIT 292
SD++SFG++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 32/292 (10%)
Query: 21 KNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKP 80
+ + + ++ PR + L + NL N+
Sbjct: 12 HHHGRRRASVAAGILV--PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 81 FTFDELAAATGNF---RSDCC------LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHR 127
EL A + S +G G FG VY G L + + A+K L
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 128 GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDT 186
+ V +F E + + HPN++ L+G C + L+V YM G L + + +
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
+ ++G+++L + ++RDL N +L+E + K++DFGLA+
Sbjct: 189 --PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 247 SGDKTHVSTRVMG------TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ V + A + T + T KSD++SFGV+L EL+T
Sbjct: 244 DKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG G FG+VY+G + + VA+K L + Q +F E + + +H N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---RPLDWNTRMKIAAGASRGLQYLH 209
IG + R ++ E M G L L + RP L + +A + G QYL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
E+ I+RD+ N LL G K+ DFG+A+ M + P
Sbjct: 198 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M G T K+D +SFGV+L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 16/219 (7%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQ--LDHRGVQGVREFSAEVMTLGS-ADH 147
+F+ LG G +G+V+K K + ++ A+K+ RG + AEV + H
Sbjct: 58 SFQRLSRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P V+L EG L E SL +H L L +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAH 172
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
LH Q +++ D+K +NI L KL DFGL + V G Y AP+
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE 226
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ G +D++S G+ +LE+ + + ++L
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
LGEG FG+VY+G + + VA+K + +F +E + + + DHP++VKLI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G E + ++ E P G L +L + + L + + + + YL E +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYL-ESIN- 133
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY----------- 263
++RD+ NIL+ KL DFGL+ R + Y
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIK 179
Query: 264 -CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRK 295
+P+ + T SD++ F V + E+++ G++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LG+G FG V + L + VA+K L D + EF E + DHP++ KL
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGL 205
+G + +++ +M G L L R P L T ++ + G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV----MG 259
+YL I+RDL N +L E ++DFGL++ SGD + ++++ +
Sbjct: 151 EYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
A + T SD+++FGV + E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 99 LGEGGFGKVYKGCL--EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG V +G K + VAIK L E E + D+P +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
C + + +LV E G L K L R + + + ++ S G++YL E+
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTG 272
++R+L N+LL ++ K+SDFGL+K + D + + + AP+
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFR 514
Query: 273 QLTFKSDIYSFGVVLLELIT-GRK 295
+ + +SD++S+GV + E ++ G+K
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G FG V+ G + VAIK + G +F E + HP LV+L G C
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
E LV E+M G L +L R T + + G+ YL E+ VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL-EEAC--VIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
RDL N L+ E K+SDFG+ + T GT + +P+ + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 276 FKSDIYSFGVVLLELIT-GRK 295
KSD++SFGV++ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
LGEG FG V +G L + VA+K + D+ + + EF +E + HPN+++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 154 IGYCAEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGLQ 206
+G C E + +++ +M G L +L R +T P + T +K + G++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV----MGT 260
YL ++RDL N +L + ++DFGL+K SGD + ++ +
Sbjct: 162 YL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
A + T KSD+++FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 29/214 (13%)
Query: 99 LGEGGFGKVYKGCL-------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
LG+G F K++KG + E V +K LD F + H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G C GD+ +LV E++ GSLD +L + ++ ++++A + + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL-EE 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHP--------KLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
+I+ ++ NILL KLSD G++ D +
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----- 184
Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELIT-GRK 295
P+ + +D +SFG L E+ + G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+G+G FG VY G + AIK L +Q V F E + + +HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 155 GYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G + ++ YM G L + + + + + +RG++YL + K
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYL-AEQK 144
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG------TYGYCAPD 267
++RDL N +L+E + K++DFGLA+ + V T A +
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198
Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
T + T KSD++SFGV+L EL+T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 53/238 (22%), Positives = 90/238 (37%), Gaps = 17/238 (7%)
Query: 71 SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
++SG+ F + ++ LGEGGF V A+K++ Q
Sbjct: 9 HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ 68
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR----LLVYEYMPLGSLDKHLHDLRPDT 186
E E +HPN+++L+ YC L+ + G+L + L+
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
L + + + G RGL+ +H + +RDLK +NILL + P L D G
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 247 SGDKTHVSTRVM-------GTYGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ + T Y AP + ++D++S G VL ++ G
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V G + VAIK + G EF E + + H LV+L G C
Sbjct: 32 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ ++ EYM G L +L ++R +++ ++YL E + ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYL-ESKQ--FLH 143
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
RDL N L+ + K+SDFGL++ + T +G+ + P+ M + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 276 FKSDIYSFGVVLLELIT 292
KSDI++FGV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V G + + VA+K + G EF E T+ HP LVK G C+
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ +V EY+ G L +L L+ + +++ G+ +L E + I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL-ESHQ--FIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
RDL N L++ K+SDFG+ + +GT + AP+ + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 276 FKSDIYSFGVVLLELIT-GRK 295
KSD+++FG+++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G FG+V+ VA+K + G V F AE + + H LVKL
Sbjct: 195 KLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ + ++ E+M GSL L + + +A + G+ ++ ++ I
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTF 276
+RDL+ +NIL+ K++DFGLA++ + + + AP+ G T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTI 364
Query: 277 KSDIYSFGVVLLELIT 292
KSD++SFG++L+E++T
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 37/214 (17%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+GEG FG V++G E VAIK + +F E +T+ DHP++VKLI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G + ++ E LG L L + LD + + A S L YL +
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK--- 135
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY----------- 263
++RD+ N+L+ KL DFGL+ R M Y
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKGKLPIK 182
Query: 264 -CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRK 295
AP+ + T SD++ FGV + E++ G K
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-35
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
+GEG FG V++G E VAIK + +F E +T+ DHP++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G + ++ E LG L L + LD + + A S L YL +
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK--- 510
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPDYA 269
++RD+ N+L+ KL DFGL++ + G + AP+
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESI 564
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
+ T SD++ FGV + E++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-35
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG V G VA+K + + + F AE + H NLV+L+G
Sbjct: 200 TIGKGEFGDVMLGDYRG--NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 158 AEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
E L +V EYM GSL +L L + +K + ++YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----MGTYGYCAPDYAMTG 272
++RDL N+L+ E K+SDFGL K T + ++ AP+
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 361
Query: 273 QLTFKSDIYSFGVVLLELIT 292
+ + KSD++SFG++L E+ +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
+GEG FG+V++ + +VA+K L + +F E + D+PN+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--------------------RPLDWN 192
L+G CA G L++EYM G L++ L + P T PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--K 250
++ IA + G+ YL + K ++RDL N L+ E K++DFGL++ S D K
Sbjct: 175 EQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 251 THVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ + M P+ + T +SD++++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G FG+V+ G VA+K L +G F AE + H LV+L
Sbjct: 20 RLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+ + ++ EYM GSL L P L N + +AA + G+ ++ E+ I
Sbjct: 78 TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI-EERN--YI 131
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTF 276
+RDL+ +NIL+ + K++DFGLA++ + + + AP+ G T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189
Query: 277 KSDIYSFGVVLLELIT 292
KSD++SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 8/240 (3%)
Query: 60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
MD ++ ++ + K D NFR + +G G F +VY+ V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 120 AIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
A+K++ + + + E+ L +HPN++K E ++ +V E G L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
+ + + R + T K L+++H + V++RD+K +N+ + KL
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 177
Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
D GL + S T + V GT Y +P+ FKSDI+S G +L E+ +
Sbjct: 178 GDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 38/218 (17%)
Query: 99 LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPNLVK 152
+GEG FG+V K ++K + AIK++ ++ R+F+ EV+ LG HPN++
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHPNIIN 90
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKIAAG 200
L+G C L EY P G+L L R L + AA
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV- 257
+RG+ YL Q + I+RDL NIL+ E Y K++DFGL++ + R+
Sbjct: 151 VARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 258 ---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
M A + T SD++S+GV+L E+++
Sbjct: 205 VRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-34
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G FG V G + VA+K + + F AE + H NLV+L+G
Sbjct: 29 IGKGEFGDVMLGDYRGNK--VAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
E L +V EYM GSL +L L + +K + ++YL E +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 139
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----MGTYGYCAPDYAMTGQ 273
+RDL N+L+ E K+SDFGL K T + ++ AP+ +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
+ KSD++SFG++L E+ + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 53/212 (25%), Positives = 79/212 (37%), Gaps = 26/212 (12%)
Query: 91 GNFRSDCCLGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHP 148
G + C+ GG G +Y + V +K L H G + AE L HP
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 149 NLVKLIGYCAEGDQRL-----LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
++V++ + D+ +V EY+ SL + + L +
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYG 262
L YLH ++Y DLK NI+L E KL D G + G + GT G
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPG 242
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ AP+ T +DIY+ G L L
Sbjct: 243 FQAPEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLIG 155
LG GG VY + VAIK + + ++ F EV H N+V +I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
E D LV EY+ +L +++ PL +T + G+++ H+
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---R 131
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
+++RD+K NIL++ K+ DFG+AK T + V+GT Y +P+ A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATD 190
Query: 276 FKSDIYSFGVVLLELITGR 294
+DIYS G+VL E++ G
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-------EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADH 147
LGEG FG+V I VA+K L D + + + E+M +G H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 100
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRM 195
N++ L+G C + ++ EY G+L ++L RP + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
+RG++YL K I+RDL N+L+ E K++DFGLA+ + D K
Sbjct: 161 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ R+ M AP+ T +SD++SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 99 LGEGGFGKVYKGCLEKIE-------QVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADH 147
LGEG FG+V I+ VA+K L D + + + E+M +G H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 146
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRM 195
N++ L+G C + ++ EY G+L ++L RP + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
+RG++YL K I+RDL N+L+ E K++DFGLA+ + D K
Sbjct: 207 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ R+ M AP+ T +SD++SFGV++ E+ T
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G G FG+V++ ++ A+K++ + E++ P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
EG + E + GS L L L + + A GL+YLH + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRIL 172
Query: 218 YRDLKCSNILL-EEGYHPKLSDFGLAK-MGPSGDKTHVSTR--VMGTYGYCAPDYAMTGQ 273
+ D+K N+LL +G L DFG A + P G + T + GT + AP+ M
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 274 LTFKSDIYSFGVVLLELITGR 294
K DI+S ++L ++ G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 10/205 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIG- 155
+G G +G+ K + +++ K+LD+ + + +EV L HPN+V+
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ--L 212
+ L +V EY G L + + + LD +++ + L+ H +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
V++RDLK +N+ L+ + KL DFGLA+ + T V GT Y +P+
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYMSPEQMNR 190
Query: 272 GQLTFKSDIYSFGVVLLELITGRKA 296
KSDI+S G +L EL
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 52/207 (25%), Positives = 78/207 (37%), Gaps = 11/207 (5%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVRE-FSAEVMTLGSADH 147
G +R +G GG G VY+ E++VA+K + R E T G
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P++V + + Q + + L L PL + I L
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDA 149
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
H +RD+K NIL+ L DFG+A T + +GT Y AP+
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPE 205
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
T+++DIY+ VL E +TG
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAE--VM-TLGSADHPN 149
LG G FGKV + + VA+K L + +E V+ LG +H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NHMN 88
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--------------RPLDWNTRM 195
+V L+G C G L++ EY G L L R LD +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
+ ++G+ +L I+RDL NILL G K+ DFGLA+ + V
Sbjct: 149 SFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 256 ------RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M AP+ TF+SD++S+G+ L EL +
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 41/226 (18%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
LGEG FGKV K + VA+K L ++ +R+ +E L +HP+++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------------------DTRPLDWN 192
L G C++ LL+ EY GSL L + R D R L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--K 250
+ A S+G+QYL ++K +++RDL NIL+ EG K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 251 THVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
R+ M A + T +SD++SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 40/223 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-------EQVVAIKQL-DHRGVQGVREFS--AEVMT-LGSADH 147
LGEG FG+V + VA+K L + + + E+M +G H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--KH 134
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------M 195
N++ L+G C + ++ EY G+L ++L RP +N +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
A +RG++YL K I+RDL N+L+ E K++DFGLA+ D K
Sbjct: 195 SCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ R+ M AP+ T +SD++SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAE--VMT-LGSADHPN 149
LG G FGKV + + VA+K L +E +M+ LG H N
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHEN 111
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR----------MKIAA 199
+V L+G C G L++ EY G L L + ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---- 255
++G+ +L I+RD+ N+LL G+ K+ DFGLA+ + V
Sbjct: 172 QVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 256 --RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ M AP+ T +SD++S+G++L E+ +
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-32
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 13/204 (6%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF-SAEVMTLGSADHPNLV 151
F LG G G V+K + V+A K + +R E+ L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
G + + E+M GSLD + + K++ +GL YL E+
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
K +++RD+K SNIL+ KL DFG++ ++ S + V GT Y +P+
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQ 203
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
+ +SDI+S G+ L+E+ GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG+G +G VY G + +AIK++ R + + E+ H N+V+ +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
+E + E +P GSL L + + T GL+YLH+ ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIV 144
Query: 218 YRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP---DYAMTG 272
+RD+K N+L+ G K+SDFG +K + + GT Y AP D G
Sbjct: 145 HRDIKGDNVLINTYSG-VLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG 201
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
+DI+S G ++E+ TG+
Sbjct: 202 -YGKAADIWSLGCTIIEMATGK 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-32
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 13/203 (6%)
Query: 98 CLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
+GEG FGK + + IK+++ + + E EV L + HPN+V+
Sbjct: 31 KIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
E +V +Y G L K ++ + + + L+++H++
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK-- 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++RD+K NI L + +L DFG+A+ + + + + GT Y +P+
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI-GTPYYLSPEICENKP 201
Query: 274 LTFKSDIYSFGVVLLELITGRKA 296
KSDI++ G VL EL T + A
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG+G FG+V K + AIK++ H + + +EVM L S +H +V+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 158 AEGDQRL-------------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
E + + EY G+L +H + ++
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEA 128
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-------------GPSGDKT 251
L Y+H Q +I+RDLK NI ++E + K+ DFGLAK G
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 252 HVSTRVMGTYGYCAPD-YAMTGQLTFKSDIYSFGVVLLELITG 293
++++ + GT Y A + TG K D+YS G++ E+I
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGY 156
CLG GGFG V++ + + AIK++ + RE EV L +HP +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 157 CAEGD---------QRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
E + ++ +Y + +L K + R + + + I +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----------GPSGDKTHVS 254
+++LH + +++RDLK SNI K+ DFGL
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
T +GT Y +P+ + K DI+S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADH 147
LG G +G V K Q++A+K++ + + + +++ + D
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTVDC 65
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P V G + E M SLDK + + + + KIA + L++
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP 266
LH +L VI+RD+K SN+L+ K+ DFG+ + K G Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMAP 178
Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ KSDI+S G+ ++EL R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
+F+ +G GGFG+V+K +I+ + IK++ + + RE V L DH N+
Sbjct: 12 DFKEIELIGSGGFGQVFK-AKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 151 VKLIGYCAEGDQRL----------------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTR 194
V G D + E+ G+L++ + R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLA 124
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
+++ ++G+ Y+H + +I RDLK SNI L + K+ DFGL + K
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
TR GT Y +P+ + + D+Y+ G++L EL+
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 48/242 (19%), Positives = 92/242 (38%), Gaps = 25/242 (10%)
Query: 68 KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR 127
S+ + F ++ + +G GG KV++ L + +Q+ AIK ++
Sbjct: 5 HHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE 63
Query: 128 GV--QGVREFSAEVMTLGSADHPNL--VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
Q + + E+ L + ++L Y +V E L+ L
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-- 120
Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
+ +D R + +H+ +++ DLK +N L+ +G KL DFG+A
Sbjct: 121 --KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIAN 174
Query: 244 MGPSGDKTHVSTRVMGTYGYCAP-----------DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ V +GT Y P + +++ KSD++S G +L +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 293 GR 294
G+
Sbjct: 235 GK 236
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPN 149
LG G FG+V + I + VA+K L + R +++ +G H N
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 150 LVKLIGYCAEGDQ-RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MK 196
+V L+G C + +++ E+ G+L +L R + P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVS 254
+ ++G+++L K I+RDL NILL E K+ DFGLA+
Sbjct: 153 YSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 255 TRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
R+ M AP+ T +SD++SFGV+L E+ +
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 45/228 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPN 149
LG G FGKV I VA+K L + ++M LG H N
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SHEN 110
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLD 190
+V L+G C L++EY G L +L R D L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD- 249
+ + A ++G+++L E ++RDL N+L+ G K+ DFGLA+ S
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 250 -KTHVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
+ R+ M AP+ G T KSD++S+G++L E+ +
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL--VKL 153
+G GG KV++ L + +Q+ AIK ++ Q + + E+ L + ++L
Sbjct: 16 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
Y +V E L+ L + +D R + +H+
Sbjct: 75 YDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
+++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ +++ KSD++S G +L + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 35/229 (15%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------------- 137
++R L +G F K+ EK + A+K+ + ++ R+F+
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 138 ----EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPL 189
E+ + + + G D+ ++YEYM S+ K T +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
I Y+H + + +RD+K SNIL+++ KLSDFG ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 250 -KTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGR 294
K GTY + P+ + + ++ K DI+S G+ L +
Sbjct: 207 IKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 13/203 (6%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
F +G+G FG+V+KG + ++VVAIK +D + + + E+ L D P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
K G + + ++ EY+ GS L L P PLD I +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEP--GPLDETQIATILREILKGLDYLHSE 138
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
K I+RD+K +N+LL E KL+DFG+ ++ + K + +GT + AP+
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIK 192
Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
K+DI+S G+ +EL G
Sbjct: 193 QSAYDSKADIWSLGITAIELARG 215
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 30/238 (12%), Positives = 71/238 (29%), Gaps = 51/238 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDH----------------------RGVQGVREFS 136
LG+ + ++ + + RG++ ++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 137 AEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEY--MP-----LGSLDKHLHDLRPDT 186
+ + D P K+I + ++ + P L + + L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
+ L + R+++ R L LH +++ L+ +I+L++ L+ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260
Query: 247 SGDKTHVSTRVMGTYGYCAPDY----------AMTGQLTFKSDIYSFGVVLLELITGR 294
G S G+ P+ +TF D ++ G+ + +
Sbjct: 261 DGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKL-- 153
LG GG +V+ + + VA+K L R F E + +HP +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 154 IGYCAEGDQRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
G AE L Y EY+ +L +H P+ +++ A A + L + H+
Sbjct: 80 TG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST-RVMGTYGYCAPDYA 269
+I+RD+K +NI++ K+ DFG+A+ + T V+GT Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
+ +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL--VKL 153
+G GG KV++ L + +Q+ AIK ++ Q + + E+ L + ++L
Sbjct: 63 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
Y +V E L+ L + +D R + +H+
Sbjct: 122 YDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
+++ DLK +N L+ +G KL DFG+A + V +G Y P
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ +++ KSD++S G +L + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
+ LG+G FGKVYK ++ + A K ++ + + + ++ E+ L + DHP +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
L+G + ++ E+ P G++D + R L + L +LH +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP---- 266
I+RDLK N+L+ +L+DFG+ AK + K +GT + AP
Sbjct: 137 RI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVM 190
Query: 267 -DYAMTGQLTFKSDIYSFGVVLLELITG 293
+ +K+DI+S G+ L+E+
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG+GGFG+V + ++ A K+L+ + + +G E L + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
Y E L LV M G L H++ + P R AA GL+ LH +
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRER- 306
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++YRDLK NILL++ H ++SD GLA P G RV GT GY AP+ +
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNER 361
Query: 274 LTFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
TF D ++ G +L E+I G+ + + R+E+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN 149
F LGEG +G VYK ++ Q+VAIKQ+ ++E E+ + D P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYL 208
+VK G + +V EY GS+ D+ R + L + I +GL+YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPD 267
H K I+RD+K NILL H KL+DFG+ ++ + K + V+GT + AP+
Sbjct: 142 HFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
+DI+S G+ +E+ G
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEV-MTLGSADHPN 149
+ + +G G +G V K + Q++A+K++ + ++ ++ + + S+D P
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYL 208
+V+ G + E M S DK + + KI + L +L
Sbjct: 83 IVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP- 266
E LK +I+RD+K SNILL+ + KL DFG+ ++ S K TR G Y AP
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPE 195
Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
A +SD++S G+ L EL TGR
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNL 150
++ +G G V ++ VAIK+++ + + E E+ + HPN+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL----DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
V D+ LV + + GS+ + + LD +T I GL+
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTR--VMGTYGY 263
YLH+ + I+RD+K NILL E +++DFG+ A + GD T R +GT +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
AP+ + FK+DI+SFG+ +EL TG
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
+ +G+G G VY Q VAI+Q++ + E++ + +PN+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ GD+ +V EY+ GSL D+ +D + + L++LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVV-TETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
VI+RD+K NILL KL+DFG A++ P K T V GT + AP+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTR 190
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
K DI+S G++ +E+I G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 34/214 (15%), Positives = 70/214 (32%), Gaps = 20/214 (9%)
Query: 98 CLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
LGEG F +VY+ K +Q +K + + L + +K
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQ 211
+ +LV E G+L ++ + + + + A ++ +H+
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 212 LKQPVIYRDLKCSNILLEEGYHP-----------KLSDFGLAKMGPSGDKTHVSTRVMGT 260
+I+ D+K N +L G+ L D G + K + T T
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
G+ + ++ D + + ++ G
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 25/252 (9%), Positives = 52/252 (20%), Gaps = 42/252 (16%)
Query: 77 SAKPFTFD-ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---V 132
T D L+ + L G V+ + + A+K +
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 133 REFSAEVMTLGSADHPNLVKLIGYC--------------------------AEGDQRLLV 166
+ + LL+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 167 YEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCS 224
L L L + + A R L + +++
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPD 223
Query: 225 NILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYS 282
N+ + L D G + S+ Y ++ T T + +
Sbjct: 224 NLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQ 278
Query: 283 FGVVLLELITGR 294
G+ + +
Sbjct: 279 LGLSIYRVWCLF 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
LG+G FG VY ++ + ++A+K L ++ + EV HPN+++L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
Y + + L+ EY PLG++ + L + ++ + T + L Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTA-TYITELANALSYCH---SKR 129
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMTGQL 274
VI+RD+K N+LL K++DFG + PS + GT Y P+
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMH 184
Query: 275 TFKSDIYSFGVVLLELITGR 294
K D++S GV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
S +GEG G V + + VA+K +D R Q EV+ + H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ G++ ++ E++ G+L D+ L+ + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQV-RLNEEQIATVCEAVLQALAYLH--- 158
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
Q VI+RD+K +ILL KLSDFG A++ K + V GT + AP+
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISR 215
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
+ DI+S G++++E++ G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG GGFG+V+ ++ ++ A K+L+ + + +G + E L +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
Y E L LV M G + H++++ D R A GL++LH++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQR-- 308
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+IYRDLK N+LL++ + ++SD GLA +G GT G+ AP+ + +
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEE 365
Query: 274 LTFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
F D ++ GV L E+I R +A + + KEL
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
LG+G FG VY ++ + ++A+K L ++ + E+ HPN++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
Y + + L+ E+ P G L K L + R + + + A L Y H ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELAD-ALHYCH---ERK 134
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
VI+RD+K N+L+ K++DFG + PS + GT Y P+
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPPEMIEGKTHD 190
Query: 276 FKSDIYSFGVVLLELITGR 294
K D++ GV+ E + G
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 23/217 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYC 157
L EGGF VY+ + A+K+L + R EV + + HPN+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 158 AEGDQR-------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
+ G + L+ + G L + L + L +T +KI R +Q++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVM-------GT 260
Q K P+I+RDLK N+LL KL DFG A P + ++ T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 261 YGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y P D + K DI++ G +L L +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 26/239 (10%), Positives = 65/239 (27%), Gaps = 52/239 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE------------------------ 134
LG+ + ++ + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 135 ----FSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLVYEYM--PLGSLDKHLHDLRPDT 186
F + ++++ + R +Y M L + + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
+ L + R+++ R L LH +++ L+ +I+L++ L+ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGR 294
+ + G+ P+ +TF D ++ G+V+ +
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 20/234 (8%)
Query: 71 SNNSGKSAKPFTFDE--LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-R 127
S +SGK T A + + +G G G+V+K K V+A+KQ+
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 128 GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
+ + ++ + + D P +V+ G + E M +K +
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEK---LKKRMQ 118
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMG 245
P+ K+ + L YL E+ VI+RD+K SNILL+E KL DFG+ ++
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 246 PSGDKTHVSTRVMGTYGYCAP-----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
K R G Y AP ++D++S G+ L+EL TG+
Sbjct: 177 DDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 44/219 (20%), Positives = 75/219 (34%), Gaps = 22/219 (10%)
Query: 90 TGNFRSDCCLGEG--GFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSA 145
G + +G+G V + + V +++ L+ + V E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GAS 202
+HPN+V ++ +V +M GS + D IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHV----STRV 257
+ L Y+H ++R +K S+IL+ LS M G + V
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 258 MGTYGYCAPDYAMTGQL--TFKSDIYSFGVVLLELITGR 294
+ + +P+ KSDIYS G+ EL G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 45/233 (19%), Positives = 79/233 (33%), Gaps = 46/233 (19%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSA--EVMTLGS-ADH 147
F +G G FG V+K C+++++ + AIK+ V E +A EV H
Sbjct: 12 EFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
++V+ AE D L+ EY GSL + + + RGL+Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 208 LHEQLKQPVIYRDLKCSNILL-------------------EEGYHPKLSDFGLAKMGPSG 248
+H +++ D+K SNI + K+ D G S
Sbjct: 131 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-SS 186
Query: 249 DKTHVST-------RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ + Y + K+DI++ + ++
Sbjct: 187 PQVEEGDSRFLANEVLQENYTH-----------LPKADIFALALTVVCAAGAE 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-27
Identities = 67/215 (31%), Positives = 92/215 (42%), Gaps = 17/215 (7%)
Query: 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHP 148
G + LG GGFG V + + + VAIKQ RE + E+ + +HP
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 149 NLVKLI------GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
N+V A D LL EY G L K+L+ + L + + S
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMG 259
L+YLHE +I+RDLK NI+L+ G K+ D G AK G+ V G
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-G 185
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
T Y AP+ + T D +SFG + E ITG
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 71 SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
S++ +S L G F +G G +G+VYKG K Q+ AIK +D G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 131 GVREFSAEVMTLGSA-DHPNLVKLIG-----YCAEGDQRL-LVYEYMPLGSLDKHLHDLR 183
E E+ L H N+ G D +L LV E+ GS+ + + +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 184 PDTRPLDWNTRMKIAA---GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240
+T +W IA RGL +LH + VI+RD+K N+LL E KL DFG
Sbjct: 123 GNTLKEEW-----IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 241 LAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQLT-----FKSDIYSFGVVLLELIT 292
+ S R +GT + AP+ + FKSD++S G+ +E+
Sbjct: 175 V-----SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 293 G 293
G
Sbjct: 230 G 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 37/303 (12%)
Query: 15 DEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNS 74
I++ +L K+ L P ++ + +V S + +
Sbjct: 126 KSAIEHVQGHLVKKQVPPDLF--QPYIEEICQNLRGDVFQKFIESDKFTRF-CQWKNVEL 182
Query: 75 GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QG 131
F +G GGFG+VY ++ A+K LD + + QG
Sbjct: 183 NIHLTMNDFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG 232
Query: 132 VREFSAE---VMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR 187
E + + + D P +V + Y +L + + M G L HL +
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291
Query: 188 PLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
M+ AA GL+++H + V+YRDLK +NILL+E H ++SD GLA
Sbjct: 292 A-----DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343
Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRK--AIDQTKDR 303
K H V GT+GY AP+ G +D +S G +L +L+ G +TKD+
Sbjct: 344 -KKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 304 KEL 306
E+
Sbjct: 400 HEI 402
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPN 149
F +G G FG VY + +VVAIK++ + G Q ++ EV L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GASRGLQ 206
++ G LV EY + D L +PL ++IAA GA +GL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD----LLEVHKKPLQ---EVEIAAVTHGALQGLA 168
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCA 265
YLH I+RD+K NILL E KL DFG + M P+ + +GT + A
Sbjct: 169 YLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NS-----FVGTPYWMA 218
Query: 266 PDYAMTGQLT---FKSDIYSFGVVLLELITG 293
P+ + K D++S G+ +EL
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LG+G V++G +K + AIK ++ + E L +H N+VKL
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 158 AEGDQRL--LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
E R L+ E+ P GSL L + + L + + + G+ +L E
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 216 VIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD---- 267
+++R++K NI+ G KL+DFG A+ ++ + GT Y PD
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTEEYLHPDMYER 189
Query: 268 ----YAMTGQLTFKSDIYSFGVVLLELITGR 294
+ D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 21/212 (9%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNL 150
+F LG G G + + + VA+K++ EV L S +HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
++ + + + E +L +++ + D L + + GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136
Query: 211 QLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYC 264
+++RDLK NIL+ +SDFGL K G + + V GT G+
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 265 AP---DYAMTGQLTFKSDIYSFGVVLLELITG 293
AP T+ DI+S G V +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
+ LG+GGF K ++ ++V A K + + RE S E+ S H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
++V G+ + D +V E SL + + T P R + G QY
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIVL-GCQY 130
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAP 266
LH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 184
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ +F+ D++S G ++ L+ G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
+ LG+GGF K ++ ++V A K + + RE S E+ S H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
++V G+ + D +V E SL + + T P R + G QY
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIVL-GCQY 156
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAP 266
LH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 210
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ +F+ D++S G ++ L+ G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
+F+ LG+G F VY+ VAIK +D + + G+ + EV H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD-WNTRMKIAAGASRGLQ 206
P++++L Y + + LV E G ++++L + +P R + + G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIIT-GML 126
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCA 265
YLH +++RDL SN+LL + K++DFGLA ++ +K + GT Y +
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYIS 180
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
P+ A +SD++S G + L+ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LG+G V++G +K + AIK ++ + E L +H N+VKL
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 158 AEGDQRL--LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
E R L+ E+ P GSL L + + L + + + G+ +L E
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 216 VIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD---- 267
+++R++K NI+ G KL+DFG A+ D + GT Y PD
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 268 ----YAMTGQLTFKSDIYSFGVVLLELITGR 294
+ D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-24
Identities = 71/245 (28%), Positives = 104/245 (42%), Gaps = 36/245 (14%)
Query: 61 DVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY---KGCLEKIEQ 117
+K + + + A P F+ L LG+G FGKV+ K Q
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLK----------VLGQGSFGKVFLVKKISGSDARQ 53
Query: 118 VVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKLIGYCAEGDQRL-LVYEYMPL 172
+ A+K L + L +HP +VKL Y + + +L L+ +++
Sbjct: 54 LYAMKVLKKATL--KVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRG 110
Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EE 230
G L L T +K A + L +LH +IYRDLK NILL EE
Sbjct: 111 GDLFTRLSKEVMFTEE-----DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE 162
Query: 231 GYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 289
G H KL+DFGL+K +K GT Y AP+ T +D +SFGV++ E
Sbjct: 163 G-HIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218
Query: 290 LITGR 294
++TG
Sbjct: 219 MLTGT 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-24
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLI 154
LGEG F V + AIK L+ R + V + E + DHP VKL
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQL 212
+ + D++L Y G L K++ D T + A L+YLH +
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFD-ETCTRFYTAEIVSALEYLHGK- 149
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
+I+RDLK NILL E H +++DFG AK+ K + +GT Y +P+
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
SD+++ G ++ +L+ G
Sbjct: 208 SACKSSDLWALGCIIYQLVAGL 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 73/301 (24%), Positives = 111/301 (36%), Gaps = 27/301 (8%)
Query: 9 KSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNA---------NLKKEEVSNDGQLS 59
+ + E N + + +I T V++ + +
Sbjct: 58 AQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAE 117
Query: 60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
MD ++ + D+S F LG+G FGKV + +
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-EFEYLKLLGKGTFGKVILVKEKATGRYY 176
Query: 120 AIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSL 175
A+K L + E + E L ++ HP L L Y + RL V EY G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL 235
Query: 176 DKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234
HL R + R + A L YLH + V+YRDLK N++L++ H
Sbjct: 236 FFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 288
Query: 235 KLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
K++DFGL K G T + GT Y AP+ D + GVV+ E++ G
Sbjct: 289 KITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 294 R 294
R
Sbjct: 346 R 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 33/301 (10%)
Query: 8 GKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNL 67
G + +D +NL Q+ K D+ + A K+ + D M VK+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEA--KEVWSNADLTERMPVKSKRT 59
Query: 68 KDDSNNSGKSAKPFTFDELAAATGNFRSD------CCLGEGGFGKVYKGCLEKI-EQVVA 120
+ + PF + A G S LG G FG+V+K C E +A
Sbjct: 60 SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLA 118
Query: 121 IKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180
K + RG++ E E+ + DH NL++L + +LV EY+ G L
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE----LF 174
Query: 181 DLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILL--EEGY 232
D R +D + + + G++++H + +++ DLK NIL +
Sbjct: 175 D-----RIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226
Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
K+ DFGLA+ +K V GT + AP+ ++F +D++S GV+ L++
Sbjct: 227 QIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
Query: 293 G 293
G
Sbjct: 284 G 284
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-23
Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 40/241 (16%)
Query: 68 KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY---KGCLEKIEQVVAIKQL 124
+ N + +P F+ L LG+GG+GKV+ K ++ A+K L
Sbjct: 4 ETSVNRGPEKIRPECFELLR----------VLGKGGYGKVFQVRKVTGANTGKIFAMKVL 53
Query: 125 -------DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLD 176
+ + + AE L HP +V LI Y + +L L+ EY+ G L
Sbjct: 54 KKAMIVRNAKDTAHTK---AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF 109
Query: 177 KHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHP 234
L A S L +LH++ +IYRDLK NI+L +G H
Sbjct: 110 MQLEREGIFMED-----TACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG-HV 160
Query: 235 KLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
KL+DFGL K T GT Y AP+ M D +S G ++ +++TG
Sbjct: 161 KLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 294 R 294
Sbjct: 218 A 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 8e-23
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 99 LGEGGFGKV-YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGY 156
LG G G V ++G + + VA+K++ E+ L S DHPN+++
Sbjct: 23 LGYGSSGTVVFQGSFQG--RPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 157 CAEGDQRLLVYEYMPLGSLDKHL---HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ E +L + + + + + + + G+ +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-- 134
Query: 214 QPVIYRDLKCSNILL-------------EEGYHPKLSDFGLAKM---GPSGDKTHVSTRV 257
+I+RDLK NIL+ E +SDFGL K G S +T+++
Sbjct: 135 -KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 258 MGTYGYCAP-------DYAMTGQLTFKSDIYSFGVVLLELITG 293
GT G+ AP + +LT DI+S G V +++
Sbjct: 194 -GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 47/264 (17%), Positives = 84/264 (31%), Gaps = 72/264 (27%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIK----------------------QLDHRGV------ 129
C+G GGFG V++ + + AIK +L+H G+
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 130 ------------------------------QGVREFSAEVMTLGSADHPNLVKLIGYCAE 159
+ S ++ + N V + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219
+ + +L K + R + + I + +++LH + +++R
Sbjct: 133 KVYLYIQMQLCRKENL-KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 220 DLKCSNILLEEGYHPKLSDFGLAKM----------GPSGDKTHVSTRVMGTYGYCAPDYA 269
DLK SNI K+ DFGL T +GT Y +P+
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
+ K DI+S G++L EL+
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLI 154
LG+G FG+V C +KI Q A+K + R V+ EV L DHPN++KL
Sbjct: 34 LGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GL 205
+ + LV E G L D AA R G+
Sbjct: 93 EFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 206 QYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
Y+H+ +++RDLK N+LL + + ++ DFGL+ + K +GT
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAY 193
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + G K D++S GV+L L++G
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-22
Identities = 29/207 (14%), Positives = 59/207 (28%), Gaps = 41/207 (19%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADH 147
G +R G + ++ +++ VA+ +D +GV ++E + + L D
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P + +++ L+V E++ GSL + ++ +
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADA 144
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
H V S + + S G +
Sbjct: 145 AHRA---GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATMPDA 179
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
+ DI G L L+ R
Sbjct: 180 -------NPQDDIRGIGASLYALLVNR 199
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-22
Identities = 57/210 (27%), Positives = 85/210 (40%), Gaps = 34/210 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLVKLIGY 156
LG G +G+V + AIK + V EV L DHPN++KL +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQY 207
+ LV E G L D AA + G+ Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
LH+ +++RDLK N+LL E+ K+ DFGL+ + + K +GT Y
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYI 205
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGR 294
AP+ + + K D++S GV+L L+ G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 55/260 (21%), Positives = 97/260 (37%), Gaps = 31/260 (11%)
Query: 48 KKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRS----DCCLGEGG 103
++ ++ + K + N K + + + LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 104 FGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162
FG V++ E+ A K + E+ T+ HP LV L + ++
Sbjct: 170 FGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 163 RLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQLKQP 215
+++YE+M G L + + D + +M A R GL ++HE
Sbjct: 229 MVMIYEFMSGGELFE----------KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 216 VIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++ DLK NI+ + KL DFGL V GT + AP+ A
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKP 332
Query: 274 LTFKSDIYSFGVVLLELITG 293
+ + +D++S GV+ L++G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
+G+G FGKV +++ A+K ++ + VR E+ + +HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
Y + ++ + +V + + G L HL +K+ L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-----EETVKLFICELVMALDYLQ---N 133
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
Q +I+RD+K NILL+E H ++DF +A M P + T + GT Y AP+ + +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRK 190
Query: 274 L---TFKSDIYSFGVVLLELITGR 294
+F D +S GV EL+ GR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 21/208 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
+G G F +V +++ QV A+K ++ + V F E L + D + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQLK 213
+ + + L LV EY G L L + R P + R +A + +H +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEM-ARFYLAEIVM-AIDSVH---R 180
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
++RD+K NILL+ H +L+DFG + V GT Y +P
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVG 239
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
TG + D ++ GV E+ G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 64/202 (31%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
LG+G FGKV + + A+K L + E + E L + HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
Y + RL V EY G L HL R T R + A L+YLH +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSR-- 124
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTG 272
V+YRD+K N++L++ H K++DFGL K G S T + GT Y AP+
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN 180
Query: 273 QLTFKSDIYSFGVVLLELITGR 294
D + GVV+ E++ GR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 2e-21
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G V+K + ++VA+K+ LD GV +RE L H N+V+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELKHKNIVR 65
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L + LV+E+ L K+ LD +GL + H +
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
V++RDLK N+L+ KL++FGLA+ P + V+ T Y PD
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLF 174
Query: 271 TGQLTFKS--DIYSFGVVLLELITGRKA-------IDQ 299
G + + D++S G + EL + DQ
Sbjct: 175 -GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-21
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR-GV--QGVREFSAEVMTLGSADHPNLVKL 153
LG G + VYKG + VA+K+ LD G +RE S + H N+V+L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHENIVRL 68
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGASRGLQYLHEQ 211
++ LV+E+M L K++ R L+ N +GL + HE
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYA 269
+++RDLK N+L+ + KL DFGLA+ P + V+ T Y APD
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD-- 178
Query: 270 MTGQLTFKS-------DIYSFGVVLLELITGR 294
+ S DI+S G +L E+ITG+
Sbjct: 179 ----VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 45/221 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-------------EVMTLGSA 145
LG G +G+V + AIK + R E+ L S
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAG 200
DHPN++KL + LV E+ G L + AA
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDAAN 150
Query: 201 ASR----GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHV 253
+ G+ YLH+ +++RD+K NILL + K+ DFGL+ K
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR- 206
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
+GT Y AP+ + + K D++S GV++ L+ G
Sbjct: 207 --DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-21
Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
LG+G FGKV+ +K Q AIK L V + + M + +HP L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
+ + L V EY+ G L H+ R AA GLQ+LH +
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQFLHSK 137
Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
++YRDLK NILL ++G H K++DFG+ K GD T GT Y AP+
Sbjct: 138 ---GIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 190
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
+ + D +SFGV+L E++ G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 51/245 (20%), Positives = 81/245 (33%), Gaps = 54/245 (22%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
+G+G +G V +E + AIK ++ + V EV + HPN+ +
Sbjct: 34 IGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 153 LIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR--- 203
L + LV E G L + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 204 ---------------------------GLQYLHEQLKQPVIYRDLKCSNILLE--EGYHP 234
L YLH Q + +RD+K N L + +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209
Query: 235 KLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPD--YAMTGQLTFKSDIYSFGVVLLE 289
KL DFGL+K +G+ ++T+ GT + AP+ K D +S GV+L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 290 LITGR 294
L+ G
Sbjct: 269 LLMGA 273
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G FG V++ C+EK +V K ++ E+ + HP L+ L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQ 211
+ + +L+ E++ G L D R + +M R GL+++HE
Sbjct: 118 EDKYEMVLILEFLSGGEL----FD-----RIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 212 LKQPVIYRDLKCSNILLE--EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+++ D+K NI+ E + K+ DFGLA + V T + AP+
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIV 222
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
+ F +D+++ GV+ L++G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-21
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYK + ++VA+K+ LD G+ +RE S L HPN+V
Sbjct: 29 VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKELHHPNIVS 83
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
LI LV+E+M L K L + + L + RG+ + H+
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
+++RDLK N+L+ KL+DFGLA+ P TH V+ T Y APD M
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLM 192
Query: 271 TGQLTFKS--DIYSFGVVLLELITGR 294
G + + DI+S G + E+ITG+
Sbjct: 193 -GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-21
Identities = 51/201 (25%), Positives = 77/201 (38%), Gaps = 32/201 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G +G+V + A K++ V+ V F E+ + S DHPN+++L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYLH 209
+ LV E G L + AA + + Y H
Sbjct: 77 DNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 210 EQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
+ V +RDLK N L KL DFGLA G + T+V GT Y +P
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSP 177
Query: 267 DYAMTGQLTFKSDIYSFGVVL 287
+ G + D +S GV++
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMM 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-21
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 19/206 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
+G G FG+V L+ ++V A+K L+ + E F E L + D + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQLK 213
Y + D L LV +Y G L L + + R P + R +A + +H +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEEM-ARFYLAEMVI-AIDSVH---Q 193
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++RD+K NIL++ H +L+DFG S V GT Y +P+ +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAME 252
Query: 274 LTFKS-----DIYSFGVVLLELITGR 294
D +S GV + E++ G
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
+G+G FGKV + E A+K L + + +E +M+ L + HP LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVGL 104
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
+ + +L V +Y+ G L HL R P R + AA + L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL 158
Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
++YRDLK NILL +G H L+DFGL K + T T GT Y AP+
Sbjct: 159 ---NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL 211
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
D + G VL E++ G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-20
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G VYK + A+K+ L+ G+ +RE S L H N+VK
Sbjct: 10 IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKELKHSNIVK 64
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L + +LV+E++ L K L L+ T G+ Y H++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
V++RDLK N+L+ K++DFGLA+ P TH ++ T Y APD
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPD--- 170
Query: 271 TGQLTFKS-------DIYSFGVVLLELITGR 294
+ S DI+S G + E++ G
Sbjct: 171 ---VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR-GV--QGVREFSAEVMTLGSADHPNLVKL 153
LGEG + VYKG + + +VA+K+ L+H G +RE S L H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHANIVTL 65
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
LV+EY+ L ++L D ++ + RGL Y H Q
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
V++RDLK N+L+ E KL+DFGLA+ P+ + V+ T Y PD +
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPDILL- 173
Query: 272 GQLTFKS--DIYSFGVVLLELITGR 294
G + + D++ G + E+ TGR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
LG G FG+V ++ A+K LD + V +++ E L + + P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ +V EY+ G + HL + + R AA +YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-----ARF-YAAQIVLTFEYLHSL-- 160
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+IYRDLK N+L+++ + +++DFG AK T + GT AP+ ++
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKG 214
Query: 274 LTFKSDIYSFGVVLLELITGR 294
D ++ GV++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 69/253 (27%), Positives = 110/253 (43%), Gaps = 28/253 (11%)
Query: 50 EEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYK 109
E + G + ++ ++ SGK++ +F +G G + KV
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DFDLLRVIGRGSYAKVLL 70
Query: 110 GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKLIGYCAEGDQRL 164
L+K +++ A++ + V E V T +++HP LV L C + + RL
Sbjct: 71 VRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRL 128
Query: 165 -LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLK 222
V EY+ G L H+ R + +A S L YLHE+ +IYRDLK
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHER---GIIYRDLK 180
Query: 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIY 281
N+LL+ H KL+D+G+ K G T T GT Y AP+ F D +
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWW 237
Query: 282 SFGVVLLELITGR 294
+ GV++ E++ GR
Sbjct: 238 ALGVLMFEMMAGR 250
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 58/208 (27%), Positives = 82/208 (39%), Gaps = 21/208 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSAEVMTLGSADHPNLVKLI--- 154
G+G FG V G + VAIK+ + RE + L HPN+V+L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 155 ---GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
G D L +V EY+P +L + + R + LH
Sbjct: 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKM-GPSGDKTH-VSTRVMGTYGYCAPD 267
V +RD+K N+L+ E KL DFG AK PS + +R Y Y AP+
Sbjct: 148 PSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPE 201
Query: 268 YAMTGQL-TFKSDIYSFGVVLLELITGR 294
Q T DI+S G + E++ G
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 34/210 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
LG+G FG+V K +Q A+K ++ + EV L DHPN++KL
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-----AAGASR----GLQY 207
+ +V E G L D + K AA + G+ Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
+H+ +++RDLK NILL E+ K+ DFGL+ K +GT Y
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYI 190
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGR 294
AP+ + G K D++S GV+L L++G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSA--EVMTLGSADHPNLVK 152
+GEG +G V+K Q+VAIK+ D + + A E+ L HPNLV
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI----KKIALREIRMLKQLKHPNLVN 66
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L+ + LV+EY ++ L + R + + I + + + H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCH--- 119
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTR-------VMGTYG 262
K I+RD+K NIL+ + KL DFG A++ GPS V+TR ++G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y P D+++ G V EL++G
Sbjct: 180 YGPP-----------VDVWAIGCVFAELLSGV 200
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 41/283 (14%)
Query: 42 DSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGE 101
A + + G+ + VK+ + + F+ L LG
Sbjct: 15 SGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----------VLGT 64
Query: 102 GGFGKVY---KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSADH-PNLVKL 153
G +GKV+ K ++ A+K L + + + T L P LV L
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
Y + + +L L+ +Y+ G L HL T ++I L++LH+
Sbjct: 125 H-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEIVLALEHLHKL 178
Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPDY 268
+IYRD+K NILL G H L+DFGL+K + ++ + GT Y APD
Sbjct: 179 ---GIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAY--DFC-GTIEYMAPDI 231
Query: 269 AMTGQL--TFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
G D +S GV++ EL+TG + + E+
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 44/217 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
LGEG +G+VYK + VAIK+ L+H GV +RE S L H N+++
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQHRNIIE 97
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS------RGLQ 206
L + L++EY +DL+ + +D N + + S G+
Sbjct: 98 LKSVIHHNHRLHLIFEYAE--------NDLK---KYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHP-----KLSDFGLAKM--GPSGDKTHVSTRVMG 259
+ H + ++RDLK N+LL K+ DFGLA+ P TH ++
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII- 199
Query: 260 TYGYCAPDYAMTGQLTFKS--DIYSFGVVLLELITGR 294
T Y P+ + G + + DI+S + E++
Sbjct: 200 TLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LG G FG V+ IK ++ Q E AE+ L S DHPN++K+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQL 212
+ +V E G L ++ + + A + L Y H Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSE-----GYVAELMKQMMNALAYFHSQ- 143
Query: 213 KQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
V+++DLK NIL K+ DFGLA++ S + + GT Y AP+
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALYMAPE-V 197
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
+TFK DI+S GVV+ L+TG
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
LG+G FGKV + +++ A+K L + V + M P L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
C + RL V EY+ G L H+ + P AA + GL +L +
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSK 461
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAM 270
+IYRDLK N++L+ H K++DFG+ K T T+ GT Y AP+
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIA 515
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
D ++FGV+L E++ G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LGEG +G+V E+ VA+K +D + E E+ +H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLH 209
EG+ + L EY G L D+ ++ + M A R G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--- 266
+ +RD+K N+LL+E + K+SDFGLA + ++ + ++ GT Y AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
++ + D++S G+VL ++ G
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIG 155
LG+G FG+V K C ++I +Q A+K ++ + EV L DHPN++KL
Sbjct: 30 LGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQ 206
+ +V E G L D + AA + G+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 207 YLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
Y+H+ +++RDLK NILL E+ K+ DFGL+ K R+ GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI-GTAYY 189
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVL 287
AP+ + G K D++S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLVKL- 153
LGEG +GKV + + A+K L + ++ + A E+ L H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 154 -IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK----IAAGASRGLQYL 208
+ Y E + +V EY G + + D P+ R I GL+YL
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID-----GLEYL 125
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H Q ++++D+K N+LL G K+S G+A+ G+ + P+
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 269 AMTGQL--TFKSDIYSFGVVLLELITGR 294
A FK DI+S GV L + TG
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
+G G + KV L+K +++ A+K + V E V T +++HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
C + + RL V EY+ G L H+ R + +A S L YLHE+
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHER 129
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAM 270
+IYRDLK N+LL+ H KL+D+G+ K G T T GT Y AP+
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILR 183
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
F D ++ GV++ E++ GR
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 96 DCCLGEGGFGKVYKGCLEKIE--QVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLV 151
C +G G +G VYK + + + A+KQ++ G+ RE + L HPN++
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVI 81
Query: 152 KLIGYCAE-GDQRL-LVYEYMPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGAS------ 202
L D+++ L+++Y D H+ ++ ++ S
Sbjct: 82 SLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKM--GPSGDKTHVSTR 256
G+ YLH V++RDLK +NIL+ K++D G A++ P +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 257 VMGTYGYCAPD-------YAMTGQLTFKSDIYSFGVVLLELITGR 294
V+ T+ Y AP+ Y T DI++ G + EL+T
Sbjct: 196 VV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY-C 157
+G G FG VY+ L ++VAIK++ +Q R + E+ + DH N+V+L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 158 AEGDQRL-----LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK-----IAAGASRGLQY 207
+ G+++ LV +Y+P ++ + + L +K + R L Y
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF----RSLAY 171
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK-TH-VSTRVMGTYGYC 264
+H + +RD+K N+LL+ KL DFG AK G+ + +R Y Y
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223
Query: 265 APDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
AP+ T D++S G VL EL+ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 45/219 (20%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA--------EVMTLGSADHPN 149
LG G G+V E+ + VAI+ + R A E+ L +HP
Sbjct: 143 LGSGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW---NTRM--KIAAGASR- 203
++K+ + + + +V E M G L D N R+
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQ 247
Query: 204 ---GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
+QYLHE +I+RDLK N+LL EE K++DFG +K+ G+ + + T
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 302
Query: 258 MGTYGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITG 293
GT Y AP T D +S GV+L ++G
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
LG+G FGKV + +++ A+K L V + M P L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
C + RL V EY+ G L H+ + P AA + GL +L +
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSK 140
Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
+IYRDLK N++L EG H K++DFG+ K T T+ GT Y AP+
Sbjct: 141 ---GIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEII 193
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
D ++FGV+L E++ G+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-20
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GVQGV-----REFSAEVMTLGSADHPN 149
+G G +G VYK VA+K + + G G+ RE + + L + +HPN
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLEAFEHPN 75
Query: 150 LVKLI----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS 202
+V+L+ + + ++ LV+E++ DLR D P I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHVSTRVM 258
RGL +LH +++RDLK NIL+ G KL+DFGLA++ T V+
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV 181
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
T Y AP+ + D++S G + E+ +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY 156
LGEG +V C+ I Q A+K ++ + EV L H N+++LI +
Sbjct: 21 LGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQL 212
E D+ LV+E M GS+ H+H R + + ++ A A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDVASA---LDFLHN-- 129
Query: 213 KQPVIYRDLKCSNILLEEGYHP---KLSDFGLAK-MGPSGDKTHVSTRVM----GTYGYC 264
+ + +RDLK NIL E K+ DF L + +GD + +ST + G+ Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 265 AP---DYAMTGQLTF--KSDIYSFGVVL 287
AP + + + D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-20
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
LG+G FGKV +++ + A+K L + + MT + +HP L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
C + RL V E++ G L H+ R R + AA L +LH++
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMFLHDK 143
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAM 270
+IYRDLK N+LL+ H KL+DFG+ K G T T GT Y AP+
Sbjct: 144 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQ 197
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
D ++ GV+L E++ G
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-20
Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 34/202 (16%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G F +V+ +++ ++ A+K + E+ L H N+V L
Sbjct: 17 LGSGAFSEVFL-VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYL 208
LV + + G L D K A+ + ++YL
Sbjct: 76 ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 209 HEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
HE +++RDLK N+L EE ++DFGL+KM ++ + + GT GY A
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175
Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
P+ + D +S GV+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-20
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
LGEG +G+V E+ VA+K +D + E E+ +H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLH 209
EG+ + L EY G L D+ ++ + M A R G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD-AQRFFHQLMAGVVYLH 122
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--- 266
+ +RD+K N+LL+E + K+SDFGLA + ++ + ++ GT Y AP
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
++ + D++S G+VL ++ G
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQ--GVREFSA--EVMTLGSADHPNLVK 152
LGEG F VYK + Q+VAIK+ L HR G+ +A E+ L HPN++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN-RTALREIKLLQELSHPNIIG 76
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L+ LV+++M L+ + D L + +GL+YLH+
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTRVMGTYGYCAPDYA 269
+++RDLK +N+LL+E KL+DFGLAK P+ TH V TR Y AP+
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRAPE-- 182
Query: 270 MTGQLTFKS-------DIYSFGVVLLELITGR 294
L F + D+++ G +L EL+
Sbjct: 183 ----LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 38/212 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
+GEG +G V K + ++VAIK+ D + V +RE L H NLV
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQLRHENLVN 88
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L+ C + + LV+E++ ++ L LD+ K G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKYLFQIINGIGFCH--- 141
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTR-------VMGTYG 262
+I+RD+K NIL+ + KL DFG A+ P V+TR ++G
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y D+++ G ++ E+ G
Sbjct: 202 YGKA-----------VDVWAIGCLVTEMFMGE 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 39/204 (19%), Positives = 82/204 (40%), Gaps = 26/204 (12%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G FG V++ C+E ++ K + +G E+ L A H N++ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQ 211
++ ++++E++ + + R + + LQ+LH
Sbjct: 71 ESMEELVMIFEFISGLDI----FE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 212 LKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ + D++ NI+ K+ +FG A+ GD + + Y AP+
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
++ +D++S G ++ L++G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLV 151
+GEG +GKV+K K + VA+K+ + G+ +RE + + L + +HPN+V
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 77
Query: 152 KLI----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS-- 202
+L + + +L LV+E++ DL D P I
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 203 -RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHVSTRVMGT 260
RGL +LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-T 182
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + D++S G + E+ +
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
+G G FG+V + +V A+K L + F E + A+ P +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
Y + D+ L +V EYMP G L + + + A L +H
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP------EKWARFYTAEVVLALDAIH---S 186
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP----DYA 269
I+RD+K N+LL++ H KL+DFG T V GT Y +P
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
G + D +S GV L E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
LG G F V K C EK A K + R + R EV L HPN++
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
L +L+ E + G L + L + + A +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------------EEATSFIKQI 124
Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
G+ YLH + + + DLK NI+L H KL DFGLA G + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---I 178
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
GT + AP+ L ++D++S GV+ L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 63/317 (19%), Positives = 109/317 (34%), Gaps = 59/317 (18%)
Query: 4 FRCSGKSNKKLDEEIDNKNKNLNK----QADKKQLIADTPRVDSNANLKKEEVSNDGQLS 59
S + K ++E + + ++++ + R D + + +N +
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQS------ANLLAEA 58
Query: 60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRS----DCCLGEGGFGKVYKGCLEKI 115
+ + K N +S P AA F +G G V + C+ +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR-CVHRA 117
Query: 116 -EQVVAIKQLDHRGVQGVREFSA--------EVMTLGS-ADHPNLVKLIGYCAEGDQRLL 165
A+K ++ + E E L A HP+++ LI L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYLHEQLKQPV 216
V++ M G L D+ T K R + +LH +
Sbjct: 178 VFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NI 221
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------DYAM 270
++RDLK NILL++ +LSDFG + G+K GT GY AP
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPEILKCSMDET 278
Query: 271 TGQLTFKSDIYSFGVVL 287
+ D+++ GV+L
Sbjct: 279 HPGYGKEVDLWACGVIL 295
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 46/215 (21%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLD--------HRGVQGVRE-FSAEVMTLGS-ADH 147
LG G V + C+ K + A+K +D VQ +RE EV L + H
Sbjct: 25 LGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGAS 202
PN+++L LV++ M G L D+ T K
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSEKETRKIM 130
Query: 203 R----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
R + LH+ +++RDLK NILL++ + KL+DFG + G+K
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVC- 184
Query: 259 GTYGYCAP------DYAMTGQLTFKSDIYSFGVVL 287
GT Y AP + D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 49/217 (22%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
+G+G F KV + VAIK QL+ +Q + EV + +HPN+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK----------IAAGASR 203
L+ EY G + +L + RMK I +
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSA--- 126
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
+QY H ++ +++RDLK N+LL+ + K++DFG + G K G Y
Sbjct: 127 -VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPY 179
Query: 264 CAP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
AP Y G + D++S GV+L L++G
Sbjct: 180 AAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-19
Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 41/207 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG+G F V + C+ K A K +L R Q + E HPN+V+
Sbjct: 14 LGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 69
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR---- 203
L E LV++ + G L + A+ +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILE 116
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ Y H +++R+LK N+LL +G KL+DFGLA + H GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFA-GT 170
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVL 287
GY +P+ + DI++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 42/216 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
LG G F V K C +K + A K + R + R + EV L HPN++
Sbjct: 13 LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
L +L+ E + G L + L + A +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------------DEATQFLKQI 117
Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRV 257
G+ YLH + + + DLK NI+L + P KL DFG+A +G++ +
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---I 171
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
GT + AP+ L ++D++S GV+ L++G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY-- 156
+G G FG V++ L + ++ VAIK++ +Q R + E+ + HPN+V L +
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 157 ---CAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ + L LV EY+P ++ + + + R L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--- 158
Query: 213 KQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK-TH-VSTRVMGTYGYCAPDYA 269
+ +RD+K N+LL+ KL DFG AK+ +G+ + +R Y Y AP+
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELI 213
Query: 270 MTGQL-TFKSDIYSFGVVLLELITGR 294
T DI+S G V+ EL+ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 57/213 (26%), Positives = 81/213 (38%), Gaps = 45/213 (21%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA--------EVMTLGSADHPN 149
LG G G+V E+ + VAIK + R A E+ L +HP
Sbjct: 18 LGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW---NTRM--KIAAGASR- 203
++K+ + + + +V E M G L D N R+
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQ 122
Query: 204 ---GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
+QYLHE +I+RDLK N+LL EE K++DFG +K+ T
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC 177
Query: 258 MGTYGYCAP---DYAMTGQLTFKSDIYSFGVVL 287
GT Y AP T D +S GV+L
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-19
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 49/216 (22%)
Query: 99 LGEGGFGKVY----KG--------CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
LG G FG+V+ + L+K E VV +KQ++H E + L
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEH-----TN---DERLMLSIVT 64
Query: 147 HPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRG 204
HP ++++ + Q++ ++ +Y+ G L L + N K AA
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLA 118
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
L+YLH + +IYRDLK NILL++ H K++DFG AK P T + GT Y
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYI 170
Query: 265 AP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
AP Y + D +SFG+++ E++ G
Sbjct: 171 APEVVSTKPYNKS------IDWWSFGILIYEMLAGY 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 42/225 (18%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--------EVMTL 142
+ + LG G FG V+ ++ + V +K + V E+ L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
+H N++K++ LV E G L +D + R+ AS
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAF------IDRHPRLDEPL-AS 133
Query: 203 R-------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
+ YL + +I+RD+K NI++ E + KL DFG A G +
Sbjct: 134 YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 256 RVMGTYGYCAPD------YAMTGQLTFKSDIYSFGVVLLELITGR 294
GT YCAP+ Y G + +++S GV L L+
Sbjct: 191 ---GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEE 227
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 26/198 (13%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G G + + C+ K A+K +D E E++ L HPN++ L
Sbjct: 30 IGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPNIITLKDVY 85
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+G +V E M G L + + + + + ++YLH Q
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKT---VEYLHAQ-- 135
Query: 214 QPVIYRDLKCSNILL---EEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
V++RDLK SNIL ++ DFG AK + + + T T + AP+
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPEVL 192
Query: 270 MTGQLTFKSDIYSFGVVL 287
DI+S GV+L
Sbjct: 193 ERQGYDAACDIWSLGVLL 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
LG G F V K C EK A K + R + R + EV L H N++
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
L +L+ E + G L + L + + A +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------------EEATSFIKQI 124
Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
G+ YLH + + + DLK NI+L H KL DFGLA G + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---I 178
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
GT + AP+ L ++D++S GV+ L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGY 156
LGEG F K C+ K Q A+K + R ++ E+ L + HPN+VKL
Sbjct: 19 LGEGSFSICRK-CVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQL 212
+ LV E + G L + + + + + M+ A + ++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDV- 125
Query: 213 KQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
V++RDLK N+L + K+ DFG A++ P ++ + T T Y AP+
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELL 181
Query: 270 MTGQLTFKSDIYSFGVVL 287
D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
LG G F V K C EK A K + R + R + EV L HPN++
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
L +L+ E + G L + L + + A +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------------EEATEFLKQI 123
Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
G+ YLH + + DLK NI+L K+ DFGLA G++ +
Sbjct: 124 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
GT + AP+ L ++D++S GV+ L++G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 35/204 (17%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIG 155
LG+G F V + C+ K A K ++ + + ++ E HPN+V+L
Sbjct: 37 LGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQ 206
E LV++ + G L + A+ + +
Sbjct: 96 SIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIA 142
Query: 207 YLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
Y H +++R+LK N+LL +G KL+DFGLA + H GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFA-GTPGY 196
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVL 287
+P+ + DI++ GV+L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-18
Identities = 54/266 (20%), Positives = 87/266 (32%), Gaps = 77/266 (28%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD-HPNLV 151
LG G FG+V + I + VA+K L + R +E+ L H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 152 KLIG--------------YCAEGDQRLLVY------------------------------ 167
L+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 168 ---------------------EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
E L +++ L + + ++G++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
+L + I+RDL NILL E K+ DFGLA+ + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
+ T +SD++SFGV+L E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 55/235 (23%), Positives = 93/235 (39%), Gaps = 57/235 (24%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--------------------- 137
+G+G +G V E A+K L + + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 138 -----EVMTLGSADHPNLVKL--IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
E+ L DHPN+VKL + D +V+E + G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127
Query: 191 WNTRMKIAAGASR--------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
T ++ +R G++YLH Q +I+RD+K SN+L+ E H K++DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGR 294
D +S V GT + AP+ + F D+++ GV L + G+
Sbjct: 185 NEFKGSDA-LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 60/229 (26%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSA--EVMTLGSADHPNLVKLIG 155
+G+G FG+V+K K Q VA+K++ +G +A E+ L H N+V LI
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83
Query: 156 YCAEGDQRL--------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS----- 202
C LV+++ HDL L N +K
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRVMQ 131
Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM------GPSGDKTH- 252
GL Y+H + +++RD+K +N+L+ KL+DFGLA+ T+
Sbjct: 132 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 253 VSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
V T ++G Y P D++ G ++ E+ T
Sbjct: 189 VVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRS 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 40/213 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
LG G FGKV G + VA+K L+ + ++ + E+ L HP+++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 156 YCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQY 207
+ +V EY+ G L D + + R++ A R + Y
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDY-----------ICKHGRVEEME-ARRLFQQILSAVDY 126
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
H + V++RDLK N+LL+ + K++DFGL+ M G+ S G+ Y AP+
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 268 ------YAMTGQLTFKSDIYSFGVVLLELITGR 294
YA G + DI+S GV+L L+ G
Sbjct: 181 VISGRLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 35/202 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
LG G VY+ + ++ A+K L + VR E+ L HPN++KL
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF 117
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYL 208
+ LV E + G L D + AA A + + YL
Sbjct: 118 ETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 209 HEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
HE +++RDLK N+L K++DFGL+K+ V GT GYCA
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCA 218
Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
P+ + D++S G++
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 40/207 (19%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
LG+G F V + C++ + Q A +L R Q + E HPN+V+
Sbjct: 19 LGKGAFSVVRR-CVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVR 74
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR---- 203
L +E L+++ + G L + A+ +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILE 121
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ + H+ V++R+LK N+LL +G KL+DFGLA + GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFA-GT 176
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVL 287
GY +P+ D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 24/206 (11%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH-PNLVKLI 154
LG G F V + C+ K Q A K L RG E E+ L A P ++ L
Sbjct: 37 LGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHE 210
+ +L+ EY G + + + + G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FS-LCLPELAEMVSE-NDVIRLIKQILEGVYYLHQ 149
Query: 211 QLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
+++ DLK NILL K+ DFG+++ + +MGT Y AP+
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPE 203
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
+T +D+++ G++ L+T
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 31/206 (15%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA-----EVMTLGSADHPNLVK 152
+G+G F V + C+ + Q A+K +D S E HP++V+
Sbjct: 32 IGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 153 LIGYCAEGDQRLLVYEYMPLGSL----DKHLHDLRP----DTRPLDWNTRMKIAAGASRG 204
L+ + +V+E+M L K M+ A
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQILEA--- 142
Query: 205 LQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
L+Y H+ +I+RD+K +LL E KL FG+A RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV-GTP 197
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVL 287
+ AP+ D++ GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 37/234 (15%)
Query: 72 NNSGKSAKPFTFDELAAATGNFRSD-----CCLGEGGFGKVYKGCLEKI-EQVVAIKQLD 125
++ S F D LG G GKV + C + Q A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLE-CFHRRTGQKCALKLLY 63
Query: 126 HRGVQGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQR----LLVYEYMPLGSLDKHLH 180
R+ EV ++ P++V ++ L++ E M G L +
Sbjct: 64 DS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 181 DLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILL---EEGYH 233
+ R T + AA R +Q+LH + +RD+K N+L E+
Sbjct: 119 E-----RGDQAFTE-REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169
Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
KL+DFG AK + T T Y AP+ + D++S GV++
Sbjct: 170 LKLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 40/213 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
LG G FGKV G E VA+K L+ + ++ + E+ L HP+++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 156 YCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQY 207
+ +V EY+ G L D + N R+ + R G+ Y
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDY-----------ICKNGRLDEKE-SRRLFQQILSGVDY 131
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP- 266
H + V++RDLK N+LL+ + K++DFGL+ M G+ S G+ Y AP
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185
Query: 267 -----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
YA G + DI+S GV+L L+ G
Sbjct: 186 VISGRLYA--GP---EVDIWSSGVILYALLCGT 213
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 40/212 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G FG + +++VA+K ++ RG E++ S HPN+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 159 EGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLHE 210
++ EY G L ++ + R A G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYER-----------ICNAGRFSEDE-ARFFFQQLLSGVSYCH- 133
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP-- 266
+ +RDLK N LL+ P K+ DFG +K + + V GT Y AP
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEV 188
Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+Y G+ +D++S GV L ++ G
Sbjct: 189 LLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 51/231 (22%), Positives = 85/231 (36%), Gaps = 52/231 (22%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------EVMTL-- 142
+R LG+GGFG V+ G VAIK + V G S EV L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 143 --GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK---- 196
HP +++L+ + + +LV E + L D + +
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDY------ITEKGPLGEGPS 141
Query: 197 -------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSG 248
+AA +Q+ H + V++RD+K NIL++ KL DFG +
Sbjct: 142 RCFFGQVVAA-----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193
Query: 249 D-KTHVSTRVMGTYGYCAPDYAM----TGQLTFKSDIYSFGVVLLELITGR 294
GT Y P++ + ++S G++L +++ G
Sbjct: 194 PYTDFD-----GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGD 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 45/233 (19%), Positives = 84/233 (36%), Gaps = 58/233 (24%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV----------REFSAEVM 140
++ LG GGFG VY G VAIK ++ + E ++
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV--LL 100
Query: 141 TLGSADHPNLVKLIGYCAEGDQRLLVYEY-MPLGSL-DKHLHDLRPDTRPLDWNTRMK-- 196
S+ +++L+ + D +L+ E P+ L D + ++
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF-----------ITERGALQEE 149
Query: 197 ---------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGP 246
+ A +++ H V++RD+K NIL+ KL DFG +
Sbjct: 150 LARSFFWQVLEA-----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201
Query: 247 SGD-KTHVSTRVMGTYGYCAPDYAM----TGQLTFKSDIYSFGVVLLELITGR 294
GT Y P++ G+ + ++S G++L +++ G
Sbjct: 202 DTVYTDFD-----GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 41/221 (18%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADH 147
G + LGEG FGKV K +Q VA+K + + ++ E+ L H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR--- 203
P+++KL ++V EY G L D + RM R
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAG-GELFDY-----------IVEKKRMTEDE-GRRFFQ 115
Query: 204 ----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
++Y H + +++RDLK N+LL++ + K++DFGL+ + G+ S G
Sbjct: 116 QIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 260 TYGYCAP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
+ Y AP YA G + D++S G+VL ++ GR
Sbjct: 170 SPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
+G G G V +++ VAIK+L R F E++ + +H N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 150 LVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
++ L+ E Q + LV E M D +L + LD +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHERMSYLLYQMLC 175
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTY 261
G+++LH +I+RDLK SNI+++ K+ DFGLA+ + +V TR
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + DI+S G ++ E++ +
Sbjct: 229 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 31/202 (15%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY 156
LG G GKV + K ++ A+K L R EV + P++V+++
Sbjct: 70 LGLGINGKVLQ-IFNKRTQEKFALKMLQDC--PKARR---EVELHWRASQCPHIVRIVDV 123
Query: 157 CAEGDQR----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYL 208
L+V E + G L + D R T + A+ + +QYL
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTE-REASEIMKSIGEAIQYL 177
Query: 209 HEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
H + +RD+K N+L KL+DFG AK S + ++T T Y A
Sbjct: 178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVA 231
Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
P+ + D++S GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 43/215 (20%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
+G G G V +E+ VAIK+L R F E++ + +H N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 150 LVKLIG-YCAEGDQRL-----LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAGA 201
++ L+ + + +V E M D +L ++ LD + RM +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ---MELD-HERMSYLLYQM 136
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKT-HVSTRVMG 259
G+++LH +I+RDLK SNI+++ K+ DFGLA G S T +V TR
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 191
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + DI+S G ++ E+I G
Sbjct: 192 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 36/217 (16%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSA---------EVMTLGSADH 147
+ G +G V ++ VAIK++ + V S E+ L H
Sbjct: 30 ISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 148 PNLVKL----IGYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAG 200
PN++ L + + +L LV E M L + + ++
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-PQHIQYFMYH 142
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKT-HVSTRVM 258
GL LHE V++RDL NILL + + DF LA + +KT +V+ R
Sbjct: 143 ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198
Query: 259 GTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGR 294
Y AP+ M T D++S G V+ E+ +
Sbjct: 199 ----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 53/248 (21%), Positives = 88/248 (35%), Gaps = 75/248 (30%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLVKLI 154
LG G FG V + + + A+K+ V + E+ + DH N++KL+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 155 GY-------------------------------------CAEGDQRL-LVYEYMPLGSLD 176
Y ++ L ++ EY+P +L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-K 235
K L R + N R + ++H + +RD+K N+L+ + K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182
Query: 236 LSDFGLAKMGPSGDK-TH-VSTRVMGTYGYCAP-------DYAMTGQLTFKSDIYSFGVV 286
L DFG AK + + +R + Y AP +Y T D++S G V
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY------TPSIDLWSIGCV 231
Query: 287 LLELITGR 294
ELI G+
Sbjct: 232 FGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
+G G +G V + VAIK+L R F + E+ L H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 150 LVKLIG-YCAEGDQRL-----LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGAS 202
++ L+ + + LV +M L ++ L + +
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK--HEKLGEDRIQFLVYQML 138
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
+GL+Y+H +I+RDLK N+ + E K+ DFGLA+ S +V TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 263 YCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
Y AP+ + T DI+S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 41/215 (19%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHP 148
+G G +G V K VA+K+L R F + E+ L H
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 149 NLVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGA 201
N++ L+ E + LV M L++ ++ + L + +
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK--CQKLTDDHVQFLIYQI 141
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGT 260
RGL+Y+H +I+RDLK SN+ + E K+ DFGLA+ + + T +V+TR
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW--- 194
Query: 261 YGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
Y AP+ + DI+S G ++ EL+TGR
Sbjct: 195 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 40/213 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
+G G +G V ++ + VAIK+L R F + E++ L H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 150 LVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
++ L+ LV +M L + + +
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG--LKFSEEKIQYLVYQMLK 137
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYG 262
GL+Y+H V++RDLK N+ + E K+ DFGLA+ + T V TR
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTRW----- 188
Query: 263 YCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
Y AP+ ++ DI+S G ++ E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-13
Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVM-TLGSADH 147
+R +G G FG +Y G + VAIK + + Q E +++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGG-- 64
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQ 206
+ + AEGD ++V M L L L DL R T + +A ++
Sbjct: 65 VGIPTIRWCGAEGDYNVMV---MEL--LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPK---LSDFGLAKM-GPSGDKTHVSTR----VM 258
Y+H + I+RD+K N L+ G + DFGLAK + H+ R +
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 259 GTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
GT Y A G + + + D+ S G VL+ G
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVM-TLGSADH 147
FR +G G FG++Y G + + VAIK + + Q + E +++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRILQGG-- 62
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
+ + + EGD +LV + LG SL+ L + R L T + +A ++
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDL--LGPSLE-DLFNFCS--RKLSLKTVLMLADQMINRVE 117
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPK---LSDFGLAKM-GPSGDKTHVSTR----VM 258
++H + ++RD+K N L+ G + DFGLAK + H+ R +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 259 GTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
GT Y A G + + + D+ S G VL+ + G
Sbjct: 175 GTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIG- 155
+GEG +G V + VAIK++ R E+ L H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 156 ---YCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAGASRGLQYLH 209
E + + +V + M + L+ L+ T+ L N + RGL+Y+H
Sbjct: 94 IRAPTIEQMKDVYIVQDLM-----ETDLYKLLK--TQHLS-NDHICYFLYQILRGLKYIH 145
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT------HVSTRVMGTYGY 263
V++RDLK SN+LL K+ DFGLA++ +V+TR Y
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR-----WY 197
Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
AP+ + + T DI+S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 49/217 (22%), Positives = 84/217 (38%), Gaps = 24/217 (11%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHP 148
+++ +GEG FG +++G Q VAIK Q E+ + G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQY 207
+ + + EG +LV + L L L DL R T A +Q
Sbjct: 67 GIPNVYYFGQEGLHNVLV---IDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPK-----LSDFGLAKM-GPSGDKTHVSTR----V 257
+HE+ ++YRD+K N L+ + DFG+ K K H+ R +
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
GT Y + + + + + + D+ + G V + + G
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIG- 155
LG GG G V+ ++ VAIK++ E+ + DH N+VK+
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 156 YCAEGDQRL-------------LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGA 201
G Q +V EYM + L + L PL
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE--QGPLLEEHARLFMYQL 129
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMG 259
RGL+Y+H V++RDLK +N+ + E K+ DFGLA+ M P + +
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 260 TYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
T Y +P ++ T D+++ G + E++TG+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 55/289 (19%), Positives = 96/289 (33%), Gaps = 79/289 (27%)
Query: 68 KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR 127
++SG+ F + N+ +G G +G VY + E+ VAIK+++
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-- 60
Query: 128 GVQGVREFSA---------EVMTLGSADHPNLVKLIG-YCAEGDQRL----LVYEYMPLG 173
R F E+ L +++L + + +V E
Sbjct: 61 -----RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--- 112
Query: 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGAS--------------RGLQYLHEQLKQPVIYR 219
D L L G ++HE +I+R
Sbjct: 113 --DSDLKKL--------------FKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHR 153
Query: 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT---- 275
DLK +N LL + K+ DFGLA+ S T++ + + + QLT
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 276 ------------FKS-----DIYSFGVVLLELITGRKA-IDQTKDRKEL 306
++ DI+S G + EL+ ++ I+ +R L
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 48/223 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLI-- 154
LGEG +G V + ++VAIK+++ + + +R E+ L H N++ +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNI 77
Query: 155 --GYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-----IAAGASRGL 205
E + ++ E M LH + T+ L + ++ R +
Sbjct: 78 QRPDSFENFNEVYIIQELM-----QTDLHRVIS--TQMLS-DDHIQYFIYQTL----RAV 125
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-------------H 252
+ LH VI+RDLK SN+L+ K+ DFGLA++
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 253 VSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
V+TR Y AP+ +T + D++S G +L EL R
Sbjct: 183 VATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 41/217 (18%), Positives = 81/217 (37%), Gaps = 47/217 (21%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-----EVMTLGS-ADHPNLVK 152
LG G + +V++ + V +K L + E+ L + PN++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLRGGPNIIT 95
Query: 153 L--IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTRMKIAAGASRG 204
L I LV+E++ + L L +
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KA 142
Query: 205 LQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMG-PSGDKTH-VSTRVMGTY 261
L Y H +++RD+K N+++ E +L D+GLA+ P + V++R
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195
Query: 262 GYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAI 297
+ P+ + Q+ + D++S G +L +I ++
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-11
Identities = 44/265 (16%), Positives = 76/265 (28%), Gaps = 70/265 (26%)
Query: 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV------ 132
P F T + +GEG FG+V++ + VAIK + G V
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQK 65
Query: 133 --REFSAEVMTL---------GSADHPNLVKLIG-YCAEG-------------------- 160
E E++ + L +C +G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 161 ---------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
DQ +V E+ G + + + T I + L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--DYA 269
L+ +RDL N+LL++ KL K + + + G DY
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYT 227
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
++ ++ + +L TG
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 26/218 (11%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHP 148
NFR +G G FG++ G + VAIK + R Q E+
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---D 65
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
+ ++ + G +V E LG SL+ L DL R T + IA ++Y
Sbjct: 66 GIPQVYYFGPCGKYNAMVLEL--LGPSLE-DLFDLCD--RTFSLKTVLMIAIQLISRMEY 120
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPK-----LSDFGLAKM-GPSGDKTHVSTR----V 257
+H + +IYRD+K N L+ + + DF LAK K H+ R +
Sbjct: 121 VHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177
Query: 258 MGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
GT Y + G + + + D+ + G + + + G
Sbjct: 178 TGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 30/159 (18%)
Query: 99 LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGY 156
LG G GKV + K ++ A+K L R EV ++ P++V+++
Sbjct: 26 LGLGINGKVLQ-IFNKRTQEKFALKMLQDC--PKARR---EVELHWRASQCPHIVRIVDV 79
Query: 157 CAEGDQR----LLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQY 207
L+V E + G L R R T + A+ + +QY
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFS------RIQDRGDQAFTE-REASEIMKSIGEAIQY 132
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAK 243
LH + +RD+K N+L KL+DFG AK
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 48/266 (18%), Positives = 88/266 (33%), Gaps = 38/266 (14%)
Query: 59 SMDVKNLNLKDDSNNSGKSAKPFTFDELAAAT--GNFRSDCCLGEGGFGKVYKGCLEKIE 116
SM VK S+ A+ F E+ ++ +G+GGFG +Y + E
Sbjct: 1 SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSE 60
Query: 117 QV-----VAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPNLVKLIGYCAEG 160
V +K E + + + + K G
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 161 DQ----RLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
R ++ M L + + T ++++ L+Y+HE
Sbjct: 121 KNGKSYRFMI---MDR--FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--- 172
Query: 216 VIYRDLKCSNILLEEGYHPK--LSDFGLAKM-GPSGDKTHVSTR----VMGTYGYCAPDY 268
++ D+K SN+LL + L D+GLA P G + GT + + D
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
+ + D+ G +++ +TG
Sbjct: 233 HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 53/314 (16%), Positives = 96/314 (30%), Gaps = 84/314 (26%)
Query: 48 KKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKV 107
++ +S + + ++S +A + +G G +G V
Sbjct: 10 QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHV 69
Query: 108 YKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPNLVKL----I 154
+ + ++VVAIK++ R F E+ L +H ++VK+ I
Sbjct: 70 CEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS----------- 202
E L +V E D L
Sbjct: 123 PKDVEKFDELYVVLEIA-----DSDFKKL--------------FRTPVYLTELHIKTLLY 163
Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---------KMGPSGDK 250
G++Y+H +++RDLK +N L+ + K+ DFGLA
Sbjct: 164 NLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 251 THVSTRVMGTYGYCAPDYAMTGQ------------LTFKS-----DIYSFGVVLLELITG 293
++ +TG L ++ D++S G + EL+
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 294 RKA-IDQTKDRKEL 306
K + DR L
Sbjct: 281 IKENVAYHADRGPL 294
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 60/234 (25%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGS-ADHP 148
LG+G +G V+K + +VVA+K++ F E+M L + H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 149 NLVKLIG-YCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-----IAAG 200
N+V L+ A+ D+ + LV++YM + LH +R L+ + +
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIR--ANILE-PVHKQYVVYQLI-- 119
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ ++YLH +++RD+K SNILL H K++DFGL++ + + + +
Sbjct: 120 --KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 261 YGYCAPDY---AMTG-----------------QLTFKSDIYSFGVVLLELITGR 294
D +T + T D++S G +L E++ G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 37/234 (15%), Positives = 78/234 (33%), Gaps = 40/234 (17%)
Query: 91 GNFRSDCCLGEGGFGKVYKGC--------LEKIEQVVAIKQLDHRGVQGVREFS------ 136
++ G +Y+ +Q ++K LD + + E +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 137 -----AEVMTLGSADHPNLVKLIGY-CAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRP 188
+ L S + +G+ + R LV +P L + L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPS--LGRSLQSALDVSPKHV 155
Query: 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK--LSDFGLAKMGP 246
L + +++A L++LHE ++ ++ NI ++ + L+ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 247 SGDKTHVSTR------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
HV+ G + + D + +SD+ S G +L+ + G
Sbjct: 213 P-SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 36/219 (16%)
Query: 99 LGEGGFGKVYKGCL-EKIEQVVAIKQL---DHRGVQGVREF-------SAEVMTLGSADH 147
LG G F V+ VA+K + E A+ S
Sbjct: 27 LGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 148 PNLVKLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGA 201
+++KL+ + G ++V+E L ++L L + + R + +I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP------KLSDFGLAKMGPSGDKTHVST 255
GL Y+H + +I+ D+K N+L+E P K++D G A + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
R Y +P+ + +DI+S ++ ELITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 51/258 (19%), Positives = 84/258 (32%), Gaps = 74/258 (28%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK---QLDHRGVQGVREFSA-EVMTLGSADHPN---LV 151
LG G F V+ + ++ VA+K +H + E + + + PN +V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 152 KLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASRGL 205
+L+ G +V+E LG HL + + + L KI +GL
Sbjct: 105 QLLDDFKISGVNGTHICMVFE--VLGH---HLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 206 QYLHEQLKQPVIYRDLKCSNILLE------------------------------------ 229
YLH + + +I+ D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 230 -------------EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
E K++D G A + TR Y + + +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 277 KSDIYSFGVVLLELITGR 294
+DI+S + EL TG
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 43/231 (18%), Positives = 81/231 (35%), Gaps = 37/231 (16%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK----------QLDH-----RGVQGVREF 135
+ +G GGFG +Y + A L + V ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 136 SAEVMTLGSADHPNLVKLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
+ + D+ + G R +V M L L +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MER--LGIDLQKISGQNGTFKK 150
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK--LSDFGLAKM-GPSG 248
+T +++ L+Y+HE ++ D+K +N+LL + L+D+GL+ P+G
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 249 DKTHVSTRV----MGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
+ GT + + D A G L+ +SD+ G +L + G+
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLD-AHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 40/214 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFS--AEVMTLGSADHPNLV 151
+G+G FG+V K K+ Q VA+K + HR Q E + + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR--QAAEEIRILEHLRKQDKDNTMNVI 162
Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGAS 202
++ C + +E L +L++L + + K A
Sbjct: 163 HMLENFTFRNHIC-------MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGT 260
+ L LH K +I+ DLK NILL++ K+ DFG + T++ +R
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y AP+ + + D++S G +L EL+TG
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFS--AEVMTLGSADHPNLV 151
+G+G FG+V K ++ VAIK + Q E + + +V
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLELMNKHDTEMKYYIV 119
Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGAS 202
L + C LV+E L +L+DL +T R + N K A
Sbjct: 120 HLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGT 260
L +L + +I+ DLK NILL K+ DFG + ++ +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y +P+ + D++S G +L+E+ TG
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 9e-05
Identities = 39/261 (14%), Positives = 79/261 (30%), Gaps = 60/261 (22%)
Query: 1 MGCFRCSGKSN-KKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLS 59
+ +K EE+ N K + + +++ + ND Q+
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR-QPSMMTRMYIEQRDRLYNDNQV- 125
Query: 60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCL---GEGGFGKVYKGCLEKIE 116
N+ + + +L A R + G G GK
Sbjct: 126 --FAKYNVS----------RLQPYLKLRQALLELRPAKNVLIDGVLGSGK---------- 163
Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
VA+ VQ +F + L + + P V L L
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--------------------LEMLQ 203
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK- 235
K L+ + P +W +R ++ + + +L++ + + + ++L + K
Sbjct: 204 KLLYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 236 LSDFGLAKMGPSGDKTHVSTR 256
+ F L K ++TR
Sbjct: 259 WNAFNL------SCKILLTTR 273
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 67/247 (27%)
Query: 99 LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADHPN--- 149
LGEG FGKV + C + + VA+K + R V RE + E+ + D N
Sbjct: 27 LGEGTFGKVVE-CLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 150 LVKLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAG 200
V + + C + +E L K+ + + +P +A
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------KLSDFGL 241
L++LH + + + DLK NIL +++DFG
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 242 AKMGPSGDKTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
A + H V+TR Y P+ + D++S G +L E G +
Sbjct: 189 ATFD---HEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLF 239
Query: 299 QTKDRKE 305
QT + +E
Sbjct: 240 QTHENRE 246
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 55/258 (21%), Positives = 88/258 (34%), Gaps = 85/258 (32%)
Query: 99 LGEGGFGKVYKGCL-EKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADH--PNLV 151
+G+G FG+V C ++ A+K + R ++ + E + + D N+V
Sbjct: 43 MGDGTFGRVLL-CQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGAS 202
K G C L++E L L+++
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------------KLS 237
+ L YL K + + DLK NILL++ Y KL
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 238 DFGLAKMGPSGDKTH---VSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
DFG A H ++TR ++ G+ SD++SFG VL
Sbjct: 205 DFGCATFK---SDYHGSIINTRQYRAPEVILN-LGW-----------DVSSDMWSFGCVL 249
Query: 288 LELITGRKAIDQTKDRKE 305
EL TG + +T + E
Sbjct: 250 AELYTG-SLLFRTHEHME 266
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 56/252 (22%), Positives = 91/252 (36%), Gaps = 75/252 (29%)
Query: 99 LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADHPN--- 149
LGEG FGKV + C + + VA+K + + V E + E+ L + D +
Sbjct: 22 LGEGAFGKVVE-CIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 150 LVKLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAG 200
V+++ + C +V+E L +D P + K+A
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------KLSDFGL 241
+ + +LH + + DLK NIL + + K+ DFG
Sbjct: 127 ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 242 AKMGPSGDKTHVSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
A T VSTR ++ G+ P D++S G +L+E G
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILA-LGWSQP-----------CDVWSIGCILIEYYLG- 230
Query: 295 KAIDQTKDRKEL 306
+ T D KE
Sbjct: 231 FTVFPTHDSKEH 242
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.75 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.62 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.44 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.15 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.6 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.41 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.92 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.21 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.76 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=402.88 Aligned_cols=212 Identities=26% Similarity=0.362 Sum_probs=191.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997542 234677999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986 45699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..|
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 44444445678999999999999999999999999999999999999999988776666555
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=401.29 Aligned_cols=210 Identities=24% Similarity=0.346 Sum_probs=190.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
..|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998665556677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+||+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 99999999875 4599999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 283 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 22345689999999999999999999999999999999999999999887776666553
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=401.04 Aligned_cols=212 Identities=24% Similarity=0.330 Sum_probs=182.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 579999999999999999999999999999999976543 346679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||+||+|.++|... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999753 245689999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 12223458999999999999999999999999999999999999999987766655554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=403.11 Aligned_cols=210 Identities=24% Similarity=0.347 Sum_probs=191.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
+.|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666777899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+||+|.+++.. ..+++..+..++.||+.||.|||+. +||||||||+||||+.+|.+||+|||+|+.......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999875 4599999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 360 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 360 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 2345689999999999999999999999999999999999999999887777666654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=388.53 Aligned_cols=217 Identities=31% Similarity=0.469 Sum_probs=187.9
Q ss_pred CCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|.+.+.||+|+||+||+|.+. .++..||||+++.......+++.+|+.+|++++|||||++++++.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888999999999999999875 3578899999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 166 VYEYMPLGSLDKHLHDLR---------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
|||||++|+|.++|+... ....++++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 2345799999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..|.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999986544433333333569999999999999999999999999999999999 899999888776666554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=377.76 Aligned_cols=208 Identities=25% Similarity=0.378 Sum_probs=172.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+|+.||+|++++... .....+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976432 33567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||| +|+|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999876 46799999999999999999999998 999999999999999999999999999986433
Q ss_pred CCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. .....+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..+.+..|
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i 224 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 224 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 22 2234589999999999998876 58999999999999999999999887765555444
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=388.61 Aligned_cols=207 Identities=23% Similarity=0.264 Sum_probs=180.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
+.|.+.++||+|+||+||+|.+..+|+.||||+++..... .+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4688889999999999999999999999999999765332 36999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCcccCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 249 (315)
+||+|.++++. ..++++..++.++.||+.||.|||+. +||||||||+|||++.++ .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999986 35699999999999999999999998 999999999999999887 69999999998654322
Q ss_pred Cc---eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 250 KT---HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 268 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 11 1123357999999999999999999999999999999999999999887766555444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=387.88 Aligned_cols=210 Identities=29% Similarity=0.379 Sum_probs=179.1
Q ss_pred CCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++++.||+|+||+||+|.+. .+++.||||++++... .....+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999873 4688999999976432 234467889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|||||+||+|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 45799999999999999999999998 9999999999999999999999999999854
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+.+..|
T Consensus 177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 238 (304)
T 3ubd_A 177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 3322 1223468999999999999999999999999999999999999999988777666655
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=386.98 Aligned_cols=217 Identities=30% Similarity=0.507 Sum_probs=181.9
Q ss_pred CCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.+|.+.+.||+|+||+||+|.+. .++..||||+++..+....+.|.+|+.+|++++|||||+++++|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45788899999999999999875 3578999999987766667889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 166 VYEYMPLGSLDKHLHDLRP-----------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
|||||++|+|.++++.... ...++++..++.|+.||+.||.|||+. +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999976432 235699999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
||+|||+++...........+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..|.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999986544443334445689999999999999999999999999999999999 899999888777666554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=376.27 Aligned_cols=199 Identities=28% Similarity=0.445 Sum_probs=173.8
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee----CCeEEEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRLLVY 167 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~ 167 (315)
++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.+++.++|||||+++++|.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999999999999999997543 2345679999999999999999999999865 35689999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEcC-CCceEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEE-GYHPKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~ 244 (315)
|||+||+|.+++.. ..++++..++.++.||+.||.|||+. + |+||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999986 45799999999999999999999987 6 999999999999984 78999999999986
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
.... .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.++..
T Consensus 182 ~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~ 236 (290)
T 3fpq_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred CCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH
Confidence 4332 2234689999999998765 69999999999999999999999998655433
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=376.84 Aligned_cols=208 Identities=31% Similarity=0.530 Sum_probs=173.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..+++.+.+.||+|+||+||+|.+.. .||||+++... ....+.+.+|+.++++++|||||++++++.+ +.++||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34578889999999999999998753 58999987543 3446779999999999999999999998865 568999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||+||+|.++|.. ...++++..+..|+.||+.||.|||+. +||||||||+|||+++++.+||+|||+|+...
T Consensus 110 mEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 999999999999975 245799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
...........+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.++...+
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~ 246 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH
Confidence 4333333445689999999999864 36899999999999999999999999887665444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=378.14 Aligned_cols=216 Identities=29% Similarity=0.439 Sum_probs=185.2
Q ss_pred CCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++++.+.||+|+||+||+|.+. .+++.||||+++... ....+.|.+|+.++++++|||||++++++.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4677889999999999999864 357899999997543 2346789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q 021249 166 VYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~ 233 (315)
|||||++|+|.++|..... ....+++..++.|+.||+.||.|||+. +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 134699999999999999999999998 9999999999999999999
Q ss_pred eEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
+||+|||+++.....+.....+...||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+.+..|.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999986544333333445679999999999999999999999999999999998 899999988777666554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=375.38 Aligned_cols=222 Identities=26% Similarity=0.385 Sum_probs=190.1
Q ss_pred CcCHHHHHHHhCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCCc-ccHHHHHHHHHHhccCCC-CCeee
Q 021249 80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADH-PNLVK 152 (315)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~ 152 (315)
++..++|....++|++.+.||+|+||+||+|.+..+ ++.||||.+..... ...+.+.+|+.+|++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 456677777888999999999999999999997643 46899999976543 345679999999999965 99999
Q ss_pred EEeEEee-CCeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 021249 153 LIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219 (315)
Q Consensus 153 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~ 219 (315)
++++|.+ ++.++||||||++|+|.++|+.... ....+++..++.++.||+.||.|||+. +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 9999866 4578999999999999999975321 134589999999999999999999998 99999
Q ss_pred cCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCccc
Q 021249 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298 (315)
Q Consensus 220 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~ 298 (315)
||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986554443334445679999999999999999999999999999999998 999998
Q ss_pred ccCchh
Q 021249 299 QTKDRK 304 (315)
Q Consensus 299 ~~~~~~ 304 (315)
+.+..+
T Consensus 290 ~~~~~~ 295 (353)
T 4ase_A 290 GVKIDE 295 (353)
T ss_dssp TCCCSH
T ss_pred CCCHHH
Confidence 876444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=375.24 Aligned_cols=215 Identities=24% Similarity=0.336 Sum_probs=185.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee------CC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE------GD 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~ 161 (315)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4679999999999999999999999999999999976432 345678899999999999999999998754 36
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+|||||||+ |+|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 679888865 46799999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCC--CceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 242 AKMGPSGD--KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 242 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
|+...... ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+++.+|...
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 98643321 12223456899999999998875 5699999999999999999999999999998888887643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=362.91 Aligned_cols=202 Identities=24% Similarity=0.367 Sum_probs=164.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--------
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-------- 161 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-------- 161 (315)
++|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458999999999999999999999999999999975443 34567899999999999999999999987544
Q ss_pred ----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 162 ----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 162 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
.+|+|||||++|+|.+++.... .....++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3699999999999999997632 223356777899999999999999998 99999999999999999999999
Q ss_pred ccCCcccCCCCCCc----------eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 238 DFGLAKMGPSGDKT----------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 238 Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999865432211 11234579999999999999999999999999999999996 7764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=365.26 Aligned_cols=212 Identities=24% Similarity=0.324 Sum_probs=178.9
Q ss_pred HHhCCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
...++|++.+.||+|+||+||+|.++ .+++.||+|.+.... ....+.+|+.+|+.+ +||||++++++|.+.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999874 467899999987653 345678999999988 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccCCc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLA 242 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg~~ 242 (315)
|+|||||+|++|.+++. .+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999884 389999999999999999999998 99999999999999876 79999999999
Q ss_pred ccCCCCCCc--------------------------eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCC
Q 021249 243 KMGPSGDKT--------------------------HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRK 295 (315)
Q Consensus 243 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~ 295 (315)
+........ ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 754332110 112335799999999998875 58999999999999999999999
Q ss_pred cccc-cCchhhhhHHhh
Q 021249 296 AIDQ-TKDRKELNLVAW 311 (315)
Q Consensus 296 pf~~-~~~~~~~~~i~~ 311 (315)
||.. .++.+++..|..
T Consensus 246 Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMT 262 (361)
T ss_dssp SSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHH
Confidence 9954 455566666644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=385.28 Aligned_cols=203 Identities=29% Similarity=0.406 Sum_probs=177.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHH---HHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVRE---FSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~---~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|.+.+.||+|+||+||+|.+..+|+.||||++.+... ..... ...++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 579999999999999999999999999999999975321 11222 334467788889999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+|||||+||+|.++|.. ...+++..++.++.||+.||.|||+. +||||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999986 45699999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
..... ....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+...
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~ 398 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 54332 234589999999999864 579999999999999999999999998765443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=381.07 Aligned_cols=212 Identities=24% Similarity=0.341 Sum_probs=191.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||+||+|.++.+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC--CceEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~--~~~kl~Dfg~~~~~~~ 247 (315)
|+||+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999998864 245699999999999999999999998 99999999999999854 8999999999987544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.. .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..|.
T Consensus 310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 32 2334589999999999999999999999999999999999999999888877776664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=356.06 Aligned_cols=201 Identities=27% Similarity=0.349 Sum_probs=164.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----eEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv 166 (315)
.+|.+.+.||+|+||+||+|.+. |+.||||+++..... ......|+..+..++|||||++++++.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45888899999999999999985 889999999754321 222345666777899999999999997654 57999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-----KQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
||||++|+|.++++. .++++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999976 45899999999999999999999641 24899999999999999999999999999
Q ss_pred cccCCCCCCce--eeeeccccccccCccccccC------CcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 242 AKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 242 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
++......... .....+||+.|||||++.+. .++.++|||||||++|||+||.+||..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 98654332221 12345799999999998764 477899999999999999999887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=325.41 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=186.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45799999999999999999999999999999999766555677789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999976 3589999999999999999999998 99999999999999999999999999987654332
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+.
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2 2234579999999999999999999999999999999999999998776554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.84 Aligned_cols=210 Identities=29% Similarity=0.374 Sum_probs=184.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999876 35689999999999999999999998 99999999999999999999999999997533
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 216 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH
Confidence 2221 22345799999999999999999999999999999999999999987765544443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=336.99 Aligned_cols=212 Identities=29% Similarity=0.420 Sum_probs=182.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 164 (315)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ......+..|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3568999999999999999999999999999999997542 23456678899999987 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999976 35699999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....|
T Consensus 174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 236 (353)
T 3txo_A 174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33222 2233458999999999999999999999999999999999999999987766655544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=330.47 Aligned_cols=210 Identities=26% Similarity=0.364 Sum_probs=185.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568999999999999999999999999999999997542 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999976 35699999999999999999999998 99999999999999999999999999997544
Q ss_pred CCCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
.... ....+||+.|+|||++.+..++ +++|||||||++|+|++|+.||.+.+..+....
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 225 (328)
T 3fe3_A 166 VGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 225 (328)
T ss_dssp SSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 3322 2345799999999999888775 899999999999999999999988775554443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=327.53 Aligned_cols=207 Identities=28% Similarity=0.425 Sum_probs=184.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999999999999999997542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||++|++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999976 45689999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 214 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 32 2235799999999999999999999999999999999999999987765554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=330.12 Aligned_cols=211 Identities=26% Similarity=0.333 Sum_probs=186.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
..++|.+.+.||+|+||.||+|.+..+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 346799999999999999999999999999999999764322 35678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEec
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSD 238 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~D 238 (315)
+++||||++|++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999965 45799999999999999999999998 999999999999998776 799999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..|
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999986544321 23357999999999999989999999999999999999999999887766555444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=342.64 Aligned_cols=217 Identities=23% Similarity=0.276 Sum_probs=187.6
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
+....++|.+.+.||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.++..++||||++++++|.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 33456789999999999999999999999999999999975321 123347889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||++||+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999762 45699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+...... .......+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+....|
T Consensus 223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 7644332 22233458999999999987 567899999999999999999999999987766666555
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.78 Aligned_cols=215 Identities=23% Similarity=0.275 Sum_probs=186.2
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
+....++|.+.+.||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 33456789999999999999999999999999999999865321 223457789999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999875 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCC----cCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....|
T Consensus 216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 285 (410)
T 3v8s_A 216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285 (410)
T ss_dssp EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence 7654332 12223468999999999988665 889999999999999999999999987766655554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=330.64 Aligned_cols=213 Identities=31% Similarity=0.474 Sum_probs=185.1
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 163 (315)
...++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999999999999999997542 23456677888888876 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999976 35689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....|
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 230 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 5332221 223458999999999999999999999999999999999999999887765555444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=330.12 Aligned_cols=212 Identities=26% Similarity=0.371 Sum_probs=185.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 164 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999999999999999997542 23456788899999887 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999976 34699999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....|
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 233 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 322211 223457999999999999999999999999999999999999999887765554443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=326.88 Aligned_cols=221 Identities=47% Similarity=0.801 Sum_probs=191.7
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++....++|.+.+.||+|+||.||+|.+. ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 33446678999999999999999999875 58899999998776666788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999976544445799999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..............||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+....+
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 44333333333456899999999999899999999999999999999999999876655444433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=337.94 Aligned_cols=219 Identities=22% Similarity=0.260 Sum_probs=188.4
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
+.....++|.+.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 334456789999999999999999999999999999999975321 23345788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..|+||||++||+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999763 34699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccc-------cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAM-------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....|.
T Consensus 209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 976543322 1223458999999999887 3578999999999999999999999999887766655553
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.33 Aligned_cols=201 Identities=30% Similarity=0.466 Sum_probs=178.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.+... .....+..|..++..+ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4579999999999999999999999999999999975422 2345578899998876 89999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999876 35699999999999999999999998 9999999999999999999999999999753
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 2221 223346899999999999999999999999999999999999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=328.73 Aligned_cols=207 Identities=25% Similarity=0.315 Sum_probs=184.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999996542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++|++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999986 34689999999999999999999998 999999999999999999999999999986433
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+....|
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 250 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence 2 12347999999999999999999999999999999999999999887665554443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=321.65 Aligned_cols=210 Identities=18% Similarity=0.278 Sum_probs=185.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999999999999999997543 3456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--CCceEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~~~~ 247 (315)
++|++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999865 235699999999999999999999998 9999999999999987 78999999999986544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+
T Consensus 157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 215 (321)
T 1tki_A 157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 322 23357999999999999888999999999999999999999999887765554443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.68 Aligned_cols=202 Identities=28% Similarity=0.414 Sum_probs=179.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999976 45699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 167 RETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 3322 234579999999998864 468999999999999999999999997544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=318.12 Aligned_cols=207 Identities=27% Similarity=0.393 Sum_probs=178.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3568999999999999999999999999999999986432 2335678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ..++++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999976 35699999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 218 (294)
T 4eqm_A 162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH
T ss_pred ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 33221 1223356999999999999999999999999999999999999999876643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.15 Aligned_cols=219 Identities=25% Similarity=0.330 Sum_probs=189.5
Q ss_pred CCcCHHHHHHHhCC----------CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCC
Q 021249 79 KPFTFDELAAATGN----------FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP 148 (315)
Q Consensus 79 ~~~~~~~~~~~~~~----------y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp 148 (315)
.+++.+++...... |...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666666555442 67778999999999999999989999999999877666677899999999999999
Q ss_pred CeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 149 nIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
||+++++++...+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999998864 4589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.+.
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999976543221 1234579999999999999999999999999999999999999998766544433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=324.56 Aligned_cols=200 Identities=31% Similarity=0.471 Sum_probs=178.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|..+++.+ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999976432 3355688899999887 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999976 35699999999999999999999998 99999999999999999999999999997532
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 221 122345899999999999999999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=320.01 Aligned_cols=210 Identities=25% Similarity=0.338 Sum_probs=184.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3569999999999999999999999999999999975432 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEecc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF 239 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~Df 239 (315)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999865 45799999999999999999999998 999999999999998877 7999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 99986543322 22347999999999999899999999999999999999999999877665554443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=329.73 Aligned_cols=211 Identities=28% Similarity=0.372 Sum_probs=176.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHH-hccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|++.+... .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3579999999999999999999999999999999976532 233456667766 577899999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999976 35689999999999999999999998 9999999999999999999999999999753
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....|
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 251 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2221 1223458999999999999999999999999999999999999999887765555443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.09 Aligned_cols=211 Identities=21% Similarity=0.306 Sum_probs=186.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999876555566789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--CCceEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~~~~ 247 (315)
+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. .+.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998865 245699999999999999999999998 9999999999999974 46799999999986544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i 262 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 322 22347999999999999999999999999999999999999999887765555443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=332.75 Aligned_cols=212 Identities=21% Similarity=0.271 Sum_probs=184.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45679999999999999999999999999999999976543 3356688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc---CCCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~---~~~~~kl~Dfg~~~ 243 (315)
|||+.|++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999876 45699999999999999999999998 999999999999998 45789999999997
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i 225 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 6543322 223457999999999999989999999999999999999999999877765555444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=316.00 Aligned_cols=206 Identities=27% Similarity=0.431 Sum_probs=182.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||+||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35799999999999999999999999999999999776666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999863 45699999999999999999999998 99999999999999999999999999997653322
Q ss_pred Cce------------eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 250 KTH------------VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 250 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 111 1113579999999999999999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.35 Aligned_cols=210 Identities=22% Similarity=0.305 Sum_probs=183.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999999999999999976533 3456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---CceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~---~~~kl~Dfg~~~ 243 (315)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998865 45689999999999999999999998 99999999999999865 459999999997
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~ 241 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 6543322 2235799999999999998999999999999999999999999987665444433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=322.04 Aligned_cols=206 Identities=27% Similarity=0.403 Sum_probs=179.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999999999999999999975433 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998865 45699999999999999999999998 9999999999999999999999999999764333
Q ss_pred CCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 32233334579999999999988776 7899999999999999999999986554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=325.57 Aligned_cols=208 Identities=21% Similarity=0.250 Sum_probs=181.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-----cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3457999999999999999999999999999999986421 22467789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc---eEEeccC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFG 240 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~---~kl~Dfg 240 (315)
++||||+++++|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988865433445689999999999999999999998 9999999999999986654 9999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 9976543321 1233479999999999999999999999999999999999999997643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=321.94 Aligned_cols=211 Identities=29% Similarity=0.411 Sum_probs=174.7
Q ss_pred hCCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCC----cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 678999999997643 2234567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999976 35689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 233 (327)
T 3a62_A 169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 7432221 1223457999999999999999999999999999999999999999887655544433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=315.77 Aligned_cols=216 Identities=28% Similarity=0.379 Sum_probs=172.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999975432 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 169 YMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|++ ++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886532 2234689999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.++.+.+..+..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 3221 12234789999999998764 689999999999999999999999999888777766643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=323.63 Aligned_cols=217 Identities=27% Similarity=0.412 Sum_probs=184.9
Q ss_pred hCCCCcccccccCCceEEEEEEEC-------CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
.++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999874 3467899999976533 3456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+.+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986432 124589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544332222233457889999999999999999999999999999999 999998877655544
Q ss_pred HH
Q 021249 308 LV 309 (315)
Q Consensus 308 ~i 309 (315)
.+
T Consensus 317 ~~ 318 (370)
T 2psq_A 317 LL 318 (370)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.74 Aligned_cols=202 Identities=26% Similarity=0.381 Sum_probs=178.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986432 12245788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6889888876 35699999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.... ....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+...
T Consensus 160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 3322 223479999999999988876 6899999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=325.94 Aligned_cols=207 Identities=16% Similarity=0.165 Sum_probs=176.2
Q ss_pred HhCCCCcccccccCCceEEEEEE-----ECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC---CCCeeeEEeEEeeC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEG 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~ 160 (315)
..++|.+.+.||+|+||+||+|. +..+++.||+|++.... ...+..|+.+++.++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45679999999999999999994 56778999999997654 345666777776665 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---------
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP-DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--------- 230 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--------- 230 (315)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975322 346799999999999999999999998 9999999999999998
Q ss_pred --CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 231 --GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 231 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999975433333334455689999999999999999999999999999999999999996543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=335.18 Aligned_cols=212 Identities=29% Similarity=0.379 Sum_probs=175.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC---CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999999999999999999753 22334567889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999876 3568999999999999999999998 6 999999999999999999999999999975
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 299 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 299 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 33221 1223457999999999999999999999999999999999999999887665544443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=324.60 Aligned_cols=216 Identities=25% Similarity=0.367 Sum_probs=176.3
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCC--e
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD--Q 162 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~ 162 (315)
...++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999999999999999998653 2344566889999999997 999999999997544 7
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 689888875 3689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCC-------------------CceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 243 KMGPSGD-------------------KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 243 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+...... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7543210 1112334579999999999886 6789999999999999999999999999988
Q ss_pred hhhhhHHhhh
Q 021249 303 RKELNLVAWL 312 (315)
Q Consensus 303 ~~~~~~i~~~ 312 (315)
.+++..|..+
T Consensus 237 ~~~~~~i~~~ 246 (388)
T 3oz6_A 237 MNQLERIIGV 246 (388)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 8887777543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=318.54 Aligned_cols=209 Identities=21% Similarity=0.254 Sum_probs=181.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 34689999999999999999999999999999999875532 24578899999999 8999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc-----eEEeccCCc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-----PKLSDFGLA 242 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~-----~kl~Dfg~~ 242 (315)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 99999999863 45799999999999999999999998 9999999999999998887 999999999
Q ss_pred ccCCCCCCce-----eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 243 KMGPSGDKTH-----VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 243 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
+......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~ 226 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence 8643322211 123457999999999999999999999999999999999999999986544433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.94 Aligned_cols=207 Identities=27% Similarity=0.409 Sum_probs=184.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+..|+.+++.++||||+++++++.+...+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678999999999999999999999999999999975422 2356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||++||+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999977544456799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...+
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 33221 233589999999999999999999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=321.46 Aligned_cols=221 Identities=24% Similarity=0.290 Sum_probs=191.7
Q ss_pred cCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----CCCeeeEEe
Q 021249 81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----HPNLVKLIG 155 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~ 155 (315)
+++.+.....++|.+.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44445556678999999999999999999999999999999999753 233456778899988886 999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-----
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE----- 230 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~----- 230 (315)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 89999999763 234589999999999999999999998 9999999999999975
Q ss_pred --------------------CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHH
Q 021249 231 --------------------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290 (315)
Q Consensus 231 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 290 (315)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7889999999998643322 234789999999999999999999999999999999
Q ss_pred HhCCCcccccCchhhhhHHhhhh
Q 021249 291 ITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 291 ltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
++|+.||...+..+.+..+..+.
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~ 275 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESII 275 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHT
T ss_pred HHCCCCCCCCcHHHHHHHHHHhc
Confidence 99999999988888877776553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=313.30 Aligned_cols=213 Identities=28% Similarity=0.348 Sum_probs=181.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|++.+.||+|+||+||+|.+.. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 45789999999999999999999864 89999999975432 2346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||++ ++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99998 478777765 245699999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+.+.+..+..
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 3221 1233478999999998876 5689999999999999999999999998888877776654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=311.25 Aligned_cols=205 Identities=25% Similarity=0.379 Sum_probs=173.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------------------------cHHHHHHHHHHh
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------------------------GVREFSAEVMTL 142 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------------------------~~~~~~~E~~~l 142 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 346899999999999999999999999999999999754321 235688999999
Q ss_pred ccCCCCCeeeEEeEEee--CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q 021249 143 GSADHPNLVKLIGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRD 220 (315)
Q Consensus 143 ~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~D 220 (315)
+.++||||+++++++.+ ....++||||+++++|.+++. ..++++..++.++.||+.||.|||+. +|+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence 99999999999999986 578999999999999987653 35799999999999999999999998 999999
Q ss_pred CCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCC---cCcccchhhHHHHHHHHHhCCCcc
Q 021249 221 LKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAI 297 (315)
Q Consensus 221 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf 297 (315)
|||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999999986543322 223457999999999987665 478899999999999999999999
Q ss_pred cccCch
Q 021249 298 DQTKDR 303 (315)
Q Consensus 298 ~~~~~~ 303 (315)
......
T Consensus 241 ~~~~~~ 246 (298)
T 2zv2_A 241 MDERIM 246 (298)
T ss_dssp CCSSHH
T ss_pred CCccHH
Confidence 875543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=309.38 Aligned_cols=211 Identities=23% Similarity=0.304 Sum_probs=178.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 579999999999999999999999999999999975433 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++ ++.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 55555544 246699999999999999999999998 9999999999999999999999999999765332
Q ss_pred CCceeeeeccccccccCccccccCC-cCcccchhhHHHHHHHHHhCCCc-ccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKA-IDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~ 310 (315)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |...+..+.+..+.
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred cc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 21 223347899999999987765 89999999999999999988777 55555555555543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=316.77 Aligned_cols=220 Identities=45% Similarity=0.761 Sum_probs=191.5
Q ss_pred CCCCcCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEe
Q 021249 77 SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIG 155 (315)
Q Consensus 77 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~ 155 (315)
....++..++....++|.+.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456788999999999999999999999999999754 588999999976532 22346889999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
++.+.+..++||||+++++|.+++........++++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987655566799999999999999999999986445899999999999999999999
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
|+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999986543322 22334569999999999988899999999999999999999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=316.21 Aligned_cols=216 Identities=30% Similarity=0.458 Sum_probs=176.3
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
+....++|++.+.||+|+||+||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344568999999999999999999874 78899999976543 3356788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEcCCCceEEeccCC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997521 112389999999999999999999998 8 99999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 97543321 1123347999999999999999999999999999999999999999987765554443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=317.93 Aligned_cols=209 Identities=24% Similarity=0.357 Sum_probs=174.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD---- 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 161 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 35689999999999999999999999999999999976532 33456889999999999999999999987654
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++||||+++++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 34999999999999999976 35689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCC-ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 242 AKMGPSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 242 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
+........ ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 975433221 122233568999999999999999999999999999999999999998766544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=316.46 Aligned_cols=215 Identities=28% Similarity=0.433 Sum_probs=182.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCC---eEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+..++ ..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457999999999999999999997544 459999997653 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999965 245699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 246 PSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 43322 112223356788999999998999999999999999999999 999998877666555443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=329.49 Aligned_cols=210 Identities=28% Similarity=0.413 Sum_probs=184.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999975422 2356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999865 45699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 228 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 4322 223479999999999988766 68999999999999999999999877655544433
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=320.26 Aligned_cols=205 Identities=27% Similarity=0.382 Sum_probs=176.5
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
.+.||+|+||.||+|.+..+|..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999999999999999999877666677899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE--cCCCceEEeccCCcccCCCCCCcee
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHV 253 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~~~ 253 (315)
.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++.........
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 998865 234689999999999999999999998 99999999999999 56778999999999865443222
Q ss_pred eeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 254 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++.+.+..+
T Consensus 246 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 300 (373)
T 2x4f_A 246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300 (373)
T ss_dssp -CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2346999999999999889999999999999999999999999887766555444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=342.86 Aligned_cols=212 Identities=26% Similarity=0.371 Sum_probs=186.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 164 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++.+.. ....+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999999999999999997532 23456678899999887 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999986 35699999999999999999999998 999999999999999999999999999985
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i 554 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 332222 233468999999999999999999999999999999999999999987766655544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=334.46 Aligned_cols=205 Identities=31% Similarity=0.447 Sum_probs=182.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999999999999999996532 2235668899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++||+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999998753 234589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 43322 233589999999999999999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=305.61 Aligned_cols=209 Identities=24% Similarity=0.312 Sum_probs=184.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999999999999999987655667889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCcccC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~~~ 245 (315)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998876 35689999999999999999999998 99999999999999 78889999999999765
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...++.+....
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 218 (277)
T 3f3z_A 160 KPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK 218 (277)
T ss_dssp CTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 43322 223469999999998765 489999999999999999999999988765554443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.97 Aligned_cols=210 Identities=26% Similarity=0.330 Sum_probs=178.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++.+.||+|+||+||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 5689999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++ +|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 888888652 35689999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 154 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 214 (288)
T 1ob3_A 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 11 12234689999999988764 58999999999999999999999999888776666554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.78 Aligned_cols=213 Identities=19% Similarity=0.228 Sum_probs=183.4
Q ss_pred hCCCCcccccccC--CceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G--~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|++.+.||+| +||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999999999999999997543 2345678889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999763 235699999999999999999999998 9999999999999999999999999988643
Q ss_pred CCCCC-----ceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 246 PSGDK-----THVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 21111 111122368999999999987 579999999999999999999999998876655443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=331.19 Aligned_cols=211 Identities=23% Similarity=0.279 Sum_probs=178.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------ 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 160 (315)
..++|++.+.||+|+||+||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754 233466788999999999999999999999654
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
...++||||+++ .|.+.+.. .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 467999999975 46555532 389999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
+++...... ..+..+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++..|...
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 210 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp CC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 997643321 223457999999999999999999999999999999999999999999888887777543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=321.73 Aligned_cols=222 Identities=25% Similarity=0.374 Sum_probs=188.0
Q ss_pred CCcCHHHHHHHhCCCCcccccccCCceEEEEEE-----ECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCee
Q 021249 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLV 151 (315)
Q Consensus 79 ~~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv 151 (315)
.++....+....++|.+.+.||+|+||.||+|. +..+++.||||++..... ...+.+.+|+.+++.+ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 355666777788899999999999999999998 456678999999976533 3456789999999999 799999
Q ss_pred eEEeEEeeCC-eEEEEEEecCCCChhhhhhhcCCC---------------------------------------------
Q 021249 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPD--------------------------------------------- 185 (315)
Q Consensus 152 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------- 185 (315)
++++++.+.+ ..++||||+++|+|.+++......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988755 489999999999999999764321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 186 -----------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 186 -----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 12289999999999999999999998 9999999999999999999999999999865444
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 303 (315)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 33333444578999999999999999999999999999999998 99999876643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=309.37 Aligned_cols=214 Identities=25% Similarity=0.307 Sum_probs=181.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999999999999999998655432 3456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999888765 45689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.+..+...
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (311)
T 4agu_A 155 PSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 221 1233478999999998876 57899999999999999999999999998887777666543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=311.24 Aligned_cols=210 Identities=25% Similarity=0.323 Sum_probs=184.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45699999999999999999999999999999999754321 356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEecc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF 239 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~Df 239 (315)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 45689999999999999999999998 999999999999999887 7999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99986544322 12346999999999999999999999999999999999999999877665554443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.48 Aligned_cols=202 Identities=22% Similarity=0.327 Sum_probs=168.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|.+.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4689999999999999999999999999999999976532 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--eEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~--~kl~Dfg~~~~~~~ 247 (315)
+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999876 34699999999999999999999998 9999999999999987765 99999999974322
Q ss_pred CCCceeeeeccccccccCccccccCCcCcc-cchhhHHHHHHHHHhCCCcccccCc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFK-SDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 21 1223479999999999988887655 8999999999999999999987554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.06 Aligned_cols=204 Identities=22% Similarity=0.295 Sum_probs=160.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee-----CCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-----GDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~ 162 (315)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999999999999999997542 3345678899999999999999999999843 357
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 4789888865 45699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------eeeeeccccccccCcccc-ccCCcCcccchhhHHHHHHHHHh----
Q 021249 243 KMGPSGDKT-------------------------HVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELIT---- 292 (315)
Q Consensus 243 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt---- 292 (315)
+........ ...+..+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 864322110 123345789999999976 45679999999999999999999
Q ss_pred -------CCCcccccC
Q 021249 293 -------GRKAIDQTK 301 (315)
Q Consensus 293 -------g~~pf~~~~ 301 (315)
|++||.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 777776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=324.31 Aligned_cols=217 Identities=26% Similarity=0.396 Sum_probs=184.0
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
....++|.+.+.||+|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3445689999999999999999999998899999999875432 334568899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999762 34589999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.............+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~ 328 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 33211111111235678999999998899999999999999999998 99999887765544433
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.57 Aligned_cols=217 Identities=33% Similarity=0.462 Sum_probs=185.3
Q ss_pred hCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467999999999999999999873 456899999997643 34467789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRP--------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC 223 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp 223 (315)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999986432 123489999999999999999999998 999999999
Q ss_pred CCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCc
Q 021249 224 SNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD 302 (315)
Q Consensus 224 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 302 (315)
+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544433322333467889999999999899999999999999999999 9999988776
Q ss_pred hhhhhHH
Q 021249 303 RKELNLV 309 (315)
Q Consensus 303 ~~~~~~i 309 (315)
.+....+
T Consensus 259 ~~~~~~~ 265 (314)
T 2ivs_A 259 ERLFNLL 265 (314)
T ss_dssp GGHHHHH
T ss_pred HHHHHHh
Confidence 5554443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.43 Aligned_cols=193 Identities=25% Similarity=0.375 Sum_probs=153.8
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 7799999999999999999999999999653 3456778999999997 99999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEeccCCcccCCCCCCce
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~Dfg~~~~~~~~~~~~ 252 (315)
.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++........
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999986 46799999999999999999999998 999999999999998765 899999999986443322
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 2233478999999999999999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.23 Aligned_cols=205 Identities=24% Similarity=0.338 Sum_probs=177.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--eEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 166 (315)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457999999999999999999999999999999997543 234667889999999999999999999997765 78999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----cCCCceEEeccCCc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA 242 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili----~~~~~~kl~Dfg~~ 242 (315)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999976322 23489999999999999999999998 99999999999999 77788999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccc--------cCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAM--------TGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
......... ....||+.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 865443221 2346999999999876 5688999999999999999999999997544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=323.17 Aligned_cols=217 Identities=29% Similarity=0.418 Sum_probs=181.3
Q ss_pred hCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|+||+||+|.+ ..++..||||++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45799999999999999999994 4567899999997543 33455688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEEe
Q 021249 164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLS 237 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl~ 237 (315)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 234689999999999999999999998 999999999999999554 59999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999974322111112223468899999999999999999999999999999998 99999887766555544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.34 Aligned_cols=215 Identities=23% Similarity=0.298 Sum_probs=176.3
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
....++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34567899999999999999999999999999999999755332 2456778999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-----CCCceEEecc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-----EGYHPKLSDF 239 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-----~~~~~kl~Df 239 (315)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ ..+.+||+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999997 599999876 35699999999999999999999998 999999999999994 4556999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
|++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+..
T Consensus 182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 99975432211 12334689999999998875 589999999999999999999999998887776666543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=316.41 Aligned_cols=219 Identities=28% Similarity=0.474 Sum_probs=185.1
Q ss_pred HHHhCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
....++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999987 3458999999986533 3456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPD--------------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRD 220 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~D 220 (315)
+..++||||+++++|.+++...... ..++++..++.++.||+.||.|||+. +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 9999999999999999999864321 25799999999999999999999998 999999
Q ss_pred CCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccc
Q 021249 221 LKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQ 299 (315)
Q Consensus 221 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 299 (315)
|||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999975433222222233468899999999998899999999999999999999 9999988
Q ss_pred cCchhhhhH
Q 021249 300 TKDRKELNL 308 (315)
Q Consensus 300 ~~~~~~~~~ 308 (315)
....+....
T Consensus 280 ~~~~~~~~~ 288 (343)
T 1luf_A 280 MAHEEVIYY 288 (343)
T ss_dssp SCHHHHHHH
T ss_pred CChHHHHHH
Confidence 765554443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.92 Aligned_cols=213 Identities=27% Similarity=0.377 Sum_probs=177.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
++|.+.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5799999999999999999999999999999999754322 122345799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
++ ++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5888888762 45689999999999999999999998 99999999999999999999999999997543222
Q ss_pred CceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..+
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 12233468999999998876 56899999999999999999999999998888777776543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=316.91 Aligned_cols=220 Identities=25% Similarity=0.286 Sum_probs=180.5
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-----CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
+....++|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 445677899999999999999999999999999999998643 234567799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPD------------------------------------TRPLDWNTRMKIAAGASRG 204 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a 204 (315)
+..++||||+++++|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998532111 1224677888999999999
Q ss_pred HHHHHhcCCCCeEEecCCCCCEEEcCCC--ceEEeccCCcccCCCCC--CceeeeeccccccccCcccccc--CCcCccc
Q 021249 205 LQYLHEQLKQPVIYRDLKCSNILLEEGY--HPKLSDFGLAKMGPSGD--KTHVSTRVMGTYGYCAPDYAMT--GQLTFKS 278 (315)
Q Consensus 205 l~~LH~~~~~~iiH~Dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 278 (315)
|.|||+. +|+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999998 999999999999998776 89999999997542211 1112234579999999998875 6789999
Q ss_pred chhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 279 DIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 279 DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
|||||||++|+|++|+.||...+..+....
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~ 287 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQ 287 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 999999999999999999987766554433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=307.99 Aligned_cols=215 Identities=27% Similarity=0.364 Sum_probs=180.3
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-----cccHHHHHHHHHHhccC---CCCCeeeEEeEEee
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSA---DHPNLVKLIGYCAE 159 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~ 159 (315)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34678999999999999999999999999999999986432 11234566777777666 49999999999987
Q ss_pred CC-----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 160 GD-----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 160 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 5899999997 6999998763 234499999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 160 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 160 KLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp EECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred EEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999976433222 2335789999999999999999999999999999999999999999888777776654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=315.64 Aligned_cols=203 Identities=25% Similarity=0.341 Sum_probs=166.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567999999999999999999999999999999997643 34567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccCCcccC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAKMG 245 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg~~~~~ 245 (315)
|+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999875 45689999999999999999999998 9999999999999975 789999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 3321 123357999999999999999999999999999999999999999766543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.85 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=173.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++...... ..+|+.++..+ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456799999999999999999999999999999999765432 34577777776 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC----CceEEeccCCcc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAK 243 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~----~~~kl~Dfg~~~ 243 (315)
||++||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+... +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999875 45699999999999999999999998 99999999999998543 359999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 6433322 223357899999999998888999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=316.02 Aligned_cols=208 Identities=26% Similarity=0.338 Sum_probs=176.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 161 (315)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999999999999999996542 233567889999999999999999999997653
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999875 4589999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|..
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9864332 223478999999998887 6899999999999999999999999999888777776644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=304.27 Aligned_cols=206 Identities=22% Similarity=0.282 Sum_probs=179.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45679999999999999999999999999999999875432 34577899999998 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc-----eEEeccCCc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-----PKLSDFGLA 242 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~-----~kl~Dfg~~ 242 (315)
||+ +++|.+++... ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999863 45699999999999999999999988 9999999999999987765 999999999
Q ss_pred ccCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 243 KMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 243 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 865433221 1123457999999999999999999999999999999999999999885543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.15 Aligned_cols=212 Identities=27% Similarity=0.455 Sum_probs=174.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeE----EEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++.+.||+|+||+||+|.+..++.. ||+|.+.... ......+.+|+.+++.++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5699999999999999999998777664 5888775432 345677999999999999999999999998754 788
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|+||+.+++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999763 45699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 232 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence 44433333334467889999999999999999999999999999999 99999887765554444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=311.94 Aligned_cols=218 Identities=26% Similarity=0.408 Sum_probs=167.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCe---EEEEEEecCC--CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
..++|.+.+.||+|+||.||+|.+..++. .||+|++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999999877665 8999999765 234467799999999999999999999999877655
Q ss_pred ------EEEEEecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceE
Q 021249 164 ------LLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235 (315)
Q Consensus 164 ------~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~k 235 (315)
++||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986532 2223689999999999999999999998 999999999999999999999
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 999999976544333333333457889999999999999999999999999999999 99999887765554443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=316.97 Aligned_cols=214 Identities=24% Similarity=0.313 Sum_probs=179.1
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee-------
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE------- 159 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------- 159 (315)
....++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999999999999998654322 2369999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 021249 160 -------------------------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208 (315)
Q Consensus 160 -------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L 208 (315)
....++||||++ ++|.+.+.........+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345889999998 588887765444567899999999999999999999
Q ss_pred HhcCCCCeEEecCCCCCEEEc-CCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHH
Q 021249 209 HEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVV 286 (315)
Q Consensus 209 H~~~~~~iiH~Dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~i 286 (315)
|+. +|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||+
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 998 999999999999998 688999999999986543322 1234689999999988775 58999999999999
Q ss_pred HHHHHhCCCcccccCchhhhhHHhh
Q 021249 287 LLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 287 l~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
+|+|++|++||.+.+..+.+..+..
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999999888777776644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=312.06 Aligned_cols=203 Identities=25% Similarity=0.351 Sum_probs=178.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999999999999999999765321 234567899999999999999999999999
Q ss_pred CeEEEEEEecCCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 161 DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 161 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
+..++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998766 99998876 45699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccC
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
|++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 175 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 175 GSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred ccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 999865443222 23479999999999988877 789999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=307.34 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=180.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 44679999999999999999999999999999999986654455678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCcccC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~~~ 245 (315)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999876 35689999999999999999999998 99999999999999 77889999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+...
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 217 (304)
T 2jam_A 160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217 (304)
T ss_dssp CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 3221 123468999999999999999999999999999999999999998766544433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.46 Aligned_cols=211 Identities=27% Similarity=0.361 Sum_probs=181.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-------------ccHHHHHHHHHHhccCCCCCeeeEEe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------------QGVREFSAEVMTLGSADHPNLVKLIG 155 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~ 155 (315)
..++|.+.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999975432 23567889999999999999999999
Q ss_pred EEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---
Q 021249 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY--- 232 (315)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~--- 232 (315)
++.+...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999876 35699999999999999999999998 999999999999998776
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 699999999986543322 22347999999999876 569999999999999999999999999887666555543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.31 Aligned_cols=213 Identities=28% Similarity=0.484 Sum_probs=179.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeE----EEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++.+.||+|+||+||+|.+..++.. ||+|.+.... ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 5799999999999999999999877765 7888775433 2334557789999999999999999999875 56889
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+.+++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999998752 34688899999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.............+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 231 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence 55444333444568889999999998999999999999999999999 999999877665555443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=301.20 Aligned_cols=211 Identities=22% Similarity=0.308 Sum_probs=184.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999999999999999987543 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc---eEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~---~kl~Dfg~~~ 243 (315)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999988876 35689999999999999999999998 9999999999999986655 9999999997
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 219 (284)
T 3kk8_A 157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219 (284)
T ss_dssp ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence 6543322 22347999999999999999999999999999999999999999877655544433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=303.47 Aligned_cols=209 Identities=27% Similarity=0.448 Sum_probs=181.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3579999999999999999999999999999999865321 2346688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999876 35689999999999999999999988 99999999999999999999999999986433
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 219 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 221 22347899999999999999999999999999999999999999987765555444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=303.17 Aligned_cols=220 Identities=45% Similarity=0.741 Sum_probs=189.0
Q ss_pred CCCcCHHHHHHHhCCCCcc------cccccCCceEEEEEEECCCCeEEEEEEecCCC----cccHHHHHHHHHHhccCCC
Q 021249 78 AKPFTFDELAAATGNFRSD------CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADH 147 (315)
Q Consensus 78 ~~~~~~~~~~~~~~~y~~~------~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~h 147 (315)
...+++.++...+++|... +.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4568888999988888776 88999999999999874 7899999986532 2345678999999999999
Q ss_pred CCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 148 pnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
|||+++++++.+.+..++||||+++++|.+++.... ...++++..++.++.||+.||.|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999987532 245699999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|.+||.......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999986544333333344579999999997765 58999999999999999999999998765443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=309.07 Aligned_cols=206 Identities=23% Similarity=0.344 Sum_probs=174.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------- 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------- 161 (315)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999999999999999997543 234677999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCChhhhhhhcCCCCCCCCH
Q 021249 162 --------------------------------------------------QRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191 (315)
Q Consensus 162 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 191 (315)
..++||||+++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3899999999999999997643 2344677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc----------eeeeeccccc
Q 021249 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------HVSTRVMGTY 261 (315)
Q Consensus 192 ~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~ 261 (315)
..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78899999999999999998 9999999999999999999999999999865443211 1123347999
Q ss_pred cccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 262 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
.|+|||++.+..++.++|||||||++|+|++|..|+..
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999999999888753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=320.33 Aligned_cols=199 Identities=26% Similarity=0.335 Sum_probs=168.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----Ce
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 162 (315)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999999999999999997542 33456789999999999999999999999776 57
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 699998875 45699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------eeeeeccccccccCcccc-ccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 243 KMGPSGDKT--------------------HVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 243 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 865432211 123456899999999986 456799999999999999999984333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=304.99 Aligned_cols=210 Identities=29% Similarity=0.349 Sum_probs=178.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|.+.+.||+|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357999999999999999999999999999999987543 3346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCcccC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~~~ 245 (315)
|+++++|.+++.........+++..++.++.||+.||.|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865433356799999999999999999999998 99999999999999 45678999999999754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
..... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+..
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~ 234 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ 234 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 33221 23347999999999775 57899999999999999999999999876654433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=327.18 Aligned_cols=210 Identities=26% Similarity=0.376 Sum_probs=184.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999997543 2346778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLA 242 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~ 242 (315)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998875 45699999999999999999999998 99999999999999 46789999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
........ .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 239 (484)
T 3nyv_A 177 THFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239 (484)
T ss_dssp HHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 76544322 223479999999998765 6999999999999999999999999987766655554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=325.92 Aligned_cols=210 Identities=27% Similarity=0.356 Sum_probs=178.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|++.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999999999999999997653 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---CceEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~---~~~kl~Dfg~~~~ 244 (315)
||+++++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998876 35689999999999999999999998 99999999999999764 4599999999976
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54332 123357999999999875 569999999999999999999999999877766555543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=315.45 Aligned_cols=218 Identities=27% Similarity=0.393 Sum_probs=185.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-------CCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEee
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE 159 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 159 (315)
..++|.+.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 45689999999999999999999743 346899999976533 3456789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999986432 124699999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986544333233333467889999999999999999999999999999999 99999887765554
Q ss_pred hHH
Q 021249 307 NLV 309 (315)
Q Consensus 307 ~~i 309 (315)
..+
T Consensus 304 ~~~ 306 (382)
T 3tt0_A 304 KLL 306 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=316.36 Aligned_cols=214 Identities=29% Similarity=0.463 Sum_probs=171.4
Q ss_pred hCCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+. .++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999876 457789999997653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 245699999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 246 PSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i 263 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4322111 1112245778999999999999999999999999999998 99999877665544443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=307.55 Aligned_cols=205 Identities=26% Similarity=0.323 Sum_probs=173.7
Q ss_pred hCCCCcc-cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+.+++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578885 7899999999999999999999999999876656677889999999884 7999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc---eEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~---~kl~Dfg~~~~ 244 (315)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999976 35689999999999999999999998 9999999999999998765 99999999875
Q ss_pred CCCCCC-----ceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 245 GPSGDK-----THVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 432111 111123469999999998875 568899999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=326.33 Aligned_cols=210 Identities=27% Similarity=0.383 Sum_probs=181.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|.+.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999999999999999986432 23467789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc---CCCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~---~~~~~kl~Dfg~~~ 243 (315)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998876 35689999999999999999999998 999999999999995 45679999999997
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+
T Consensus 173 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 234 (486)
T 3mwu_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 543332 1233479999999998865 5999999999999999999999999887766655544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=301.65 Aligned_cols=205 Identities=27% Similarity=0.451 Sum_probs=160.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 457999999999999999999999899999999996432 12356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...++++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999875 246799999999999999999999998 99999999999999999999999999997644
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 32211 1234689999999999988999999999999999999999999986553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=299.87 Aligned_cols=210 Identities=25% Similarity=0.368 Sum_probs=182.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4679999999999999999998874 77899999976543 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999763 34589999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
.. ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH
Confidence 22 2223456778999999998899999999999999999999 9999987765554443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.11 Aligned_cols=205 Identities=30% Similarity=0.443 Sum_probs=172.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----eEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 165 (315)
.++|++.+.||+|+||+||+|.+. ++.||||++.... ........|+.+++.++||||+++++++.+.. .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 457999999999999999999887 7899999997543 22344566899999999999999999998744 4799
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEEecCCCCCEEEcCCCceEEec
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-------KQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
||||+++++|.+++.. .++++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999976 34899999999999999999999631 12899999999999999999999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCcccccc-----CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999976544333322333579999999999886 3567789999999999999999999987544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=301.90 Aligned_cols=211 Identities=27% Similarity=0.415 Sum_probs=182.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4579999999999999999999874 77899999986543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999975 245689999999999999999999998 99999999999999999999999999997543321
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~ 220 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 1 11122356778999999998999999999999999999999 99999887765554443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.88 Aligned_cols=216 Identities=23% Similarity=0.340 Sum_probs=182.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee--------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE-------- 159 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------- 159 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3679999999999999999999999999999999865432 234567899999999999999999999977
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
.+..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999975 77776654 235699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCC--ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 240 GLAKMGPSGDK--THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 240 g~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99976432211 122234578999999998876 46899999999999999999999999998888777776654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.17 Aligned_cols=207 Identities=28% Similarity=0.403 Sum_probs=180.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999999999999999987543 334577899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998865 45689999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
...........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 222222334578999999999887765 7899999999999999999999987554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.68 Aligned_cols=203 Identities=32% Similarity=0.433 Sum_probs=177.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
..|.+.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458999999999999999999999999999999975432 23456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+. |+|.+++... ..++++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6788877642 45799999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
. ....||+.|+|||++. +..++.++|||||||++|+|++|+.||...+....+
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 262 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 2 2347999999999884 567899999999999999999999999876654443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.53 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=182.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457999999999999999999999999999999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998876 35689999999999999999999998 99999999999999999999999999997643
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32211 2234689999999999988999999999999999999999999987665443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=300.03 Aligned_cols=209 Identities=25% Similarity=0.359 Sum_probs=181.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3569999999999999999999999999999999875432 2367789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEecc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF 239 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~Df 239 (315)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999976 35689999999999999999999998 999999999999998876 8999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
|++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||......+.+..
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 222 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN 222 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 99976433221 2234689999999999988999999999999999999999999988765554443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.99 Aligned_cols=208 Identities=25% Similarity=0.351 Sum_probs=183.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999999999999999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998876 35689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+..
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 250 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred cCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 32211 22347899999999999989999999999999999999999999876654433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=311.67 Aligned_cols=212 Identities=26% Similarity=0.422 Sum_probs=179.0
Q ss_pred HhCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 161 (315)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456799999999999999999997 3457789999997543 23456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPD-------------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK 222 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlk 222 (315)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999764321 13489999999999999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 223 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999975544333333334467889999999999999999999999999999998 999998766
Q ss_pred ch
Q 021249 302 DR 303 (315)
Q Consensus 302 ~~ 303 (315)
..
T Consensus 280 ~~ 281 (344)
T 1rjb_A 280 VD 281 (344)
T ss_dssp CS
T ss_pred cH
Confidence 43
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.84 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=180.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35799999999999999999999999999999998654332 3455789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999998887654 45699999999999999999999998 999999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....+.+.+..+.
T Consensus 177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 221 12334789999999988775 78999999999999999999999999888776665553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=300.79 Aligned_cols=207 Identities=25% Similarity=0.389 Sum_probs=182.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999999999999999986432 12346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999976 34689999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 222 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR 222 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH
Confidence 322 123478999999999999999999999999999999999999998766554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.98 Aligned_cols=199 Identities=24% Similarity=0.320 Sum_probs=165.3
Q ss_pred hCCCCcc-cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHh-ccCCCCCeeeEEeEEee----CCeE
Q 021249 90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNLVKLIGYCAE----GDQR 163 (315)
Q Consensus 90 ~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~~ 163 (315)
.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++ +..+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 6899999999999999999999999998643 4566788876 45689999999999875 5678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG 240 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg 240 (315)
|+||||++||+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999762 234699999999999999999999998 9999999999999997 7889999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 998643322 1234578999999999999999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=314.37 Aligned_cols=209 Identities=27% Similarity=0.370 Sum_probs=166.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------C
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------D 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 161 (315)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999999999999999997542 23456788999999999999999999998654 5
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6889888754 4699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|..+
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9754322 233579999999999877 67899999999999999999999999998888777776543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=306.15 Aligned_cols=205 Identities=31% Similarity=0.476 Sum_probs=174.3
Q ss_pred hCCCCcccccccCCceEEEEEE----ECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGC----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 163 (315)
.++|++.+.||+|+||+||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4679999999999999999998 566789999999987766667789999999999999999999999854 3568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999763 34589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
........ .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 65332211 1222345777899999999999999999999999999999999988643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=302.96 Aligned_cols=206 Identities=25% Similarity=0.315 Sum_probs=171.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999975432 234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ..++++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999976 35689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 332211 12234689999999999999999999999999999999999999986554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=315.07 Aligned_cols=213 Identities=23% Similarity=0.296 Sum_probs=184.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC------CCCCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA------DHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~~~~~~~ 162 (315)
...+|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999999999999999997542 2345567777777665 67899999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--eEEeccC
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFG 240 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~--~kl~Dfg 240 (315)
.++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6899988763 234589999999999999999999998 9999999999999999887 9999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..++
T Consensus 248 ~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~ 315 (429)
T 3kvw_A 248 SSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELL 315 (429)
T ss_dssp TCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 997543322 23478999999999999999999999999999999999999999998888877776543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.47 Aligned_cols=215 Identities=23% Similarity=0.337 Sum_probs=184.5
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------ccHHHHHHHHHHhccC-CCCCeeeEE
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSA-DHPNLVKLI 154 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l-~hpnIv~~~ 154 (315)
.......++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 4445566789999999999999999999998999999999875431 1145578899999998 799999999
Q ss_pred eEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
+++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999976 35689999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCcccccc------CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
+|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....+..
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999976543322 223579999999998863 3588999999999999999999999987665544433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.77 Aligned_cols=213 Identities=27% Similarity=0.455 Sum_probs=174.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeE----EEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~----vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
.++|++.+.||+|+||.||+|.+..++.. ||+|.+... .......+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35799999999999999999999877764 577777543 3345678999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++++|+.+++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999763 45699999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 232 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 544333333333457889999999999999999999999999999999 99999887766554444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.00 Aligned_cols=216 Identities=27% Similarity=0.412 Sum_probs=182.4
Q ss_pred hCCCCcccccccCCceEEEEEEEC-------CCCeEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999975 356789999997653 23456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPD------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili 228 (315)
+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999764321 23489999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 229 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999986554433233333467889999999998899999999999999999999 999998776555444
Q ss_pred H
Q 021249 308 L 308 (315)
Q Consensus 308 ~ 308 (315)
.
T Consensus 271 ~ 271 (334)
T 2pvf_A 271 L 271 (334)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.43 Aligned_cols=212 Identities=28% Similarity=0.432 Sum_probs=183.0
Q ss_pred HhCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 161 (315)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456799999999999999999985 45678999999976543 3456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
..++||||+++++|.+++..... ...++++..++.++.||+.||.|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999976432 123589999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCch
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR 303 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 303 (315)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999986554443333334467889999999999999999999999999999999 99999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=311.04 Aligned_cols=214 Identities=28% Similarity=0.371 Sum_probs=177.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-----cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999999999999999999753221 13467899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999985 88888765 245688899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.++.+.+..+.
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 76433221 22335789999999988764 58999999999999999999999999888777666553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=304.03 Aligned_cols=215 Identities=27% Similarity=0.443 Sum_probs=187.6
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
...++|++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567999999999999999999999999999999997643 34677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999763 345689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~ 225 (288)
T 3kfa_A 164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225 (288)
T ss_dssp SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 322 22233457889999999998999999999999999999999 99999887665544443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=304.67 Aligned_cols=213 Identities=24% Similarity=0.388 Sum_probs=180.1
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4567999999999999999999887 477899999986543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999753 34599999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus 174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 11 11122356788999999998899999999999999999998 999998877665555443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=309.38 Aligned_cols=213 Identities=25% Similarity=0.317 Sum_probs=182.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----CeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 163 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4689999999999999999999999999999999975432 3356788999999999999999999998654 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 589988865 4589999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCc-eeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 64332111 11233579999999998654 4589999999999999999999999999888887777654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.74 Aligned_cols=199 Identities=24% Similarity=0.239 Sum_probs=166.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhcc-CCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ........|+..+.. .+||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3579999999999999999999999999999999865432 223344455555444 4899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+ +++|.+++... ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67998888763 45699999999999999999999998 99999999999999999999999999997643
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||..
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 1233469999999998776 799999999999999999999766654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=299.51 Aligned_cols=207 Identities=30% Similarity=0.436 Sum_probs=183.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999999999999999997554 3446779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.. .++++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999998864 4689999999999999999999998 9999999999999999999999999999764332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+..
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 228 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL 228 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH
Confidence 21 122347899999999999999999999999999999999999999876654443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.99 Aligned_cols=216 Identities=26% Similarity=0.438 Sum_probs=186.8
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.....+|.+.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 334567899999999999999999999889999999997654 3467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999763 235689999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+
T Consensus 370 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~ 432 (495)
T 1opk_A 370 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432 (495)
T ss_dssp TCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 322 111222346778999999999999999999999999999999 99999887765554444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=316.55 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=168.2
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------ccHHHHHHHHHHhccCCCCCeeeEEeEEee
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSADHPNLVKLIGYCAE 159 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 159 (315)
...++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456899999999999999999999999999999999875321 122347899999999999999999999865
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC---ceEE
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKL 236 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---~~kl 236 (315)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999988865 46799999999999999999999998 999999999999997544 5999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9999998643322 2234579999999998863 5788999999999999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.29 Aligned_cols=213 Identities=27% Similarity=0.406 Sum_probs=170.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccE
Confidence 346799999999999999999998643 5679999987643 3345678999999999999999999999854 5789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999762 34689999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+.+..+
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i 230 (281)
T 1mp8_A 166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence 4332211 1222356789999999998899999999999999999997 99999887766555444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.18 Aligned_cols=205 Identities=18% Similarity=0.227 Sum_probs=170.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCC-----CeEEEEEEecCCCccc-----------HHHHHHHHHHhccCCCCCeeeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG-----------VREFSAEVMTLGSADHPNLVKL 153 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~-----~~~vavK~i~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~ 153 (315)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998764 5789999987654211 1123446667788899999999
Q ss_pred EeEEeeC----CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc
Q 021249 154 IGYCAEG----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229 (315)
Q Consensus 154 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~ 229 (315)
++++... ...++||||+ +++|.+++.. ...++++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999976 246799999999999999999999998 999999999999999
Q ss_pred --CCCceEEeccCCcccCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 230 --EGYHPKLSDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 230 --~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8899999999999754322111 11123459999999999999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=309.90 Aligned_cols=208 Identities=25% Similarity=0.302 Sum_probs=172.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 161 (315)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999999999999999997542 234567889999999999999999999997655
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++||||++ ++|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999997 578777742 488999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 97543221 1233579999999999999999999999999999999999999999888766665553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=308.10 Aligned_cols=222 Identities=27% Similarity=0.451 Sum_probs=186.1
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEE
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYC 157 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 157 (315)
+++....++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556678999999999999999999876 3578899999975432 3455688999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q 021249 158 AEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG 231 (315)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~ 231 (315)
.+.+..++||||+++++|.+++.... ....++++..++.++.||+.||.|||+. +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 99999999999999999999987532 1125679999999999999999999998 99999999999999999
Q ss_pred CceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 232 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
+.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 9999999999975433222222223457889999999998899999999999999999999 8999987765544433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.82 Aligned_cols=210 Identities=25% Similarity=0.309 Sum_probs=174.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC------CeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~~~ 164 (315)
.+|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 469999999999999999999999999999999865432 234699999999999999999988432 2467
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-CceEEeccCCcc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAK 243 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-~~~kl~Dfg~~~ 243 (315)
+||||+++ +|.+.+.........+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999974 66666654333456799999999999999999999998 99999999999999965 578999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+++..|..
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 6543322 1234789999999988765 799999999999999999999999998887777666543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=302.99 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=175.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCC-------eEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIE-------QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
.++|.+.+.||+|+||+||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457999999999999999999988766 5799999987666667889999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc--------e
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--------P 234 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~--------~ 234 (315)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999762 34489999999999999999999998 9999999999999998877 9
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhC-CCcccccCch
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITG-RKAIDQTKDR 303 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg-~~pf~~~~~~ 303 (315)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+..
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 99999998643221 12358899999999887 6789999999999999999995 5666554433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.38 Aligned_cols=206 Identities=26% Similarity=0.355 Sum_probs=180.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357999999999999999999999999999999997653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999976 34689999999999999999999983 28999999999999999999999999998643221
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 12234789999999999999999999999999999999999999987665443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=301.70 Aligned_cols=213 Identities=23% Similarity=0.328 Sum_probs=181.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEe--eCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~l 165 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4679999999999999999999999999999999976432 34567899999999999999999999874 4678999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEecCCCCCEEEcCCCceEEeccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-----VIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~-----iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
||||+++++|.+++.........+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544456699999999999999999999998 7 9999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 226 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH
Confidence 9976433221 1123468999999999998899999999999999999999999998776544333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.00 Aligned_cols=217 Identities=22% Similarity=0.268 Sum_probs=183.9
Q ss_pred HHHHHhCCCCcc-cccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCC-CCCeeeEEeEEeeC
Q 021249 85 ELAAATGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEG 160 (315)
Q Consensus 85 ~~~~~~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 160 (315)
......++|.+. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 445566788887 88999999999999999999999999987542 234677889999999985 69999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEe
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLS 237 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~ 237 (315)
...++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999988542 246799999999999999999999998 9999999999999987 7899999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+
T Consensus 177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 9999986543221 22347999999999999999999999999999999999999999887766554443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=315.88 Aligned_cols=207 Identities=28% Similarity=0.409 Sum_probs=178.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC-eEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~ 167 (315)
..++|.+.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 4467899999999999999999986 7799999998654 4567899999999999999999999987655 799999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999998632 33479999999999999999999998 999999999999999999999999999975332
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
.. ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 21 12257889999999999999999999999999999998 99999887766555444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=296.71 Aligned_cols=201 Identities=31% Similarity=0.573 Sum_probs=173.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999999999999999998654321 1267889999999999999999999997765
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEcCCCc-----eE
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYH-----PK 235 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~~~~~-----~k 235 (315)
++||||+++++|.+++.. ...++++..++.++.|++.||.|||+. + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999988865 345799999999999999999999998 7 999999999999988776 99
Q ss_pred EeccCCcccCCCCCCceeeeeccccccccCccccc--cCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 236 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
|+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 999999974322 123357999999999883 456789999999999999999999999865543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=303.24 Aligned_cols=206 Identities=25% Similarity=0.365 Sum_probs=169.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457999999999999999999999899999999997532 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.........+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999876444456799999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 3221 122346899999999999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.24 Aligned_cols=206 Identities=29% Similarity=0.416 Sum_probs=176.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999999999999999997653 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998742 45689999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 232 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 11 1223468999999999999899999999999999999999999998765433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=295.65 Aligned_cols=209 Identities=26% Similarity=0.386 Sum_probs=174.8
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999999899999999986532 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ..++++..++.++.||+.||.|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999976 34689999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
..... .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||......+...
T Consensus 162 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 162 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 43221 223468999999999887765 689999999999999999999998765544433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.74 Aligned_cols=213 Identities=25% Similarity=0.334 Sum_probs=177.3
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC----cccHHHHHHHHHHhccCCCCCeeeEEeEE--eeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYC--AEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~--~~~~~ 162 (315)
..++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999999999999999997542 23456789999999999999999999998 44568
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||++++ |.+++.... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999866 777776532 45689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCC--cCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
................||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence 8654333333333457999999999887643 4789999999999999999999998766544433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=307.61 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=168.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCC--CCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADH--PNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~l 165 (315)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.++| |||+++++++.+.+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 457999999999999999999885 588999999875433 345678999999999976 999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999986 45689999999999999999999998 999999999999997 578999999999865
Q ss_pred CCCCCceeeeeccccccccCcccccc-----------CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 44333323334579999999998865 678899999999999999999999997643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=295.81 Aligned_cols=202 Identities=31% Similarity=0.497 Sum_probs=166.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc----ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 457999999999999999999986 78999999875432 235678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEEecCCCCCEEEcC--------CCce
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP---VIYRDLKCSNILLEE--------GYHP 234 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~---iiH~Dlkp~Nili~~--------~~~~ 234 (315)
||||+++++|.+++.. .++++..++.++.|++.||.|||+. + ++||||||+||+++. ++.+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999998853 4689999999999999999999998 7 999999999999986 6789
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
||+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 156 kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 156 KITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred EEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999975433221 134689999999999999999999999999999999999999987664443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.59 Aligned_cols=216 Identities=26% Similarity=0.417 Sum_probs=171.2
Q ss_pred HhCCCCcccccccCCceEEEEEEECC---CCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-- 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 161 (315)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45679999999999999999998754 56689999987543 334567899999999999999999999997755
Q ss_pred ---eEEEEEEecCCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 162 ---QRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 162 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985432 2346799999999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhh
Q 021249 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN 307 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 307 (315)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 99999976543332222233457889999999999999999999999999999999 999998776655443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.21 Aligned_cols=209 Identities=25% Similarity=0.430 Sum_probs=176.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|++.+.||+|+||.||+|.+..++..||+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34679999999999999999999999999999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999988753 35689999999999999999999998 9999999999999999999999999987532111
Q ss_pred CCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
........||+.|+|||++. +..++.++||||||+++|+|++|..||...+....
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230 (302)
T ss_dssp --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 01112346899999999873 66789999999999999999999999987665443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.25 Aligned_cols=220 Identities=25% Similarity=0.383 Sum_probs=185.4
Q ss_pred CcCHHHHHHHhCCCCcccccccCCceEEEEEEE-----CCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeee
Q 021249 80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVK 152 (315)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~ 152 (315)
++....+....++|.+.+.||+|+||.||+|.+ ..+++.||+|++..... .....+.+|+.+++.+ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345556666778999999999999999999985 35678999999976543 3456788999999999 6999999
Q ss_pred EEeEEeeCC-eEEEEEEecCCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 021249 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPD------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219 (315)
Q Consensus 153 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~ 219 (315)
+++++...+ .+++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987654 589999999999999999764321 12389999999999999999999998 99999
Q ss_pred cCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCccc
Q 021249 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298 (315)
Q Consensus 220 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~ 298 (315)
||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986544333333334467889999999999999999999999999999998 999998
Q ss_pred ccCc
Q 021249 299 QTKD 302 (315)
Q Consensus 299 ~~~~ 302 (315)
....
T Consensus 253 ~~~~ 256 (316)
T 2xir_A 253 GVKI 256 (316)
T ss_dssp TCCC
T ss_pred ccch
Confidence 7654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=295.15 Aligned_cols=200 Identities=28% Similarity=0.433 Sum_probs=174.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee----CCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 164 (315)
..|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999999999999999987543 3345678999999999999999999998865 45689
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEc-CCCceEEeccCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLE-EGYHPKLSDFGL 241 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~-~~~~~kl~Dfg~ 241 (315)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999976 35689999999999999999999997 7 99999999999998 788999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.....
T Consensus 179 ~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 179 ATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred cccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 97543332 22347999999999776 4689999999999999999999999987544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.51 Aligned_cols=220 Identities=25% Similarity=0.419 Sum_probs=185.0
Q ss_pred cCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
+..+.+....++|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+++.++||||+++++++. .
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~ 254 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 254 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence 3334455567789999999999999999999875 6789999998654 34678999999999999999999999987 5
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred CccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence 6789999999999999999752 123588999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
+++....... .......+++.|+|||++....++.++|||||||++|||++ |+.||.+.+..+.+..+
T Consensus 330 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 398 (454)
T 1qcf_A 330 LARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398 (454)
T ss_dssp GGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9986433211 11122346788999999998899999999999999999999 99999887766555444
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.61 Aligned_cols=212 Identities=29% Similarity=0.438 Sum_probs=177.6
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEE--EEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVV--AIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~v--avK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|.+.+.||+|+||.||+|.+..++..+ |+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999998888755 999887532 33456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 167 YEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
|||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997632 2235799999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 999999997422211 1122357889999999988899999999999999999998 9999987765544433
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=305.65 Aligned_cols=214 Identities=30% Similarity=0.423 Sum_probs=176.2
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEee----
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE---- 159 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---- 159 (315)
++....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445678999999999999999999999899999999987543 3356788999999998 79999999999976
Q ss_pred --CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 160 --GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 568999999999999999997632 35689999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||...+....+
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9999875432211 122346899999999887 567889999999999999999999999876654443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.04 Aligned_cols=205 Identities=15% Similarity=0.190 Sum_probs=165.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC---CcccHHHHHHHH---HHhccCCCCCeeeEE-------eE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEV---MTLGSADHPNLVKLI-------GY 156 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~ 156 (315)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35799999999999999999999888999999999743 334467788999 455566899999998 66
Q ss_pred EeeCC-----------------eEEEEEEecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021249 157 CAEGD-----------------QRLLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216 (315)
Q Consensus 157 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 216 (315)
+.+.+ ..++||||+ +|+|.+++..... ....+++..++.++.||+.||.|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 6899999975311 112344588889999999999999998 99
Q ss_pred EEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccC-----------CcCcccchhhHHH
Q 021249 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----------QLTFKSDIYSFGV 285 (315)
Q Consensus 217 iH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~ 285 (315)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2234467 999999999887 8999999999999
Q ss_pred HHHHHHhCCCcccccCchh
Q 021249 286 VLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 286 il~elltg~~pf~~~~~~~ 304 (315)
++|+|++|+.||.......
T Consensus 302 il~elltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG 320 (377)
T ss_dssp HHHHHHHSSCCC------C
T ss_pred HHHHHHHCCCCCccccccc
Confidence 9999999999998765433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=298.35 Aligned_cols=206 Identities=33% Similarity=0.553 Sum_probs=164.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|++.+.||+|+||.||+|.+.. .||+|++.... ....+.+.+|+.+++.++||||+++++++ .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 45689999999999999999998753 59999987543 23456789999999999999999999965 45678999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999865 246699999999999999999999998 99999999999999999999999999997544
Q ss_pred CCCCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
............||+.|+|||++. +..++.++||||||+++|+|++|+.||......+
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 332233333457999999999886 5678899999999999999999999998765543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.59 Aligned_cols=209 Identities=27% Similarity=0.320 Sum_probs=180.8
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---------ccHHHHHHHHHHhccCC-CCCeeeEEeEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---------QGVREFSAEVMTLGSAD-HPNLVKLIGYC 157 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 157 (315)
...++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999999999999999975431 12456788999999995 99999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||+|+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999976 35689999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccc------cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
|||++........ .....|++.|+|||++. ...++.++||||||+++|+|++|..||...+..+..
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 167 DFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 9999976543322 22346899999999875 456889999999999999999999999876654433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=297.39 Aligned_cols=202 Identities=21% Similarity=0.234 Sum_probs=174.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999999999999999987543 23456688899999888 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---------------
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--------------- 231 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~--------------- 231 (315)
|||+++++|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976433336689999999999999999999998 99999999999999844
Q ss_pred ----CceEEeccCCcccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 232 ----YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 232 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
..+||+|||.+....... ...||+.|+|||++.+. .+++++|||||||++|+|++|.+|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998654332 12589999999998766 6678999999999999999999877543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.59 Aligned_cols=201 Identities=23% Similarity=0.328 Sum_probs=169.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCC--CCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD--HPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv 166 (315)
.+|.+.+.||+|+||.||+|.+.. +..||||++.... ......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 469999999999999999998875 8899999997543 234567899999999996 59999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999986 34689999999999999999999998 999999999999996 5789999999998654
Q ss_pred CCCCceeeeeccccccccCcccccc-----------CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 3332222334579999999998865 368899999999999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.13 Aligned_cols=213 Identities=24% Similarity=0.389 Sum_probs=181.5
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCe-----EEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~-----~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
...++|.+.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999876654 799999976533 3456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP----------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE 230 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~ 230 (315)
+..++||||+++++|.+++..... ...++++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 999999999999999999875311 134689999999999999999999998 9999999999999999
Q ss_pred CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCch
Q 021249 231 GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR 303 (315)
Q Consensus 231 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 303 (315)
++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999975433333222333457889999999999999999999999999999998 99999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=310.20 Aligned_cols=204 Identities=27% Similarity=0.351 Sum_probs=173.9
Q ss_pred hCCCCcccccccCCceEEEEEEEC---CCCeEEEEEEecCCCc----ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 161 (315)
.++|.+.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357999999999999999999984 4789999999875421 2345567899999998 6999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999976 34689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 975432221 12234579999999999885 357899999999999999999999997544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.19 Aligned_cols=205 Identities=24% Similarity=0.336 Sum_probs=176.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--eEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLV 166 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv 166 (315)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999999999999999997543 234567889999999999999999999998755 78999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----cCCCceEEeccCCc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA 242 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili----~~~~~~kl~Dfg~~ 242 (315)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999976322 23489999999999999999999998 99999999999999 77778999999999
Q ss_pred ccCCCCCCceeeeeccccccccCcccccc--------CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMT--------GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 86443221 223479999999998865 567889999999999999999999997544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=299.13 Aligned_cols=194 Identities=18% Similarity=0.298 Sum_probs=171.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEee--CCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAE--GDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57999999999999999999999999999999997543 467889999999997 9999999999987 67889999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCcccCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGP 246 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~~~ 246 (315)
||+.+++|.+++.. +++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++....
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988854 78999999999999999999998 999999999999999776 89999999998654
Q ss_pred CCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
..... ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 33221 23468999999999877 67899999999999999999999999543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.93 Aligned_cols=207 Identities=24% Similarity=0.323 Sum_probs=171.7
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEE-eeCCeEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLLV 166 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv 166 (315)
...++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+..|+.+++.++|++++..+..+ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999999999999999987654322 3477899999999888766666554 777889999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCcc
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAK 243 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~ 243 (315)
|||+ +++|.+++... ..++++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999998752 45699999999999999999999998 99999999999999 788999999999998
Q ss_pred cCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 244 MGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 244 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 65433221 1122457999999999999999999999999999999999999999875543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.84 Aligned_cols=219 Identities=25% Similarity=0.298 Sum_probs=178.7
Q ss_pred CHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-----------cHHHHHHHHHHhccCCCCCe
Q 021249 82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPNL 150 (315)
Q Consensus 82 ~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-----------~~~~~~~E~~~l~~l~hpnI 150 (315)
.+.++....++|.+.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356777888999999999999999999998865 899999998643221 13678999999999999999
Q ss_pred eeEEeEEee-----CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 151 VKLIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 151 v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
+++++++.. ....++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 999999843 347899999997 688887764 345799999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999997433322 1223478999999998877 678999999999999999999999999888777
Q ss_pred hhhHHhh
Q 021249 305 ELNLVAW 311 (315)
Q Consensus 305 ~~~~i~~ 311 (315)
.+..+..
T Consensus 242 ~~~~i~~ 248 (362)
T 3pg1_A 242 QLNKIVE 248 (362)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7666643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=298.59 Aligned_cols=203 Identities=29% Similarity=0.429 Sum_probs=174.4
Q ss_pred CCCCcccccccCCceEEEEEE----ECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGC----LEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR 163 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 163 (315)
.+|++.+.||+|+||.||+|. +..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458999999999999999998 46789999999997543 34467789999999999999999999999876 678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999653 35699999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|..|+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 65443322 222334688889999999999999999999999999999999998743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.60 Aligned_cols=212 Identities=26% Similarity=0.372 Sum_probs=174.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe----------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA---------- 158 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---------- 158 (315)
..++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3568999999999999999999999999999999998776666778999999999999999999999873
Q ss_pred ----eCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCCc
Q 021249 159 ----EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYH 233 (315)
Q Consensus 159 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~~ 233 (315)
+....++||||++ ++|.+++.. .++++..++.++.||+.||.|||+. +|+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 4468899999997 699998854 5689999999999999999999998 999999999999997 5679
Q ss_pred eEEeccCCcccCCCCCC-ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 234 PKLSDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+||+|||++........ ........+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999976432211 111223467899999998765 67899999999999999999999999988876665554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.27 Aligned_cols=208 Identities=25% Similarity=0.312 Sum_probs=176.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe----eCCeEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA----EGDQRL 164 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~ 164 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3467999999999999999999999999999999997766666778999999999999999999999986 334789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++........++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999987555567899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCCce-------eeeeccccccccCccccccCC---cCcccchhhHHHHHHHHHhCCCcccc
Q 021249 245 GPSGDKTH-------VSTRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 245 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 32211000 001235799999999887553 68999999999999999999999965
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=294.15 Aligned_cols=210 Identities=27% Similarity=0.392 Sum_probs=181.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 457999999999999999999987 477899999986543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999762 35689999999999999999999998 99999999999999999999999999997543221
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH
Confidence 111122357788999999998899999999999999999999 8999987765554433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.85 Aligned_cols=213 Identities=28% Similarity=0.428 Sum_probs=179.1
Q ss_pred hCCCCccc-ccccCCceEEEEEEEC--CCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDC-CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34677776 8999999999999864 467889999998653 34467789999999999999999999999 4567899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999865 245699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 246 PSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i 226 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 433221 11222356889999999988899999999999999999998 99999887765554443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=292.28 Aligned_cols=205 Identities=26% Similarity=0.368 Sum_probs=174.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP 171 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 171 (315)
.|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34555689999999999999999999999999987766667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEeccCCcccCCCCCC
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+++|.+++.... ....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997632 234577899999999999999999998 9999999999999987 88999999999976543221
Q ss_pred ceeeeeccccccccCccccccCC--cCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 122346899999999887653 78999999999999999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.45 Aligned_cols=220 Identities=23% Similarity=0.275 Sum_probs=171.6
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe-
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ- 162 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~- 162 (315)
.......++|.+.+.||+|+||.||+|.+..++..||||++.... ........++..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999999999999999986543 223455677888888999999999999865333
Q ss_pred ------EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEecCCCCCEEEcC-CCc
Q 021249 163 ------RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--EQLKQPVIYRDLKCSNILLEE-GYH 233 (315)
Q Consensus 163 ------~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~iiH~Dlkp~Nili~~-~~~ 233 (315)
.++||||+++ +|...+.........+++..++.++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999985 555554433334667899999999999999999999 77 9999999999999996 899
Q ss_pred eEEeccCCcccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999999986543322 2234789999999988665 489999999999999999999999999887777666643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.56 Aligned_cols=212 Identities=30% Similarity=0.455 Sum_probs=177.1
Q ss_pred hCCCCccc-ccccCCceEEEEEEE--CCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 90 TGNFRSDC-CLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 90 ~~~y~~~~-~ig~G~~g~V~~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
.++|.+.+ .||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788888 999999999999954 56688999999976532 2356789999999999999999999999 557789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999986 35689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 233 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 54433221 1222346788999999988899999999999999999999 99999887665544443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=294.61 Aligned_cols=204 Identities=25% Similarity=0.325 Sum_probs=174.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEE-eeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~ 167 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 35789999999999999999999999999999999876533 24678999999999988766655544 6778889999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~~ 244 (315)
||+ +++|.+++... ..++++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999999752 35699999999999999999999998 99999999999999 4788999999999976
Q ss_pred CCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 245 GPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 5433221 11234579999999999999999999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=305.69 Aligned_cols=202 Identities=19% Similarity=0.230 Sum_probs=167.0
Q ss_pred hCCCCcccccccCCceEEEEEEECC---CCeEEEEEEecCCCcc-----------cHHHHHHHHHHhccCCCCCeeeEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPNLVKLIG 155 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~~ 155 (315)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 7889999998765321 1123567888899999999999999
Q ss_pred EEee----CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC
Q 021249 156 YCAE----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG 231 (315)
Q Consensus 156 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~ 231 (315)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9987 78899999999 9999999876 23799999999999999999999998 99999999999999987
Q ss_pred C--ceEEeccCCcccCCCCCC-----ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 232 Y--HPKLSDFGLAKMGPSGDK-----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 232 ~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 999999999975432211 1111334799999999999999999999999999999999999999965
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=302.19 Aligned_cols=205 Identities=31% Similarity=0.420 Sum_probs=179.6
Q ss_pred CCCCcccccccCCceEEEEEE----ECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe--eCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGC----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~ 164 (315)
++|++.+.||+|+||.||+|. +..++..||+|++........+.+.+|+.+++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 579999999999999999998 46678999999998877666778999999999999999999999886 556789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999763 24589999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 245 GPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 54433221 2223457888999999999999999999999999999999999996544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.74 Aligned_cols=214 Identities=27% Similarity=0.431 Sum_probs=175.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCC----CeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~----~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
..+|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 35788899999999999999987654 34699999976532 34556889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999762 45699999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 4332211 11122346788999999998999999999999999999999 99999877655544443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=299.42 Aligned_cols=212 Identities=21% Similarity=0.311 Sum_probs=182.7
Q ss_pred HhCCCCcccccccCCceEEEEEEE-CCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCC------CeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCL-EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP------NLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~-~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp------nIv~~~~~~~~~~ 161 (315)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+|+.+++.++|+ +|+++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 356899999999999999999998 5678999999997542 3356688899988887655 5999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-----------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE----------- 230 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~----------- 230 (315)
..++||||+ +++|.+++... ...++++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 89999998763 234689999999999999999999998 9999999999999987
Q ss_pred --------CCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 231 --------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 231 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999997643321 234789999999999999999999999999999999999999998887
Q ss_pred hhhhhHHhhh
Q 021249 303 RKELNLVAWL 312 (315)
Q Consensus 303 ~~~~~~i~~~ 312 (315)
.+.+..+..+
T Consensus 240 ~~~~~~~~~~ 249 (339)
T 1z57_A 240 KEHLAMMERI 249 (339)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7777666544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=303.99 Aligned_cols=216 Identities=29% Similarity=0.423 Sum_probs=175.8
Q ss_pred hCCCCcccccccCCceEEEEEE-----ECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~-----~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|.+.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4579999999999999999998 45678899999997543 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEe
Q 021249 164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLS 237 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~ 237 (315)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986432 124589999999999999999999998 9999999999999984 4469999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence 9999874433222222233467899999999998999999999999999999998 9999987765554443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=291.81 Aligned_cols=202 Identities=23% Similarity=0.349 Sum_probs=174.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeC--CeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357999999999999999999986 7889999997653 23456789999999999999999999999887 78899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
||||+++++|.+++... ...++++..++.++.||+.||.|||+. + ++||||||+||+++.++.++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999999762 234689999999999999999999987 7 9999999999999999999999888875
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCc---ccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
..... ...||+.|+|||++.+..++. ++||||||+++|+|++|+.||...+..+.
T Consensus 162 ~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 162 SFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp TTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred eeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 32221 236899999999988765554 79999999999999999999987765544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.72 Aligned_cols=203 Identities=27% Similarity=0.359 Sum_probs=171.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSADHPNLVKLIGYCAEG 160 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 160 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 44679999999999999999999999999999999975422 1234578999999999999999999998776
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc---eEEe
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLS 237 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~---~kl~ 237 (315)
. .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999998865 45799999999999999999999998 9999999999999987654 9999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 999998643321 122346899999999874 46789999999999999999999999976543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=295.54 Aligned_cols=216 Identities=28% Similarity=0.438 Sum_probs=181.2
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++....++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 344456789999999999999999999864 6789999997653 345778999999999999999999999875 5689
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999998642 123689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+
T Consensus 159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 159 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp CSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 543321 11222356788999999988899999999999999999999 99999877665544433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.65 Aligned_cols=210 Identities=25% Similarity=0.314 Sum_probs=171.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------eE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------QR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~~ 163 (315)
..+|.+.+.||+|+||+||+|.+..++. +|+|++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3469999999999999999999987666 78887754322 1236899999999999999999985433 37
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCCceEEeccCCc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLA 242 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~~~kl~Dfg~~ 242 (315)
++||||++++ +...+.........+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999864 4443332222356799999999999999999999998 999999999999999 7899999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
+........ ....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 865433222 234789999999988765 589999999999999999999999999887777766654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=301.63 Aligned_cols=215 Identities=27% Similarity=0.397 Sum_probs=162.3
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
....++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999998889999999987543 2345668899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 166 VYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999986421 1245689999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCC---ceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 242 AKMGPSGDK---THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 242 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
+........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 875433211 111223468999999998876 568999999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.25 Aligned_cols=199 Identities=26% Similarity=0.401 Sum_probs=165.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc--CCCCCeeeEEeEEee----CCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCAE----GDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~----~~~ 162 (315)
..++|++.+.||+|+||+||+|.+. ++.||||++... ....+..|.+++.. ++||||+++++++.+ ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3568999999999999999999884 889999998754 23445556666555 899999999998654 356
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEecCCCCCEEEcCCCce
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--------EQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
.++||||+++++|.+++.. ..+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 8999999999999999954 46999999999999999999999 76 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCce--eeeeccccccccCccccccC------CcCcccchhhHHHHHHHHHhC----------CCc
Q 021249 235 KLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITG----------RKA 296 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~p 296 (315)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997543332221 11234799999999998876 566799999999999999999 889
Q ss_pred cccc
Q 021249 297 IDQT 300 (315)
Q Consensus 297 f~~~ 300 (315)
|...
T Consensus 233 f~~~ 236 (301)
T 3q4u_A 233 FYDV 236 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 8654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=301.44 Aligned_cols=213 Identities=24% Similarity=0.343 Sum_probs=179.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----Ce
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 162 (315)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35689999999999999999999999999999999975432 3355688999999999999999999987654 67
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 689888875 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCce--------eeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 243 KMGPSGDKTH--------VSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 243 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 7653321110 1123468999999998764 678999999999999999999999999888766665543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.33 Aligned_cols=211 Identities=25% Similarity=0.392 Sum_probs=175.9
Q ss_pred hCCCCcccccccCCceEEEEEEECC---CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4579999999999999999998643 34579999997653 34567789999999999999999999998764 5689
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999763 35689999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 432211 1223357889999999988899999999999999999998 9999986665554433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=304.09 Aligned_cols=208 Identities=24% Similarity=0.342 Sum_probs=177.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE---
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR--- 163 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~--- 163 (315)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34689999999999999999999999999999999976432 2356788999999999999999999999877654
Q ss_pred ---EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccC
Q 021249 164 ---LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240 (315)
Q Consensus 164 ---~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg 240 (315)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 67877663 3489999999999999999999998 99999999999999999999999999
Q ss_pred CcccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 190 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 190 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99754322 223478999999999887 6889999999999999999999999998887776666543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=316.61 Aligned_cols=216 Identities=31% Similarity=0.454 Sum_probs=178.6
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
.+....++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 344456789999999999999999999976 4679999998654 335678999999999999999999999876 6789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999752 134589999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
...... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 330 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 330 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 433221 11222356789999999998999999999999999999999 99999887766655444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=309.91 Aligned_cols=211 Identities=22% Similarity=0.306 Sum_probs=178.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC-CCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 167 (315)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 35789999999999999999999999999999999875432 2347789999999986 56666667778888999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE---cCCCceEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili---~~~~~~kl~Dfg~~~~ 244 (315)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999999753 45699999999999999999999998 99999999999999 6889999999999986
Q ss_pred CCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 245 GPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 245 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 5433221 112245799999999999999999999999999999999999999988665443333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=301.18 Aligned_cols=202 Identities=22% Similarity=0.306 Sum_probs=176.6
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCccc-----------------HHHHHHHHHHhccCCCCCeee
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----------------VREFSAEVMTLGSADHPNLVK 152 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~-----------------~~~~~~E~~~l~~l~hpnIv~ 152 (315)
.++|.+.+.||+|+||.||+|.+ +++.||+|++....... ...+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 69999999986432111 177899999999999999999
Q ss_pred EEeEEeeCCeEEEEEEecCCCChhhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCC
Q 021249 153 LIGYCAEGDQRLLVYEYMPLGSLDKH------LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSN 225 (315)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~N 225 (315)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ . +++||||+|+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence 99999999999999999999999998 432 125679999999999999999999998 7 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccC-CcCc-ccchhhHHHHHHHHHhCCCcccccCc
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTF-KSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||.....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999764332 22345799999999998877 6666 99999999999999999999987665
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=302.64 Aligned_cols=214 Identities=23% Similarity=0.290 Sum_probs=181.9
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CC-----CeeeEEeEEeeCC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HP-----NLVKLIGYCAEGD 161 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~~~~~~~~~~ 161 (315)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999999999999999997542 33456777888887774 44 4999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc--CCCceEEecc
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE--EGYHPKLSDF 239 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~--~~~~~kl~Df 239 (315)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 5999998763 235589999999999999999999952 23999999999999995 4778999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999865332 1234789999999999999999999999999999999999999999888777776654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=293.25 Aligned_cols=205 Identities=25% Similarity=0.295 Sum_probs=163.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999999999999999999765322 2233445555688899999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++ ++|.+++........++++..++.++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 588888765444567799999999999999999999984 2899999999999999999999999999975433
Q ss_pred CCCceeeeeccccccccCcccc----ccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYA----MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 221 1223689999999986 4567899999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.79 Aligned_cols=209 Identities=27% Similarity=0.321 Sum_probs=161.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEe--------e
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCA--------E 159 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~--------~ 159 (315)
...+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3457999999999999999999999999999999997666666777899999999996 999999999983 4
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEecCCCCCEEEcCCCceEEe
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~--iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
...++++|||+. |+|.+++..... ..++++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 456899999996 789888865332 35699999999999999999999997 7 9999999999999999999999
Q ss_pred ccCCcccCCCCCCce----------eeeeccccccccCcccc---ccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 238 DFGLAKMGPSGDKTH----------VSTRVMGTYGYCAPDYA---MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999997654322111 11134589999999988 566789999999999999999999999976543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=292.54 Aligned_cols=199 Identities=27% Similarity=0.420 Sum_probs=174.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee---------
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--------- 159 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--------- 159 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999999899999999997653 346689999999999999999998854
Q ss_pred -------CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC
Q 021249 160 -------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232 (315)
Q Consensus 160 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~ 232 (315)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 445899999999999999997532 35689999999999999999999998 999999999999999999
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999999976543321 1234689999999999999999999999999999999999999854
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=320.50 Aligned_cols=212 Identities=28% Similarity=0.422 Sum_probs=175.2
Q ss_pred CCCccc-ccccCCceEEEEEEEC--CCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 92 NFRSDC-CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 92 ~y~~~~-~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999875 356789999997653 2356789999999999999999999999976 5689999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999865 245699999999999999999999998 999999999999999999999999999986533
Q ss_pred CCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 248 GDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 2211 11122345689999999999999999999999999999998 999999888776665554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=292.26 Aligned_cols=210 Identities=29% Similarity=0.388 Sum_probs=173.3
Q ss_pred CCCcccccccCCceEEEEEEECCCC---eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE-EEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR-LLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-~lv 166 (315)
.|.+.+.||+|+||+||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999975443 4799999976433 3467788999999999999999999999766655 999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999975 346689999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCC--ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCcccccCchhhhh
Q 021249 247 SGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELN 307 (315)
Q Consensus 247 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~ 307 (315)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~ 239 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH
Confidence 3211 1112234678899999999999999999999999999999995 55565555444333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=293.75 Aligned_cols=210 Identities=28% Similarity=0.438 Sum_probs=173.4
Q ss_pred CCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEE-eeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~l 165 (315)
.+|.+.+.||+|+||.||+|.+..+ ...+|+|.+.... ......+.+|+.+++.++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4688999999999999999997543 3468999987643 34456789999999999999999999985 45668899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999975 345689999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCC--ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 246 PSGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 246 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
..... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~ 242 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 33221 112233467889999999999999999999999999999999 66777766554433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=297.13 Aligned_cols=204 Identities=31% Similarity=0.480 Sum_probs=176.9
Q ss_pred hCCCCcccccccCCceEEEEEEE----CCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC--eE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~ 163 (315)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45699999999999999999984 5679999999998776666778999999999999999999999986644 78
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999863 35689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 244 MGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 244 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 654433221 12223577789999999988999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=291.22 Aligned_cols=211 Identities=27% Similarity=0.382 Sum_probs=181.3
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 445678999999999999999999999899999999986542 234677899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC---CceEEeccCC
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGL 241 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~---~~~kl~Dfg~ 241 (315)
+|+||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||+|+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999998875 34689999999999999999999998 99999999999999754 4699999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 308 (315)
+........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+..+.+..
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 975433221 122358999999998765 489999999999999999999999987765544443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.90 Aligned_cols=212 Identities=21% Similarity=0.281 Sum_probs=181.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCC-eEEEEEEecCCCcccHHHHHHHHHHhccCCCCC------eeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN------LVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~-~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~~~~~~ 161 (315)
..++|++.+.||+|+||+||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999998776 78999999754 234566788999998887655 999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE-------------
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL------------- 228 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili------------- 228 (315)
..++||||+ +++|.+++... ...++++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 56777777652 235699999999999999999999998 99999999999999
Q ss_pred ------cCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 229 ------EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 229 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 567899999999998643322 234799999999999999999999999999999999999999998887
Q ss_pred hhhhhHHhhh
Q 021249 303 RKELNLVAWL 312 (315)
Q Consensus 303 ~~~~~~i~~~ 312 (315)
.+.+..+..+
T Consensus 245 ~~~~~~~~~~ 254 (355)
T 2eu9_A 245 REHLVMMEKI 254 (355)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7777666554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=307.92 Aligned_cols=206 Identities=27% Similarity=0.383 Sum_probs=157.7
Q ss_pred CCCCc-ccccccCCceEEEEEEEC--CCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEe--eCCeEEE
Q 021249 91 GNFRS-DCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRLL 165 (315)
Q Consensus 91 ~~y~~-~~~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~l 165 (315)
+.|.+ .++||+|+||+||+|.+. .++..||+|++..... ...+.+|+.+|+.++||||+++++++. .....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34766 457999999999999976 5688999999976543 356789999999999999999999995 4678999
Q ss_pred EEEecCCCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEE----cCCCceEE
Q 021249 166 VYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKL 236 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili----~~~~~~kl 236 (315)
||||+. ++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999997 57877775321 1223599999999999999999999998 99999999999999 67789999
Q ss_pred eccCCcccCCCCCC-ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 237 SDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999976533211 1222345799999999998874 589999999999999999999999976553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=298.98 Aligned_cols=206 Identities=24% Similarity=0.350 Sum_probs=175.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe-----
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ----- 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~----- 162 (315)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4679999999999999999999999999999999976432 235678899999999999999999999987654
Q ss_pred -EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 163 -RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 163 -~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
+++||||+. ++|.+++. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58877663 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9753322 223478999999998877 678999999999999999999999999887766655543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=304.08 Aligned_cols=202 Identities=24% Similarity=0.251 Sum_probs=172.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC--------CCCeeeEEeEEe--
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD--------HPNLVKLIGYCA-- 158 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~~~~~-- 158 (315)
..++|.+.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 457899999999999999999999999999999999754 234566888999998885 788999999987
Q ss_pred --eCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----
Q 021249 159 --EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---- 232 (315)
Q Consensus 159 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~---- 232 (315)
.....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhh
Confidence 556899999999 56666666542 235699999999999999999999984 2899999999999998775
Q ss_pred ---------------------------------------------ceEEeccCCcccCCCCCCceeeeeccccccccCcc
Q 021249 233 ---------------------------------------------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267 (315)
Q Consensus 233 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 267 (315)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999764332 12347899999999
Q ss_pred ccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 268 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
++.+..++.++|||||||++|+|++|+.||...+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 9999999999999999999999999999998665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=303.74 Aligned_cols=209 Identities=28% Similarity=0.440 Sum_probs=166.1
Q ss_pred CCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEe-eCCeEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCA-EGDQRLLV 166 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv 166 (315)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477788999999999999987432 3568999987543 345677999999999999999999999864 45678999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 245689999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCCc--eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 247 SGDKT--HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~ 306 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH
Confidence 32211 11223457889999999999999999999999999999999 78888876654443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.78 Aligned_cols=201 Identities=17% Similarity=0.210 Sum_probs=171.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCC--------CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeee---------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI--------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK--------- 152 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 152 (315)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 36799999999999999999999874 789999998754 35778999999999999988
Q ss_pred ------EEeEEee-CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 153 ------LIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 153 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5667665 77899999999 99999999863 136799999999999999999999998 99999999999
Q ss_pred EEEcCCC--ceEEeccCCcccCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 226 ILLEEGY--HPKLSDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 226 ili~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 8999999999754322111 11123479999999999999999999999999999999999999998
Q ss_pred ccC
Q 021249 299 QTK 301 (315)
Q Consensus 299 ~~~ 301 (315)
...
T Consensus 270 ~~~ 272 (352)
T 2jii_A 270 NCL 272 (352)
T ss_dssp GGT
T ss_pred cCC
Confidence 764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.79 Aligned_cols=213 Identities=27% Similarity=0.379 Sum_probs=178.1
Q ss_pred HhCCCCcccccccCCceEEEEEEEC-CCCeEEEEEEecCCCc--ccHHHHHHHHHHhccC---CCCCeeeEEeEEe----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCA---- 158 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~-~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~---- 158 (315)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3468999999999999999999995 6789999999864321 2223455677766655 8999999999987
Q ss_pred -eCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEe
Q 021249 159 -EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS 237 (315)
Q Consensus 159 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~ 237 (315)
.....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 69999987632 34589999999999999999999998 99999999999999999999999
Q ss_pred ccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 238 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+.
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 999997543221 1233478999999999999999999999999999999999999999888776665553
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.32 Aligned_cols=205 Identities=28% Similarity=0.407 Sum_probs=169.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-CeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-DQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e 168 (315)
.++|++.+.||+|+||.||+|.+. +..||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467999999999999999999886 7899999997653 456788999999999999999999987544 47899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999997521 22378999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL 308 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 308 (315)
. ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 226 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1 12357889999999998899999999999999999998 9999987665544433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=320.71 Aligned_cols=206 Identities=31% Similarity=0.470 Sum_probs=172.4
Q ss_pred cccccCCceEEEEEEE--CCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 45678999999976432 346789999999999999999999999975 458899999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC-c
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-T 251 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 251 (315)
++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976 45689999999999999999999998 999999999999999999999999999986543322 1
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 22223356789999999999999999999999999999998 999999887766655554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=304.83 Aligned_cols=196 Identities=11% Similarity=0.038 Sum_probs=153.8
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHH---HHhccCCCCCeeeEE-------eEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEV---MTLGSADHPNLVKLI-------GYCA 158 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~~~-------~~~~ 158 (315)
.|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+ .+|+. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 58899999999999999999999999999999987543 2345577774 45555 799988865 4443
Q ss_pred eC-----------------CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 021249 159 EG-----------------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------MKIAAGASRGLQYLHEQLKQP 215 (315)
Q Consensus 159 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~~ 215 (315)
.. ..+++||||++ ++|.+++... ...+++..+ +.++.||+.||.|||+. +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 32 34899999998 8999999763 223344455 67789999999999998 9
Q ss_pred eEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhC
Q 021249 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITG 293 (315)
Q Consensus 216 iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg 293 (315)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999864321 113467799999999987 6899999999999999999999
Q ss_pred CCccccc
Q 021249 294 RKAIDQT 300 (315)
Q Consensus 294 ~~pf~~~ 300 (315)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=294.54 Aligned_cols=202 Identities=32% Similarity=0.489 Sum_probs=173.1
Q ss_pred CCC-CcccccccCCceEEEEEEE----CCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCe
Q 021249 91 GNF-RSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQ 162 (315)
Q Consensus 91 ~~y-~~~~~ig~G~~g~V~~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 162 (315)
++| ++.+.||+|+||+||++.+ ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 9999999999999988764 45788999999986532 345678999999999999999999999987 468
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 8999999999999999975 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 243 KMGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 243 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 865443322 2223346788999999999999999999999999999999999999754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=293.55 Aligned_cols=199 Identities=33% Similarity=0.469 Sum_probs=165.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56899999999999999999886 788999999754 345678899999999999999999998874 478999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc-eEEeccCCcccCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-PKLSDFGLAKMGPSGD 249 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~ 249 (315)
++++|.+++.... ....++...++.++.|++.||.|||+...++|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999997532 1234788999999999999999999832238999999999999998876 799999999753322
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 122368999999999999999999999999999999999999998643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=318.81 Aligned_cols=216 Identities=31% Similarity=0.455 Sum_probs=182.6
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
.+....++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 344556789999999999999999999976 4679999998654 335678999999999999999999999876 6789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||+.+++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999752 134589999999999999999999998 999999999999999999999999999975
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
..... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 413 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 413 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp CCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred cCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 43211 111122346788999999998999999999999999999999 99999987766655544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=292.94 Aligned_cols=208 Identities=25% Similarity=0.349 Sum_probs=175.6
Q ss_pred CcCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc--CCCCCeeeEEeEE
Q 021249 80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYC 157 (315)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~ 157 (315)
..+........++|.+.+.||+|+||.||+|.+. ++.||+|++... ....+..|+.++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 4455556677889999999999999999999984 889999999654 34556778888776 7899999999999
Q ss_pred eeCC----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEecCCCCC
Q 021249 158 AEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--------EQLKQPVIYRDLKCSN 225 (315)
Q Consensus 158 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~iiH~Dlkp~N 225 (315)
.... ..++||||+++++|.+++.. .++++..++.++.|++.||.||| +. +|+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 8876 78999999999999999975 35899999999999999999999 66 99999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCce--eeeeccccccccCccccccC------CcCcccchhhHHHHHHHHHhC----
Q 021249 226 ILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITG---- 293 (315)
Q Consensus 226 ili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg---- 293 (315)
||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997644332211 12334799999999988765 344789999999999999999
Q ss_pred ------CCccccc
Q 021249 294 ------RKAIDQT 300 (315)
Q Consensus 294 ------~~pf~~~ 300 (315)
..||...
T Consensus 258 ~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 258 GIHEDYQLPYYDL 270 (342)
T ss_dssp TBCCCCCCTTTTT
T ss_pred CcccccccCcccc
Confidence 7898764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=290.78 Aligned_cols=213 Identities=30% Similarity=0.426 Sum_probs=169.9
Q ss_pred hCCCCcccccccCCceEEEEEEECC-CC--eEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEK-IE--QVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~-~~--~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|++.+.||+|+||+||+|.+.. ++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4579999999999999999998643 23 369999987542 234667899999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++|+||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999998763 35589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+.+..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 654433221 1223457888999999988889999999999999999999 99999877655544433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=295.35 Aligned_cols=207 Identities=22% Similarity=0.320 Sum_probs=175.4
Q ss_pred HHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------cHHHHHHHHHHhccCC--CCCeeeEE
Q 021249 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSAD--HPNLVKLI 154 (315)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~ 154 (315)
..+.....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.+++.++ ||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 344555678899999999999999999999999999999999754321 1244667899999886 59999999
Q ss_pred eEEeeCCeEEEEEEecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCC
Q 021249 155 GYCAEGDQRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGY 232 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~ 232 (315)
+++.+.+..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence 999999999999999976 899999876 35689999999999999999999998 999999999999999 788
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCccccc
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99999999998654322 123469999999999887766 68899999999999999999999753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.89 Aligned_cols=210 Identities=25% Similarity=0.327 Sum_probs=169.2
Q ss_pred cCHHHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhcc--CCCCCeeeEEeEEe
Q 021249 81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCA 158 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~ 158 (315)
.+........++|++.+.||+|+||.||+|.+. +..||||++.... ......|.+++.. ++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 344455566788999999999999999999986 8899999986432 2334445555544 48999999999998
Q ss_pred eC----CeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEecCCCCCEEEc
Q 021249 159 EG----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-----KQPVIYRDLKCSNILLE 229 (315)
Q Consensus 159 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~iiH~Dlkp~Nili~ 229 (315)
.. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 87 789999999999999999975 35899999999999999999999641 22899999999999999
Q ss_pred CCCceEEeccCCcccCCCCCCce--eeeeccccccccCccccccCCcCcc------cchhhHHHHHHHHHhC--------
Q 021249 230 EGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTGQLTFK------SDIYSFGVVLLELITG-------- 293 (315)
Q Consensus 230 ~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~elltg-------- 293 (315)
.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997543322211 1123479999999999987766655 9999999999999999
Q ss_pred --CCccccc
Q 021249 294 --RKAIDQT 300 (315)
Q Consensus 294 --~~pf~~~ 300 (315)
..||...
T Consensus 257 ~~~~p~~~~ 265 (337)
T 3mdy_A 257 EYQLPYHDL 265 (337)
T ss_dssp CCCCTTTTT
T ss_pred cccccHhhh
Confidence 7777653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.94 Aligned_cols=201 Identities=22% Similarity=0.282 Sum_probs=149.4
Q ss_pred HhCCCCccc-ccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee----CCeE
Q 021249 89 ATGNFRSDC-CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQR 163 (315)
Q Consensus 89 ~~~~y~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~ 163 (315)
..++|.+.+ .||+|+||+||+|.+..+++.||+|++.... .........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456899865 6999999999999999999999999986532 122222334566799999999999876 4568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG 240 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg 240 (315)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999763 235699999999999999999999998 9999999999999986 4459999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 997543322 1234689999999999888999999999999999999999999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=287.55 Aligned_cols=196 Identities=29% Similarity=0.403 Sum_probs=163.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee----------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE---------- 159 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---------- 159 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45799999999999999999999999999999999643 2345678899999999999999999998865
Q ss_pred ---CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEE
Q 021249 160 ---GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 160 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 35789999999999999999762 35678899999999999999999998 9999999999999999999999
Q ss_pred eccCCcccCCCCCC------------ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHh
Q 021249 237 SDFGLAKMGPSGDK------------THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELIT 292 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt 292 (315)
+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999975432110 1112334689999999998765 68999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.08 Aligned_cols=205 Identities=25% Similarity=0.389 Sum_probs=166.6
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------cHHHHHHHHHHhccC----CCCCeeeEE
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSA----DHPNLVKLI 154 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~~~ 154 (315)
......++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445567899999999999999999999999999999999765321 223355688888887 899999999
Q ss_pred eEEeeCCeEEEEEEe-cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCC
Q 021249 155 GYCAEGDQRLLVYEY-MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGY 232 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~ 232 (315)
+++.+.+..++|+|+ +.+++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999976 34689999999999999999999998 999999999999999 789
Q ss_pred ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcC-cccchhhHHHHHHHHHhCCCccccc
Q 021249 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 233 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||...
T Consensus 178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 99999999998654432 1234689999999988877664 5899999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.91 Aligned_cols=201 Identities=29% Similarity=0.460 Sum_probs=160.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHH--HHHhccCCCCCeeeEEeEEe-----eCCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE--VMTLGSADHPNLVKLIGYCA-----EGDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E--~~~l~~l~hpnIv~~~~~~~-----~~~~ 162 (315)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ...+..| +..+..++||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 468999999999999999999874 8899999997543 2333334 44455689999999998553 2336
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEecCCCCCEEEcCCCceEE
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------KQPVIYRDLKCSNILLEEGYHPKL 236 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~iiH~Dlkp~Nili~~~~~~kl 236 (315)
+++||||+++++|.+++.. ...++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 7899999999999999976 33588999999999999999999741 128999999999999999999999
Q ss_pred eccCCcccCCCCCC------ceeeeeccccccccCcccccc-------CCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 237 SDFGLAKMGPSGDK------THVSTRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 237 ~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999976533211 111223479999999999876 45678999999999999999997776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.70 Aligned_cols=213 Identities=23% Similarity=0.343 Sum_probs=173.4
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 161 (315)
.++....++|.+.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3444456789999999999999999998864 48999987542 233455778999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++ ++.++|+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999875 235689999999999999999999998 999999999999998 67999999999
Q ss_pred cccCCCCC---CceeeeeccccccccCcccccc---------CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 242 AKMGPSGD---KTHVSTRVMGTYGYCAPDYAMT---------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 242 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
+....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 86532111 1111223468999999998864 35788999999999999999999999876655443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=295.10 Aligned_cols=201 Identities=21% Similarity=0.251 Sum_probs=169.9
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----------CCCeeeEEeEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----------HPNLVKLIGYCA 158 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~ 158 (315)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467999999999999999999999999999999997542 33456788998888876 899999999987
Q ss_pred eCC----eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-----
Q 021249 159 EGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE----- 229 (315)
Q Consensus 159 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~----- 229 (315)
..+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+. .+|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence 654 789999999 899999997642 34589999999999999999999983 2899999999999994
Q ss_pred -CCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 230 -EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 230 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 34479999999997643321 23478999999999999999999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=313.63 Aligned_cols=214 Identities=27% Similarity=0.404 Sum_probs=178.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
...++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 3456799999999999999999998643 56799999875432 345678999999999999999999999854 568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999999762 35689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+
T Consensus 540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i 605 (656)
T 2j0j_A 540 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 65433221 1223357789999999998899999999999999999997 99999887766555444
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=288.09 Aligned_cols=204 Identities=23% Similarity=0.328 Sum_probs=168.4
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCC--CCCeeeEEeEEeeCCeE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD--HPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~ 163 (315)
...++|.+.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345679999999999999999998864 8899999997543 234567899999999997 59999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 557899999986 35789999999999999999999998 9999999999999975 799999999997
Q ss_pred cCCCCCCceeeeeccccccccCcccccc-----------CCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
...............||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 6543322222234578999999998875 468889999999999999999999997653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.20 Aligned_cols=206 Identities=26% Similarity=0.338 Sum_probs=154.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHH-HhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3679999999999999999999999999999999976532 23344555555 778889999999999999999999999
Q ss_pred EecCCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 168 EYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 7877765321 1246789999999999999999999984 289999999999999999999999999997543
Q ss_pred CCCCceeeeeccccccccCcccc----ccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYA----MTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||....
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 3211 1223689999999988 45678999999999999999999999997643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=297.48 Aligned_cols=193 Identities=19% Similarity=0.193 Sum_probs=160.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--------cccHHHHHHHHHHhccCC---------CCCee
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--------VQGVREFSAEVMTLGSAD---------HPNLV 151 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--------~~~~~~~~~E~~~l~~l~---------hpnIv 151 (315)
..++|.+.+.||+|+||+||+|.+ +|+.||||++.... ....+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346799999999999999999998 48999999997543 223477888998888775 66666
Q ss_pred eEEeEE-----------------ee-------------CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHH
Q 021249 152 KLIGYC-----------------AE-------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201 (315)
Q Consensus 152 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi 201 (315)
++.+++ .+ .+..++||||+++|++.+.+.. ..+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHH
Confidence 666653 32 6889999999999977666633 458999999999999
Q ss_pred HHHHHHHH-hcCCCCeEEecCCCCCEEEcCCC--------------------ceEEeccCCcccCCCCCCceeeeecccc
Q 021249 202 SRGLQYLH-EQLKQPVIYRDLKCSNILLEEGY--------------------HPKLSDFGLAKMGPSGDKTHVSTRVMGT 260 (315)
Q Consensus 202 ~~al~~LH-~~~~~~iiH~Dlkp~Nili~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 260 (315)
+.||.||| +. +|+||||||+|||++.++ .+||+|||+++..... ..+||
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence 99999999 88 999999999999999887 8999999999864332 23799
Q ss_pred ccccCccccccCCcCcccchhhHHHH-HHHHHhCCCcccc
Q 021249 261 YGYCAPDYAMTGQLTFKSDIYSFGVV-LLELITGRKAIDQ 299 (315)
Q Consensus 261 ~~y~aPE~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~ 299 (315)
+.|+|||++.+.. +.++||||||++ .+++++|..||..
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9999999988766 899999998766 8888999999965
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=283.70 Aligned_cols=201 Identities=28% Similarity=0.394 Sum_probs=154.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-c-HHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-G-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... . .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35689999999999999999999999999999999765432 2 233445556788889999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||+ ++.+..+.... ..++++..++.++.||+.||.|||+ . +++||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 55555555432 4568999999999999999999998 5 89999999999999999999999999997543
Q ss_pred CCCCceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.... .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 3221 22346899999999884 457889999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.68 Aligned_cols=204 Identities=31% Similarity=0.440 Sum_probs=175.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEee------CCe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE------GDQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~ 162 (315)
.++|++.+.||+|+||.||+|.+..+|..||||++... .....+.+.+|+.+++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999999999999999998764 33446678999999999999999999998765 677
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc---eEEecc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDF 239 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~---~kl~Df 239 (315)
.++||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997633 234688999999999999999999998 9999999999999997664 899999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99986543322 23357999999999999999999999999999999999999999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.20 Aligned_cols=195 Identities=28% Similarity=0.406 Sum_probs=167.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe----
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ---- 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 162 (315)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 45789999999999999999999975 68999999987543 2345668899999999999999999999987655
Q ss_pred -EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 163 -RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 163 -~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.|+||||++|++|.+++.. ++++..++.++.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999876642 689999999999999999999998 99999999999999986 899999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred chhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 9865432 234799999999988765 489999999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.24 Aligned_cols=200 Identities=24% Similarity=0.305 Sum_probs=157.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.+|.+.+.||+|+||+|+.. ...+++.||||++...... .+.+|+.+|+.+ +||||+++++++.+....++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 46889999999999996643 3346889999999765433 245799999998 799999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-----CCceEEeccCCccc
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKM 244 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-----~~~~kl~Dfg~~~~ 244 (315)
+. ++|.+++... ...+....++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 6999998763 23344456678999999999999998 9999999999999953 23578999999976
Q ss_pred CCCCCC-ceeeeeccccccccCccccc---cCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 245 GPSGDK-THVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 245 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
...... ........||+.|+|||++. ...++.++|||||||++|+|++ |..||....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 543221 12233457999999999987 4567889999999999999999 999997544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=295.27 Aligned_cols=203 Identities=24% Similarity=0.281 Sum_probs=156.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+.+..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 346667889999999998753 456899999998653 235577899999876 899999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC-------------Cc
Q 021249 170 MPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-------------YH 233 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~-------------~~ 233 (315)
+. ++|.+++......... .++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 6999999763221111 13334578999999999999998 99999999999999754 48
Q ss_pred eEEeccCCcccCCCCCCce--eeeeccccccccCcccccc-------CCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 234 PKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999998654432211 1223579999999999875 578999999999999999999 999997653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=273.48 Aligned_cols=177 Identities=17% Similarity=0.168 Sum_probs=156.0
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 44689999999999999999999999999999999986543 234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++|++|.+++.. . .....+..++.||+.||.|||+. +|+||||||+|||++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999854 2 35557888999999999999998 99999999999999999999998443
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
|++| ++.++|||||||++|+|++|+.||.+.+..
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 3333 688999999999999999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=287.80 Aligned_cols=203 Identities=15% Similarity=0.189 Sum_probs=158.7
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCC-CCe---------ee------
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADH-PNL---------VK------ 152 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~h-pnI---------v~------ 152 (315)
.|...+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.+.| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 47788899999999999999999999999999874332 236778999999999977 221 11
Q ss_pred ------EEeEEee-----CCeEEEEEEecCCCChhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 021249 153 ------LIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218 (315)
Q Consensus 153 ------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH 218 (315)
+..++.. ...++++|+++ +++|.+++... .....++++..++.++.||+.||.|||+. +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 1111111 12356777765 68999888522 22345688889999999999999999998 9999
Q ss_pred ecCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCcccc----------ccCCcCcccchhhHHHHHH
Q 021249 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA----------MTGQLTFKSDIYSFGVVLL 288 (315)
Q Consensus 219 ~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il~ 288 (315)
|||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998753322 233467 999999998 5557889999999999999
Q ss_pred HHHhCCCcccccCchh
Q 021249 289 ELITGRKAIDQTKDRK 304 (315)
Q Consensus 289 elltg~~pf~~~~~~~ 304 (315)
+|++|+.||...+..+
T Consensus 309 elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 309 WIWCADLPNTDDAALG 324 (413)
T ss_dssp HHHHSSCCCCTTGGGS
T ss_pred HHHHCCCCCCCcchhh
Confidence 9999999998765443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=269.93 Aligned_cols=178 Identities=24% Similarity=0.345 Sum_probs=154.1
Q ss_pred hCCCCcc-cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHh-ccCCCCCeeeEEeEEee----CCeE
Q 021249 90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNLVKLIGYCAE----GDQR 163 (315)
Q Consensus 90 ~~~y~~~-~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~----~~~~ 163 (315)
.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 7899999999999999999999999998643 4566788887 66789999999999977 6788
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG 240 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg 240 (315)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999873 235699999999999999999999998 9999999999999998 7889999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
++.... +..++.++|||||||++|+|++|..||....
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 986321 2457889999999999999999999997554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=282.86 Aligned_cols=186 Identities=16% Similarity=0.086 Sum_probs=132.4
Q ss_pred cccCCceEEEEEEECCCCeEEEEEEecCCCc----------ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEEE
Q 021249 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----------QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 99 ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
.+.|++|.+..+...-.|+.|++|++..... ...+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566677666666666788999999975421 2345699999999999 6999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||++|++|.++|.. ..+++.. .|+.||+.||+|||+. |||||||||+|||++.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999986 4567664 5889999999999998 999999999999999999999999999986443
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcc
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 297 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 297 (315)
.. ......+||+.|||||++.+ .+..++|+||+|+++++|.++..||
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 12234689999999998765 4677899999999988776665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-31 Score=248.30 Aligned_cols=186 Identities=17% Similarity=0.174 Sum_probs=144.6
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc--------cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
...+.||+|+||.||+|... +..+++|........ ..+.+.+|+.++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567999999999999544 778899986543221 13457899999999999999955555556677899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||++|++|.+++.. +..++.|++.||.|||+. +|+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999998864 457999999999999998 9999999999999998 9999999999875
Q ss_pred CCCCCce-----eeeeccccccccCcccccc--CCcCcccchhhHHHHHHHHHhCCCccc
Q 021249 246 PSGDKTH-----VSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAID 298 (315)
Q Consensus 246 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~ 298 (315)
....... ......||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4422111 1134579999999999887 578889999999999888888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=205.22 Aligned_cols=164 Identities=13% Similarity=0.033 Sum_probs=128.0
Q ss_pred HHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------------------ccHHHHHHHHHHhccCC
Q 021249 85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------------------QGVREFSAEVMTLGSAD 146 (315)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------------------~~~~~~~~E~~~l~~l~ 146 (315)
........|.+.+.||+|+||.||+|.+ .+|..||+|+++.... .....+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3344455677889999999999999999 7899999999964321 12456889999999998
Q ss_pred CCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 021249 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226 (315)
Q Consensus 147 hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Ni 226 (315)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+. +|+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 4 566665544 45699999999999987 421 12457999999999999998 999999999999
Q ss_pred EEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCcccccc----------CCcCcccchhhH
Q 021249 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT----------GQLTFKSDIYSF 283 (315)
Q Consensus 227 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diwsl 283 (315)
|++ ++.+||+|||+++. +..++|||++.. ..|+..+|+|.+
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 999 99999999999862 345788997754 345666677653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.7e-23 Score=175.48 Aligned_cols=137 Identities=16% Similarity=0.081 Sum_probs=106.1
Q ss_pred CCCcccccccCCceEEEEEEECCCCeE--EEEEEecCCCcc------------------------cHHHHHHHHHHhccC
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQV--VAIKQLDHRGVQ------------------------GVREFSAEVMTLGSA 145 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~--vavK~i~~~~~~------------------------~~~~~~~E~~~l~~l 145 (315)
-|.+.+.||+|+||.||+|.+..+|.. ||||+++..... ....+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999998667888 999997543211 013578899999999
Q ss_pred CCCCe--eeEEeEEeeCCeEEEEEEecCC-C----ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 021249 146 DHPNL--VKLIGYCAEGDQRLLVYEYMPL-G----SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH-EQLKQPVI 217 (315)
Q Consensus 146 ~hpnI--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~ii 217 (315)
.|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 87754 334432 356899999942 3 56555432 224456789999999999999 87 999
Q ss_pred EecCCCCCEEEcCCCceEEeccCCccc
Q 021249 218 YRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 218 H~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=161.05 Aligned_cols=141 Identities=12% Similarity=0.041 Sum_probs=99.5
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-----c---------cHHH--------HHHHHHHhccC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----Q---------GVRE--------FSAEVMTLGSA 145 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-----~---------~~~~--------~~~E~~~l~~l 145 (315)
....-|.+.+.||.|+||.||+|.+. +|+.||||+++.... . .... ..+|...|.++
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33445999999999999999999885 589999999753211 0 0111 23455666666
Q ss_pred CCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 021249 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN 225 (315)
Q Consensus 146 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~N 225 (315)
.++++.-..-+... ..+|||||++|++|..+... .....++.||+.+|.+||.. +||||||||.|
T Consensus 171 ~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 171 YEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp HHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred HhcCCCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 44433211111111 23799999999888654321 12456889999999999998 99999999999
Q ss_pred EEEcCCC----------ceEEeccCCccc
Q 021249 226 ILLEEGY----------HPKLSDFGLAKM 244 (315)
Q Consensus 226 ili~~~~----------~~kl~Dfg~~~~ 244 (315)
||+++++ .+.|+||+-+..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEEeCCCCcccccccccceEEEEeCCccc
Confidence 9998776 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=3.6e-14 Score=120.95 Aligned_cols=146 Identities=16% Similarity=0.068 Sum_probs=113.0
Q ss_pred HHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEE
Q 021249 87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 87 ~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l 165 (315)
....+.|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.++++++.+.+..|+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344567988888999999999998754 6789999987532122345788999988874 6778889999999899999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--------------------------------- 212 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------- 212 (315)
||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999998765321 1123467889999999999821
Q ss_pred -----------------------CCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 213 -----------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 213 -----------------------~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0258999999999999876556799998875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=7.8e-13 Score=112.17 Aligned_cols=137 Identities=15% Similarity=0.099 Sum_probs=98.5
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEEeEEeeCCeEEEEEEe
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~ 169 (315)
.|.+....+.|..+.||++.. .+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344433334566799999854 45678999997654 2245678888888875444 45688888887889999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------------------------------------- 212 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 212 (315)
++|.+|. ... .. ...++.+++.+|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998883 211 11 1356778888888888752
Q ss_pred ------------------CCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 213 ------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 213 ------------------~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776667999999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=109.92 Aligned_cols=142 Identities=12% Similarity=0.156 Sum_probs=105.5
Q ss_pred cccccccCCceEEEEEEECCCCeEEEEEEec--CCCc-ccHHHHHHHHHHhccCC--CCCeeeEEeEEeeC---CeEEEE
Q 021249 95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGV-QGVREFSAEVMTLGSAD--HPNLVKLIGYCAEG---DQRLLV 166 (315)
Q Consensus 95 ~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~--~~~~-~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---~~~~lv 166 (315)
.++.|+.|.++.||++... +..+++|... .... .....+.+|..+++.+. +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567899999999998765 4578888876 3321 22345778999988886 44578888888776 458999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL---------------------------------- 212 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 212 (315)
|||++|..+.+.. ...++......++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999988874421 223678888899999999999999731
Q ss_pred ---------------------CCCeEEecCCCCCEEEcCCCc--eEEeccCCccc
Q 021249 213 ---------------------KQPVIYRDLKCSNILLEEGYH--PKLSDFGLAKM 244 (315)
Q Consensus 213 ---------------------~~~iiH~Dlkp~Nili~~~~~--~kl~Dfg~~~~ 244 (315)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=106.90 Aligned_cols=186 Identities=16% Similarity=0.130 Sum_probs=122.7
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCC--eeeEEeEEeeCC---eEEEEEEe
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPN--LVKLIGYCAEGD---QRLLVYEY 169 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~~~~~~~~~~---~~~lv~e~ 169 (315)
++.++.|....||++. ..+++|..... .....+.+|..+++.+. +.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458899999999862 45888986532 33567888999987763 322 334444443333 35889999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------------------------------------- 212 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 212 (315)
++|.+|.+... ..++......++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865432 23677778888899999999888621
Q ss_pred ------------------CCCeEEecCCCCCEEEcC--CCceEEeccCCcccCCCCCCceeeeeccccccc---cCcccc
Q 021249 213 ------------------KQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY---CAPDYA 269 (315)
Q Consensus 213 ------------------~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~ 269 (315)
...++|+|++|.||+++. +..+.|+||+.+......... .....+ .+|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHH
Confidence 124799999999999998 556789999998653221100 001111 222211
Q ss_pred cc-----C---------CcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 270 MT-----G---------QLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 270 ~~-----~---------~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
.. . ....-.+.|++|.++|.+.+|..+|-..
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 10 0 0112258999999999999999998543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=4.2e-08 Score=83.43 Aligned_cols=135 Identities=16% Similarity=0.138 Sum_probs=96.9
Q ss_pred cccCCce-EEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCeEEEEEEecCCCChh
Q 021249 99 LGEGGFG-KVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176 (315)
Q Consensus 99 ig~G~~g-~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~ 176 (315)
+..|..+ .||+......+..+++|.-... ....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 6898877766778999986543 3456778888888774 223667888888999999999999998887
Q ss_pred hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 021249 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK------------------------------------------- 213 (315)
Q Consensus 177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~------------------------------------------- 213 (315)
+..... ......+..+++..|..||+...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654331 11233466677777777775420
Q ss_pred ------------CCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 214 ------------QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 214 ------------~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877677999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=5.5e-08 Score=84.49 Aligned_cols=137 Identities=17% Similarity=0.076 Sum_probs=94.4
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCC---CeeeEEeEEe-eCCeEEEEEEecC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP---NLVKLIGYCA-EGDQRLLVYEYMP 171 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~lv~e~~~ 171 (315)
++.++.|....||+. +..+++|+... ......+..|..+|+.+.+. .+.+++.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 345788888899987 45688888532 23356788999999988642 2455666653 4456789999999
Q ss_pred CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 021249 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--------------------------------------- 212 (315)
Q Consensus 172 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------------------------------------- 212 (315)
|.++.+... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988866321 12345555556666666666666431
Q ss_pred ------------------CCCeEEecCCCCCEEEcC---CCc-eEEeccCCcccC
Q 021249 213 ------------------KQPVIYRDLKCSNILLEE---GYH-PKLSDFGLAKMG 245 (315)
Q Consensus 213 ------------------~~~iiH~Dlkp~Nili~~---~~~-~kl~Dfg~~~~~ 245 (315)
...++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 224699999999999987 355 489999988653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5.8e-07 Score=80.85 Aligned_cols=76 Identities=16% Similarity=0.142 Sum_probs=48.6
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCc-------ccHHHHHHHHHHhccCCC--CCe-eeEEeEEeeCCeEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------QGVREFSAEVMTLGSADH--PNL-VKLIGYCAEGDQRLL 165 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-------~~~~~~~~E~~~l~~l~h--pnI-v~~~~~~~~~~~~~l 165 (315)
.+.||.|..+.||++.....+..+++|....... .....+..|..+++.+.. |.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4569999999999997665577899998653211 123456778888876632 333 345543 3445689
Q ss_pred EEEecCCC
Q 021249 166 VYEYMPLG 173 (315)
Q Consensus 166 v~e~~~~~ 173 (315)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=2.6e-07 Score=81.80 Aligned_cols=82 Identities=7% Similarity=0.015 Sum_probs=53.7
Q ss_pred cccc-ccCCceEEEEEEEC---C---CCeEEEEEEecCCC---cccHHHHHHHHHHhccCC-C--CCeeeEEeEEeeC--
Q 021249 96 DCCL-GEGGFGKVYKGCLE---K---IEQVVAIKQLDHRG---VQGVREFSAEVMTLGSAD-H--PNLVKLIGYCAEG-- 160 (315)
Q Consensus 96 ~~~i-g~G~~g~V~~~~~~---~---~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~-- 160 (315)
.+.| +.|....+|+.... . ++..+++|...... ......+..|..+++.+. + -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3457 78888999987653 0 15678899865432 111244667888777763 2 2466677776654
Q ss_pred -CeEEEEEEecCCCChhh
Q 021249 161 -DQRLLVYEYMPLGSLDK 177 (315)
Q Consensus 161 -~~~~lv~e~~~~~~L~~ 177 (315)
+..++||||++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.36 E-value=6.9e-06 Score=71.92 Aligned_cols=142 Identities=15% Similarity=0.191 Sum_probs=79.1
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccC-----CCCCeeeEE-e--EEeeCCeEEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKLI-G--YCAEGDQRLLVYE 168 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~-~--~~~~~~~~~lv~e 168 (315)
+.|+.|..+.||++... +..+++|..... ...+..|..+++.| ..|.++... + +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778899998764 335899998752 12333444444443 234444311 0 1234677899999
Q ss_pred ecCCCChh-----------h---hhhhcCC-C----CC-----CCCHHH-------------------------------
Q 021249 169 YMPLGSLD-----------K---HLHDLRP-D----TR-----PLDWNT------------------------------- 193 (315)
Q Consensus 169 ~~~~~~L~-----------~---~l~~~~~-~----~~-----~l~~~~------------------------------- 193 (315)
|++|.++. . .++.... . .. .-.+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 0 1111100 0 00 011111
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 194 RMKIAAGASRGLQYLHE----------QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 194 ~~~i~~qi~~al~~LH~----------~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
...+..++..++.+|+. .....++|+|++|.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223445666653 0135899999999999998778899999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.9e-05 Score=68.49 Aligned_cols=75 Identities=19% Similarity=0.099 Sum_probs=58.3
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC---CCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
.+.|+.|....+|+.... +..+++|..... ....+..|...|+.|. ...+.+++.+....+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456899999999998653 667889987643 3456788888887773 35677888888878899999999998
Q ss_pred CCh
Q 021249 173 GSL 175 (315)
Q Consensus 173 ~~L 175 (315)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.4e-05 Score=70.80 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=27.1
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 214 ~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..++|+|++|.||+++.++ +.|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4899999999999999876 99999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.87 E-value=5.5e-05 Score=65.70 Aligned_cols=160 Identities=16% Similarity=0.124 Sum_probs=85.3
Q ss_pred cCHHHHHHHhCCCCc-----ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----CCCe
Q 021249 81 FTFDELAAATGNFRS-----DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----HPNL 150 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~-----~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----hpnI 150 (315)
.+.+++......|.+ .+.|+.|....+|++.... | .+++|...... ....+..|..+++.+. .|.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 444555555555655 2346678888999987642 3 68899887631 1233455666665542 3333
Q ss_pred eeEE-e--EEeeCCeEEEEEEecCCCChhh--------------hhhhcCCC-CCC----CC---HHHHHH---------
Q 021249 151 VKLI-G--YCAEGDQRLLVYEYMPLGSLDK--------------HLHDLRPD-TRP----LD---WNTRMK--------- 196 (315)
Q Consensus 151 v~~~-~--~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~~~-~~~----l~---~~~~~~--------- 196 (315)
+... + +....+..+++++|++|..+.. .++..... ..+ .. +.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3211 0 1123467789999999865421 01111100 000 11 111000
Q ss_pred ---HHHHHHHHHHHHHhcC----CCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 197 ---IAAGASRGLQYLHEQL----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 197 ---i~~qi~~al~~LH~~~----~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+...+...+.++.... ...++|+|++|.||+++.+..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0111344555555321 24799999999999999875568999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=4.3e-05 Score=65.81 Aligned_cols=71 Identities=8% Similarity=0.060 Sum_probs=42.5
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEEEec-CCC
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYM-PLG 173 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~-~~~ 173 (315)
++.|+.|....+|++ ..+++|+....... ......|..+++.+...++ .+++... .+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 567888999999998 35888987653211 1122457766665532222 3455443 33356899999 665
Q ss_pred Ch
Q 021249 174 SL 175 (315)
Q Consensus 174 ~L 175 (315)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=7.4e-05 Score=63.89 Aligned_cols=80 Identities=16% Similarity=0.142 Sum_probs=55.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC---CCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---PNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~~~~~~lv~ 167 (315)
....-++.+|.|..+.||++... +|+.|++|+...........+..|...|+.|.. --+.+++.+ + ..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEE
Confidence 34555677999999999999765 488999998765544444567889888887732 124445543 2 247899
Q ss_pred EecCCCCh
Q 021249 168 EYMPLGSL 175 (315)
Q Consensus 168 e~~~~~~L 175 (315)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00016 Score=65.60 Aligned_cols=74 Identities=18% Similarity=0.141 Sum_probs=48.5
Q ss_pred ccccccCCceEEEEEEECC-------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~ 167 (315)
++.|+.|....+|++.... .+..+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3467788889999987653 256899998854221 2445578888877743333 456665542 3899
Q ss_pred EecCCCCh
Q 021249 168 EYMPLGSL 175 (315)
Q Consensus 168 e~~~~~~L 175 (315)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00034 Score=63.88 Aligned_cols=74 Identities=12% Similarity=-0.021 Sum_probs=46.8
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+.|+.|-...+|++.....+..+++|+....... .-.-..|..+++.|...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4577788889999887644578999987543211 1112578888887764444 45666663 2 259999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00065 Score=59.21 Aligned_cols=32 Identities=28% Similarity=0.354 Sum_probs=27.7
Q ss_pred CCeEEecCCCCCEEEcCC----CceEEeccCCcccC
Q 021249 214 QPVIYRDLKCSNILLEEG----YHPKLSDFGLAKMG 245 (315)
Q Consensus 214 ~~iiH~Dlkp~Nili~~~----~~~kl~Dfg~~~~~ 245 (315)
..++|+|+.|.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 67899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00039 Score=61.83 Aligned_cols=143 Identities=18% Similarity=0.206 Sum_probs=81.2
Q ss_pred cccccCCceEEEEEEECC-------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCCeEEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e 168 (315)
+.|..|-...+|++.... .+..+++|+.... ........+|..+++.+...+ ..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456667778899987642 3468999986432 233555668888887764222 2556666543 28999
Q ss_pred ecCCCChhhh-----------------hhhcC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 021249 169 YMPLGSLDKH-----------------LHDLR-PDTRPLD--WNTRMKIAAGASR-------------------GLQYLH 209 (315)
Q Consensus 169 ~~~~~~L~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~qi~~-------------------al~~LH 209 (315)
|++|.+|..- |+... ....+.. +..+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 11111 1111222 3444445444321 223332
Q ss_pred ----hc-CCCCeEEecCCCCCEEEcCC----CceEEeccCCccc
Q 021249 210 ----EQ-LKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAKM 244 (315)
Q Consensus 210 ----~~-~~~~iiH~Dlkp~Nili~~~----~~~kl~Dfg~~~~ 244 (315)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12368999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00032 Score=62.18 Aligned_cols=74 Identities=9% Similarity=0.021 Sum_probs=42.6
Q ss_pred cccccCCceEEEEEEECCC--------CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCCeEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKI--------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~ 167 (315)
..|+.|....+|++..... +..+++|+..... ........|..+++.+...+ ..++++.+ . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4577788889999876531 2678889875432 22222356777777664333 33556544 2 26899
Q ss_pred EecCCCCh
Q 021249 168 EYMPLGSL 175 (315)
Q Consensus 168 e~~~~~~L 175 (315)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00067 Score=58.86 Aligned_cols=142 Identities=12% Similarity=0.070 Sum_probs=77.9
Q ss_pred ccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC--eeeEEeE-----EeeCCeEEEEEEec
Q 021249 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGY-----CAEGDQRLLVYEYM 170 (315)
Q Consensus 98 ~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~-----~~~~~~~~lv~e~~ 170 (315)
.++ |....||++... +|..+++|....... ....+..|..+++.+.... +.+++.. ....+..+++++|+
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 777899987543 366799999874321 2345666777776653111 2333332 22356678999999
Q ss_pred CCCChhh-----------h---hhhcCCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 021249 171 PLGSLDK-----------H---LHDLRPD-----TRPLDWNTR----MKI---------------AAGASRGLQYLHEQ- 211 (315)
Q Consensus 171 ~~~~L~~-----------~---l~~~~~~-----~~~l~~~~~----~~i---------------~~qi~~al~~LH~~- 211 (315)
+|.++.. . ++..... ...++.... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754320 1 1111000 011221110 001 11111223333321
Q ss_pred ---CCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 212 ---LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 212 ---~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
....++|+|++|.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 134689999999999999 4 899999988764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0036 Score=54.69 Aligned_cols=31 Identities=13% Similarity=0.179 Sum_probs=27.5
Q ss_pred CCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 214 ~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..++|+|+.|.||+++.++.+.|+||..+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999878899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0051 Score=49.76 Aligned_cols=103 Identities=16% Similarity=0.115 Sum_probs=65.9
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCce
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 252 (315)
-+|.+.|..+ +.|++++++|.++.|.+.+|.-+-.. +.+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc---------
Confidence 4788888763 68999999999999999988776211 011 1233457889999998887764 1111
Q ss_pred eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCc
Q 021249 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296 (315)
Q Consensus 253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 296 (315)
.....+.|||... ...+.+.=|||||+++|..+-=..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122477888653 3456778899999999998864333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0082 Score=54.11 Aligned_cols=75 Identities=8% Similarity=-0.008 Sum_probs=45.8
Q ss_pred ccccccCCceEEEEEEECCC-------CeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCCeEEEEE
Q 021249 96 DCCLGEGGFGKVYKGCLEKI-------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~ 167 (315)
++.+..|-...+|++..... +..+++++..... ...-...+|..+++.+...+ ..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34576777888999876521 4678999875432 22222346777776664222 344554332 26899
Q ss_pred EecCCCCh
Q 021249 168 EYMPLGSL 175 (315)
Q Consensus 168 e~~~~~~L 175 (315)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.024 Score=45.68 Aligned_cols=91 Identities=10% Similarity=0.060 Sum_probs=65.1
Q ss_pred HHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 021249 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217 (315)
Q Consensus 138 E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~ii 217 (315)
|+.+|.. .||++++. .+-.+.+.+.+.++.-+.+.=...++ .++....++++.+|+....++++. +
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~ 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----Y 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----E
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----e
Confidence 4444433 58999977 56666677666666543221122233 378889999999999988777644 8
Q ss_pred EecCCCCCEEEcCCCceEEeccCCc
Q 021249 218 YRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 218 H~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
|--|+|+||+++.++.+++.-.|+-
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEET
T ss_pred EEEEecceEEEcCCCCEEEEEccCc
Confidence 8899999999999999999877664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.093 Score=42.42 Aligned_cols=83 Identities=10% Similarity=0.030 Sum_probs=61.9
Q ss_pred CCCCeeeEEeEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEecCCCC
Q 021249 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ-YLHEQLKQPVIYRDLKCS 224 (315)
Q Consensus 146 ~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~iiH~Dlkp~ 224 (315)
.||++ -..+-.+++.+.+.++--+++.-...++ .++....++++.+|+.... +++. -+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 58888 4445567778777777653333333343 3788899999999998877 6664 488899999
Q ss_pred CEEEcCCCceEEeccCCc
Q 021249 225 NILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 225 Nili~~~~~~kl~Dfg~~ 242 (315)
||+++.++.+++.-.|+-
T Consensus 114 NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GEEECTTCCEEESCCEET
T ss_pred eEEEeCCCcEEEEEcCCc
Confidence 999999999999877764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.21 E-value=0.23 Score=44.23 Aligned_cols=29 Identities=31% Similarity=0.312 Sum_probs=24.6
Q ss_pred eEEecCCCCCEEE------cCCCceEEeccCCccc
Q 021249 216 VIYRDLKCSNILL------EEGYHPKLSDFGLAKM 244 (315)
Q Consensus 216 iiH~Dlkp~Nili------~~~~~~kl~Dfg~~~~ 244 (315)
++|+|+.+.||++ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3456799999998863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.76 E-value=0.052 Score=49.50 Aligned_cols=62 Identities=11% Similarity=0.101 Sum_probs=18.0
Q ss_pred CcccccccCCceEEEEEEECCCCeEEEE------EEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEe
Q 021249 94 RSDCCLGEGGFGKVYKGCLEKIEQVVAI------KQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCA 158 (315)
Q Consensus 94 ~~~~~ig~G~~g~V~~~~~~~~~~~vav------K~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 158 (315)
.+.+.|| ||.||+|.+.....+||+ |....... .....+.+|..+.+.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 999999998765567888 65543221 23446778888888899999999987654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 315 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-67
Identities = 68/226 (30%), Positives = 108/226 (47%), Gaps = 15/226 (6%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
G +G G FG VYKG K VA+K L+ Q ++ F EV L H
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
N++ +GY Q +V ++ SL HLH + + + IA ++G+ YL
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYL 120
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + +I+RDLK +NI L E K+ DFGLA + +H ++ G+ + AP+
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 269 AMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
+F+SD+Y+FG+VL EL+TG+ +R ++ +
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-63
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 12/219 (5%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNL 150
+F LG G G V+K + V+A K + +R E+ L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
V G + + E+M GSLD+ L + K++ +GL YL E
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
K +++RD+K SNIL+ KL DFG++ ++ +GT Y +P+
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 176
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ +SDI+S G+ L+E+ GR I D KEL L+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELM 214
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-61
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 9/228 (3%)
Query: 79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
KP+ DE + LG G FG+V+ G VA+K L +G F AE
Sbjct: 1 KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
+ H LV+L + + ++ EYM GSL L P L N + +A
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMA 115
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
A + G+ ++ E+ I+RDL+ +NIL+ + K++DFGLA++ ++
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAK 171
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ AP+ G T KSD++SFG++L E++T + E+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 6e-60
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 22/243 (9%)
Query: 80 PFTFDELAAATGNF---------RSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHR 127
PFTF++ A F + + +G G FG+V G L+ K E VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 128 GV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
+ R+F +E +G DHPN++ L G + +++ E+M GSLD L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
+ + G + G++YL ++RDL NIL+ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 247 SGDKTHVSTRV---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
T + AP+ + T SD++S+G+V+ E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 304 KEL 306
+++
Sbjct: 240 QDV 242
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-59
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 13/217 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG+G FGKVYK ++ + A K +D + + + ++ E+ L S DHPN+VKL+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ ++ E+ G++D + +L RPL + + L YLH+ +I+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL---- 274
RDLK NIL KL+DFG++ + +GT + AP+ M
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRP 191
Query: 275 -TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
+K+D++S G+ L+E+ + + L +A
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 8e-59
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPN 149
++ +G G +G+ K + +++ K+LD+ + + +EV L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 150 LVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
+V+ + L V EY G L + + + LD +++ + L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 208 LHEQ--LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
H + V++RDLK +N+ L+ + KL DFGLA++ T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
P+ KSDI+S G +L EL
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-58
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 9/218 (4%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPN 149
++ LGEG +G+V E+ VA+K +D R V E+ +H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+VK G+ EG+ + L EY G L + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
+ +RD+K N+LL+E + K+SDFGLA + ++ + ++ GT Y AP+
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 270 MTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ D++S G+VL ++ G DQ D +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 9e-58
Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 7/224 (3%)
Query: 83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL 142
+D+ + LG G +G+VY+G +K VA+K L ++ V EF E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
HPNLV+L+G C ++ E+M G+L +L + + + + +A S
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 125
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
++YL K+ I+RDL N L+ E + K++DFGL+++ +GD
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK 181
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ AP+ + + KSD+++FGV+L E+ T + D ++
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-57
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 9/208 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V G + + VAIK + G EF E + + H LV+L G C
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ ++ EYM G L +L ++R +++ ++YL + ++
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RDL N L+ + K+SDFGL++ D+ S + P+ M + + KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKEL 306
DI++FGV++ E+ + K + E
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSET 210
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 4e-57
Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVR-EFSAEVMTLGSA 145
N +GEG FG+V++ + +VA+K L ++ +F E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------------- 186
D+PN+VKL+G CA G L++EYM G L++ L + P T
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 187 -RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
PL ++ IA + G+ YL E+ ++RDL N L+ E K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
S D + P+ + T +SD++++GVVL E+ + +E
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 306 L 306
+
Sbjct: 251 V 251
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-57
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL 150
+ D +G G F VYKG + VA +L R + + F E L HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 151 VKLIGYCAEGDQR----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
V+ + +LV E M G+L +L + + +GLQ
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQ 126
Query: 207 YLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
+LH + P+I+RDLKC NI + K+ D GLA + + + V+GT + A
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMA 181
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
P+ + D+Y+FG+ +LE+ T + ++ ++
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-56
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
+F LG+G FG VY ++ + ++A+K L + + EV HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
N+++L GY + + L+ EY PLG++ + L D + L Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 122
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + VI+RD+K N+LL K++DFG + PS +T + GT Y P+
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEM 175
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
K D++S GV+ E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-56
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 95 SDCCLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
+D LG G FG V +G K + VAIK L + E E + D+P +V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
+LIG C + + +LV E G L K L R + + ++ S G++YL
Sbjct: 73 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE-- 126
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAM 270
++ ++RDL N+LL ++ K+SDFGL+K +G + + AP+
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ + +SD++S+GV + E ++ + + E+
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 221
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-56
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
+ +G+G FG V G VA+K + + + F AE + H NLV
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
+L+G E L +V EYM GSL +L L + +K + ++YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE- 120
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
++RDL N+L+ E K+SDFGL K S T + AP+
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR 173
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ + KSD++SFG++L E+ + + K++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-55
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 9/215 (4%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
+ R + LG+G FG+V+ G VAIK L G F E + H LV
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
+L + +V EYM GSL L + L + +AA + G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+ ++RDL+ +NIL+ E K++DFGLA++ ++ + AP+ A+
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALY 188
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
G+ T KSD++SFG++L EL T + +E+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-55
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 9/208 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G FG V+ G + VAIK + G +F E + HP LV+L G C
Sbjct: 13 IGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
E LV+E+M G L +L T + + G+ YL E VI+
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 124
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RDL N L+ E K+SDFG+ + D+ ST + +P+ + + KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKEL 306
D++SFGV++ E+ + K + + E+
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEV 211
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-55
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 13/213 (6%)
Query: 99 LGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLI 154
LG G FG V KG + K+ + VA+K L + E AE + D+P +V++I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
G C E + +LV E LG L+K+L R + +++ S G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ES 126
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++RDL N+LL ++ K+SDFGL+K + + T + AP+ +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ KSD++SFGV++ E + + + E+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-55
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 29/234 (12%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
LG G FGKV I + VA+K L + RE +E+ + H N+V
Sbjct: 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLDWN 192
L+G C L++EY G L +L R D L +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
+ A ++G+++L + ++RDL N+L+ G K+ DFGLA+ S
Sbjct: 165 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
V + AP+ G T KSD++S+G++L E+ +
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 8e-55
Identities = 61/229 (26%), Positives = 91/229 (39%), Gaps = 24/229 (10%)
Query: 99 LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
LG G FGKV + + VA+K L RE +E+ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKI 197
L+G C G L++ EY G L L R D LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
+ ++G+ +L + I+RDL NILL G K+ DFGLA+ + V
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ AP+ TF+SD++S+G+ L EL + +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-54
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 13/215 (6%)
Query: 99 LGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLI 154
+G G FG VY G L + + A+K L+ G V +F E + + HPN++ L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 155 GYCAEGDQR-LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G C + L+V YM G L + +T + ++G+++L
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA---S 148
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+ ++RDL N +L+E + K++DFGLA+ D H T + A + T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ T KSD++SFGV+L EL+T + ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (451), Expect = 2e-54
Identities = 62/217 (28%), Positives = 92/217 (42%), Gaps = 19/217 (8%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
+G G FG VY + +VVAIK++ + G Q ++ EV L HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
LV EY + D +PL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
+I+RD+K NILL E KL DFG A + + +GT + AP+ + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
Q K D++S G+ +EL + + L +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-53
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 10/212 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G+G G VY Q VAI+Q++ + E++ + +PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
GD+ +V EY+ GSL + + +D + + L++LH VI+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
RD+K NILL KL+DFG + ++GT + AP+ K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
DI+S G++ +E+I G + L L+A
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 1e-53
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
+F+ LGEG F V + AIK L+ R + V + E + DHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
VKL + ++ Y G L K++ D A L+YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + +I+RDLK NILL E H +++DFG AK+ K + +GT Y +P+
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
SD+++ G ++ +L+ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-52
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
+G+G FG+V++G + VA+K R + AE+ H N++ I
Sbjct: 10 SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 158 AEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
+ + Q LV +Y GSL +L+ + +K+A + GL +LH ++
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
K + +RDLK NIL+++ ++D GLA S T +GT Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 267 DYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
+ + ++DIY+ G+V E+ +D +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-52
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGV-QGVREFSAEVMTLGS-ADH 147
+ + +GEG FG+V K ++K + AIK++ R+F+ E+ L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD------------LRPDTRPLDWNTRM 195
PN++ L+G C L EY P G+L L L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
AA +RG+ YL ++ I+RDL NIL+ E Y K++DFGL++ K T
Sbjct: 131 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ A + T SD++S+GV+L E+++ EL
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-52
Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 14/222 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV---QGVREFSAEVMTLGSA 145
+ R LG+G FG V +G + VA+K L + + + +F EV + S
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
DH NL++L G ++ V E PLGSL L T + A + G+
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGM 124
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYC 264
YL + I+RDL N+LL K+ DFGL + P D +V + +C
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
AP+ T + SD + FGV L E+ T + + ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-51
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 12/219 (5%)
Query: 93 FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADH 147
F+ LG G FG VYKG EK++ VAIK+L + +E E + S D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P++ +L+G C +L + + MP G L ++ + + + + ++G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNY 126
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
L + +++RDL N+L++ H K++DFGLAK+ + +K + + + A +
Sbjct: 127 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ T +SD++S+GV + EL+T E+
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-51
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 12/214 (5%)
Query: 99 LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKL 153
+G G FG+VYKG L K E VAIK L + R +F E +G H N+++L
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
G ++ +++ EYM G+LDK L + + + G + G++YL
Sbjct: 75 EGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM-- 129
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
++RDL NIL+ K+SDFGL++ + + T+ ++ + AP+
Sbjct: 130 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ T SD++SFG+V+ E++T + E+
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 99 LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
LG+G FG VY+G + + E VAIK ++ R EF E + + ++V+
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQ 206
L+G ++G L++ E M G L +L LR P P + +++A + G+
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
YL+ ++RDL N ++ E + K+ DFG+ + D + + + +P
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ G T SD++SFGVVL E+ T + Q +++
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 1e-49
Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 11/213 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V++ A K + E+ T+ HP LV L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ ++ +++YE+M G L + + D + + ++ +GL ++HE ++
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
DLK NI+ + KL DFGL V GT + AP+ A + +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGY 204
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+D++S GV+ L++G D + L V
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 237
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 98 CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
C+GEG FG V++G E VAIK + VRE F E +T+ DHP++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
IG E + ++ E LG L L LD + + A S L YL +
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
++RD+ N+L+ KL DFGL++ + +++ + AP+ +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
T SD++ FGV + E++ Q ++
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (413), Expect = 2e-48
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 11/213 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V++ + +V K ++ E+ + HP L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
+ + +L+ E++ G L + + + A GL+++HE +++
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 219 RDLKCSNILLE--EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
D+K NI+ E + K+ DFGLA + T + AP+ + F
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGF 207
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+D+++ GV+ L++G D + L V
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (407), Expect = 2e-48
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSAD 146
+ + LG GG +V+ ++ + VA+K L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 147 HPNLVKLIGYCAE----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
HP +V + G +V EY+ +L +H P+ +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTY 261
+ L + H+ +I+RD+K +NI++ K+ DFG+A+ + SG+ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
Y +P+ A + +SD+YS G VL E++TG
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-47
Identities = 37/198 (18%), Positives = 81/198 (40%), Gaps = 12/198 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G FG V++ ++ K + +G E+ L A H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
++ ++++E++ + + ++ L+ + LQ+LH + +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
D++ NI+ K+ +FG A+ GD + + Y AP+ ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVST 182
Query: 277 KSDIYSFGVVLLELITGR 294
+D++S G ++ L++G
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (404), Expect = 5e-47
Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMT---LGSA 145
+F +G GGFG+VY ++ A+K LD + + QG E + + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
D P +V + D+ + + M G L HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGL 120
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
+++H + V+YRDLK +NILL+E H ++SD GLA +GT+GY A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173
Query: 266 PDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLR 314
P+ G +D +S G +L +L+ G Q K + + + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 6e-47
Identities = 46/198 (23%), Positives = 78/198 (39%), Gaps = 8/198 (4%)
Query: 98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGY 156
LG G F +V ++ +++VAIK + + ++G E+ L HPN+V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
G L+ + + G L + + ++ ++YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
+ L+E +SDFGL+KM G + GT GY AP+ +
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSK 188
Query: 277 KSDIYSFGVVLLELITGR 294
D +S GV+ L+ G
Sbjct: 189 AVDCWSIGVIAYILLCGY 206
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQ-GVREFSAEVMTLGS-ADHPN 149
LGEG FG+V +++ VA+K L + + + +E+ + H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKI 197
++ L+G C + ++ EY G+L ++L RP L +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
A +RG++YL + I+RDL N+L+ E K++DFGLA+ D +T
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ AP+ T +SD++SFGV+L E+ T + +EL
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-46
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 23/228 (10%)
Query: 99 LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQG-VREFSAEVMTLGSADH-PNLV 151
LG G FG+V + I+ + VA+K L R +E+ L H N+V
Sbjct: 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
L+G C + G +++ E+ G+L +L R + P L + +
Sbjct: 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
++G+++L + I+RDL NILL E K+ DFGLA+
Sbjct: 141 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
+ AP+ T +SD++SFGV+L E+ + + E
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 66/207 (31%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DH 147
+F LG+G FGKV+ +K Q AIK L V V E L A +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
P L + + V EY+ G L H+ D + AA GLQ+
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
LH + ++YRDLK NILL++ H K++DFG+ K GD GT Y AP+
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
+ + D +SFGV+L E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 6e-46
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 15/221 (6%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
+F+ LG G FG+V+ + A+K L V + V + E + L HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
++++ G + Q ++ +Y+ L L ++ AA L+YL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + +IYRDLK NILL++ H K++DFG AK P T GT Y AP+
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEV 172
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
T D +SFG+++ E++ G + K +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 1e-44
Identities = 59/234 (25%), Positives = 94/234 (40%), Gaps = 26/234 (11%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--------HRGVQGVRE-FSAEVMTL 142
N+ LG G V + + + A+K +D VQ +RE EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 143 GS-ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
+ HPN+++L LV++ M G L +L + L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
+ LH+ +++RDLK NILL++ + KL+DFG + G+K V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173
Query: 262 GYCAPDYAMTGQL------TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
Y AP+ + D++S GV++ L+ G K L ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-43
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
LGEG F VYK + Q+VAIK++ R E+ L HPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
+ LV+++M ++ ++ L + +GL+YLH+
Sbjct: 66 LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
+++RDLK +N+LL+E KL+DFGLAK S ++ + T + T Y AP+ +
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176
Query: 274 L-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
+ D+++ G +L EL+ + D +L +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-43
Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 17/222 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
+G G FG VY+ L ++VAIK++ Q R + E+ + DH N+V+L +
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 159 EGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
++ LV +Y+P H R + L R L Y+H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHS-- 140
Query: 213 KQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
+ +RD+K N+LL + KL DFG AK G+ + + Y
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGA 197
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
T D++S G VL EL+ G+ +L + +L
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 7/229 (3%)
Query: 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHP 148
+ + +GEG +G V + VAIK++ Q + E+ L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
N++ + + Y+ + L+ L T+ L + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYI 125
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPD 267
H V++RDLK SN+LL K+ DFGLA+ P D T T + T Y AP+
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 268 YAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLRK 315
+ + T DI+S G +L E+++ R +LN + +L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-42
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 20/206 (9%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG------VREFSAEVMTLGSADHPNLVK 152
LG G F V K + A K + R + + EV L HPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
L +L+ E + G L D + L + G+ YLH
Sbjct: 78 LHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-- 131
Query: 213 KQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
+ + DLK NI+L K+ DFGLA G++ + GT + AP+
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 187
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
L ++D++S GV+ L++G
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 14/224 (6%)
Query: 99 LGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVREFS-----AEVMTLGSADHPNLVK 152
+GEG +GKV+K L+ + VA+K++ + + S A + L + +HPN+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 153 LIGYCAEGDQRLLVYEYMPLGSL--DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
L C + + D + + + T + RGL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
V++RDLK NIL+ KL+DFGLA++ T V+ T Y AP+ +
Sbjct: 135 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLL 188
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLR 314
D++S G + E+ + + D +L + ++
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 2e-41
Identities = 44/236 (18%), Positives = 79/236 (33%), Gaps = 20/236 (8%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PN 149
+++ +GEG FG +++G Q VAIK R + E T
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+ + + EG +LV + + L R T A +Q +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHP-----KLSDFGLAKMGPSGD-----KTHVSTRVMG 259
E+ ++YRD+K N L+ + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLLRK 315
T Y + + + + + + D+ + G V + + G K + K
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-41
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 20/214 (9%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLG- 143
++ LG GGFG VY G VAIK + D + EV+ L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 144 -SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
S+ +++L+ + D +L+ E R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVL 120
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
+++ H V++RD+K NIL+ KL DFG + K V T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 173
Query: 262 GYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
Y P++ + + ++S G++L +++ G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 9/224 (4%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPN 149
NF+ +GEG +G VYK + +VVA+K++ D E+ L +HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+VKL+ ++ LV+E++ + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
V++RDLK N+L+ KL+DFGLA+ +T+ + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
+ DI+S G + E++T R + +L + L
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-40
Identities = 61/206 (29%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
+F LG+G FGKV + + A+K L + V E L + HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
L L D+ V EY G L HL R A L+YL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL 121
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
H + V+YRD+K N++L++ H K++DFGL K G S T GT Y AP+
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEV 176
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
D + GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (347), Expect = 3e-39
Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 18/228 (7%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
+R +G G FG +Y G + VAIK + + E
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64
Query: 151 VKLIGYC-AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
+ I +C AEGD ++V E + D +R T + +A ++Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH 120
Query: 210 EQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGD-----KTHVSTRVMGTY 261
+ I+RD+K N L ++G + DFGLAK + + GT
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
Y + + + + + + D+ S G VL+ G K +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 8e-39
Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYC 157
LG G GKV + ++ ++ A+K L + EV A P++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 158 ----AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
A L+V E + G L + D + +I +QYLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---S 129
Query: 214 QPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+ +RD+K N+L KL+DFG AK S + T Y AP+
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
+ D++S GV++ L+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (336), Expect = 7e-38
Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 11/217 (5%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+GEG +G VYK + A+K++ + E+ L H N+VKL
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ +LV+E++ L L+ T G+ Y H++ V
Sbjct: 69 IHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RDLK N+L+ K++DFGLA+ + + ++ + + + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYST 180
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
DI+S G + E++ G + +L + +L
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-37
Identities = 49/236 (20%), Positives = 94/236 (39%), Gaps = 20/236 (8%)
Query: 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHP 148
+ +G+G FG+V+K K Q VA+K++ + E+ L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 149 NLVKLIGYCAEGDQR--------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG 200
N+V LI C LV+++ + L + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS--TRVM 258
GL Y+H +++RD+K +N+L+ KL+DFGLA+ + + T +
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 259 GTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313
T Y P+ + + D++ G ++ E+ T + ++ +L L++ L
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-37
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 10/210 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+GEG +G V+K + ++VA+K++ D E+ L H N+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ LV+E+ LD +GL + H + V
Sbjct: 70 LHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
++RDLK N+L+ KL++FGLA+ + + S V+ + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYST 181
Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
D++S G + EL + + D +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 7e-36
Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 15/199 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
LG G FG+V ++ A+K LD + V + + E L + + P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
+ +V EY+ G + HL AA +YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
+IYRDLK N+L+++ + +++DFG AK T + GT AP+ ++
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216
Query: 276 FKSDIYSFGVVLLELITGR 294
D ++ GV++ E+ G
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-36
Identities = 43/198 (21%), Positives = 78/198 (39%), Gaps = 9/198 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+G G +G V + VAIK+L + + E+ L H N++ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ ++ + L + + +GL+Y+H +
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGI 142
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
I+RDLK N+ + E K+ DFGLA+ S ++ V+ + + T
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 277 KSDIYSFGVVLLELITGR 294
DI+S G ++ E+ITG+
Sbjct: 199 TVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 2e-34
Identities = 42/242 (17%), Positives = 94/242 (38%), Gaps = 24/242 (9%)
Query: 73 NSGKSAKPFTFDELAAATGN---FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV 129
N+ + + + ++ GN ++ LG G + +V++ + V +K L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73
Query: 130 QGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRL--LVYEYMPLGSLDKHLHDLRPDT 186
+ + E+ L + PN++ L + R LV+E++ +
Sbjct: 74 K---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------- 123
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMG 245
+ L + L Y H +++RD+K N+++ E +L D+GLA+
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
G + + + + P+ + Q+ + D++S G +L +I ++ D
Sbjct: 181 HPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 305 EL 306
+
Sbjct: 238 DQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 92 NFRSDCCLGEGGFGKVYKG---CLEKIEQVVAIKQLDHRGV----QGVREFSAEVMTLGS 144
NF LG G +GKV+ ++ A+K L + + E L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 145 ADH-PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
P LV L + L+ +Y+ G L HL +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVL 140
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
L++LH+ +IYRD+K NILL+ H L+DFGL+K + + + GT Y
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 196
Query: 264 CAPDYAMTGQ--LTFKSDIYSFGVVLLELITGR 294
APD G D +S GV++ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-31
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 9/198 (4%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+G G +G V K VA+K+L + + + E+ L H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
+ + L + + L + + RGL+Y+H +
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
I+RDLK SN+ + E K+ DFGLA+ +V+TR +
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMHYNQ 198
Query: 277 KSDIYSFGVVLLELITGR 294
DI+S G ++ EL+TGR
Sbjct: 199 TVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 3e-30
Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
+G G G V +++ VAIK+L + + E++ + +H N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 157 CA------EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
E LV E M LD + G+++LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS 137
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
+I+RDLK SNI+++ K+ DFGLA+ + + + T + T Y AP+ +
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
DI+S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 1e-28
Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 16/209 (7%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
LG G F V+ VA+K + V E+ L + + K A
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 159 EGDQRLLVYEY------------MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
+LL + + + + + R + +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 207 YLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
Y+H + +I+ D+K N+L+E L +A +G + T + T Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
P+ + +DI+S ++ ELITG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.5 bits (177), Expect = 7e-16
Identities = 22/159 (13%), Positives = 48/159 (30%), Gaps = 30/159 (18%)
Query: 99 LGEGGFGKVYKGCLEKIEQVVAIK----------QLDHRGVQGVREFSAEVMTLGSADHP 148
+GEG V+ EK +K ++ + G FS + +
Sbjct: 8 MGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 149 NLVKLIGYCA----EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
L KL G + ++ E + + + ++
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILEE 115
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
+ + + +++ DL N+L+ E + DF +
Sbjct: 116 VAKFYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-55 Score=376.82 Aligned_cols=209 Identities=26% Similarity=0.387 Sum_probs=188.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998765556778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
+||+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998765 4599999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 223457999999999999999999999999999999999999999887766655443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=376.80 Aligned_cols=207 Identities=27% Similarity=0.401 Sum_probs=181.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4579999999999999999999999999999999976543 334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999865 45799999999999999999999998 9999999999999999999999999999865444
Q ss_pred CCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|++||....+.
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 33333445689999999999988876 57899999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=370.91 Aligned_cols=209 Identities=27% Similarity=0.449 Sum_probs=187.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||++|+|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999976 45699999999999999999999998 999999999999999999999999999976443
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 217 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 32 234579999999999999999999999999999999999999999887766666553
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=377.50 Aligned_cols=212 Identities=26% Similarity=0.362 Sum_probs=185.8
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++.+.||+|+||+||+|.+..+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999997532 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||+||+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999876 45799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 222 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH
Confidence 44333444568999999999999999999999999999999999999999988776665554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=371.66 Aligned_cols=218 Identities=23% Similarity=0.322 Sum_probs=177.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee--CCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 165 (315)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.++++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 3579999999999999999999999999999999976543 345668899999999999999999999865 456899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
|||||++|+|.+++.........+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998764444567999999999999999999999861 1249999999999999999999999999998
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
...... .......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+....|
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i 226 (269)
T d2java1 163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 654322 2223458999999999999999999999999999999999999999987766655554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=373.40 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=186.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
+.|++.+.||+|+||+||+|.+..++..||+|+++.......+.+.+|+.+|+.++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46999999999999999999999999999999998776677788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++|+|.+++... ..++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 999999987652 45699999999999999999999998 9999999999999999999999999999753221
Q ss_pred ceeeeeccccccccCccccc-----cCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 251 THVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
........||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.+..+.+..+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i 227 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 227 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 11122357999999999884 456899999999999999999999999988776665544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=373.68 Aligned_cols=210 Identities=29% Similarity=0.379 Sum_probs=188.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|.+++.||+|+||+||+|.+..+|+.||||++++.. ......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997542 234677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999887 45689999999999999999999998 999999999999999999999999999986443
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 222 233468999999999999999999999999999999999999999988766655544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.7e-53 Score=372.83 Aligned_cols=212 Identities=21% Similarity=0.306 Sum_probs=189.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++++.||+|+||+||+|.+..+|+.||||+++.........+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999877655667788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc--CCCceEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE--EGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~--~~~~~kl~Dfg~~~~~~~ 247 (315)
|+||+|.+++.. ...++++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999887754 345799999999999999999999998 999999999999998 568999999999987554
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..|.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 182 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 322 233579999999999999999999999999999999999999999887776665553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.9e-53 Score=372.80 Aligned_cols=212 Identities=24% Similarity=0.345 Sum_probs=189.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC--CCceEEeccCCcccCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~--~~~~kl~Dfg~~~~~~~ 247 (315)
|+||+|.+++.. ...++++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999998864 245699999999999999999999998 9999999999999964 57899999999986544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
... .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|.
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 322 234579999999999999999999999999999999999999999887776666553
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=375.02 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=181.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++++.||+|+||+||+|.+..+|+.||+|+++... ......+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999999999999999997643 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|++||+|.+++.. ...+++..++.++.||+.||.|||+. ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999976 35699999999999999999999973 28999999999999999999999999999754221
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCch
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 303 (315)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 123458999999999999999999999999999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-53 Score=369.17 Aligned_cols=211 Identities=25% Similarity=0.372 Sum_probs=170.9
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
+.+.|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34679999999999999999999999999999999976543 23456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc---CCCceEEeccCCccc
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKM 244 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~---~~~~~kl~Dfg~~~~ 244 (315)
|||+||+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999975 46799999999999999999999998 999999999999995 578999999999986
Q ss_pred CCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....|
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 221 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 221 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 43322 223457999999999999999999999999999999999999999887765554443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-52 Score=367.82 Aligned_cols=207 Identities=28% Similarity=0.430 Sum_probs=186.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++++.||+|+||+||+|.+..+|+.||||++++.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999999999999999997532 234677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
|||+||+|..++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998876 56689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 213 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH
Confidence 22 2358999999999999999999999999999999999999999987766665554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-52 Score=364.79 Aligned_cols=205 Identities=30% Similarity=0.407 Sum_probs=181.3
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
.|+.++.||+|+||+||+|.+..+++.||||+++.... ...+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999976543 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
||.+|+|..++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999776655 46799999999999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..+
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i 226 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 23479999999999864 46899999999999999999999999887766555443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=362.71 Aligned_cols=208 Identities=32% Similarity=0.547 Sum_probs=173.7
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
..++|.+.+.||+|+||+||+|.+.. .||||+++... ....+.+.+|+.++++++|||||++++++.+ +.+++|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 45789999999999999999997653 59999997543 3456789999999999999999999998755 568999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||++|+|.+++... ..++++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999752 45699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeccccccccCcccccc---CCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
............||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.++...+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence 4433334445689999999999864 35889999999999999999999999987765544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=355.53 Aligned_cols=204 Identities=29% Similarity=0.462 Sum_probs=174.5
Q ss_pred CCC-CcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee----CCeE
Q 021249 91 GNF-RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQR 163 (315)
Q Consensus 91 ~~y-~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~ 163 (315)
++| ++.+.||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+|++++|||||++++++.+ +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 66778999999999999999999999999987543 2345678999999999999999999999865 4568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEc-CCCceEEeccCCc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLA 242 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~-~~~~~kl~Dfg~~ 242 (315)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +.+|+||||||+|||++ +++.+||+|||++
T Consensus 88 ~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999999976 35699999999999999999999987 11299999999999996 5789999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
+...... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..+..
T Consensus 163 ~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 163 TLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred eeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence 8643322 234589999999998765 69999999999999999999999998765443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=359.21 Aligned_cols=210 Identities=25% Similarity=0.338 Sum_probs=186.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc------ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR 163 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 163 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+... ...+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999975422 2357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC----ceEEecc
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF 239 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----~~kl~Df 239 (315)
|+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 999999999999999976 35699999999999999999999998 999999999999998776 5999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 228 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99986544322 22347999999999999999999999999999999999999999987776665554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-52 Score=367.35 Aligned_cols=207 Identities=25% Similarity=0.313 Sum_probs=186.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
++|++++.||+|+||.||+|.++.+|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999999999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999876 35699999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.. ....||+.|||||++.+..++.++|||||||++|+|+||++||.+.+....+..|
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i 250 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 22 2357999999999999999999999999999999999999999987766655554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-52 Score=360.03 Aligned_cols=215 Identities=26% Similarity=0.414 Sum_probs=184.7
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+....++|++.+.||+|+||+||+|.+..+++.||||+++... ...+++.+|+.+|++++|||||++++++.+++.+++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3344567999999999999999999999999999999997654 346779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
|||||++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 91 v~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 91 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999998763 346799999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcc-cccCchhhhh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI-DQTKDRKELN 307 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~ 307 (315)
..... .......|++.|+|||++.+..|+.++|||||||++|||++|..|| ...+..+...
T Consensus 166 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~ 227 (287)
T d1opja_ 166 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227 (287)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH
Confidence 44322 2223346889999999999999999999999999999999976655 4444433333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=359.10 Aligned_cols=210 Identities=30% Similarity=0.479 Sum_probs=184.5
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC---cccHHHHHHHHHHhc-cCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|.+.+.||+|+||+||+|.+..+++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 233455666776654 68999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999976 45689999999999999999999998 99999999999999999999999999998544
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..|
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 215 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 332 2233457999999999999999999999999999999999999999988877666555
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=356.83 Aligned_cols=214 Identities=26% Similarity=0.442 Sum_probs=173.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe---EEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~---~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||+||+|.+..+++ .||||.+.... ....+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 468888999999999999999876654 68999987643 34456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 245699999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCce---eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 247 SGDKTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 247 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+..+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 332211 1122457899999999999999999999999999999998 899999888776666554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=355.76 Aligned_cols=211 Identities=18% Similarity=0.273 Sum_probs=186.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
..++|.+.+.||+|+||+||+|.+..+++.||||+++.... ....+.+|+.+|+.++||||++++++|.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35789999999999999999999999999999999987643 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCC--CceEEeccCCcccCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFGLAKMGP 246 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~--~~~kl~Dfg~~~~~~ 246 (315)
||+||+|.+++.. ...++++.+++.++.||+.||.|||+. +|+||||||+|||++.+ ..+||+|||++....
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999975 245699999999999999999999998 99999999999999854 479999999998654
Q ss_pred CCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
.... .....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+.+..|
T Consensus 156 ~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i 215 (321)
T d1tkia_ 156 PGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp TTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3322 23357899999999999999999999999999999999999999988776665554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-50 Score=361.61 Aligned_cols=206 Identities=29% Similarity=0.407 Sum_probs=177.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHH---HHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVR---EFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~---~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|++.+.||+|+||.||+|.+..+|+.||||++.+... .... ....|+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999999999999999864321 1122 2334577888899999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+|||||+||+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999976 45689999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 307 (315)
..... ....+||+.|+|||++.. ..|+.++|||||||++|+|+||+.||.+.+......
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 216 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 54332 223479999999999875 568999999999999999999999998766544433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=348.48 Aligned_cols=211 Identities=27% Similarity=0.417 Sum_probs=173.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||+||+|.+.. +..||||+++... ...+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 578999999999999999999874 6789999997654 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999875 246689999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
. ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.+..+.
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~ 216 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred e-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 2 2233478999999999999999999999999999999999 567777666655555543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=360.05 Aligned_cols=216 Identities=27% Similarity=0.420 Sum_probs=181.6
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCC-----eEEEEEEecCCC-cccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCC
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD 161 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~-----~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 161 (315)
..++|++.+.||+|+||+||+|.+..++ ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3467999999999999999999986544 379999986543 33456788999999988 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK 222 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlk 222 (315)
..++|||||++|+|.++++..+. ....+++..++.++.||+.||.|||+. +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999976431 124589999999999999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccC
Q 021249 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301 (315)
Q Consensus 223 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 301 (315)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |++||.+.+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986554444333444578999999999999999999999999999999998 899999877
Q ss_pred chhhhh
Q 021249 302 DRKELN 307 (315)
Q Consensus 302 ~~~~~~ 307 (315)
..+.+.
T Consensus 272 ~~~~~~ 277 (325)
T d1rjba_ 272 VDANFY 277 (325)
T ss_dssp CSHHHH
T ss_pred HHHHHH
Confidence 655444
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-50 Score=349.37 Aligned_cols=210 Identities=24% Similarity=0.362 Sum_probs=176.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc---ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----e
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----Q 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~ 162 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... .....+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4689999999999999999999999999999999976533 33557899999999999999999999987644 4
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
+|+||||++|++|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 8999999999999998876 45799999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCC-CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhh
Q 021249 243 KMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306 (315)
Q Consensus 243 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 306 (315)
....... ........+||+.|+|||++.+..+++++|||||||++|+|+||++||.+.+..+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 223 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH
Confidence 7543322 222233457999999999999999999999999999999999999999877655543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=348.57 Aligned_cols=213 Identities=28% Similarity=0.420 Sum_probs=180.9
Q ss_pred CCCCcccc-cccCCceEEEEEEECC--CCeEEEEEEecCCC-cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCC-LGEGGFGKVYKGCLEK--IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~-ig~G~~g~V~~~~~~~--~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++... ....+.+.+|+.+|++++|||||++++++.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666674 9999999999998753 45689999997653 3446779999999999999999999999875 468899
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~ 246 (315)
||||++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998765 245799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc-eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 247 SGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 247 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
..... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..|.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~ 226 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 43322 22233468999999999999999999999999999999998 999999888776666554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-50 Score=345.20 Aligned_cols=210 Identities=27% Similarity=0.327 Sum_probs=184.1
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc---------cHHHHHHHHHHhccCC-CCCeeeEEeEEee
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---------GVREFSAEVMTLGSAD-HPNLVKLIGYCAE 159 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~ 159 (315)
.++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999999999999999999765321 1345788999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
++..|+|||||++|+|.+++.. ..++++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999976 45799999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCcccccc------CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
|+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+
T Consensus 155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 99986544322 233579999999998863 35788999999999999999999999988766655544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=341.70 Aligned_cols=212 Identities=25% Similarity=0.381 Sum_probs=187.0
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++|++.+.||+|+||+||+|.++ ++..||||+++.... ..+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57999999999999999999986 578999999986543 3567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++|+|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999998765 245689999999999999999999998 999999999999999999999999999976544322
Q ss_pred ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 311 (315)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....|..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 2 2233578999999999999999999999999999999998 8999999888777766654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=349.63 Aligned_cols=213 Identities=27% Similarity=0.422 Sum_probs=179.4
Q ss_pred HHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEE
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 167 (315)
...++|++.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 34567999999999999999999986 47789999997654 345679999999999999999999998865 5678999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 247 (315)
||+++|+|.+++... ...++++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 87 Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 999999999987542 234589999999999999999999998 999999999999999999999999999987544
Q ss_pred CCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCcccccCchhhhhHH
Q 021249 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLV 309 (315)
Q Consensus 248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i 309 (315)
.. ........||+.|+|||++.+..++.++|||||||++|||+|| .+||...+..+.+..+
T Consensus 162 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i 223 (272)
T d1qpca_ 162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (272)
T ss_dssp SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred Cc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 32 2222345789999999999999999999999999999999995 5566665555544444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=346.22 Aligned_cols=206 Identities=31% Similarity=0.471 Sum_probs=174.1
Q ss_pred cccccCCceEEEEEEEC--CCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEecCC
Q 021249 97 CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~--~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 172 (315)
+.||+|+||+||+|.+. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 456789999997543 2335679999999999999999999999965 457899999999
Q ss_pred CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCCc-
Q 021249 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT- 251 (315)
Q Consensus 173 ~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 251 (315)
|+|.+++.. ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999976 46699999999999999999999998 9999999999999999999999999999865443322
Q ss_pred eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence 22234578999999999999999999999999999999998 899999887766555543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=354.14 Aligned_cols=202 Identities=24% Similarity=0.312 Sum_probs=173.9
Q ss_pred hCCCCccc-ccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhc-cCCCCCeeeEEeEEee----CCeE
Q 021249 90 TGNFRSDC-CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGYCAE----GDQR 163 (315)
Q Consensus 90 ~~~y~~~~-~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~----~~~~ 163 (315)
.++|.+.. .||+|+||+||+|.+..+++.||||+++.. ..+.+|+.++. .++|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45798875 599999999999999999999999998643 45678998865 4589999999999875 4678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccC
Q 021249 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG 240 (315)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg 240 (315)
|+|||||+||+|.+++... ...++++..++.++.||+.||.|||+. +|+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 9999999999999999752 235799999999999999999999998 9999999999999985 4579999999
Q ss_pred CcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchh
Q 021249 241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304 (315)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 304 (315)
+|+....... ....+||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+...
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 9986544322 233579999999999999999999999999999999999999998765443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=350.22 Aligned_cols=208 Identities=28% Similarity=0.324 Sum_probs=177.1
Q ss_pred ccccccCCceEEEEEEECCCCeEEEEEEecCCCcc-----cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEec
Q 021249 96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM 170 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 170 (315)
++.||+|+||+||+|.+..+|+.||||+++..... ..+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46799999999999999999999999999754322 1346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
.++++..+... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 98877655543 56689999999999999999999998 999999999999999999999999999976443322
Q ss_pred ceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
. ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+++..|..+
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 2 2234799999999988754 6799999999999999999999999999888888777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=347.90 Aligned_cols=213 Identities=27% Similarity=0.459 Sum_probs=177.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe----EEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~----~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
++|++++.||+|+||+||+|.+..+|+ +||+|.+... .....+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987765 5888888653 334567899999999999999999999999875 5678
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
++||+.+++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 356799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
.............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~ 227 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 55444433444568999999999999999999999999999999998 899998877666555543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=345.24 Aligned_cols=212 Identities=26% Similarity=0.350 Sum_probs=179.7
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++++.||+|+||+||+|.+..+|+.||||+++.... .....+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999999999999999975432 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+.++ +.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99754 44444331 346699999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeeeccccccccCccccccCC-cCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
.. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~ 216 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence 22 222347999999999877765 5789999999999999999999999888777666553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=340.17 Aligned_cols=213 Identities=27% Similarity=0.416 Sum_probs=172.1
Q ss_pred CCCCcccccccCCceEEEEEEECCCC----eEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~----~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
+.|++.+.||+|+||+||+|.+..++ ..||||.+..... .....+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888999999999999999987554 4799999975433 345578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+.++++.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988776 346799999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC-ceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCC-CcccccCchhhhhHH
Q 021249 246 PSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAIDQTKDRKELNLV 309 (315)
Q Consensus 246 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i 309 (315)
..... ........||+.|+|||++.+..++.++|||||||++|||++|. +||...+..+.+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence 43322 22223346899999999999999999999999999999999965 555555554444444
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=336.23 Aligned_cols=213 Identities=27% Similarity=0.411 Sum_probs=172.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCC---CeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL 165 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 165 (315)
.++|++.+.||+|+||.||+|.+..+ +..||||.++.... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 46799999999999999999998644 45799999875433 345679999999999999999999999964 67899
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccC
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~ 245 (315)
||||+++|+|.+++.. ...++++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 245799999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHHh
Q 021249 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 310 (315)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~ 223 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 43222 22334568999999999999999999999999999999998 899999888777665553
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-49 Score=342.08 Aligned_cols=219 Identities=28% Similarity=0.461 Sum_probs=186.4
Q ss_pred HhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCcc-cHHHHHHHHHHhccCCCCCeeeEEeEEeeCCe
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 162 (315)
..++|++.+.||+|+||+||+|.+.. ++..||||+++..... ..+++.+|+.+++.++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45679999999999999999999753 5678999999765433 35679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRP--------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK 222 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlk 222 (315)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 9999999999999999865321 124589999999999999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCC-CcccccC
Q 021249 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAIDQTK 301 (315)
Q Consensus 223 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~ 301 (315)
|+|||++.++.+||+|||+|+...........+...|++.|+|||++.+..++.++|||||||++|||++|. +||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998654444344444567899999999999999999999999999999999985 7898888
Q ss_pred chhhhhHHh
Q 021249 302 DRKELNLVA 310 (315)
Q Consensus 302 ~~~~~~~i~ 310 (315)
+.+.+..+.
T Consensus 248 ~~e~~~~v~ 256 (301)
T d1lufa_ 248 HEEVIYYVR 256 (301)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777666553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=340.60 Aligned_cols=223 Identities=26% Similarity=0.365 Sum_probs=175.3
Q ss_pred CcCHHHHHHHhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeee
Q 021249 80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVK 152 (315)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~ 152 (315)
|+..+++....++|++.+.||+|+||.||+|.+.. +++.||||+++.... ...+.+..|...+.++ +||||+.
T Consensus 2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 35566676667889999999999999999999753 457899999975433 3455677777777666 6899999
Q ss_pred EEeEEee-CCeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 021249 153 LIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219 (315)
Q Consensus 153 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~ 219 (315)
+++++.. +..+++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 9998765 4568999999999999999975321 134589999999999999999999998 99999
Q ss_pred cCCCCCEEEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCccc
Q 021249 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAID 298 (315)
Q Consensus 220 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~ 298 (315)
||||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865444333333445799999999999999999999999999999999986 57887
Q ss_pred ccCchhh
Q 021249 299 QTKDRKE 305 (315)
Q Consensus 299 ~~~~~~~ 305 (315)
+.+..+.
T Consensus 239 ~~~~~~~ 245 (299)
T d1ywna1 239 GVKIDEE 245 (299)
T ss_dssp TCCCSHH
T ss_pred CCCHHHH
Confidence 7664443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-48 Score=335.64 Aligned_cols=211 Identities=24% Similarity=0.293 Sum_probs=179.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++++.||+|+||+||+|.++ +|+.||||+++.... .....+.+|+.+|++++||||+++++++.+++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 689999999976533 335778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+.++.+..+... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987766665543 56799999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
... .....+++.|+|||.+.+. .++.++|||||||++|||++|++||.+.++.+++..+..
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 154 VRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 222 2234689999999988764 568999999999999999999999998887777766543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=338.39 Aligned_cols=212 Identities=31% Similarity=0.452 Sum_probs=174.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEEe
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 169 (315)
.++|++.+.||+|+||+||+|.+..+ ..||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 46799999999999999999999765 579999997654 345779999999999999999999999865 567899999
Q ss_pred cCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCC
Q 021249 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249 (315)
Q Consensus 170 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 249 (315)
+++|+|..++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999888652 234699999999999999999999998 99999999999999999999999999997643332
Q ss_pred CceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCcccccCchhhhhHHh
Q 021249 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVA 310 (315)
Q Consensus 250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~ 310 (315)
. .......||+.|+|||++.+..++.++|||||||++|||++| .+||......+.+..+.
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2 222334689999999999999999999999999999999995 55566666666666554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=337.46 Aligned_cols=200 Identities=22% Similarity=0.331 Sum_probs=172.4
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------cHHHHHHHHHHhccCC--CCCeeeEEeEEeeCC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSAD--HPNLVKLIGYCAEGD 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~ 161 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||++...... ....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999999999999999998753221 1233668999999886 899999999999999
Q ss_pred eEEEEEEecCC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-CCceEEecc
Q 021249 162 QRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDF 239 (315)
Q Consensus 162 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-~~~~kl~Df 239 (315)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 577777765 45699999999999999999999998 9999999999999985 479999999
Q ss_pred CCcccCCCCCCceeeeeccccccccCccccccCCc-CcccchhhHHHHHHHHHhCCCccccc
Q 021249 240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 240 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
|+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 9998643322 234579999999999987765 57899999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=338.05 Aligned_cols=214 Identities=26% Similarity=0.340 Sum_probs=177.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCC-CeEEEEEEecCCC--cccHHHHHHHHHHhccC---CCCCeeeEEeEEee----
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRG--VQGVREFSAEVMTLGSA---DHPNLVKLIGYCAE---- 159 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~-~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~---- 159 (315)
.++|++++.||+|+||+||+|.+..+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999655 6789999986432 22233456777776655 89999999999853
Q ss_pred -CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEec
Q 021249 160 -GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238 (315)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~D 238 (315)
....+++|||+.++.+...... ....+++..++.++.|++.||+|||+. +|+||||||+|||++..+.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3478999999988776544433 346689999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 239 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++.+.+..|..+
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 230 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 9998753322 2233457999999999999999999999999999999999999999999888887776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=333.73 Aligned_cols=212 Identities=30% Similarity=0.431 Sum_probs=171.7
Q ss_pred CCCCcccccccCCceEEEEEEECC-C--CeEEEEEEecCCC---cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEK-I--EQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL 164 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~-~--~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 164 (315)
++|++.+.||+|+||.||+|.+.. + ...||||++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998643 2 3478999987542 2345679999999999999999999999976 4678
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
+||||++++++.+++... ..++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999887652 45699999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCce-eeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 245 GPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 245 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i 227 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH
Confidence 64443322 2233467889999999999999999999999999999998 89999988877666554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=330.96 Aligned_cols=206 Identities=28% Similarity=0.412 Sum_probs=171.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee-CCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e 168 (315)
.++|++.+.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.++++++||||+++++++.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 356889999999999999999986 7789999997653 45778999999999999999999999854 466899999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
|+++|+|.+++... ...++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 99999999999652 124589999999999999999999998 9999999999999999999999999999754332
Q ss_pred CCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhhhHH
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 309 (315)
. ....+|+.|+|||++.+..+++++|||||||++|||+| |++||...+..+....|
T Consensus 157 ~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i 213 (262)
T d1byga_ 157 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred C-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 2 22368899999999999999999999999999999998 78999887766655554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=333.60 Aligned_cols=218 Identities=27% Similarity=0.408 Sum_probs=180.5
Q ss_pred HhCCCCcccccccCCceEEEEEEECCCC-------eEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEee
Q 021249 89 ATGNFRSDCCLGEGGFGKVYKGCLEKIE-------QVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE 159 (315)
Q Consensus 89 ~~~~y~~~~~ig~G~~g~V~~~~~~~~~-------~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 159 (315)
..++|.+.+.||+|+||.||+|.+..++ ..||||+++.... .....+.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3467999999999999999999876543 4799999976543 3456788888888887 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEE
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nil 227 (315)
++..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999975431 235689999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhhh
Q 021249 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306 (315)
Q Consensus 228 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 306 (315)
++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999986544443333445678999999999999999999999999999999998 79999887766555
Q ss_pred hHH
Q 021249 307 NLV 309 (315)
Q Consensus 307 ~~i 309 (315)
..+
T Consensus 248 ~~i 250 (299)
T d1fgka_ 248 KLL 250 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-47 Score=327.40 Aligned_cols=207 Identities=22% Similarity=0.280 Sum_probs=177.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC-CCeeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.... ...+.+|++.++.+.| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 5789999999999999999999999999999999865432 2346678888888865 899999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC-----CCceEEeccCCcc
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAK 243 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~-----~~~~kl~Dfg~~~ 243 (315)
|+ +++|.+++.. ....++...+..++.|++.||+|||+. +|+||||||+|||++. .+.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 6899998876 245699999999999999999999998 9999999999999974 5689999999998
Q ss_pred cCCCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 244 MGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 244 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
........ .......||+.|||||++.+..+++++|||||||++|||++|..||.+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 65432211 122345799999999999999999999999999999999999999986654433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=333.55 Aligned_cols=217 Identities=22% Similarity=0.316 Sum_probs=180.2
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEee--------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-------- 159 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-------- 159 (315)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999999999999999986543 2345678899999999999999999998855
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEecc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Df 239 (315)
.+..|+||||+.++.+..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 346899999998776654443 356789999999999999999999998 9999999999999999999999999
Q ss_pred CCcccCCCCCCc--eeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhhh
Q 021249 240 GLAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWLL 313 (315)
Q Consensus 240 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 313 (315)
|++......... ......+||+.|+|||++.+. .+++++|||||||++|||++|++||.+.++.+.+..+..++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 999754432211 122234799999999998765 68999999999999999999999999988888887776653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=332.73 Aligned_cols=213 Identities=29% Similarity=0.425 Sum_probs=178.2
Q ss_pred CCCCcccccccCCceEEEEEEECCCCe--EEEEEEecCC-CcccHHHHHHHHHHhccC-CCCCeeeEEeEEeeCCeEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHR-GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~--~vavK~i~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 166 (315)
++|++.+.||+|+||+||+|.+..++. .||||.++.. .....+.+.+|+.+|+++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578999999999999999999987776 4778887543 233566799999999998 799999999999999999999
Q ss_pred EEecCCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 167 YEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999986531 2346799999999999999999999998 99999999999999999999
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCC-CcccccCchhhhhHH
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAIDQTKDRKELNLV 309 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i 309 (315)
||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|. +||.+.+..+.+..+
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999975432221 12346899999999999999999999999999999999965 678877766655544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=336.12 Aligned_cols=215 Identities=24% Similarity=0.302 Sum_probs=177.5
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----eEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRL 164 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~ 164 (315)
+.+|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999999999999999999976543 34567889999999999999999999986643 234
Q ss_pred EEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++++|+.+++|.+++.. ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 45566678999999975 3599999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCc-eeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhhh
Q 021249 245 GPSGDKT-HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWL 312 (315)
Q Consensus 245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 312 (315)
....... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+....+..+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~ 228 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh
Confidence 4332211 12234579999999998854 46789999999999999999999999988876666655443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=332.31 Aligned_cols=217 Identities=28% Similarity=0.418 Sum_probs=186.0
Q ss_pred HHhCCCCcccccccCCceEEEEEEEC-----CCCeEEEEEEecCCCc-ccHHHHHHHHHHhccC-CCCCeeeEEeEEeeC
Q 021249 88 AATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG 160 (315)
Q Consensus 88 ~~~~~y~~~~~ig~G~~g~V~~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 160 (315)
...++|++.+.||+|+||.||+|.+. .+++.||||+++.... .....+.+|+.+++.+ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34568999999999999999999863 4678999999976543 3456788999999998 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCE
Q 021249 161 DQRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226 (315)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Ni 226 (315)
+..++|||||++|+|.+++..... ...++++..+..++.||+.||.|||+. +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 999999999999999999876431 234689999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHh-CCCcccccCchhh
Q 021249 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKE 305 (315)
Q Consensus 227 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 305 (315)
+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655544444555689999999999999999999999999999999998 6777777665554
Q ss_pred hh
Q 021249 306 LN 307 (315)
Q Consensus 306 ~~ 307 (315)
+.
T Consensus 257 ~~ 258 (311)
T d1t46a_ 257 FY 258 (311)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=334.77 Aligned_cols=208 Identities=26% Similarity=0.335 Sum_probs=175.0
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC------
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------ 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 161 (315)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999999999999999999975432 33567889999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+|+||||+ +.+|..+++. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 5677777654 4699999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
|+...... +...||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 98654322 234799999999988764 568999999999999999999999998887777665543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=334.06 Aligned_cols=222 Identities=27% Similarity=0.432 Sum_probs=188.9
Q ss_pred HHHHhCCCCcccccccCCceEEEEEEECC-----CCeEEEEEEecCCCc-ccHHHHHHHHHHhccCCCCCeeeEEeEEee
Q 021249 86 LAAATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE 159 (315)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~~g~V~~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 159 (315)
|....++|++.+.||+|+||+||+|.+.. ++..||||+++.... .....+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 33445789999999999999999998753 357899999975432 344568999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCc
Q 021249 160 GDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233 (315)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~ 233 (315)
.+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999886421 2235579999999999999999999998 9999999999999999999
Q ss_pred eEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhC-CCcccccCchhhhhHHh
Q 021249 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVA 310 (315)
Q Consensus 234 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~ 310 (315)
+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999865444333333445789999999999999999999999999999999998 58898888777776654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=335.22 Aligned_cols=209 Identities=25% Similarity=0.310 Sum_probs=174.6
Q ss_pred CCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEee------CCeEEE
Q 021249 92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE------GDQRLL 165 (315)
Q Consensus 92 ~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~~~~l 165 (315)
+|+..++||+|+||+||+|.+..+|+.||||++...... ..+|+.+|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588999999999999999999999999999999765422 2369999999999999999999853 345789
Q ss_pred EEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCccc
Q 021249 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKM 244 (315)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~ 244 (315)
|||||+++.+ +.+.........+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999976544 33332222356799999999999999999999998 999999999999999765 899999999986
Q ss_pred CCCCCCceeeeeccccccccCcccccc-CCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHhh
Q 021249 245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311 (315)
Q Consensus 245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 311 (315)
...... .....||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+..+.+..|.+
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 543322 223479999999998765 5789999999999999999999999998888777776654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=320.43 Aligned_cols=211 Identities=22% Similarity=0.272 Sum_probs=180.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCC--cccHHHHHHHHHHhccCCCCCeeeEEeEEeeCCeEEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 168 (315)
++|++++.||+|+||+||+|.+..+++.||||+++... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999999999999999996543 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG 248 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 248 (315)
++.+++|..++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999988877764 56789999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCceeeeeccccccccCccccccCC-cCcccchhhHHHHHHHHHhCCCccc-ccCchhhhhHHh
Q 021249 249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAID-QTKDRKELNLVA 310 (315)
Q Consensus 249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~ 310 (315)
... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||. +.+..+.+..+.
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred Ccc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 222 22235788999999887664 6899999999999999999998864 444444454443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=325.02 Aligned_cols=201 Identities=27% Similarity=0.338 Sum_probs=163.9
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCeeeEEeEEeeCC----eEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLLV 166 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~lv 166 (315)
.+|.+.+.||+|+||.||+|.+. |+.||||+++..... ......|+..+..++||||+++++++.+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46788899999999999999875 889999999754321 222344566667889999999999997654 68999
Q ss_pred EEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-----LKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
||||++|+|.++++. .++++..++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999976 3589999999999999999999962 124999999999999999999999999999
Q ss_pred cccCCCCCCc--eeeeeccccccccCccccccC------CcCcccchhhHHHHHHHHHhCCCcccc
Q 021249 242 AKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITGRKAIDQ 299 (315)
Q Consensus 242 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~ 299 (315)
++........ .......||+.|+|||++.+. .++.++|||||||++|||+||.+||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9865433222 122346799999999988754 367899999999999999999988754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=329.96 Aligned_cols=211 Identities=27% Similarity=0.362 Sum_probs=179.4
Q ss_pred CCCCcccccccCCceEEEEEEE---CCCCeEEEEEEecCCC----cccHHHHHHHHHHhccCCC-CCeeeEEeEEeeCCe
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQ 162 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~---~~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 162 (315)
++|++++.||+|+||+||+|.+ +.+|+.||||+++... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 4468999999987542 2235667889999999976 899999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
++++|||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999976 35678899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccC--CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
+......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i 244 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7654433222 2335799999999988765 4678999999999999999999999887655554443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=320.05 Aligned_cols=207 Identities=23% Similarity=0.276 Sum_probs=170.7
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCC-eeeEEeEEeeCCeEEEEEE
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e 168 (315)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+..|+.+++.++|++ |+.+..++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4679999999999999999999999999999999876532 235778999999998666 5555666788889999999
Q ss_pred ecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcC---CCceEEeccCCcccC
Q 021249 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAKMG 245 (315)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~---~~~~kl~Dfg~~~~~ 245 (315)
|+ +++|.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++. +..++|+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5666666554 246799999999999999999999998 9999999999999863 457999999999865
Q ss_pred CCCCCc-----eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhh
Q 021249 246 PSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305 (315)
Q Consensus 246 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 305 (315)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 433221 122345799999999999999999999999999999999999999987654443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=321.48 Aligned_cols=199 Identities=29% Similarity=0.461 Sum_probs=168.8
Q ss_pred ccccccCCceEEEEEEECCC---CeEEEEEEecCC-CcccHHHHHHHHHHhccCCCCCeeeEEeEEee-CCeEEEEEEec
Q 021249 96 DCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYEYM 170 (315)
Q Consensus 96 ~~~ig~G~~g~V~~~~~~~~---~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e~~ 170 (315)
.++||+|+||+||+|.+..+ ...||||.++.. .....+++.+|+.+|++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999998653 346999999753 44456789999999999999999999999865 56899999999
Q ss_pred CCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCcccCCCCCC
Q 021249 171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250 (315)
Q Consensus 171 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 250 (315)
++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998875 345678889999999999999999998 999999999999999999999999999986543322
Q ss_pred c--eeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCccccc
Q 021249 251 T--HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300 (315)
Q Consensus 251 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 300 (315)
. .......||+.|+|||.+.+..++.++||||||+++|||+||..||...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1 1222346899999999999999999999999999999999987777543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-45 Score=322.61 Aligned_cols=196 Identities=18% Similarity=0.299 Sum_probs=170.3
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEee--CCeEEEEE
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAE--GDQRLLVY 167 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~~~~lv~ 167 (315)
++|++++.||+|+||+||+|.+..+|+.||||+++... .+.+.+|+.+|+.+. ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47999999999999999999999999999999997543 467889999999985 9999999999974 45689999
Q ss_pred EecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-ceEEeccCCcccCC
Q 021249 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGP 246 (315)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~-~~kl~Dfg~~~~~~ 246 (315)
|||.+++|..+. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+|....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 3489999999999999999999998 999999999999998655 69999999998654
Q ss_pred CCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCc
Q 021249 247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKD 302 (315)
Q Consensus 247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~ 302 (315)
.... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....+
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 4322 2334789999999988765 579999999999999999999999976553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=327.51 Aligned_cols=207 Identities=23% Similarity=0.273 Sum_probs=169.8
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEee------CC
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE------GD 161 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------~~ 161 (315)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+++.++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3689999999999999999999999999999999976532 345568899999999999999999999953 46
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCC
Q 021249 162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241 (315)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~ 241 (315)
.+|+||||+.++.+. .+. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 889999999765544 332 3489999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHH
Q 021249 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309 (315)
Q Consensus 242 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 309 (315)
++...... ......+|+.|+|||++.+..+++++||||+||++|+|++|++||.+.++...+..+
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 87543322 223457999999999999999999999999999999999999999988877666655
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=325.46 Aligned_cols=208 Identities=25% Similarity=0.334 Sum_probs=175.3
Q ss_pred hCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCc--ccHHHHHHHHHHhccCCCCCeeeEEeEEeeC-----Ce
Q 021249 90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ 162 (315)
Q Consensus 90 ~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~ 162 (315)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5689999999999999999999999999999999976533 3456788999999999999999999998533 34
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCceEEeccCCc
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~ 242 (315)
.+++++|+.+++|.+++.. .++++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4666778889999998854 4699999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCceeeeeccccccccCccccccC-CcCcccchhhHHHHHHHHHhCCCcccccCchhhhhHHh
Q 021249 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310 (315)
Q Consensus 243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 310 (315)
...... .....||+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......|.
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~ 232 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 753322 2234789999999987765 46899999999999999999999999888776666553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-39 Score=286.75 Aligned_cols=202 Identities=22% Similarity=0.228 Sum_probs=161.4
Q ss_pred CCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----------CCCeeeEEeEEee
Q 021249 91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----------HPNLVKLIGYCAE 159 (315)
Q Consensus 91 ~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~~~~~~ 159 (315)
++|++++.||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 469999999999999999999999999999999976532 3456778888887764 5789999988754
Q ss_pred --CCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCC-----
Q 021249 160 --GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----- 232 (315)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~----- 232 (315)
....+++++++..+......... .....+++..++.++.||+.||.|||+. .+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence 45667777776554433322221 2356789999999999999999999983 2999999999999998654
Q ss_pred -ceEEeccCCcccCCCCCCceeeeeccccccccCccccccCCcCcccchhhHHHHHHHHHhCCCcccccC
Q 021249 233 -HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301 (315)
Q Consensus 233 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 301 (315)
.++++|||.+....... ...+||+.|+|||++.+..++.++|+||+||++++|++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 38999999997543322 23479999999999999999999999999999999999999997544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=7.1e-27 Score=188.79 Aligned_cols=163 Identities=13% Similarity=0.049 Sum_probs=118.7
Q ss_pred CCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcc------------------cHHHHHHHHHHhccCCCCCeeeEE
Q 021249 93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------------------GVREFSAEVMTLGSADHPNLVKLI 154 (315)
Q Consensus 93 y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~------------------~~~~~~~E~~~l~~l~hpnIv~~~ 154 (315)
+.+.+.||+|+||+||+|.+. +|+.||||+++..... .......|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 456788999999999999885 5899999987532110 012345688889999999999988
Q ss_pred eEEeeCCeEEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCEEEcCCCce
Q 021249 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234 (315)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~iiH~Dlkp~Nili~~~~~~ 234 (315)
++.. .+++|||+++..+.+ ++...+..++.|++.+|.|||+. +|+||||||+|||++++ .+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred EecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence 7632 379999998765532 23344567999999999999998 99999999999999965 58
Q ss_pred EEeccCCcccCCCCCCceeeeeccccccccCc--cc---cccCCcCcccchhhHHH
Q 021249 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--DY---AMTGQLTFKSDIYSFGV 285 (315)
Q Consensus 235 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~DiwslG~ 285 (315)
+|+|||.|......... .|... +. .-...|+.++|+||+.-
T Consensus 142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 99999999754322111 11111 00 11356889999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=4.3e-09 Score=87.16 Aligned_cols=150 Identities=17% Similarity=0.058 Sum_probs=101.9
Q ss_pred HHHHHHhCCCCcccccccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-CCCeeeEEeEEeeCCe
Q 021249 84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ 162 (315)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 162 (315)
.++......|++.+..+.++.+.||+... .+..+++|............+.+|...++.+. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35566667888777665566678998753 36677888876554334445677877776653 3235667778888899
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 021249 163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK----------------------------- 213 (315)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----------------------------- 213 (315)
.++||++++|.++.+.... . .. ...++.+++..+..||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~----~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED----E--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT----C--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc----c--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998887654321 0 11 22345556666666664320
Q ss_pred ---------------------------CCeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 214 ---------------------------QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 214 ---------------------------~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876667999988853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.29 E-value=1.8e-06 Score=70.44 Aligned_cols=129 Identities=17% Similarity=0.110 Sum_probs=81.9
Q ss_pred cccCC-ceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC--CCeeeEEeEEeeCCeEEEEEEecCCCCh
Q 021249 99 LGEGG-FGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH--PNLVKLIGYCAEGDQRLLVYEYMPLGSL 175 (315)
Q Consensus 99 ig~G~-~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~~~L 175 (315)
+..|. -+.||+.... .+..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 3678988654 366788898665433 235567776665532 2356678888888899999999988665
Q ss_pred hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 021249 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------------------------------------------- 212 (315)
Q Consensus 176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 212 (315)
.+.. ... ...+.++...|.-||+..
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3210 111 112233333444444211
Q ss_pred ------------CCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 213 ------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 213 ------------~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0137999999999999987667899998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.19 E-value=2.8e-06 Score=74.13 Aligned_cols=76 Identities=14% Similarity=0.117 Sum_probs=47.7
Q ss_pred cccccCCceEEEEEEECCCCeEEEEEEecCC------C-cccHHHHHHHHHHhccCC--CC-CeeeEEeEEeeCCeEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR------G-VQGVREFSAEVMTLGSAD--HP-NLVKLIGYCAEGDQRLLV 166 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~~~~~vavK~i~~~------~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~~~~lv 166 (315)
+.||.|....||++....+++.+++|.-... + .....+...|...|+.+. .| .+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4589999999999988777888999975421 1 122345566777776552 23 35555544 44556799
Q ss_pred EEecCCCC
Q 021249 167 YEYMPLGS 174 (315)
Q Consensus 167 ~e~~~~~~ 174 (315)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.22 E-value=0.00063 Score=58.76 Aligned_cols=73 Identities=18% Similarity=0.166 Sum_probs=48.3
Q ss_pred cccccCCceEEEEEEECC-------CCeEEEEEEecCCCcccHHHHHHHHHHhccCCCCCe-eeEEeEEeeCCeEEEEEE
Q 021249 97 CCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYE 168 (315)
Q Consensus 97 ~~ig~G~~g~V~~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e 168 (315)
+.|+.|-.-.+|++.... ....|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999987643 2456778877632 223345678888887753343 467777643 58999
Q ss_pred ecCCCCh
Q 021249 169 YMPLGSL 175 (315)
Q Consensus 169 ~~~~~~L 175 (315)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.20 E-value=0.0026 Score=52.82 Aligned_cols=159 Identities=15% Similarity=0.055 Sum_probs=80.7
Q ss_pred cCHHHHHHHhCCCCcccc-----cccCCceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCC-----CCCe
Q 021249 81 FTFDELAAATGNFRSDCC-----LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----HPNL 150 (315)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~-----ig~G~~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----hpnI 150 (315)
.+.+++.....+|.+.+. |..|---+.|+..... | .+++|++.... ....+..|+.++..|. .|..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 345677777788877544 3456667789887653 4 58999986532 2233444555555542 2332
Q ss_pred eeEEe---EEeeCCeEEEEEEecCCCChhh--------------hhhhc----C-CCCCCCCHHH---------------
Q 021249 151 VKLIG---YCAEGDQRLLVYEYMPLGSLDK--------------HLHDL----R-PDTRPLDWNT--------------- 193 (315)
Q Consensus 151 v~~~~---~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~----~-~~~~~l~~~~--------------- 193 (315)
+...+ +.........++.++.+..... .++.. . ..........
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 22211 1223456667777766543211 00000 0 0000000000
Q ss_pred ---HHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCEEEcCCCceEEeccCCcc
Q 021249 194 ---RMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243 (315)
Q Consensus 194 ---~~~i~~qi~~al~~LH~-~~~~~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~ 243 (315)
....+..+...+...+. ..+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11112222222222221 113579999999999999988777899999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.0012 Score=55.44 Aligned_cols=137 Identities=13% Similarity=0.087 Sum_probs=75.0
Q ss_pred ceEEEEEEECCCCeEEEEEEecCCCcccHHHHHHHHHHhccCCC---C--CeeeEE--eEEeeCCeEEEEEEecCCCChh
Q 021249 104 FGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---P--NLVKLI--GYCAEGDQRLLVYEYMPLGSLD 176 (315)
Q Consensus 104 ~g~V~~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---p--nIv~~~--~~~~~~~~~~lv~e~~~~~~L~ 176 (315)
.-.||++... +|..|++|+.+... ...+++..|...+..|.. | ..+..- ..+...+..+.+++++.|..+.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4589998664 47889999987543 234567778877766532 1 111111 1234567788999998864321
Q ss_pred h-----------h---hhh----cC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCC
Q 021249 177 K-----------H---LHD----LR-PDTRPLDWN-------------------TRMKIAAGASRGLQYLHE----QLKQ 214 (315)
Q Consensus 177 ~-----------~---l~~----~~-~~~~~l~~~-------------------~~~~i~~qi~~al~~LH~----~~~~ 214 (315)
. . ++. .. .....++.. ....+...+...+..+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 0 0 110 00 000111111 111122222223333322 1234
Q ss_pred CeEEecCCCCCEEEcCCCceEEeccCCccc
Q 021249 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244 (315)
Q Consensus 215 ~iiH~Dlkp~Nili~~~~~~kl~Dfg~~~~ 244 (315)
++||+|+.|.|||++++ ..++||+.|..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998864
|